PMid	title	source	time_article_has_been_cited	pubdate	disease	gene
1	Inactivation of the tumor suppressor WTX in a subset of pediatric tumors.	Genes Chromosomes Cancer	2	2014 Jan	eRMS	AMER1
1	Association of ataxia telangiectasia mutated (ATM) gene mutation/deletion with rhabdomyosarcoma.	Cancer Biol Ther	9	2003 Jan-Feb	eRMS	ATM
1	Genes, chromosomes, and rhabdomyosarcoma.	Genes Chromosomes Cancer	35	1999 Dec	eRMS	ATR
29719592	EGR1 interacts with TBX2 and functions as a tumor suppressor in rhabdomyosarcoma.	Oncotarget	4	2018 Apr 6	eRMS	BAX
25939344	Therapeutic Effect of Supercritical CO2 Extracts of Curcuma Species with Cancer Drugs in Rhabdomyosarcoma Cell Lines.	Phytother Res	4	2015 Aug	eRMS	BAX
21911456	2-deoxyglucose induces Noxa-dependent apoptosis in alveolar rhabdomyosarcoma.	Cancer Res	34	2011 Nov 1	eRMS	BAX
19707204	MI-63: a novel small-molecule inhibitor targets MDM2 and induces apoptosis in embryonal and alveolar rhabdomyosarcoma cells with wild-type p53.	Br J Cancer	23	2009 Sep 1	eRMS	BAX
12394275	Selective chemosensitization of rhabdomyosarcoma cell lines following wild-type p53 adenoviral transduction.	Anticancer Drugs	2	2002 Sep	eRMS	BAX
25749378	Identification of a novel synthetic lethality of combined inhibition of hedgehog and PI3K signaling in rhabdomyosarcoma.	Oncotarget	18	2015 Apr 20	eRMS	BAX
17234787	Sphingosine-induced apoptosis in rhabdomyosarcoma cell lines is dependent on pre-mitochondrial Bax activation and post-mitochondrial caspases.	Cancer Res	15	2007 Jan 15	eRMS	BAX
1	Integrated genetic and epigenetic analysis defines novel molecular subgroups in rhabdomyosarcoma.	Nat Commun	28	2015 Jul 3	eRMS	BCOR
1	TDP1 and PARP1 deficiency are cytotoxic to rhabdomyosarcoma cells.	Mol Cancer Res	7	2013 Oct	eRMS	BRCA1
1	TDP1 and PARP1 deficiency are cytotoxic to rhabdomyosarcoma cells.	Mol Cancer Res	7	2013 Oct	eRMS	BRCA2
1	PD-1 and PD-L1 expression in bone and soft tissue sarcomas.	Pathology	6	2017 Aug	eRMS	CD274
21412928	High-resolution array CGH identifies common mechanisms that drive embryonal rhabdomyosarcoma pathogenesis.	Genes Chromosomes Cancer	39	2011 Jun	eRMS	CDKN2A
10534762	Genes, chromosomes, and rhabdomyosarcoma.	Genes Chromosomes Cancer	35	1999 Dec	eRMS	CDKN2A
15489287	Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: cooperativity of Ink4a/ARF and Trp53 loss of function.	Genes Dev	118	2004 Nov 1	eRMS	CDKN2A
20596646	Tumor suppressor gene alterations of spontaneously malignant transformed cells from human embryonic muscle in vitro.	Oncol Rep	1	2010 Aug	eRMS	CDKN2A
30353028	Analysis of the relationship between the KRAS G12V oncogene and the Hippo effector YAP1 in embryonal rhabdomyosarcoma.	Sci Rep		2018 Oct 23	eRMS	CDKN2A
1	CD133 marks a myogenically primitive subpopulation in rhabdomyosarcoma cell lines that are relatively chemoresistant but sensitive to mutant HSV.	Pediatr Blood Cancer	13	2013 Jan	eRMS	CIC
1	Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers.	N Engl J Med	94	2012 Jan 19	eRMS	DICER1
1	Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers.	N Engl J Med	94	2012 Jan 19	eRMS	DROSHA
26251675	MicroRNA-101 is repressed by EZH2 and its restoration inhibits tumorigenic features in embryonal rhabdomyosarcoma.	Clin Epigenetics	9	2015	eRMS	EZH2
23435416	JARID2 is a direct target of the PAX3-FOXO1 fusion protein and inhibits myogenic differentiation of rhabdomyosarcoma cells.	Oncogene	30	2014 Feb 27	eRMS	EZH2
24213577	The Polycomb group (PcG) protein EZH2 supports the survival of PAX3-FOXO1 alveolar rhabdomyosarcoma by repressing FBXO32 (Atrogin1/MAFbx).	Oncogene	27	2014 Aug 7	eRMS	EZH2
25625846	Overexpression of HOX genes is prevalent in Ewing sarcoma and is associated with altered epigenetic regulation of developmental transcription programs.	Epigenetics	19	2014 Dec	eRMS	EZH2
24575771	Pharmacological inhibition of EZH2 as a promising differentiation therapy in embryonal RMS.	BMC Cancer	18	2014 Feb 27	eRMS	EZH2
28722764	12-O-tetradecanoylphorbol-13-acetate and EZH2 inhibition: A novel approach for promoting myogenic differentiation in embryonal rhabdomyosarcoma cells.	J Cell Physiol	1	2018 Mar	eRMS	EZH2
30120321	High expression of EZH2 as a marker for the differential diagnosis of malignant and benign myogenic tumors.	Sci Rep		2018 Aug 17	eRMS	EZH2
1	The Antiviral Effect of Baicalin on Enterovirus 71 In Vitro.	Viruses	7	2015 Aug 19	eRMS	FAS
26138366	Integrated genetic and epigenetic analysis defines novel molecular subgroups in rhabdomyosarcoma.	Nat Commun	28	2015 Jul 3	eRMS	FBXW7
26872011	Frequent HRAS Mutations in Malignant Ectomesenchymoma: Overlapping Genetic Abnormalities With Embryonal Rhabdomyosarcoma.	Am J Surg Pathol	1	2016 Jul	eRMS	FBXW7
27488535	Heme Oxygenase-1 Controls an HDAC4-miR-206 Pathway of Oxidative Stress in Rhabdomyosarcoma.	Cancer Res	9	2016 Oct 1	eRMS	FOXO1
24618610	Myogenin, AP2Î², NOS-1, and HMGA2 are surrogate markers of fusion status in rhabdomyosarcoma: a report from the soft tissue sarcoma committee of the children's oncology group.	Am J Surg Pathol	9	2014 May	eRMS	FOXO1
27853183	Exosomes derived from embryonal and alveolar rhabdomyosarcoma carry differential miRNA cargo and promote invasion of recipient fibroblasts.	Sci Rep	6	2016 Nov 17	eRMS	FOXO1
27385213	Anaplastic lymphoma kinase aberrations correlate with metastatic features in pediatric rhabdomyosarcoma.	Oncotarget	6	2016 Sep 13	eRMS	FOXO1
27277678	PAX7 is a required target for microRNA-206-induced differentiation of fusion-negative rhabdomyosarcoma.	Cell Death Dis	6	2016 Jun 9	eRMS	FOXO1
27984116	MicroRNA and gene co-expression networks characterize biological and clinical behavior of rhabdomyosarcomas.	Cancer Lett	5	2017 Jan 28	eRMS	FOXO1
27454080	Comparative transcriptomic analysis reveals the oncogenic fusion protein PAX3-FOXO1 globally alters mRNA and miRNA to enhance myoblast invasion.	Oncogenesis	5	2016 Jul 25	eRMS	FOXO1
26071485	Secreted Frizzled-Related Protein 3 (SFRP3) Is Required for Tumorigenesis of PAX3-FOXO1-Positive Alveolar Rhabdomyosarcoma.	Clin Cancer Res	5	2015 Nov 1	eRMS	FOXO1
26473193	Clinical Application of Prognostic Gene Expression Signature in Fusion Gene-Negative Rhabdomyosarcoma: A Report from the Children's Oncology Group.	Clin Cancer Res	4	2015 Oct 15	eRMS	FOXO1
26412593	Human rhabdomyosarcoma cells express functional erythropoietin receptor: Potential therapeutic implications.	Int J Oncol	4	2015 Nov	eRMS	FOXO1
24797362	Hyper-activation of Notch3 amplifies the proliferative potential of rhabdomyosarcoma cells.	PLoS One	4	2014	eRMS	FOXO1
24793135	A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations.	Nat Genet	33	2014 Jun	eRMS	FOXO1
28058850	Molecular diagnostics in the management of rhabdomyosarcoma.	Expert Rev Mol Diagn	3	2017 Feb	eRMS	FOXO1
26209235	Uncovering metabolism in rhabdomyosarcoma.	Cell Cycle	3	2016	eRMS	FOXO1
26138366	Integrated genetic and epigenetic analysis defines novel molecular subgroups in rhabdomyosarcoma.	Nat Commun	28	2015 Jul 3	eRMS	FOXO1
28981396	Cancer-Specific Energy Metabolism in Rhabdomyosarcoma Cells Is Regulated by MicroRNA.	Nucleic Acid Ther	2	2017 Dec	eRMS	FOXO1
28380437	NELL1, whose high expression correlates with negative outcomes, has different methylation patterns in alveolar and embryonal rhabdomyosarcoma.	Oncotarget	1	2017 May 16	eRMS	FOXO1
27840956	MET/ERK2 pathway regulates the motility of human alveolar rhabdomyosarcoma cells.	Oncol Rep	1	2017 Jan	eRMS	FOXO1
31493794	OLIG2 is a novel immunohistochemical marker associated with the presence of PAX3/7-FOXO1 translocation in rhabdomyosarcomas.	Diagn Pathol		2019 Sep 7	eRMS	FOXO1
31099166	Evaluation of entinostat alone and in combination with standard-of-care cytotoxic agents against rhabdomyosarcoma xenograft models.	Pediatr Blood Cancer		2019 Aug	eRMS	FOXO1
25344940	Glypican 3 expression in pediatric malignant solid tumors.	Eur J Pediatr Surg	6	2015 Feb	eRMS	GPC3
21493758	Glypican-3 is expressed in rhabdomyosarcomas but not adult spindle cell and pleomorphic sarcomas.	J Clin Pathol	6	2011 Jul	eRMS	GPC3
30867793	Glypican-3 expression in malignant small round cell tumors.	Oncol Lett		2019 Mar	eRMS	GPC3
1	LEF1 reduces tumor progression and induces myodifferentiation in a subset of rhabdomyosarcoma.	Oncotarget	4	2017 Jan 10	eRMS	LEF1
1	Genetic and molecular alterations in rhabdomyosarcoma: mRNA overexpression of MCL1 and MAP2K4 genes.	Histol Histopathol	6	2009 Jan	eRMS	MAP2K4
26387541	Hedgehog/Patched-associated rhabdomyosarcoma formation from delta1-expressing mesodermal cells.	Oncogene	3	2016 Jun 2	eRMS	MAX
26099010	Nuclear Brachyury Expression Is Consistent in Chordoma, Common in Germ Cell Tumors and Small Cell Carcinomas, and Rare in Other Carcinomas and Sarcomas: An Immunohistochemical Study of 5229 Cases.	Am J Surg Pathol	16	2015 Oct	eRMS	MAX
25724000	Sox10--a marker for not only schwannian and melanocytic neoplasms but also myoepithelial cell tumors of soft tissue: a systematic analysis of 5134 tumors.	Am J Surg Pathol	15	2015 Jun	eRMS	MAX
18847459	The molecular basis of genistein-induced mitotic arrest and exit of self-renewal in embryonal carcinoma and primary cancer cell lines.	BMC Med Genomics	13	2008 Oct 10	eRMS	MAX
1	EGR1 interacts with TBX2 and functions as a tumor suppressor in rhabdomyosarcoma.	Oncotarget	4	2018 Apr 6	eRMS	NDRG1
10524458	Rhabdomyosarcoma in a patient with cardio-facio-cutaneous syndrome.	J Pediatr Hematol Oncol	4	1999 Sep-Oct	eRMS	NF1
21412928	High-resolution array CGH identifies common mechanisms that drive embryonal rhabdomyosarcoma pathogenesis.	Genes Chromosomes Cancer	39	2011 Jun	eRMS	NF1
1	NRF2 orchestrates the redox regulation induced by radiation therapy, sustaining embryonal and alveolar rhabdomyosarcoma cells radioresistance.	J Cancer Res Clin Oncol	1	2019 Apr	eRMS	NFE2L2
26636678	Histone Deacetylase Inhibitors Antagonize Distinct Pathways to Suppress Tumorigenesis of Embryonal Rhabdomyosarcoma.	PLoS One	9	2015	eRMS	NOTCH1
28614716	The NOTCH1/SNAIL1/MEF2C Pathway Regulates Growth and Self-Renewal in Embryonal Rhabdomyosarcoma.	Cell Rep	8	2017 Jun 13	eRMS	NOTCH1
24797362	Hyper-activation of Notch3 amplifies the proliferative potential of rhabdomyosarcoma cells.	PLoS One	4	2014	eRMS	NOTCH1
21948088	Inhibition of the Notch-Hey1 axis blocks embryonal rhabdomyosarcoma tumorigenesis.	Clin Cancer Res	21	2011 Dec 1	eRMS	NOTCH1
24272621	Transactivating mutation of the MYOD1 gene is a frequent event in adult spindle cell rhabdomyosarcoma.	J Pathol	19	2014 Feb	eRMS	NOTCH1
1	Genomic Profiling of a Large Set of Diverse Pediatric Cancers Identifies Known and Novel Mutations across Tumor Spectra.	Cancer Res	9	2017 Jan 15	eRMS	NTRK1
19145202	PAX immunoreactivity identifies alveolar rhabdomyosarcoma.	Am J Surg Pathol	4	2009 May	eRMS	PAX5
24897005	PAX immunoreactivity in poorly differentiated small round cell tumors of childhood.	Fetal Pediatr Pathol	2	2014 Aug	eRMS	PAX5
1	JARID2 is a direct target of the PAX3-FOXO1 fusion protein and inhibits myogenic differentiation of rhabdomyosarcoma cells.	Oncogene	30	2014 Feb 27	eRMS	PML
1	Oncofetal expression of Wilms' tumor 1 (WT1) protein in human fetal, adult and neoplastic skeletal muscle tissues.	Acta Histochem	3	2015 May-Jun	eRMS	POLE
21316601	Evidence for an unanticipated relationship between undifferentiated pleomorphic sarcoma and embryonal rhabdomyosarcoma.	Cancer Cell	77	2011 Feb 15	eRMS	PTCH1
20818440	Activation of the hedgehog pathway confers a poor prognosis in embryonal and fusion gene-negative alveolar rhabdomyosarcoma.	Oncogene	40	2010 Dec 2	eRMS	PTCH1
21779473	Reduction of human embryonal rhabdomyosarcoma tumor growth by inhibition of the hedgehog signaling pathway.	Genes Cancer	30	2010 Sep	eRMS	PTCH1
29230040	Congenital embryonal rhabdomyosarcoma caused by heterozygous concomitant PTCH1 and PTCH2 germline mutations.	Eur J Hum Genet	3	2018 Jan	eRMS	PTCH1
16254458	The Fem1a gene is downregulated in Rhabdomyosarcoma.	Tumour Biol	2	2005 Nov-Dec	eRMS	PTCH1
20152358	Increased expression of the hedgehog signaling pathway in pediatric solid malignancies.	J Pediatr Surg	17	2010 Feb	eRMS	PTCH1
29719592	EGR1 interacts with TBX2 and functions as a tumor suppressor in rhabdomyosarcoma.	Oncotarget	4	2018 Apr 6	eRMS	PTEN
26138366	Integrated genetic and epigenetic analysis defines novel molecular subgroups in rhabdomyosarcoma.	Nat Commun	28	2015 Jul 3	eRMS	PTEN
21316601	Evidence for an unanticipated relationship between undifferentiated pleomorphic sarcoma and embryonal rhabdomyosarcoma.	Cancer Cell	77	2011 Feb 15	eRMS	RB1
8418305	Expression of the retinoblastoma susceptibility gene in childhood rhabdomyosarcomas.	J Natl Cancer Inst	7	1993 Jan 20	eRMS	RB1
24274149	Rb1 loss modifies but does not initiate alveolar rhabdomyosarcoma.	Skelet Muscle	2	2013 Nov 25	eRMS	RB1
18386058	Alterations of RB1 gene in embryonal and alveolar rhabdomyosarcoma: special reference to utility of pRB immunoreactivity in differential diagnosis of rhabdomyosarcoma subtype.	J Cancer Res Clin Oncol	15	2008 Oct	eRMS	RB1
1	Vangl2/RhoA Signaling Pathway Regulates Stem Cell Self-Renewal Programs and Growth in Rhabdomyosarcoma.	Cell Stem Cell	6	2018 Mar 1	eRMS	RHOA
17439748	Smad4 and ERK2 stimulated by transforming growth factor beta1 in rhabdomyosarcoma.	Chin Med J (Engl)	5	2007 Mar 20	eRMS	SMAD4
17016646	Effects of RNAi-mediated Smad4 silencing on growth and apoptosis of human rhabdomyosarcoma cells.	Int J Oncol	1	2006 Nov	eRMS	SMAD4
1	Deregulation of the hedgehog signalling pathway: a possible role for the PTCH and SUFU genes in human rhabdomyoma and rhabdomyosarcoma development.	J Pathol	85	2006 Jan	eRMS	SUFU
1	High expression of EZH2 as a marker for the differential diagnosis of malignant and benign myogenic tumors.	Sci Rep		2018 Aug 17	eRMS	SUZ12
1	MyoD and E-protein heterodimers switch rhabdomyosarcoma cells from an arrested myoblast phase to a differentiated state.	Genes Dev	37	2009 Mar 15	eRMS	TCF3
10534762	Genes, chromosomes, and rhabdomyosarcoma.	Genes Chromosomes Cancer	35	1999 Dec	eRMS	TP53
26138366	Integrated genetic and epigenetic analysis defines novel molecular subgroups in rhabdomyosarcoma.	Nat Commun	28	2015 Jul 3	eRMS	TP53
30192230	&lt;i&gt;tp53&lt;/i&gt; deficiency causes a wide tumor spectrum and increases embryonal rhabdomyosarcoma metastasis in zebrafish.	Elife	2	2018 Sep 7	eRMS	TP53
18708938	Diffuse myogenin expression by immunohistochemistry is an independent marker of poor survival in pediatric rhabdomyosarcoma: a tissue microarray study of 71 primary tumors including correlation with molecular phenotype.	Am J Surg Pathol	13	2008 Oct	eRMS	TP53
26029996	Sensitivity to cdk1-inhibition is modulated by p53 status in preclinical models of embryonal tumors.	Oncotarget	10	2015 Jun 20	eRMS	TP53
29702195	Hedgehog signaling negatively co-regulates BH3-only protein Noxa and TAp73 in TP53-mutated cells.	Cancer Lett		2018 Aug 10	eRMS	TP53
1	p63 immunohistochemical staining is limited in soft tissue tumors.	Am J Clin Pathol	12	2011 Nov	eRMS	TP63
9242365	Actinomycin D treatment leads to differentiation and inhibits proliferation in rhabdomyosarcoma cells.	J Lab Clin Med	4	1997 Jul	eRMS	TPM3
8997525	Low sample volume causes differentiation in human rhabdomyosarcoma cell line RD subjected to electroporation.	Cell Mol Biol (Noisy-le-grand)		1996 Dec	eRMS	TPM3
1	Immunostaining of the von Hippel-Lindau gene product in normal and neoplastic human tissues.	Hum Pathol	21	1997 Apr	eRMS	VHL
1	Hedgehog/Patched-associated rhabdomyosarcoma formation from delta1-expressing mesodermal cells.	Oncogene	3	2016 Jun 2	eRMS	WIF1
22152856	Expression of Wilms tumor 1 gene in a variety of pediatric tumors.	J Pediatr Surg	5	2011 Dec	eRMS	WT1
25800978	Oncofetal expression of Wilms' tumor 1 (WT1) protein in human fetal, adult and neoplastic skeletal muscle tissues.	Acta Histochem	3	2015 May-Jun	eRMS	WT1
24249259	Inactivation of the tumor suppressor WTX in a subset of pediatric tumors.	Genes Chromosomes Cancer	2	2014 Jan	eRMS	WT1
12379755	The expression of WT1 in the differentiation of rhabdomyosarcoma from other pediatric small round blue cell tumors.	Mod Pathol	15	2002 Oct	eRMS	WT1
7495283	Detection of chimeric transcripts in desmoplastic small round cell tumor and related developmental tumors by reverse transcriptase polymerase chain reaction. A specific diagnostic assay.	Am J Pathol	15	1995 Dec	eRMS	WT1
18469708	Mullerian adenosarcomas: an immunophenotypic analysis of 35 cases.	Am J Surg Pathol	12	2008 Jul	eRMS	WT1
9841704	Expression of WT1 in pediatric small cell tumors: report of two cases with a possible mesothelial origin.	Pediatr Dev Pathol		1999 Jan-Feb	eRMS	WT1
1	Reciprocal regulation of Abl kinase by Crk Y251 and Abi1 controls invasive phenotypes in glioblastoma.	Oncotarget	5	2015 Nov 10	glioma	ABI1
22919349	Potential canonical wnt pathway activation in high-grade astrocytomas.	ScientificWorldJournal	9	2012	glioma	APC
26191234	Gene mutation profiling of primary glioblastoma through multiple tumor biopsy guided by 1H-magnetic resonance spectroscopy.	Int J Clin Exp Pathol	7	2015	glioma	APC
25307863	Stromal Indian hedgehog signaling is required for intestinal adenoma formation in mice.	Gastroenterology	7	2015 Jan	glioma	APC
23525311	CTNNB1, AXIN1 and APC expression analysis of different medulloblastoma variants.	Clinics (Sao Paulo)	6	2013	glioma	APC
27741356	MIIP haploinsufficiency induces chromosomal instability and promotes tumour progression in colorectal cancer.	J Pathol	3	2017 Jan	glioma	APC
25395662	Tumor suppression by miR-26 overrides potential oncogenic activity in intestinal tumorigenesis.	Genes Dev	22	2014 Dec 1	glioma	APC
27815074	MicroRNA-106a-5p facilitates human glioblastoma cell proliferation and invasion by targeting adenomatosis polyposis coli protein.	Biochem Biophys Res Commun	2	2016 Dec 9	glioma	APC
27424145	Tumor antigen-specific T cells for immune monitoring of dendritic cell-treated glioblastoma patients.	Cytotherapy	2	2016 Sep	glioma	APC
26476273	Gamma-secretase-independent role for cadherin-11 in neurotrophin receptor p75 (p75(NTR)) mediated glioblastoma cell migration.	Mol Cell Neurosci	2	2015 Nov	glioma	APC
25938542	CDC20 maintains tumor initiating cells.	Oncotarget	19	2015 May 30	glioma	APC
22589395	Differential expression of 2',3'-cyclic-nucleotide 3'-phosphodiesterase and neural lineage markers correlate with glioblastoma xenograft infiltration and patient survival.	Clin Cancer Res	18	2012 Jul 1	glioma	APC
20418911	Inhibition of gliomagenesis and attenuation of mitotic transition by MIIP.	Oncogene	14	2010 Jun 17	glioma	APC
24695855	SHH, WNT, and NOTCH pathways in medulloblastoma: when cancer stem cells maintain self-renewal and differentiation properties.	Childs Nerv Syst	12	2014 Jul	glioma	APC
23826121	CARP-1 functional mimetics: a novel class of small molecule inhibitors of medulloblastoma cell growth.	PLoS One	11	2013	glioma	APC
29753700	Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort.	Lancet Oncol	10	2018 Jun	glioma	APC
26547933	ST3GAL1-Associated Transcriptomic Program in Glioblastoma Tumor Growth, Invasion, and Prognosis.	J Natl Cancer Inst	10	2016 Feb	glioma	APC
23974731	Relationship among expression of basic-fibroblast growth factor, MTDH/astrocyte elevated gene-1, adenomatous polyposis coli, matrix metalloproteinase 9,and COX-2 markers with prognostic factors in prostate carcinomas.	Niger J Clin Pract	1	2013 Oct-Dec	glioma	APC
31266783	Immunologic Profiling of Mutational and Transcriptional Subgroups in Pediatric and Adult High-Grade Gliomas.	Cancer Immunol Res		2019 Sep	glioma	APC
30523493	Immunohistochemical detection of ALK protein identifies APC mutated medulloblastoma and differentiates the WNT-activated medulloblastoma from other types of posterior fossa childhood tumors.	Brain Tumor Pathol		2019 Jan	glioma	APC
27592301	The ubiquitin-proteasome system and chromosome 17 in cerebellar granule cells and medulloblastoma subgroups.	Cell Mol Life Sci		2017 Feb	glioma	APC
22825724	Identification of a novel population in high-grade oligodendroglial tumors not deleted on 1p/19q using array CGH.	J Neurooncol	5	2012 Sep	glioma	APOBEC3B
30226610	APOBEC3B is expressed in human glioma, and influences cell proliferation and temozolomide resistance.	Oncol Rep		2018 Nov	glioma	APOBEC3B
26357005	ETV/Pea3 family transcription factor-encoding genes are overexpressed in CIC-mutant oligodendrogliomas.	Genes Chromosomes Cancer	9	2015 Dec	glioma	ARID1A
29374058	Glioma tumor suppressor candidate region gene 1 (GLTSCR1) and its paralog GLTSCR1-like form SWI/SNF chromatin remodeling subcomplexes.	J Biol Chem	8	2018 Mar 16	glioma	ARID1A
23698369	BAF complexes facilitate decatenation of DNA by topoisomerase IIÎ±.	Nature	77	2013 May 30	glioma	ARID1A
30051528	The genetic landscape of anaplastic pleomorphic xanthoastrocytoma.	Brain Pathol	7	2019 Jan	glioma	ARID1A
30333046	TERT promoter wild-type glioblastomas show distinct clinical features and frequent PI3K pathway mutations.	Acta Neuropathol Commun	2	2018 Oct 17	glioma	ARID1A
26524630	Genomic dynamics associated with malignant transformation in IDH1 mutated gliomas.	Oncotarget	2	2015 Dec 22	glioma	ARID1A
23222069	[Chromatin remodeling defects and cancer: the SWI/SNF example].	Bull Cancer	2	2012 Dec	glioma	ARID1A
30077762	A four-protein expression prognostic signature predicts clinical outcome of lower-grade glioma.	Gene		2018 Dec 30	glioma	ARID1A
1	[Chromatin remodeling defects and cancer: the SWI/SNF example].	Bull Cancer	2	2012 Dec	glioma	ARID1B
29374058	Glioma tumor suppressor candidate region gene 1 (GLTSCR1) and its paralog GLTSCR1-like form SWI/SNF chromatin remodeling subcomplexes.	J Biol Chem	8	2018 Mar 16	glioma	ARID2
23222069	[Chromatin remodeling defects and cancer: the SWI/SNF example].	Bull Cancer	2	2012 Dec	glioma	ARID2
25059231	Genetic drivers of metastatic dissemination in sonic hedgehog medulloblastoma.	Acta Neuropathol Commun	8	2014 Jul 25	glioma	ARNT
12354771	Identification of functional hypoxia response elements in the promoter region of the DEC1 and DEC2 genes.	J Biol Chem	54	2002 Dec 6	glioma	ARNT
25968345	Effect of treatment with baicalein on the intracerebral tumor growth and survival of orthotopic glioma models.	J Neurooncol	3	2015 Aug	glioma	ARNT
25010988	Prolyl-4-hydroxylase 2 enhances hypoxia-induced glioblastoma cell death by regulating the gene expression of hypoxia-inducible factor-Î±.	Cell Death Dis	2	2014 Jul 10	glioma	ARNT
26861754	Induction of WNT11 by hypoxia and hypoxia-inducible factor-1Î± regulates cell proliferation, migration and invasion.	Sci Rep	16	2016 Feb 10	glioma	ARNT
23712868	AGR2 expression is regulated by HIF-1 and contributes to growth and angiogenesis of glioblastoma.	Cell Biochem Biophys	12	2013	glioma	ARNT
1	The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes.	Nat Commun	111	2014 Apr 8	glioma	ASXL1
29654065	Induced Telomere Damage to Treat Telomerase Expressing Therapy-Resistant Pediatric Brain Tumors.	Mol Cancer Ther	6	2018 Jul	glioma	ATM
29348882	MicroRNA203a suppresses glioma tumorigenesis through an ATM-dependent interferon response pathway.	Oncotarget	6	2017 Dec 22	glioma	ATM
28903382	MicroRNA16 regulates glioma cell proliferation, apoptosis and invasion by targeting Wip1-ATM-p53 feedback loop.	Oncotarget	6	2017 Aug 15	glioma	ATM
29378238	Loss of ATRX suppresses ATM dependent DNA damage repair by modulating H3K9me3 to enhance temozolomide sensitivity in glioma.	Cancer Lett	3	2018 Apr 10	glioma	ATM
28833137	Telomerase reverse transcriptase (TERT) - enhancer of zeste homolog 2 (EZH2) network regulates lipid metabolism and DNA damage responses in glioblastoma.	J Neurochem	3	2017 Dec	glioma	ATM
29574252	Targeting Long Noncoding RNA HMMR-AS1 Suppresses and Radiosensitizes Glioblastoma.	Neoplasia	2	2018 May	glioma	ATM
29348487	H1/pHGFK1 nanoparticles exert anti-tumoural and radiosensitising effects by inhibition of MET in glioblastoma.	Br J Cancer	2	2018 Feb 20	glioma	ATM
30796178	The SIAH1-HIPK2-p53ser46 Damage Response Pathway is Involved in Temozolomide-Induced Glioblastoma Cell Death.	Mol Cancer Res	1	2019 May	glioma	ATM
30783513	Inhibition of ATM kinase upregulates levels of cell death induced by cannabidiol and Î³-irradiation in human glioblastoma cells.	Oncotarget	1	2019 Jan 25	glioma	ATM
30760578	IDH1-R132H acts as a tumor suppressor in glioma via epigenetic up-regulation of the DNA damage response.	Sci Transl Med	1	2019 Feb 13	glioma	ATM
30338650	Loss of GINS2 inhibits cell proliferation and tumorigenesis in human gliomas.	CNS Neurosci Ther	1	2019 Feb	glioma	ATM
29599344	Racial Disparities in the Molecular Landscape of Cancer.	Anticancer Res	1	2018 Apr	glioma	ATM
29463172	Radiation-induced G2/M arrest rarely occurred in glioblastoma stem-like cells.	Int J Radiat Biol	1	2018 Apr	glioma	ATM
28958992	Identification of MEK162 as a Radiosensitizer for the Treatment of Glioblastoma.	Mol Cancer Ther	1	2018 Feb	glioma	ATM
31098343	Molecular Characterization of Primary Human Astrocytes Using Digital Gene Expression Analysis.	Korean J Neurotrauma		2019 Apr	glioma	ATM
30943920	Decrease of Nibrin expression in chronic hypoxia is associated with hypoxia-induced chemoresistance in some brain tumour cells.	BMC Cancer		2019 Apr 3	glioma	ATM
30361826	Molecular features unique to glioblastoma radiation resistant residual cells may affect patient outcome - a short report.	Cell Oncol (Dordr)		2019 Feb	glioma	ATM
30050935	Caffeine Sensitizes U87-MG Human Glioblastoma Cells to Temozolomide through Mitotic Catastrophe by Impeding G2 Arrest.	Biomed Res Int		2018	glioma	ATM
29369420	ATM and p53 combined analysis predicts survival in glioblastoma multiforme patients: A clinicopathologic study.	J Cell Biochem		2018 Jun	glioma	ATM
29251333	Efficacy of ribavirin against malignant glioma cell lines: Follow-up study.	Oncol Rep		2018 Feb	glioma	ATM
21498719	Immunohistochemical analyses of alpha1 and alpha3 Na+/K+-ATPase subunit expression in medulloblastomas.	Anticancer Res	7	2011 Mar	glioma	ATP1A1
29653366	Bufalin inhibits glioblastoma growth by promoting proteasomal degradation of the Na&lt;sup&gt;+&lt;/sup&gt;/K&lt;sup&gt;+&lt;/sup&gt;-ATPase Î±1 subunit.	Biomed Pharmacother	4	2018 Jul	glioma	ATP1A1
22575386	Quantitative proteomic Isotope-Coded Protein Label (ICPL) analysis reveals alteration of several functional processes in the glioblastoma.	J Proteomics	15	2012 Jul 16	glioma	ATP1A1
30130132	Update on the effects of the sodium pump Î±1 subunit on human glioblastoma: from the laboratory to the clinic.	Expert Opin Investig Drugs	1	2018 Sep	glioma	ATP1A1
31114755	ATP1A1 Integrates AKT and ERK Signaling via Potential Interaction With Src to Promote Growth and Survival in Glioma Stem Cells.	Front Oncol		2019	glioma	ATP1A1
30739221	The sodium pump Î±1 subunit regulates bufalin sensitivity of human glioblastoma cells through the p53 signaling pathway.	Cell Biol Toxicol		2019 Feb 9	glioma	ATP1A1
29582577	Marinobufagenin inhibits glioma growth through sodium pump Î±1 subunit and ERK signaling-mediated mitochondrial apoptotic pathway.	Cancer Med		2018 May	glioma	ATP1A1
22095529	Resveratrol acts as a topoisomerase II poison in human glioma cells.	Int J Cancer	9	2012 Aug 1	glioma	ATR
26874961	Brain tumour differentiation: rapid stratified serum diagnostics via attenuated total reflection Fourier-transform infrared spectroscopy.	J Neurooncol	8	2016 May	glioma	ATR
25351918	Evaluation of novel imidazotetrazine analogues designed to overcome temozolomide resistance and glioblastoma regrowth.	Mol Cancer Ther	8	2015 Jan	glioma	ATR
26498391	Resveratrol sensitizes glioblastoma-initiating cells to temozolomide by inducing cell apoptosis and promoting differentiation.	Oncol Rep	7	2016 Jan	glioma	ATR
29654065	Induced Telomere Damage to Treat Telomerase Expressing Therapy-Resistant Pediatric Brain Tumors.	Mol Cancer Ther	6	2018 Jul	glioma	ATR
22173583	Oncolytic virus-mediated manipulation of DNA damage responses: synergy with chemotherapy in killing glioblastoma stem cells.	J Natl Cancer Inst	41	2012 Jan 4	glioma	ATR
28419269	Dual-Genotype Diffuse Low-Grade Glioma: Is It Really Time to Abandon Oligoastrocytoma As a Distinct Entity?	J Neuropathol Exp Neurol	4	2017 May 1	glioma	ATR
28383788	Replication stress, DNA damage signalling, and cytomegalovirus infection in human medulloblastomas.	Mol Oncol	4	2017 Aug	glioma	ATR
24218165	Cisplatin associated with LY294002 increases cytotoxicity and induces changes in transcript profiles of glioblastoma cells.	Mol Biol Rep	4	2014 Jan	glioma	ATR
20734998	Proliferation inhibition, DNA damage, and cell-cycle arrest of human astrocytoma cells after acrylamide exposure.	Chem Res Toxicol	3	2010 Sep 20	glioma	ATR
21652733	A sensitized RNA interference screen identifies a novel role for the PI3K p110Î³ isoform in medulloblastoma cell proliferation and chemoresistance.	Mol Cancer Res	19	2011 Jul	glioma	ATR
26486089	Common cancer-associated imbalances in the DNA damage response confer sensitivity to single agent ATR inhibition.	Oncotarget	13	2015 Oct 20	glioma	ATR
30796178	The SIAH1-HIPK2-p53ser46 Damage Response Pathway is Involved in Temozolomide-Induced Glioblastoma Cell Death.	Mol Cancer Res	1	2019 May	glioma	ATR
29753759	Multiple DNA damage-dependent and DNA damage-independent stress responses define the outcome of ATR/Chk1 targeting in medulloblastoma cells.	Cancer Lett	1	2018 Aug 28	glioma	ATR
27803059	ATR maintains chromosomal integrity during postnatal cerebellar neurogenesis and is required for medulloblastoma formation.	Development	1	2016 Nov 1	glioma	ATR
25530717	Induction of H2AX phosphorylation in tumor cells by gossypol acetic acid is mediated by phosphatidylinositol 3-kinase (PI3K) family.	Cancer Cell Int	1	2014	glioma	ATR
24597751	Label-free identification of the glioma stem-like cell fraction using Fourier-transform infrared spectroscopy.	Int J Radiat Biol	1	2014 Aug	glioma	ATR
31273061	Temozolomide Sensitizes MGMT-Deficient Tumor Cells to ATR Inhibitors.	Cancer Res		2019 Sep 1	glioma	ATR
30777204	Diffusion kurtosis imaging histogram parameter metrics predicting survival in integrated molecular subtypes of diffuse glioma: An observational cohort study.	Eur J Radiol		2019 Mar	glioma	ATR
30388586	Glycogen synthase kinase-3 inhibition in glioblastoma multiforme cells induces apoptosis, cell cycle arrest and changing biomolecular structure.	Spectrochim Acta A Mol Biomol Spectrosc		2019 Feb 15	glioma	ATR
30531922	The molecular landscape of glioma in patients with Neurofibromatosis 1.	Nat Med	3	2019 Jan	glioma	ATRX
30333046	TERT promoter wild-type glioblastomas show distinct clinical features and frequent PI3K pathway mutations.	Acta Neuropathol Commun	2	2018 Oct 17	glioma	ATRX
30760578	IDH1-R132H acts as a tumor suppressor in glioma via epigenetic up-regulation of the DNA damage response.	Sci Transl Med	1	2019 Feb 13	glioma	ATRX
30611004	Allergy may confer better survival on patients with gliomas.	Clin Neurol Neurosurg	1	2019 Feb	glioma	ATRX
30272052	Increased expression of von Willebrand factor gene is associated with poorer survival in primary lower grade glioma.	Glioma	1	2018 Jul-Aug	glioma	ATRX
31508376	Recurrent Glioma With Lineage Conversion From Oligodendroglioma to Astrocytoma in Two Cases.	Front Oncol		2019	glioma	ATRX
31350684	Anaplastic pleomorphic xanthoastrocytoma associated with an H3G34 mutation: a case report with review of literature.	Brain Tumor Pathol		2019 Jul 26	glioma	ATRX
31290679	Comparative proteogenomic characterization of glioblastoma.	CNS Oncol		2019 Jun	glioma	ATRX
31096221	Immunostaining of Increased Expression of Enhancer of Zeste Homolog 2 (EZH2) in Diffuse Midline Glioma H3K27M-Mutant Patients with Poor Survival.	Pathobiology		2019	glioma	ATRX
31062529	von Willebrand Factor Gene Expression in Primary Lower Grade Glioma: Mutually Co-Occurring Mutations in von Willebrand Factor, ATRX, and TP53.	Brain Tumor Res Treat		2019 Apr	glioma	ATRX
31025086	Integrated diagnostics of diffuse astrocytic and oligodendroglial tumors.	Pathologe		2019 Jun	glioma	ATRX
30937985	High frequency of H3K27M immunopositivity in adult thalamic glioblastoma.	Neuropathology		2019 Apr	glioma	ATRX
30831644	[Clinicopathological characteristics and prognosis of diffuse midline gliomas with histone H3K27M mutation: an analysis of 30 cases].	Zhonghua Bing Li Xue Za Zhi		2019 Mar 8	glioma	ATRX
30830680	Telomere elongation via alternative lengthening of telomeres (ALT) and telomerase activation in primary metastatic medulloblastoma of childhood.	J Neurooncol		2019 May	glioma	ATRX
30790013	[Integrated diagnostics of diffuse astrocytic and oligodendroglial tumors. German version].	Pathologe		2019 Mar	glioma	ATRX
30777204	Diffusion kurtosis imaging histogram parameter metrics predicting survival in integrated molecular subtypes of diffuse glioma: An observational cohort study.	Eur J Radiol		2019 Mar	glioma	ATRX
30664534	The Application of FOXO1A Expression Predicts Aggressive Behavior and Poor Prognosis in Gliomas.	Appl Immunohistochem Mol Morphol		2019 Jan 19	glioma	ATRX
30655743	Significance of TERT and ATRX mutations in glioma.	Oncol Lett		2019 Jan	glioma	ATRX
30504574	Molecular profile of tumors with oligodendroglial morphology: Clinical relevance.	Neurol India		2018 Nov-Dec	glioma	ATRX
30222900	Granular cell astrocytoma: an aggressive IDH-wildtype diffuse glioma with molecular genetic features of primary glioblastoma.	Brain Pathol		2019 Mar	glioma	ATRX
27959385	Microtubule actin cross-linking factor 1, a novel target in glioblastoma.	Int J Oncol	6	2017 Jan	glioma	AXIN1
23525311	CTNNB1, AXIN1 and APC expression analysis of different medulloblastoma variants.	Clinics (Sao Paulo)	6	2013	glioma	AXIN1
23588680	All-trans retinoic acid upregulates the expression of p53 via Axin and inhibits the proliferation of glioma cells.	Oncol Rep	4	2013 Jun	glioma	AXIN1
21648318	AXIN-1 protein expression and localization in glioblastoma.	Coll Antropol	4	2011 Jan	glioma	AXIN1
29387236	Expression profile and clinical significance of Wnt signaling in human gliomas.	Oncol Lett	3	2018 Jan	glioma	AXIN1
12209999	Role of Wnt pathway in medulloblastoma oncogenesis.	Int J Cancer	23	2002 Sep 10	glioma	AXIN1
17373666	Mutations of the Wnt antagonist AXIN2 (Conductin) result in TCF-dependent transcription in medulloblastomas.	Int J Cancer	17	2007 Jul 15	glioma	AXIN1
28187755	Long noncoding RNA papillary thyroid carcinoma susceptibility candidate 3 (PTCSC3) inhibits proliferation and invasion of glioma cells by suppressing the Wnt/Î²-catenin signaling pathway.	BMC Neurol	16	2017 Feb 10	glioma	AXIN1
28370670	Origin and characterization of alpha smooth muscle actin-positive cells during murine lung development.	Stem Cells	9	2017 Jun	glioma	AXIN2
27736002	MicroRNA-105 targets SOX9 and inhibits human glioma cell progression.	FEBS Lett	7	2016 Dec	glioma	AXIN2
29138341	Long Noncoding RNA &lt;i&gt;NEAT1&lt;/i&gt;, Regulated by the EGFR Pathway, Contributes to Glioblastoma Progression Through the WNT/&lt;b&gt;Î²&lt;/b&gt;-Catenin Pathway by Scaffolding EZH2.	Clin Cancer Res	31	2018 Feb 1	glioma	AXIN2
29387236	Expression profile and clinical significance of Wnt signaling in human gliomas.	Oncol Lett	3	2018 Jan	glioma	AXIN2
21666490	Wnt and hedgehog gene pathway expression in serous ovarian cancer.	Int J Gynecol Cancer	20	2011 Aug	glioma	AXIN2
17373666	Mutations of the Wnt antagonist AXIN2 (Conductin) result in TCF-dependent transcription in medulloblastomas.	Int J Cancer	17	2007 Jul 15	glioma	AXIN2
26452219	MAGI3 negatively regulates Wnt/Î²-catenin signaling and suppresses malignant phenotypes of glioma cells.	Oncotarget	12	2015 Nov 3	glioma	AXIN2
24013885	Nonsteroidal anti-inflammatory drugs diclofenac and celecoxib attenuates Wnt/Î²-catenin/Tcf signaling pathway in human glioblastoma cells.	Neurochem Res	12	2013 Nov	glioma	AXIN2
26222502	Pharmacologic Wnt Inhibition Reduces Proliferation, Survival, and Clonogenicity of Glioblastoma Cells.	J Neuropathol Exp Neurol	11	2015 Sep	glioma	AXIN2
25764520	miR-577 inhibits glioblastoma tumor growth via the Wnt signaling pathway.	Mol Carcinog	11	2016 May	glioma	AXIN2
28805815	AAV-mediated direct in vivo CRISPR screen identifies functional suppressors in glioblastoma.	Nat Neurosci	23	2017 Oct	glioma	B2M
23401227	LOH in the HLA class I region at 6p21 is associated with shorter survival in newly diagnosed adult glioblastoma.	Clin Cancer Res	16	2013 Apr 1	glioma	B2M
26463634	Identification of valid endogenous control genes for determining gene expression in C6 glioma cell line treated with conditioned medium from adipose-derived stem cell.	Biomed Pharmacother	1	2015 Oct	glioma	B2M
10378372	Quantitative analysis of NF1 and OMGP gene transcripts in sporadic gliomas, sporadic meningiomas and neurofibromatosis type 1-associated plexiform neurofibromas.	Acta Neuropathol		1999 Jun	glioma	B2M
12800201	Novel tumor antigens identified by autologous antibody screening of childhood medulloblastoma cDNA libraries.	Int J Cancer	16	2003 Aug 20	glioma	BAP1
26191197	Cytoplasmic expression of BAP1 as an independent prognostic biomarker for patients with gliomas.	Int J Clin Exp Pathol	1	2015	glioma	BAP1
31138312	Integrated analysis of 34 microarray datasets reveals CBX3 as a diagnostic and prognostic biomarker in glioblastoma.	J Transl Med		2019 May 28	glioma	BARD1
28467792	Assessment of citalopram and escitalopram on neuroblastoma cell lines. Cell toxicity and gene modulation.	Oncotarget		2017 Jun 27	glioma	BARD1
30587839	Honokiol Eliminates Glioma/Glioblastoma Stem Cell-Like Cells Via JAK-STAT3 Signaling and Inhibits Tumor Progression by Targeting Epidermal Growth Factor Receptor.	Cancers (Basel)	3	2018 Dec 26	glioma	BAX
31100944	Application of Electric Cell-Substrate Impedance Sensing to Investigate the Cytotoxic Effects of Andrographolide on U-87 MG Glioblastoma Cell Migration and Apoptosis.	Sensors (Basel)	1	2019 May 16	glioma	BAX
30834619	C-type lectin domain family 5, member A (CLEC5A, MDL-1) promotes brain glioblastoma tumorigenesis by regulating PI3K/Akt signalling.	Cell Prolif	1	2019 May	glioma	BAX
30796178	The SIAH1-HIPK2-p53ser46 Damage Response Pathway is Involved in Temozolomide-Induced Glioblastoma Cell Death.	Mol Cancer Res	1	2019 May	glioma	BAX
30657567	Influences of LncRNA SNHG20 on proliferation and apoptosis of glioma cells through regulating the PTEN/PI3K/AKT signaling pathway.	Eur Rev Med Pharmacol Sci	1	2019 Jan	glioma	BAX
30610811	Cycloartenol exerts anti-proliferative effects on Glioma U87 cells via induction of cell cycle arrest and p38 MAPK-mediated apoptosis.	J BUON	1	2018 Nov-Dec	glioma	BAX
30596403	Ivermectin inhibits the growth of glioma cells by inducing cell cycle arrest and apoptosis in vitro and in vivo.	J Cell Biochem	1	2019 Jan	glioma	BAX
30583528	Mifepristone Overcomes Tumor Resistance to Temozolomide Associated with DNA Damage Repair and Apoptosis in an Orthotopic Model of Glioblastoma.	Cancers (Basel)	1	2018 Dec 22	glioma	BAX
31485607	miR-217 inhibits the migration and invasion of HeLa cells through modulating MAPK1.	Int J Mol Med		2019 Sep 2	glioma	BAX
31241046	Knockdown long non-coding RNA PEG10 inhibits proliferation, migration and invasion of glioma cell line U251 by regulating miR-506.	Gen Physiol Biophys		2019 Jul	glioma	BAX
31173255	Effect of metformin on cell proliferation, apoptosis, migration and invasion in A172 glioma cells and its mechanisms.	Mol Med Rep		2019 Aug	glioma	BAX
31164145	Toxoplasma gondii ROP18 inhibits human glioblastoma cell apoptosis through a mitochondrial pathway by targeting host cell P2X1.	Parasit Vectors		2019 Jun 4	glioma	BAX
31085295	Photodynamic therapy combined with temozolomide inhibits C6 glioma migration and invasion and promotes mitochondrial-associated apoptosis by inhibiting sodium-hydrogen exchanger isoform 1.	Photodiagnosis Photodyn Ther		2019 Jun	glioma	BAX
31035045	Ovatodiolide inhibits the oncogenicity and cancer stem cell-like phenotype of glioblastoma cells, as well as potentiate the anticancer effect of temozolomide.	Phytomedicine		2019 Jan 19	glioma	BAX
31011879	Quercetin and Sodium Butyrate Synergistically Increase Apoptosis in Rat C6 and Human T98G Glioblastoma Cells Through Inhibition of Autophagy.	Neurochem Res		2019 Jul	glioma	BAX
31005632	In vitro and in vivo Study on Glioma Treatment Enhancement by Combining Temozolomide with Calycosin and Formononetin.	J Ethnopharmacol		2019 Oct 5	glioma	BAX
30816477	Deoxypodophyllotoxin inhibits cell viability and invasion by blocking the PI3K/Akt signaling pathway in human glioblastoma cells.	Oncol Rep		2019 Apr	glioma	BAX
30695861	[Promoting migration and apoptosis of glioma cells by macrophage migration inhibitory factor].	Zhonghua Bing Li Xue Za Zhi		2019 Feb 8	glioma	BAX
30657552	Aclidinium bromide inhibits proliferation of osteosarcoma cells through regulation of PI3K/Akt pathway.	Eur Rev Med Pharmacol Sci		2019 Jan	glioma	BAX
30610508	Induction of apoptosis by in vitro and in vivo plant extracts derived from Menyanthes trifoliata L. in human cancer cells.	Cytotechnology		2019 Feb	glioma	BAX
24553260	PHLPP2 suppresses the NF-ÎºB pathway by inactivating IKKÎ² kinase.	Oncotarget	11	2014 Feb 15	glioma	BCL10
24552816	Distinctive effects of the cellular inhibitor of apoptosis protein c-IAP2 through stabilization by XIAP in glioblastoma multiforme cells.	Cell Cycle	10	2014	glioma	BCL10
31178130	ZNF436 promotes tumor cell proliferation through transcriptional activation of BCL10 in glioma.	Biochem Biophys Res Commun		2019 Aug 6	glioma	BCL10
1	Depletion of B cell CLL/Lymphoma 11B Gene Expression Represses Glioma Cell Growth.	Mol Neurobiol	1	2016 Aug	glioma	BCL11B
30051528	The genetic landscape of anaplastic pleomorphic xanthoastrocytoma.	Brain Pathol	7	2019 Jan	glioma	BCOR
26727948	Spatial genomic heterogeneity in diffuse intrinsic pontine and midline high-grade glioma: implications for diagnostic biopsy and targeted therapeutics.	Acta Neuropathol Commun	26	2016 Jan 4	glioma	BCOR
30895378	DNA methylation profiling distinguishes Ewing-like sarcoma with EWSR1-NFATc2 fusion from Ewing sarcoma.	J Cancer Res Clin Oncol	1	2019 May	glioma	BCOR
31104347	High-grade neuroepithelial tumor with BCOR exon 15 internal tandem duplication-a comprehensive clinical, radiographic, pathologic, and genomic analysis.	Brain Pathol		2019 May 18	glioma	BCOR
25490438	Controlling COR competence: BCL-6 regulates neurogenesis and tumor suppression.	Cancer Cell		2014 Dec 8	glioma	BCOR
30051528	The genetic landscape of anaplastic pleomorphic xanthoastrocytoma.	Brain Pathol	7	2019 Jan	glioma	BCORL1
31104347	High-grade neuroepithelial tumor with BCOR exon 15 internal tandem duplication-a comprehensive clinical, radiographic, pathologic, and genomic analysis.	Brain Pathol		2019 May 18	glioma	BCORL1
27074575	Analysis of the inhibitors of apoptosis identifies BIRC3 as a facilitator of malignant progression in glioma.	Oncotarget	6	2017 Feb 21	glioma	BIRC3
29168084	Bioinformatic analysis of gene expression and methylation regulation in glioblastoma.	J Neurooncol	5	2018 Feb	glioma	BIRC3
25939870	ZFP36 stabilizes RIP1 via degradation of XIAP and cIAP2 thereby promoting ripoptosome assembly.	BMC Cancer	4	2015 May 6	glioma	BIRC3
19536297	Modulation of angiogenic and inflammatory response in glioblastoma by hypoxia.	PLoS One	39	2009 Jun 17	glioma	BIRC3
28839258	BIRC3 is a biomarker of mesenchymal habitat of glioblastoma, and a mediator of survival adaptation in hypoxia-driven glioblastoma habitats.	Sci Rep	2	2017 Aug 24	glioma	BIRC3
21279667	An NF-ÎºB p65-cIAP2 link is necessary for mediating resistance to TNF-Î± induced cell death in gliomas.	J Neurooncol	18	2011 May	glioma	BIRC3
26888114	BIRC3 is a novel driver of therapeutic resistance in Glioblastoma.	Sci Rep	17	2016 Feb 18	glioma	BIRC3
25863126	Radiation-induced homotypic cell fusions of innately resistant glioblastoma cells mediate their sustained survival and recurrence.	Carcinogenesis	14	2015 Jun	glioma	BIRC3
27344170	Transcriptome sequencing of neurologic diseases associated genes in HHV-6A infected human astrocyte.	Oncotarget	1	2016 Jul 26	glioma	BIRC3
26182949	Up-Regulation of Glioma-Associated Oncogene Homolog 1 Expression by Serum Starvation Promotes Cell Survival in ER-Positive Breast Cancer Cells.	Cell Physiol Biochem		2015	glioma	BIRC3
24962072	Differential effects of antofine N-oxide on solid tumor and leukemia cells.	Anticancer Agents Med Chem		2014	glioma	BIRC3
10582665	Expression of different extracellular matrix components in human brain tumor and melanoma cells in respect to variant culture conditions.	J Neurooncol	12	1999 Aug	glioma	BLM
2620007	[In situ nick translation for detection of DNA damages in glioma cells].	No To Shinkei		1989 Nov	glioma	BLM
26683138	Bone morphogenetic protein signaling promotes tumorigenesis in a murine model of high-grade glioma.	Neuro Oncol	6	2016 Jul	glioma	BMPR1A
24480809	miR-656 inhibits glioma tumorigenesis through repression of BMPR1A.	Carcinogenesis	12	2014 Aug	glioma	BMPR1A
25277523	The polyamine catabolic enzyme SAT1 modulates tumorigenesis and radiation response in GBM.	Cancer Res	9	2014 Dec 1	glioma	BRCA1
24793792	Progranulin promotes Temozolomide resistance of glioblastoma by orchestrating DNA repair and tumor stemness.	Oncogene	8	2015 Apr 2	glioma	BRCA1
25337721	Downregulation of BRCA1-BRCA2-containing complex subunit 3 sensitizes glioma cells to temozolomide.	Oncotarget	7	2014 Nov 15	glioma	BRCA1
26764186	SGEF Is Regulated via TWEAK/Fn14/NF-ÎºB Signaling and Promotes Survival by Modulation of the DNA Repair Response to Temozolomide.	Mol Cancer Res	6	2016 Mar	glioma	BRCA1
25880076	BRCA1 germline mutation and glioblastoma development: report of cases.	BMC Cancer	5	2015 Mar 26	glioma	BRCA1
18559551	Pathway analysis of single-nucleotide polymorphisms potentially associated with glioblastoma multiforme susceptibility using random forests.	Cancer Epidemiol Biomarkers Prev	40	2008 Jun	glioma	BRCA1
15780200	Effect of 7-hydroxystaurosporine on glioblastoma cell invasion and migration.	Acta Pharmacol Sin	4	2005 Apr	glioma	BRCA1
15367334	Methylation profiles of thirty four promoter-CpG islands and concordant methylation behaviours of sixteen genes that may contribute to carcinogenesis of astrocytoma.	BMC Cancer	30	2004 Sep 14	glioma	BRCA1
27572852	Identification of hub genes and regulatory factors of glioblastoma multiforme subgroups by RNA-seq data analysis.	Int J Mol Med	3	2016 Oct	glioma	BRCA1
11071894	Pescadillo, a novel cell cycle regulatory protein abnormally expressed in malignant cells.	J Biol Chem	28	2001 Mar 2	glioma	BRCA1
21908773	Mutual exclusivity analysis identifies oncogenic network modules.	Genome Res	225	2012 Feb	glioma	BRCA1
29286157	hsa-miR-212 modulates the radiosensitivity of glioma cells by targeting BRCA1.	Oncol Rep	2	2018 Mar	glioma	BRCA1
28852018	Ape1 guides DNA repair pathway choice that is associated with drug tolerance in glioblastoma.	Sci Rep	2	2017 Aug 29	glioma	BRCA1
27845331	BRCA1-regulated RRM2 expression protects glioblastoma cells from endogenous replication stress and promotes tumorigenicity.	Nat Commun	18	2016 Nov 15	glioma	BRCA1
22210863	An integer linear programming approach for finding deregulated subgraphs in regulatory networks.	Nucleic Acids Res	14	2012 Mar	glioma	BRCA1
15950434	Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues.	Genomics	115	2005 Aug	glioma	BRCA1
26191197	Cytoplasmic expression of BAP1 as an independent prognostic biomarker for patients with gliomas.	Int J Clin Exp Pathol	1	2015	glioma	BRCA1
21873780	[Transcriptomic regulation and molecular mechanism of polygenic tumor at different stages].	Zhong Nan Da Xue Xue Bao Yi Xue Ban	1	2011 Jul	glioma	BRCA1
29453736	Reproductive epidemiology of glial tumors may reveal novel treatments: high-dose progestins or progesterone antagonists as endocrino-immune modifiers against glioma.	Neurosurg Rev		2019 Jun	glioma	BRCA1
25481245	Human Hematopoietic Signal peptide-containing Secreted 1 (hHSS1) modulates genes and pathways in glioma: implications for the regulation of tumorigenicity and angiogenesis.	BMC Cancer		2014 Dec 6	glioma	BRCA1
10203181	Ultraviolet radiation down-regulates expression of the cell-cycle inhibitor p21WAF1/CIP1 in human cancer cells independently of p53.	Int J Radiat Biol	8	1999 Mar	glioma	BRCA2
25337721	Downregulation of BRCA1-BRCA2-containing complex subunit 3 sensitizes glioma cells to temozolomide.	Oncotarget	7	2014 Nov 15	glioma	BRCA2
28378638	Expression signatures of DNA repair genes correlate with survival prognosis of astrocytoma patients.	Tumour Biol	6	2017 Apr	glioma	BRCA2
22073281	Rad51 and BRCA2--New molecular targets for sensitizing glioma cells to alkylating anticancer drugs.	PLoS One	24	2011	glioma	BRCA2
10340383	DNA-PK, the DNA-activated protein kinase, is differentially expressed in normal and malignant human tissues.	Oncogene	23	1999 May 20	glioma	BRCA2
21908773	Mutual exclusivity analysis identifies oncogenic network modules.	Genome Res	225	2012 Feb	glioma	BRCA2
24145349	BCCIP suppresses tumor initiation but is required for tumor progression.	Cancer Res	14	2013 Dec 1	glioma	BRCA2
26486089	Common cancer-associated imbalances in the DNA damage response confer sensitivity to single agent ATR inhibition.	Oncotarget	13	2015 Oct 20	glioma	BRCA2
19653894	Alterations of BCCIP, a BRCA2 interacting protein, in astrocytomas.	BMC Cancer	11	2009 Aug 4	glioma	BRCA2
16137202	DNA damage responses at low radiation doses.	Radiat Res	11	2005 Sep	glioma	BRCA2
29753700	Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort.	Lancet Oncol	10	2018 Jun	glioma	BRCA2
25481245	Human Hematopoietic Signal peptide-containing Secreted 1 (hHSS1) modulates genes and pathways in glioma: implications for the regulation of tumorigenicity and angiogenesis.	BMC Cancer		2014 Dec 6	glioma	BRCA2
20713847	Astrocytoma in a breast cancer lineage: part of the BRCA2 phenotype?	J Clin Oncol		2010 Oct 20	glioma	BRCA2
1	Expression signatures of DNA repair genes correlate with survival prognosis of astrocytoma patients.	Tumour Biol	6	2017 Apr	glioma	BRIP1
24928548	Gene expression analysis in MCF-7 breast cancer cells treated with recombinant bromelain.	Appl Biochem Biotechnol	3	2014 Aug	glioma	BTG1
30916818	The treatment effects and the underlying mechanism of B cell translocation gene 1 on the oncogenesis of brain glioma.	J Cell Biochem		2019 Aug	glioma	BTG1
30787206	PUM2 Promotes Glioblastoma Cell Proliferation and Migration via Repressing BTG1 Expression.	Cell Struct Funct		2019	glioma	BTG1
28716053	Ibrutinib, a Bruton's tyrosine kinase inhibitor, exhibits antitumoral activity and induces autophagy in glioblastoma.	J Exp Clin Cancer Res	8	2017 Jul 17	glioma	BTK
28946903	High expression of Bruton's tyrosine kinase (BTK) is required for EGFR-induced NF-ÎºB activation and predicts poor prognosis in human glioma.	J Exp Clin Cancer Res	6	2017 Sep 25	glioma	BTK
27564106	Preclinical investigation of ibrutinib, a Bruton's kinase tyrosine (Btk) inhibitor, in suppressing glioma tumorigenesis and stem cell phenotypes.	Oncotarget	10	2016 Oct 25	glioma	BTK
30733667	Specific Expression of a New Bruton Tyrosine Kinase Isoform (p65BTK) in the Glioblastoma Gemistocytic Histotype.	Front Mol Neurosci	1	2019	glioma	BTK
31384539	Development of the triazole-fused pyrimidine derivatives as highly potent and reversible inhibitors of histone lysine specific demethylase 1 (LSD1/KDM1A).	Acta Pharm Sin B		2019 Jul	glioma	BTK
29467892	Transcription factor PU.1 is involved in the progression of glioma.	Oncol Lett		2018 Mar	glioma	BTK
29039578	The FOXM1/BUB1B signaling pathway is essential for the tumorigenicity and radioresistance of glioblastoma.	Oncol Rep	6	2017 Dec	glioma	BUB1B
28855212	Sensitivity to &lt;i&gt;BUB1B&lt;/i&gt; Inhibition Defines an Alternative Classification of Glioblastoma.	Cancer Res	5	2017 Oct 15	glioma	BUB1B
26678675	Phenethyl isothiocyanate alters the gene expression and the levels of protein associated with cell cycle regulation in human glioblastoma GBM 8401 cells.	Environ Toxicol	5	2017 Jan	glioma	BUB1B
22022424	The accuracy of survival time prediction for patients with glioma is improved by measuring mitotic spindle checkpoint gene expression.	PLoS One	20	2011	glioma	BUB1B
21857646	CAMTA1 is a novel tumour suppressor regulated by miR-9/9* in glioblastoma stem cells.	EMBO J	58	2011 Aug 19	glioma	CAMTA1
15709179	Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.	Clin Cancer Res	47	2005 Feb 1	glioma	CAMTA1
12734316	Preclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathway.	J Natl Cancer Inst	85	2003 May 7	glioma	CARS
23939024	Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma.	Mol Ther	77	2013 Nov	glioma	CARS
22952576	Cancer association study of aminoacyl-tRNA synthetase signaling network in glioblastoma.	PLoS One	7	2012	glioma	CARS
29503195	Adoptive Transfer of IL13RÎ±2-Specific Chimeric Antigen Receptor T Cells Creates a Pro-inflammatory Environment in Glioblastoma.	Mol Ther	6	2018 Apr 4	glioma	CARS
27163741	Redirecting T-Cell Specificity to EGFR Using mRNA to Self-limit Expression of Chimeric Antigen Receptor.	J Immunother	5	2016 Jun	glioma	CARS
25604432	Disialoganglioside GD2 as a therapeutic target for human diseases.	Expert Opin Ther Targets	34	2015 Mar	glioma	CARS
28550091	Transgenic Expression of IL15 Improves Antiglioma Activity of IL13RÎ±2-CAR T Cells but Results in Antigen Loss Variants.	Cancer Immunol Res	23	2017 Jul	glioma	CARS
25962108	Engineering NK Cells Modified With an EGFRvIII-specific Chimeric Antigen Receptor to Overexpress CXCR4 Improves Immunotherapy of CXCL12/SDF-1Î±-secreting Glioblastoma.	J Immunother	21	2015 Jun	glioma	CARS
30306125	Checkpoint Blockade Reverses Anergy in IL-13RÎ±2 Humanized scFv-Based CAR T Cells to Treat Murine and Canine Gliomas.	Mol Ther Oncolytics	2	2018 Dec 21	glioma	CARS
29959057	Glycogen synthase kinase 3 inhibition lowers PD-1 expression, promotes long-term survival and memory generation in antigen-specific CAR-T cells.	Cancer Lett	2	2018 Oct 1	glioma	CARS
29622795	Antitumor activity of CD56-chimeric antigen receptor T cells in neuroblastoma and SCLC models.	Oncogene	2	2018 Jul	glioma	CARS
24841514	T cells redirected to interleukin-13RÎ±2 with interleukin-13 mutein--chimeric antigen receptors have anti-glioma activity but also recognize interleukin-13RÎ±1.	Cytotherapy	18	2014 Aug	glioma	CARS
25696001	Rational development and characterization of humanized anti-EGFR variant III chimeric antigen receptor T cells for glioblastoma.	Sci Transl Med	107	2015 Feb 18	glioma	CARS
28651374	CD70, a novel target of CAR T-cell therapy for gliomas.	Neuro Oncol	10	2018 Jan 10	glioma	CARS
30409424	Generation of regulable EGFRvIII targeted chimeric antigen receptor T cells for adoptive cell therapy of glioblastoma.	Biochem Biophys Res Commun		2018 Dec 9	glioma	CARS
24573400	Novel cancer-testis antigen expression on glioma cell lines derived from high-grade glioma patients.	Oncol Rep	7	2014 Apr	glioma	CASC5
28918420	Computer Analysis of Glioma Transcriptome Profiling: Alternative Splicing Events.	J Integr Bioinform	2	2017 Sep 18	glioma	CASC5
27528031	YM155 sensitizes TRAIL-induced apoptosis through cathepsin S-dependent down-regulation of Mcl-1 and NF-ÎºB-mediated down-regulation of c-FLIP expression in human renal carcinoma Caki cells.	Oncotarget	7	2016 Sep 20	glioma	CASP8
25619640	6-Shogaol enhances renal carcinoma Caki cells to TRAIL-induced apoptosis through reactive oxygen species-mediated cytochrome c release and down-regulation of c-FLIP(L) expression.	Chem Biol Interact	7	2015 Feb 25	glioma	CASP8
25577511	Icaritin Sensitizes Human Glioblastoma Cells to TRAIL-Induced Apoptosis.	Cell Biochem Biophys	7	2015 Jun	glioma	CASP8
25394252	Integrin antagonist augments the therapeutic effect of adenovirus-mediated REIC/Dkk-3 gene therapy for malignant glioma.	Gene Ther	7	2015 Feb	glioma	CASP8
27770821	The 1,4 benzoquinone-featured 5-lipoxygenase inhibitor RF-Id induces apoptotic death through downregulation of IAPs in human glioblastoma cells.	J Exp Clin Cancer Res	6	2016 Oct 22	glioma	CASP8
27927008	MicroRNA-296-5p Promotes Invasiveness through Downregulation of Nerve Growth Factor Receptor and Caspase-8.	Mol Cells	5	2017 Apr	glioma	CASP8
26657652	Patient-derived glioblastoma cells show significant heterogeneity in treatment responses to the inhibitor-of-apoptosis-protein antagonist birinapant.	Br J Cancer	5	2016 Jan 19	glioma	CASP8
28594322	Caspase-8 contributes to angiogenesis and chemotherapy resistance in glioblastoma.	Elife	4	2017 Jun 8	glioma	CASP8
26142735	Temozolomide sensitizes stem-like cells of glioma spheres to TRAIL-induced apoptosis via upregulation of casitas B-lineage lymphoma (c-Cbl) protein.	Tumour Biol	4	2015 Dec	glioma	CASP8
25535898	Gli2 silencing enhances TRAIL-induced apoptosis and reduces tumor growth in human hepatoma cells in vivo.	Cancer Biol Ther	4	2014	glioma	CASP8
28427190	Pygopus2 inhibits the efficacy of paclitaxel-induced apoptosis and induces multidrug resistance in human glioma cells.	Oncotarget	2	2017 Apr 25	glioma	CASP8
28350076	Osthole enhances TRAIL-mediated apoptosis through downregulation of c-FLIP expression in renal carcinoma Caki cells.	Oncol Rep	2	2017 Apr	glioma	CASP8
27729209	Jaceosidin induces apoptosis through Bax activation and down-regulation of Mcl-1 and c-FLIP expression in human renal carcinoma Caki cells.	Chem Biol Interact	2	2016 Dec 25	glioma	CASP8
27210546	Overcoming resistance to TRAIL-induced apoptosis in solid tumor cells by simultaneously targeting death receptors, c-FLIP and IAPs.	Int J Oncol	14	2016 Jul	glioma	CASP8
28806703	NOX4-mediated ROS production induces apoptotic cell death via down-regulation of c-FLIP and Mcl-1 expression in combined treatment with thioridazine and curcumin.	Redox Biol	10	2017 Oct	glioma	CASP8
28182008	Thioridazine enhances sensitivity to carboplatin in human head and neck cancer cells through downregulation of c-FLIP and Mcl-1 expression.	Cell Death Dis	10	2017 Feb 9	glioma	CASP8
25880091	Identification of RIP1 as a critical mediator of Smac mimetic-mediated sensitization of glioblastoma cells for Drozitumab-induced apoptosis.	Cell Death Dis	10	2015 Apr 16	glioma	CASP8
27671304	Dehydroleucodine Induces a TP73-dependent Transcriptional Regulation of Multiple Cell Death Target Genes in Human Glioblastoma Cells.	Anticancer Agents Med Chem	1	2017	glioma	CASP8
31433208	Prognostic Markers Identification in Glioma by Gene Expression Profile Analysis.	J Comput Biol		2019 Aug 22	glioma	CASP8
29777390	Synergistic effect of TRAIL and irradiation in elimination of glioblastoma stem-like cells.	Clin Exp Med		2018 Aug	glioma	CASP8
19121369	Transactivation by Runt related factor-2 of matrix metalloproteinase-13 in astrocytes.	Neurosci Lett	5	2009 Feb 20	glioma	CBFB
25781272	Proteomic screening and identification of microRNA-128 targets in glioma cells.	Proteomics		2015 Aug	glioma	CBFB
24876153	Protein tyrosine phosphatase receptor U (PTPRU) is required for glioma growth and motility.	Carcinogenesis	6	2014 Aug	glioma	CBL
20717917	c-Cbl regulates glioma invasion through matrix metalloproteinase 2.	J Cell Biochem	6	2010 Dec 1	glioma	CBL
26142735	Temozolomide sensitizes stem-like cells of glioma spheres to TRAIL-induced apoptosis via upregulation of casitas B-lineage lymphoma (c-Cbl) protein.	Tumour Biol	4	2015 Dec	glioma	CBL
23581227	LRIG1 enhances cisplatin sensitivity of glioma cell lines.	Oncol Res	3	2012	glioma	CBL
22074469	EphrinA5 suppresses colon cancer development by negatively regulating epidermal growth factor receptor stability.	FEBS J	3	2012 Jan	glioma	CBL
18542056	LRIG1 negatively regulates the oncogenic EGF receptor mutant EGFRvIII.	Oncogene	23	2008 Sep 25	glioma	CBL
23770238	A mechanism for the upregulation of EGF receptor levels in glioblastomas.	Cell Rep	21	2013 Jun 27	glioma	CBL
28724758	The ShcD phosphotyrosine adaptor subverts canonical EGF receptor trafficking.	J Cell Sci	2	2017 Sep 1	glioma	CBL
27073553	High c-Cbl expression in gliomas is associated with tumor progression and poor prognosis.	Oncol Lett	2	2016 Apr	glioma	CBL
26152360	Deleterious c-Cbl Exon Skipping Contributes to Human Glioma.	Neoplasia	2	2015 Jun	glioma	CBL
19270726	EphrinA5 acts as a tumor suppressor in glioma by negative regulation of epidermal growth factor receptor.	Oncogene	18	2009 Apr 16	glioma	CBL
12532415	Spontaneous activation and signaling by overexpressed epidermal growth factor receptors in glioblastoma cells.	Int J Cancer	14	2003 Mar 10	glioma	CBL
25691332	Ionizing radiation-inducible miR-30e promotes glioma cell invasion through EGFR stabilization by directly targeting CBL-B.	FEBS J	12	2015 Apr	glioma	CBL
29317233	C-Cbl and Cbl-b expression in skull base chordomas is associated with tumor progression and poor prognosis.	Hum Pathol		2018 Apr	glioma	CBL
10595738	Epidermal growth factor-dependent dissociation of CrkII proto-oncogene product from the epidermal growth factor receptor in human glioma cells.	Jpn J Cancer Res		1999 Oct	glioma	CBL
25333456	Association between DNA methylation and multidrug resistance in human glioma SHG-44 cells.	Mol Med Rep	2	2015 Jan	glioma	CBLB
29317233	C-Cbl and Cbl-b expression in skull base chordomas is associated with tumor progression and poor prognosis.	Hum Pathol		2018 Apr	glioma	CBLB
1	Integrins mediate adhesion of medulloblastoma cells to tenascin and activate pathways associated with survival and proliferation.	Lab Invest	20	2008 Nov	glioma	CCDC6
1	Knocking down SMC1A inhibits growth and leads to G2/M arrest in human glioma cells.	Int J Clin Exp Pathol	10	2013	glioma	CCNB1IP1
29510196	PD-L1 confers glioblastoma multiforme malignancy via Ras binding and Ras/Erk/EMT activation.	Biochim Biophys Acta Mol Basis Dis	9	2018 May	glioma	CD274
29900065	The immune checkpoint protein PD-L1 induces and maintains regulatory T cells in glioblastoma.	Oncoimmunology	8	2018	glioma	CD274
28721584	miR-34a attenuates glioma cells progression and chemoresistance via targeting PD-L1.	Biotechnol Lett	7	2017 Oct	glioma	CD274
29396299	Radiotherapy Upregulates Programmed Death Ligand-1 through the Pathways Downstream of Epidermal Growth Factor Receptor in Glioma.	EBioMedicine	5	2018 Feb	glioma	CD274
29147863	Prognostic relevance of programmed cell death ligand 1 expression in glioblastoma.	J Neurooncol	5	2018 Feb	glioma	CD274
28620836	SOX2 immunity and tissue resident memory in children and young adults with glioma.	J Neurooncol	5	2017 Aug	glioma	CD274
30333036	The IFN-Î³/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy.	J Neuroinflammation	4	2018 Oct 17	glioma	CD274
29910795	Predictors of Response to Autologous Dendritic Cell Therapy in Glioblastoma Multiforme.	Front Immunol	3	2018	glioma	CD274
29350470	Specific expression of PD-L1 in RELA-fusion supratentorial ependymoma: Implications for PD-1-targeted therapy.	Pediatr Blood Cancer	3	2018 May	glioma	CD274
29532035	Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles.	Sci Adv	26	2018 Mar	glioma	CD274
30777100	Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma.	J Exp Clin Cancer Res	2	2019 Feb 18	glioma	CD274
28652622	The prognostic significance of PD-L1 expression in patients with glioma: A meta-analysis.	Sci Rep	15	2017 Jun 26	glioma	CD274
28591697	Relationship between expression of PD-L1 and tumor angiogenesis, proliferation, and invasion in glioma.	Oncotarget	13	2017 Jul 25	glioma	CD274
30709339	Crosslink between Temozolomide and PD-L1 immune-checkpoint inhibition in glioblastoma multiforme.	BMC Cancer	1	2019 Feb 1	glioma	CD274
30687086	The Prognostic and Therapeutic Value of PD-L1 in Glioma.	Front Pharmacol	1	2018	glioma	CD274
29784449	A radiosensitivity gene signature and PD-L1 predict the clinical outcomes of patients with lower grade glioma in TCGA.	Radiother Oncol	1	2018 Aug	glioma	CD274
30483834	Tumor-infiltrating immune cell subpopulations and programmed death ligand 1 (PD-L1) expression associated with clinicopathological and prognostic parameters in ependymoma.	Cancer Immunol Immunother		2019 Feb	glioma	CD274
30259750	Personalized Tumor RNA Loaded Lipid-Nanoparticles Prime the Systemic and Intratumoral Milieu for Response to Cancer Immunotherapy.	Nano Lett		2018 Oct 10	glioma	CD274
30009488	Dendritic cells cross-talk with tumour antigen-specific CD8&lt;sup&gt;+&lt;/sup&gt; T cells, VÎ³9Î³Î´T cells and VÎ±24NKT cells in patients with glioblastoma multiforme and in healthy donors.	Clin Exp Immunol		2018 Oct	glioma	CD274
29730815	PD-1/PD-L1 and immune-related gene expression pattern in pediatric malignant brain tumors: clinical correlation with survival data in Korean population.	J Neurooncol		2018 Sep	glioma	CD274
28874566	Cellular responses to human cytomegalovirus infection: Induction of a mesenchymal-to-epithelial transition (MET) phenotype.	Proc Natl Acad Sci U S A	8	2017 Sep 26	glioma	CDH1
27705942	RND3 promotes Snail 1 protein degradation and inhibits glioblastoma cell migration and invasion.	Oncotarget	7	2016 Dec 13	glioma	CDH1
27122306	MicroRNA-130b promotes cell proliferation and invasion by inhibiting peroxisome proliferator-activated receptor-Î³ in human glioma cells.	Int J Mol Med	6	2016 Jun	glioma	CDH1
25266804	Knockdown of Rho-associated protein kinase 1 suppresses proliferation and invasion of glioma cells.	Tumour Biol	6	2015 Jan	glioma	CDH1
28851312	Prognostic significance of E-cadherin and N-cadherin expression in Gliomas.	BMC Cancer	5	2017 Aug 29	glioma	CDH1
27667169	AEG-1 promotes mesenchymal transition through the activation of Rho GTPases in human glioblastoma cells.	Oncol Rep	4	2016 Nov	glioma	CDH1
27341836	TP53INP1 3'-UTR functions as a ceRNA in repressing the metastasis of glioma cells by regulating miRNA activity.	Biotechnol Lett	4	2016 Oct	glioma	CDH1
29679856	B7-H6 expression is induced by lipopolysaccharide and facilitates cancer invasion and metastasis in human gliomas.	Int Immunopharmacol	3	2018 Jun	glioma	CDH1
28991229	Hypoxia activates cadherin-22 synthesis via eIF4E2 to drive cancer cell migration, invasion and adhesion.	Oncogene	3	2018 Feb 1	glioma	CDH1
24589600	[miR-221 mediates epithelial-mesenchymal transition-related gene expressions via regulation of PTEN/Akt signaling in drug-resistant glioma cells].	Nan Fang Yi Ke Da Xue Xue Bao	2	2014 Feb	glioma	CDH1
24369236	[Transforming growth factor Î²1 enhances the invasiveness of human glioma cell line via ERK/MAPK pathway].	Nan Fang Yi Ke Da Xue Xue Bao	2	2013 Dec	glioma	CDH1
27801803	miR-92a-3p Exerts Various Effects in Glioma and Glioma Stem-Like Cells Specifically Targeting CDH1/Î²-Catenin and Notch-1/Akt Signaling Pathways.	Int J Mol Sci	10	2016 Oct 27	glioma	CDH1
26547933	ST3GAL1-Associated Transcriptomic Program in Glioblastoma Tumor Growth, Invasion, and Prognosis.	J Natl Cancer Inst	10	2016 Feb	glioma	CDH1
28887916	Angelica polysaccharides inhibit the growth and promote the apoptosis of U251 glioma cells in vitro and in vivo.	Phytomedicine	1	2017 Sep 15	glioma	CDH1
30844730	BMP4 inhibits glioblastoma invasion by promoting E-cadherin and claudin expression.	Front Biosci (Landmark Ed)		2019 Mar 1	glioma	CDH1
30119208	Exendin-4 inhibits glioma cell migration, invasion and epithelial-to-mesenchymal transition through GLP-1R/sirt3 pathway.	Biomed Pharmacother		2018 Oct	glioma	CDH1
30015885	Candidate genes and microRNAs for glioma pathogenesis and prognosis based on gene expression profiles.	Mol Med Rep		2018 Sep	glioma	CDH1
29671226	LncRNA LINC00152 promoted glioblastoma progression through targeting the miR-107 expression.	Environ Sci Pollut Res Int		2018 Jun	glioma	CDH1
29534578	Ste20-like kinase is upregulated in glioma and induces glioma invasion.	Neoplasma		2018	glioma	CDH1
29224276	[Expression and mechanism of Twist2 in glioma].	Zhonghua Bing Li Xue Za Zhi		2017 Dec 8	glioma	CDH1
23951053	Cadherin-11 regulates motility in normal cortical neural precursors and glioblastoma.	PLoS One	9	2013	glioma	CDH11
21722156	Identification and functional validation of CDH11, PCSK6 and SH3GL3 as novel glioma invasion-associated candidate genes.	Neuropathol Appl Neurobiol	19	2012 Apr	glioma	CDH11
28483947	Regulation of &lt;i&gt;USP37&lt;/i&gt; Expression by REST-Associated G9a-Dependent Histone Methylation.	Mol Cancer Res	7	2017 Aug	glioma	CDKN1B
27600331	Dabigatran antagonizes growth, cell-cycle progression, migration, and endothelial tube formation induced by thrombin in breast and glioblastoma cell lines.	Cancer Med	7	2016 Oct	glioma	CDKN1B
26088461	Nrdp1-mediated ErbB3 degradation inhibits glioma cell migration and invasion by reducing cytoplasmic localization of p27(Kip1).	J Neurooncol	7	2015 Sep	glioma	CDKN1B
26535026	CELF1 is Up-Regulated in Glioma and Promotes Glioma Cell Proliferation by Suppression of CDKN1B.	Int J Biol Sci	6	2015	glioma	CDKN1B
25399650	Probucol suppresses human glioma cell proliferation in vitro via ROS production and LKB1-AMPK activation.	Acta Pharmacol Sin	6	2014 Dec	glioma	CDKN1B
27472461	Novel function of MDA-9/Syntenin (SDCBP) as a regulator of survival and stemness in glioma stem cells.	Oncotarget	5	2016 Aug 23	glioma	CDKN1B
27142352	CPEB1 restrains proliferation of Glioblastoma cells through the regulation of p27(Kip1) mRNA translation.	Sci Rep	5	2016 May 4	glioma	CDKN1B
26856755	RNF135, RING finger protein, promotes the proliferation of human glioblastoma cells in vivo and in vitro via the ERK pathway.	Sci Rep	5	2016 Feb 9	glioma	CDKN1B
24443386	SKP2 overexpression is associated with increased serine 10 phosphorylation of p27 (pSer10p27) in triple-negative breast cancer.	J Cell Physiol	4	2014 Sep	glioma	CDKN1B
24022637	Mitogenic signalling in the absence of epidermal growth factor receptor activation in a human glioblastoma cell line.	J Neurooncol	4	2013 Dec	glioma	CDKN1B
23339869	TRIP6 regulates p27 KIP1 to promote tumorigenesis.	Mol Cell Biol	4	2013 Apr	glioma	CDKN1B
22525274	ADAR2-editing activity inhibits glioblastoma growth through the modulation of the CDC14B/Skp2/p21/p27 axis.	Oncogene	34	2013 Feb 21	glioma	CDKN1B
30753603	The novel chromatin architectural regulator SND1 promotes glioma proliferation and invasion and predicts the prognosis of patients.	Neuro Oncol	2	2019 Jun 10	glioma	CDKN1B
22313636	Bortezomib induces apoptosis and growth suppression in human medulloblastoma cells, associated with inhibition of AKT and NF-Ä¸B signaling, and synergizes with an ERK inhibitor.	Cancer Biol Ther	15	2012 Apr	glioma	CDKN1B
24018641	Knockdown of CRM1 inhibits the nuclear export of p27(Kip1) phosphorylated at serine 10 and plays a role in the pathogenesis of epithelial ovarian cancer.	Cancer Lett	12	2014 Feb 1	glioma	CDKN1B
28381184	Integrated Cox's model for predicting survival time of glioblastoma multiforme.	Tumour Biol	1	2017 Apr	glioma	CDKN1B
26383528	LIM domain only 2 induces glioma invasion via cytosolic p27(KIP1).	Tumour Biol	1	2016 Feb	glioma	CDKN1B
22313596	Long-term molecular changes in WHO grade II astrocytomas following radiotherapy.	Chin J Cancer	1	2012 Mar	glioma	CDKN1B
30425057	Aberrant Activation of Î²-Catenin Signaling Drives Glioma Tumorigenesis via USP1-Mediated Stabilization of EZH2.	Cancer Res		2019 Jan 1	glioma	CDKN1B
30135192	Reduced Expression of PROX1 Transitions Glioblastoma Cells into a Mesenchymal Gene Expression Subtype.	Cancer Res		2018 Oct 15	glioma	CDKN1B
30051528	The genetic landscape of anaplastic pleomorphic xanthoastrocytoma.	Brain Pathol	7	2019 Jan	glioma	CDKN2A
30048971	Effects of Fibronectin 1 on Cell Proliferation, Senescence and Apoptosis of Human Glioma Cells Through the PI3K/AKT Signaling Pathway.	Cell Physiol Biochem	6	2018	glioma	CDKN2A
30192422	Alternative lengthening of telomeres, ATRX loss and H3-K27M mutations in histologically defined pilocytic astrocytoma with anaplasia.	Brain Pathol	5	2019 Jan	glioma	CDKN2A
30531922	The molecular landscape of glioma in patients with Neurofibromatosis 1.	Nat Med	3	2019 Jan	glioma	CDKN2A
30038703	Genetic landscape of long noncoding RNA (lncRNAs) in glioblastoma: identification of complex lncRNA regulatory networks and clinically relevant lncRNAs in glioblastoma.	Oncotarget	2	2018 Jul 3	glioma	CDKN2A
29564591	Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations.	Acta Neuropathol	17	2018 Aug	glioma	CDKN2A
30401645	Comprehensive analysis of Reverse Phase Protein Array data reveals characteristic unique proteomic signatures for glioblastoma subtypes.	Gene	1	2019 Feb 15	glioma	CDKN2A
29355710	HBP1 phosphorylation by AKT regulates its transcriptional activity and glioblastoma cell proliferation.	Cell Signal	1	2018 Apr	glioma	CDKN2A
29288440	Functional requirement of a wild-type allele for mutant IDH1 to suppress anchorage-independent growth through redox homeostasis.	Acta Neuropathol	1	2018 Feb	glioma	CDKN2A
31428092	Immune Cytolytic Activity Is Associated With Genetic and Clinical Properties of Glioma.	Front Immunol		2019	glioma	CDKN2A
31417657	The Loss of &lt;i&gt;SMAD4/DPC4&lt;/i&gt; Expression Associated with a Strongly Activated Hedgehog Signaling Pathway Predicts Poor Prognosis in Resected Pancreatic Cancer.	J Cancer		2019	glioma	CDKN2A
31214915	Evaluation of EZH2 expression, BRAF V600E mutation, and CDKN2A/B deletions in epithelioid glioblastoma and anaplastic pleomorphic xanthoastrocytoma.	J Neurooncol		2019 Aug	glioma	CDKN2A
31157866	Systematically characterize the clinical and biological significances of 1p19q genes in 1p/19q non-codeletion glioma.	Carcinogenesis		2019 Jun 3	glioma	CDKN2A
31104347	High-grade neuroepithelial tumor with BCOR exon 15 internal tandem duplication-a comprehensive clinical, radiographic, pathologic, and genomic analysis.	Brain Pathol		2019 May 18	glioma	CDKN2A
30558563	BRAF V600E mutation and 9p21: CDKN2A/B and MTAP co-deletions - Markers in the clinical stratification of pediatric gliomas.	BMC Cancer		2018 Dec 17	glioma	CDKN2A
30535594	Comprehensive genetic alteration profiling in primary and recurrent glioblastoma.	J Neurooncol		2019 Mar	glioma	CDKN2A
30416682	IDH1&lt;sup&gt;R132H&lt;/sup&gt; is intrinsically tumor-suppressive but functionally attenuated by the glutamate-rich cerebral environment.	Oncotarget		2018 Oct 12	glioma	CDKN2A
30222900	Granular cell astrocytoma: an aggressive IDH-wildtype diffuse glioma with molecular genetic features of primary glioblastoma.	Brain Pathol		2019 Mar	glioma	CDKN2A
29769617	A new method of identifying glioblastoma subtypes and creation of corresponding animal models.	Oncogene		2018 Aug	glioma	CDKN2A
29728520	&lt;i&gt;FGFR1&lt;/i&gt; actionable mutations, molecular specificities, and outcome of adult midline gliomas.	Neurology		2018 Jun 5	glioma	CDKN2A
20534551	Pattern of retinoblastoma pathway inactivation dictates response to CDK4/6 inhibition in GBM.	Proc Natl Acad Sci U S A	77	2010 Jun 22	glioma	CDKN2C
16260494	The tumor suppressors Ink4c and p53 collaborate independently with Patched to suppress medulloblastoma formation.	Genes Dev	69	2005 Nov 15	glioma	CDKN2C
18394558	Feedback circuit among INK4 tumor suppressors constrains human glioblastoma development.	Cancer Cell	61	2008 Apr	glioma	CDKN2C
22711607	p16-Cdk4-Rb axis controls sensitivity to a cyclin-dependent kinase inhibitor PD0332991 in glioblastoma xenograft cells.	Neuro Oncol	51	2012 Jul	glioma	CDKN2C
28181325	Recurrent copy number alterations in low-grade and anaplastic pleomorphic xanthoastrocytoma with and without BRAF V600E mutation.	Brain Pathol	4	2018 Mar	glioma	CDKN2C
12187958	Immunohistochemical markers for prognosis of oligodendroglial neoplasms.	J Neurooncol	4	2002 Jul	glioma	CDKN2C
17363588	Genetic alterations in mouse medulloblastomas and generation of tumors de novo from primary cerebellar granule neuron precursors.	Cancer Res	38	2007 Mar 15	glioma	CDKN2C
18398573	Gene expression profile analysis of primary glioblastomas and non-neoplastic brain tissue: identification of potential target genes by oligonucleotide microarray and real-time quantitative PCR.	J Neurooncol	36	2008 Jul	glioma	CDKN2C
20516124	Atoh1 inhibits neuronal differentiation and collaborates with Gli1 to generate medulloblastoma-initiating cells.	Cancer Res	31	2010 Jul 1	glioma	CDKN2C
19147535	Two tumor suppressors, p27Kip1 and patched-1, collaborate to prevent medulloblastoma.	Mol Cancer Res	29	2009 Jan	glioma	CDKN2C
18381405	Identification of p18 INK4c as a tumor suppressor gene in glioblastoma multiforme.	Cancer Res	23	2008 Apr 15	glioma	CDKN2C
27172220	Copy Number Profiling of Brazilian Astrocytomas.	G3 (Bethesda)	2	2016 Jul 7	glioma	CDKN2C
12698196	Antitumour effect of cyclin-dependent kinase inhibitors (p16(INK4A), p18(INK4C), p19(INK4D), p21(WAF1/CIP1) and p27(KIP1)) on malignant glioma cells.	Br J Cancer	17	2003 Apr 22	glioma	CDKN2C
12548606	Low expression of p27 indicates a poor prognosis in patients with high-grade astrocytomas.	Cancer	14	2003 Feb 1	glioma	CDKN2C
27165745	Integrated Genomics for Pinpointing Survival Loci within Arm-Level Somatic Copy Number Alterations.	Cancer Cell	12	2016 May 9	glioma	CDKN2C
21807073	Candidate genes influencing sensitivity and resistance of human glioblastoma to Semustine.	Brain Res Bull	12	2011 Oct 10	glioma	CDKN2C
19805107	Inhibition of Hsp90 via 17-DMAG induces apoptosis in a p53-dependent manner to prevent medulloblastoma.	Proc Natl Acad Sci U S A	11	2009 Oct 6	glioma	CDKN2C
16479172	The CDK inhibitor p18Ink4c is a tumor suppressor in medulloblastoma.	Cell Cycle	10	2006 Feb	glioma	CDKN2C
11800646	Immunohistochemical analysis of p18INK4C and p14ARF protein expression in 117 oligodendrogliomas: correlation with tumor grade and clinical outcome.	Arch Pathol Lab Med	1	2002 Jan	glioma	CDKN2C
30592284	miRâ34a derived from mesenchymal stem cells stimulates senescence in glioma cells by inducing DNA damage.	Mol Med Rep		2019 Mar	glioma	CDKN2C
25950430	The Effects and Molecular Mechanisms of MiR-106a in Multidrug Resistance Reversal in Human Glioma U87/DDP and U251/G Cell Lines.	PLoS One	6	2015	glioma	CDX2
26526635	Construction and analysis of dynamic transcription factor regulatory networks in the progression of glioma.	Sci Rep	5	2015 Nov 3	glioma	CDX2
20536385	Wild type p53-dependent transcriptional upregulation of cathepsin L expression is mediated by C/EBP&amp;amp;#x03B1; in human glioblastoma cells.	Biol Chem	4	2010 Sep	glioma	CEBPA
29464001	PIWIL3/OIP5-AS1/miR-367-3p/CEBPA feedback loop regulates the biological behavior of glioma cells.	Theranostics	10	2018	glioma	CEBPA
27346347	Oncogenic EGFR Represses the TET1 DNA Demethylase to Induce Silencing of Tumor Suppressors in Cancer Cells.	Cell Rep	10	2016 Jul 12	glioma	CEBPA
29543748	Allopregnanolone Alters the Gene Expression Profile of Human Glioblastoma Cells.	Int J Mol Sci		2018 Mar 15	glioma	CEBPA
28498432	Time-Â and oxygen-dependent expression and regulation of NDRG1 in human brain cancer cells.	Oncol Rep		2017 Jun	glioma	CEBPA
22095529	Resveratrol acts as a topoisomerase II poison in human glioma cells.	Int J Cancer	9	2012 Aug 1	glioma	CHEK2
19969004	Chk2 down-regulation by promoter hypermethylation in human bulk gliomas.	Life Sci	6	2010 Jan 30	glioma	CHEK2
17980860	Enhanced radiation-induced cytotoxic effect by 2-ME in glioma cells is mediated by induction of cell cycle arrest and DNA damage via activation of ATM pathways.	Brain Res	6	2007 Dec 14	glioma	CHEK2
17016233	Variant of the CHEK2 gene as a prognostic marker in glioblastoma multiforme.	Neurosurgery	5	2006 Nov	glioma	CHEK2
15930307	Akt activation suppresses Chk2-mediated, methylating agent-induced G2 arrest and protects from temozolomide-induced mitotic catastrophe and cellular senescence.	Cancer Res	48	2005 Jun 1	glioma	CHEK2
24880341	Exome sequencing identifies somatic gain-of-function PPM1D mutations in brainstem gliomas.	Nat Genet	41	2014 Jul	glioma	CHEK2
18955550	Sonic Hedgehog signaling impairs ionizing radiation-induced checkpoint activation and induces genomic instability.	J Cell Biol	26	2008 Nov 3	glioma	CHEK2
28852018	Ape1 guides DNA repair pathway choice that is associated with drug tolerance in glioblastoma.	Sci Rep	2	2017 Aug 29	glioma	CHEK2
23568705	MicroRNAs involved in chemo- and radioresistance of high-grade gliomas.	Tumour Biol	16	2013 Aug	glioma	CHEK2
22481303	Knockdown of checkpoint kinase 1 is associated with the increased radiosensitivity of glioblastoma stem-like cells.	Tohoku J Exp Med	11	2012 Apr	glioma	CHEK2
30338650	Loss of GINS2 inhibits cell proliferation and tumorigenesis in human gliomas.	CNS Neurosci Ther	1	2019 Feb	glioma	CHEK2
30077762	A four-protein expression prognostic signature predicts clinical outcome of lower-grade glioma.	Gene		2018 Dec 30	glioma	CHEK2
26357005	ETV/Pea3 family transcription factor-encoding genes are overexpressed in CIC-mutant oligodendrogliomas.	Genes Chromosomes Cancer	9	2015 Dec	glioma	CIC
28827401	Inactivation of Capicua in adult mice causes T-cell lymphoblastic lymphoma.	Genes Dev	7	2017 Jul 15	glioma	CIC
28939681	&lt;i&gt;Cic&lt;/i&gt; Loss Promotes Gliomagenesis via Aberrant Neural Stem Cell Proliferation and Differentiation.	Cancer Res	6	2017 Nov 15	glioma	CIC
26061751	Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.	N Engl J Med	527	2015 Jun 25	glioma	CIC
29245920	NAMPT overexpression induces cancer stemness and defines a novel tumor signature for glioma prognosis.	Oncotarget	5	2017 Nov 21	glioma	CIC
25314060	TERT promoter mutations in gliomas, genetic associations and clinico-pathological correlations.	Br J Cancer	43	2014 Nov 11	glioma	CIC
28295365	Comparative transcriptome analysis of isogenic cell line models and primary cancers links capicua (CIC) loss to activation of the MAPK signalling cascade.	J Pathol	4	2017 Jun	glioma	CIC
25694352	Tumor-specific mutations in low-frequency genes affect their functional properties.	J Neurooncol	4	2015 May	glioma	CIC
25468223	Glioma biology and molecular markers.	Cancer Treat Res	38	2015	glioma	CIC
26017892	CIC inactivating mutations identify aggressive subset of 1p19q codeleted gliomas.	Ann Neurol	21	2015 Sep	glioma	CIC
24637491	A mesenchymal glioma stem cell profile is related to clinical outcome.	Oncogenesis	21	2014 Mar 17	glioma	CIC
28768910	Sexual dimorphism in glioma glycolysis underlies sex differences in survival.	JCI Insight	2	2017 Aug 3	glioma	CIC
25085214	Olig2 labeling index is correlated with histological and molecular classifications in low-grade diffuse gliomas.	J Neurooncol	2	2014 Nov	glioma	CIC
25277207	Mutations in CIC and IDH1 cooperatively regulate 2-hydroxyglutarate levels and cell clonogenicity.	Oncotarget	10	2014 Sep 15	glioma	CIC
30895378	DNA methylation profiling distinguishes Ewing-like sarcoma with EWSR1-NFATc2 fusion from Ewing sarcoma.	J Cancer Res Clin Oncol	1	2019 May	glioma	CIC
30093628	Transcriptomic analysis of CIC and ATXN1L reveal a functional relationship exploited by cancer.	Oncogene	1	2019 Jan	glioma	CIC
31043608	Capicua regulates neural stem cell proliferation and lineage specification through control of Ets factors.	Nat Commun		2019 May 1	glioma	CIC
30737375	CIC protein instability contributes to tumorigenesis in glioblastoma.	Nat Commun		2019 Feb 8	glioma	CIC
30222900	Granular cell astrocytoma: an aggressive IDH-wildtype diffuse glioma with molecular genetic features of primary glioblastoma.	Brain Pathol		2019 Mar	glioma	CIC
29050068	[Diagnostic and prognostic roles of loss of CIC protein expression in oligodendroglial tumors].	Zhonghua Bing Li Xue Za Zhi		2017 Oct 8	glioma	CIC
10022534	Tumor gene therapy made easy: allogeneic major histocompatibility complex in the C6 rat glioma model.	Hum Gene Ther	9	1999 Jan 1	glioma	CIITA
14966870	Regulation of MHC class II expression in glioma cells by class II transactivator (CIITA).	Glia	6	2004 Mar	glioma	CIITA
9916712	IL-1 beta inhibits IFN-gamma-induced class II MHC expression by suppressing transcription of the class II transactivator gene.	J Immunol	6	1999 Jan 15	glioma	CIITA
9421426	Major histocompatibility class II HLA-DR alpha gene expression in thyrocytes: counter regulation by the class II transactivator and the thyroid Y box protein.	Endocrinology	5	1998 Jan	glioma	CIITA
9036950	TGF-beta suppresses IFN-gamma induction of class II MHC gene expression by inhibiting class II transactivator messenger RNA expression.	J Immunol	36	1997 Mar 1	glioma	CIITA
12507768	Toxoplasma gondii inhibits MHC class II expression in neural antigen-presenting cells by down-regulating the class II transactivator CIITA.	J Neuroimmunol	24	2003 Jan	glioma	CIITA
30131377	TLR2 Promotes Glioma Immune Evasion by Downregulating MHC Class II Molecules in Microglia.	Cancer Immunol Res	2	2018 Oct	glioma	CIITA
8759739	Stat1 alpha expression is involved in IFN-gamma induction of the class II transactivator and class II MHC genes.	J Immunol	19	1996 Aug 15	glioma	CIITA
11746775	Malignant glioma cells use MHC class II transactivator (CIITA) promoters III and IV to direct IFN-gamma-inducible CIITA expression and can function as nonprofessional antigen presenting cells in endocytic processing and CD4(+) T-cell activation.	Glia	12	2001 Dec	glioma	CIITA
9630166	Kinase inhibitors abrogate IFN-gamma-induced class II transactivator and class II MHC gene expression in astroglioma cell lines.	J Neuroimmunol	1	1998 May 15	glioma	CIITA
24716865	OASIS regulates chondroitin 6-O-sulfotransferase 1 gene transcription in the injured adult mouse cerebral cortex.	J Neurochem	4	2014 Sep	glioma	CREB3L1
29631562	Comparative analysis of histologically classified oligodendrogliomas reveals characteristic molecular differences between subgroups.	BMC Cancer	2	2018 Apr 10	glioma	CREB3L1
23335989	OASIS/CREB3L1 is induced by endoplasmic reticulum stress in human glioma cell lines and contributes to the unfolded protein response, extracellular matrix production and cell migration.	PLoS One	12	2013	glioma	CREB3L1
29531016	CREB3L1 and PTN expressions correlate with prognosis of brain glioma patients.	Biosci Rep		2018 May 29	glioma	CREB3L1
28460484	The Î²-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner.	Oncotarget	7	2017 Apr 18	glioma	CREBBP
21295555	Riluzole-induced glial cell line-derived neurotrophic factor production is regulated through fibroblast growth factor receptor signaling in rat C6 glioma cells.	Brain Res	6	2011 Apr 12	glioma	CREBBP
21852380	Oncogene AEG-1 promotes glioma-induced neurodegeneration by increasing glutamate excitotoxicity.	Cancer Res	40	2011 Oct 15	glioma	CREBBP
24810017	BASI, a potent small molecular inhibitor, inhibits glioblastoma progression by targeting microRNA-mediated Î²-catenin signaling.	CNS Neurosci Ther	3	2014 Sep	glioma	CREBBP
23408876	Linking proteomic and transcriptional data through the interactome and epigenome reveals a map of oncogene-induced signaling.	PLoS Comput Biol	28	2013	glioma	CREBBP
24252690	Identification of a neuronal transcription factor network involved in medulloblastoma development.	Acta Neuropathol Commun	17	2013 Jul 11	glioma	CREBBP
11907158	Ethanol stimulates cAMP-responsive element (CRE)-mediated transcription via CRE-binding protein and cAMP-dependent protein kinase.	J Pharmacol Exp Ther	16	2002 Apr	glioma	CREBBP
16632469	CAAT/enhancer-binding protein delta and cAMP-response element-binding protein mediate inducible expression of the nerve growth factor gene in the central nervous system.	J Biol Chem	15	2006 Jun 30	glioma	CREBBP
24710217	The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes.	Nat Commun	111	2014 Apr 8	glioma	CREBBP
24877714	Effect of Tenuifoliside A isolated from Polygala tenuifolia on the ERK and PI3K pathways in C6 glioma cells.	Phytomedicine	10	2014 Sep 15	glioma	CREBBP
15967875	Thromboxane A2 promotes interleukin-6 biosynthesis mediated by an activation of cyclic AMP-response element-binding protein in 1321N1 human astrocytoma cells.	Mol Pharmacol	10	2005 Sep	glioma	CREBBP
18599546	Temporal recruitment of transcription factors at the 3',5'-cyclic adenosine 5'-monophosphate-response element of the human GnRH-II promoter.	Endocrinology	1	2008 Oct	glioma	CREBBP
16838434	ACHE gene expression in human brain tumors involves alternative splicing and CREB-induced proliferative signals.	Isr Med Assoc J		2006 May	glioma	CREBBP
29549165	Bivalent Chromatin Domains in Glioblastoma Reveal a Subtype-Specific Signature of Glioma Stem Cells.	Cancer Res	3	2018 May 15	glioma	CTCF
26856236	Oncometabolite Tinkers with Genome Folding, Boosting Oncogene Expression.	Trends Mol Med	3	2016 Mar	glioma	CTCF
22544282	Integrating role of T antigen, Rb2/p130, CTCF and BORIS in mediating non-canonical endoplasmic reticulum-dependent death pathways triggered by chronic ER stress in mouse medulloblastoma.	Cell Cycle	3	2012 May 1	glioma	CTCF
26700815	Insulator dysfunction and oncogene activation in IDH mutant gliomas.	Nature	221	2016 Jan 7	glioma	CTCF
26983574	Epigenetic silencing of miR-181c by DNA methylation in glioblastoma cell lines.	BMC Cancer	12	2016 Mar 16	glioma	CTCF
21663659	Gain of DNA methylation is enhanced in the absence of CTCF at the human retinoblastoma gene promoter.	BMC Cancer	11	2011 Jun 10	glioma	CTCF
31288858	Clustered protocadherins methylation alterations in cancer.	Clin Epigenetics		2019 Jul 9	glioma	CTCF
26859452	Bringing IDH into the Fold.	Cancer Cell		2016 Feb 8	glioma	CTCF
29331585	Cathepsin L promotes ionizing radiation-induced U251 glioma cell migration and invasion through regulating the GSK-3Î²/CUX1 pathway.	Cell Signal	3	2018 Apr	glioma	CUX1
29036362	CUX1 stimulates APE1 enzymatic activity and increases the resistance of glioblastoma cells to the mono-alkylating agent temozolomide.	Neuro Oncol	2	2018 Mar 27	glioma	CUX1
25096634	The transcription factor Cux1 in cerebellar granule cell development and medulloblastoma pathogenesis.	Cerebellum	1	2014 Dec	glioma	CUX1
31377983	Upregulated Expression of CUX1 Correlates with Poor Prognosis in Glioma Patients: a Bioinformatic Analysis.	J Mol Neurosci		2019 Aug 3	glioma	CUX1
25071012	Hypoxia suppresses cylindromatosis (CYLD) expression to promote inflammation in glioblastoma: possible link to acquired resistance to anti-VEGF therapy.	Oncotarget	7	2014 Aug 15	glioma	CYLD
23006329	TGF-Î² induces miR-182 to sustain NF-ÎºB activation in glioma subsets.	J Clin Invest	67	2012 Oct	glioma	CYLD
28534976	miR-130b regulates the proliferation, invasion and apoptosis of glioma cells via targeting of CYLD.	Oncol Rep	5	2017 Jul	glioma	CYLD
23034333	MicroRNA-10b pleiotropically regulates invasion, angiogenicity and apoptosis of tumor cells resembling mesenchymal subtype of glioblastoma multiforme.	Cell Death Dis	43	2012 Oct 4	glioma	CYLD
23247627	miR-486 sustains NF-ÎºB activity by disrupting multiple NF-ÎºB-negative feedback loops.	Cell Res	36	2013 Feb	glioma	CYLD
28901464	MicroRNAâ1288 promotes cell proliferation of human glioblastoma cells by repressing ubiquitin carboxylâterminal hydrolase CYLD expression.	Mol Med Rep	2	2017 Nov	glioma	CYLD
27671304	Dehydroleucodine Induces a TP73-dependent Transcriptional Regulation of Multiple Cell Death Target Genes in Human Glioblastoma Cells.	Anticancer Agents Med Chem	1	2017	glioma	CYLD
29934657	A case of multiple familial trichoepitheliomas responding to treatment with the Hedgehog signaling pathway inhibitor vismodegib.	Virchows Arch		2018 Aug	glioma	CYLD
27153061	Inhibition of REST Suppresses Proliferation and Migration in Glioblastoma Cells.	Int J Mol Sci	9	2016 May 3	glioma	DAXX
22286061	Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma.	Nature	643	2012 Jan 29	glioma	DAXX
28064387	The role of histone modifications and telomere alterations in the pathogenesis of diffuse gliomas in adults and children.	J Neurooncol	6	2017 Mar	glioma	DAXX
28135248	Systematic analysis of telomere length and somatic alterations in 31 cancer types.	Nat Genet	52	2017 Mar	glioma	DAXX
29973652	Subependymal giant cell astrocytoma-like astrocytoma: a neoplasm with a distinct phenotype and frequent neurofibromatosis type-1-association.	Mod Pathol	5	2018 Dec	glioma	DAXX
23530248	TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal.	Proc Natl Acad Sci U S A	383	2013 Apr 9	glioma	DAXX
15126347	Microarray-based screening for molecular markers in medulloblastoma revealed STK15 as independent predictor for survival.	Cancer Res	33	2004 May 1	glioma	DAXX
22928601	Molecular and morphologic correlates of the alternative lengthening of telomeres phenotype in high-grade astrocytomas.	Brain Pathol	31	2013 May	glioma	DAXX
24445767	Molecular genetics of gliomas.	Cancer J	27	2014 Jan-Feb	glioma	DAXX
17938171	A suppressive role of the prolyl isomerase Pin1 in cellular apoptosis mediated by the death-associated protein Daxx.	J Biol Chem	23	2007 Dec 14	glioma	DAXX
26833422	ATRX in Diffuse Gliomas With its Mosaic/Heterogeneous Expression in a Subset.	Brain Pathol	2	2017 Mar	glioma	DAXX
28497778	PTEN regulates glioblastoma oncogenesis through chromatin-associated complexes of DAXX and histone H3.3.	Nat Commun	19	2017 May 12	glioma	DAXX
26022452	Alternative lengthening of telomeres and loss of ATRX are frequent events in pleomorphic and dedifferentiated liposarcomas.	Mod Pathol	14	2015 Aug	glioma	DAXX
25479829	Altered global histone-trimethylation code and H3F3A-ATRX mutation in pediatric GBM.	J Neurooncol	12	2015 Feb	glioma	DAXX
27228211	Further understanding of the pathology of glioma: implications for the clinic.	Expert Rev Neurother	1	2016 Sep	glioma	DAXX
28040793	TERT Promoter Mutations but not the Alternative Lengthening of Telomeres Phenotype Are Present in a Subset of Ependymomas and Are Associated With Adult Onset and Progression to Ependymosarcoma.	J Neuropathol Exp Neurol		2017 Jan 1	glioma	DAXX
28061476	MiR-675-5p supports hypoxia induced epithelial to mesenchymal transition in colon cancer cells.	Oncotarget	9	2017 Apr 11	glioma	DDB2
28378638	Expression signatures of DNA repair genes correlate with survival prognosis of astrocytoma patients.	Tumour Biol	6	2017 Apr	glioma	DDB2
16247447	Identification of novel genomic markers related to progression to glioblastoma through genomic profiling of 25 primary glioma cell lines.	Oncogene	40	2006 Mar 9	glioma	DDB2
18089819	Differential sensitivity of malignant glioma cells to methylating and chloroethylating anticancer drugs: p53 determines the switch by regulating xpc, ddb2, and DNA double-strand breaks.	Cancer Res	28	2007 Dec 15	glioma	DDB2
24608801	RNA binding protein-mediated post-transcriptional gene regulation in medulloblastoma.	Mol Cells	8	2014 May	glioma	DDX3X
26184164	DDX3X Biomarker Correlates with Poor Survival in Human Gliomas.	Int J Mol Sci	5	2015 Jul 9	glioma	DDX3X
21237216	The role of DDX3 in regulating Snail.	Biochim Biophys Acta	29	2011 Mar	glioma	DDX3X
22832583	Dissecting the genomic complexity underlying medulloblastoma.	Nature	287	2012 Aug 2	glioma	DDX3X
24651015	Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition.	Cancer Cell	171	2014 Mar 17	glioma	DDX3X
25724843	Cancer-associated mutants of RNA helicase DDX3X are defective in RNA-stimulated ATP hydrolysis.	J Mol Biol	15	2015 May 8	glioma	DDX3X
27058758	Medulloblastoma-associated DDX3 variant selectively alters the translational response to stress.	Oncotarget	13	2016 May 10	glioma	DDX3X
27180681	Cancer-associated DDX3X mutations drive stress granule assembly and impair global translation.	Sci Rep	12	2016 May 16	glioma	DDX3X
26598523	Autoinhibitory Interdomain Interactions and Subfamily-specific Extensions Redefine the Catalytic Core of the Human DEAD-box Protein DDX3.	J Biol Chem	10	2016 Jan 29	glioma	DDX3X
29582169	Medulloblastoma, WNT-activated/SHH-activated: clinical impact of molecular analysis and histogenetic evaluation.	Childs Nerv Syst		2018 May	glioma	DDX3X
19520829	Dicer-regulated microRNAs 222 and 339 promote resistance of cancer cells to cytotoxic T-lymphocytes by down-regulation of ICAM-1.	Proc Natl Acad Sci U S A	71	2009 Jun 30	glioma	DICER1
23811941	AC1MMYR2, an inhibitor of dicer-mediated biogenesis of Oncomir miR-21, reverses epithelial-mesenchymal transition and suppresses tumor growth and progression.	Cancer Res	54	2013 Sep 1	glioma	DICER1
30621721	MOV10 binding circ-DICER1 regulates the angiogenesis of glioma via miR-103a-3p/miR-382-5p mediated ZIC4 expression change.	J Exp Clin Cancer Res	4	2019 Jan 8	glioma	DICER1
26773048	MicroRNA Biogenesis and Hedgehog-Patched Signaling Cooperate to Regulate an Important Developmental Transition in Granule Cell Development.	Genetics	3	2016 Mar	glioma	DICER1
25323651	Drosophila oncogene Gas41 is an RNA interference modulator that intersects heterochromatin and the small interfering RNA pathway.	FEBS J	3	2015 Jan	glioma	DICER1
17663465	Markers of mRNA stabilization and degradation, and RNAi within astrocytoma GW bodies.	J Neurosci Res	12	2007 Dec	glioma	DICER1
19806572	[The effect of silencing Dicer by small interference RNA on the biological characteristics of human glioma cells].	Zhonghua Yi Xue Yi Chuan Xue Za Zhi	1	2009 Oct	glioma	DICER1
27421140	DICER governs characteristics of glioma stem cells and the resulting tumors in xenograft mouse models of glioblastoma.	Oncotarget		2016 Aug 30	glioma	DICER1
1	Exosomes impact survival to radiation exposure in cell line models of nervous system cancer.	Oncotarget	2	2018 Nov 16	glioma	DNM2
29861161	MLL4 Is Required to Maintain Broad H3K4me3 Peaks and Super-Enhancers at Tumor Suppressor Genes.	Mol Cell	9	2018 Jun 7	glioma	DNMT3A
27212030	Integrative functional genomic analysis identifies epigenetically regulated fibromodulin as an essential gene for glioma cell migration.	Oncogene	7	2017 Jan 5	glioma	DNMT3A
26892683	Expression of DNA methyltransferases 1 and 3B correlates with EZH2 and this 3-marker epigenetic signature predicts outcome in glioblastomas.	Exp Mol Pathol	6	2016 Apr	glioma	DNMT3A
21229291	Epigenetic regulation of DNA methyltransferases: DNMT1 and DNMT3B in gliomas.	J Neurooncol	35	2011 Sep	glioma	DNMT3A
17653095	Loss of pericentromeric DNA methylation pattern in human glioblastoma is associated with altered DNA methyltransferases expression and involves the stem cell compartment.	Oncogene	26	2008 Jan 10	glioma	DNMT3A
21364627	Impact of the DNA methyltransferases expression on the methylation status of apoptosis-associated genes in glioblastoma multiforme.	Cell Death Dis	22	2010	glioma	DNMT3A
19451595	Folate supplementation limits the aggressiveness of glioma via the remethylation of DNA repeats element and genes governing apoptosis and proliferation.	Clin Cancer Res	21	2009 May 15	glioma	DNMT3A
30323870	MicroRNA-129-5p inhibits human glioma cell proliferation and induces cell cycle arrest by directly targeting DNMT3A.	Am J Transl Res	2	2018	glioma	DNMT3A
28454437	Polycomb group expression signatures in the malignant progression of gliomas.	Oncol Lett	2	2017 Apr	glioma	DNMT3A
23051921	PGE2 induces interleukin-8 derepression in human astrocytoma through coordinated DNA demethylation and histone hyperacetylation.	Epigenetics	15	2012 Nov	glioma	DNMT3A
25829251	MiR-101 reverses the hypomethylation of the LMO3 promoter in glioma cells.	Oncotarget	14	2015 Apr 10	glioma	DNMT3A
25349213	Loss of nucleolar histone chaperone NPM1 triggers rearrangement of heterochromatin and synergizes with a deficiency in DNA methyltransferase DNMT3A to drive ribosomal DNA transcription.	J Biol Chem	13	2014 Dec 12	glioma	DNMT3A
26701852	miR-101 reverses hypomethylation of the PRDM16 promoter to disrupt mitochondrial function in astrocytoma cells.	Oncotarget	10	2016 Jan 26	glioma	DNMT3A
25625222	miR-29s inhibit the malignant behavior of U87MG glioblastoma cell line by targeting DNMT3A and 3B.	Neurosci Lett	10	2015 Mar 17	glioma	DNMT3A
27543768	High expression of DNA methyltransferases in primary human medulloblastoma.	Folia Neuropathol	1	2016	glioma	DNMT3A
28530704	Upregulation of CYP17A1 by Sp1-mediated DNA demethylation confers temozolomide resistance through DHEA-mediated protection in glioma.	Oncogenesis		2017 May 22	glioma	DNMT3A
28986522	Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism.	Nat Commun	8	2017 Oct 6	glioma	DROSHA
26121981	DEAD-box RNA helicase DDX23 modulates glioma malignancy via elevating miR-21 biogenesis.	Brain	8	2015 Sep	glioma	DROSHA
19520829	Dicer-regulated microRNAs 222 and 339 promote resistance of cancer cells to cytotoxic T-lymphocytes by down-regulation of ICAM-1.	Proc Natl Acad Sci U S A	71	2009 Jun 30	glioma	DROSHA
23811941	AC1MMYR2, an inhibitor of dicer-mediated biogenesis of Oncomir miR-21, reverses epithelial-mesenchymal transition and suppresses tumor growth and progression.	Cancer Res	54	2013 Sep 1	glioma	DROSHA
30621721	MOV10 binding circ-DICER1 regulates the angiogenesis of glioma via miR-103a-3p/miR-382-5p mediated ZIC4 expression change.	J Exp Clin Cancer Res	4	2019 Jan 8	glioma	DROSHA
26773048	MicroRNA Biogenesis and Hedgehog-Patched Signaling Cooperate to Regulate an Important Developmental Transition in Granule Cell Development.	Genetics	3	2016 Mar	glioma	DROSHA
25323651	Drosophila oncogene Gas41 is an RNA interference modulator that intersects heterochromatin and the small interfering RNA pathway.	FEBS J	3	2015 Jan	glioma	DROSHA
26766590	MiR-215 Is Induced Post-transcriptionally via HIF-Drosha Complex and Mediates Glioma-Initiating Cell Adaptation to Hypoxia by Targeting KDM1B.	Cancer Cell	24	2016 Jan 11	glioma	DROSHA
26240386	Genome-wide analysis of YB-1-RNA interactions reveals a novel role of YB-1 in miRNA processing in glioblastoma multiforme.	Nucleic Acids Res	13	2015 Sep 30	glioma	DROSHA
17663465	Markers of mRNA stabilization and degradation, and RNAi within astrocytoma GW bodies.	J Neurosci Res	12	2007 Dec	glioma	DROSHA
19806572	[The effect of silencing Dicer by small interference RNA on the biological characteristics of human glioma cells].	Zhonghua Yi Xue Yi Chuan Xue Za Zhi	1	2009 Oct	glioma	DROSHA
27421140	DICER governs characteristics of glioma stem cells and the resulting tumors in xenograft mouse models of glioblastoma.	Oncotarget		2016 Aug 30	glioma	DROSHA
1	Meta-analysis of IDH-mutant cancers identifies EBF1 as an interaction partner for TET2.	Nat Commun	54	2013	glioma	EBF1
25823503	Eukaryotic initiation factor 3C silencing inhibits cell proliferation and promotes apoptosis in human glioma.	Oncol Rep	7	2015 Jun	glioma	EIF3E
26137101	Eukaryotic translation initiation factor 3, subunit C is overexpressed and promotes cell proliferation in human glioma U-87 MG cells.	Oncol Lett	6	2015 Jun	glioma	EIF3E
18232056	Unique proteomic features induced by a potential antiglioma agent, Nordy (dl-nordihydroguaiaretic acid), in glioma cells.	Proteomics	3	2008 Feb	glioma	EIF3E
25682860	RNAi-Mediated Silencing of EIF3D Alleviates Proliferation and Migration of Glioma U251 and U87MG Cells.	Chem Biol Drug Des	2	2015 Oct	glioma	EIF3E
22234522	Knockdown of eukaryotic translation initiation factors 3B (EIF3B) inhibits proliferation and promotes apoptosis in glioblastoma cells.	Neurol Sci	13	2012 Oct	glioma	EIF3E
24481065	Int6/eIF3e is essential for proliferation and survival of human glioblastoma cells.	Int J Mol Sci	10	2014 Jan 29	glioma	EIF3E
31171919	Systematically profiling the expression of eIF3 subunits in glioma reveals the expression of eIF3i has prognostic value in IDH-mutant lower grade glioma.	Cancer Cell Int		2019	glioma	EIF3E
27900644	Elevated levels of p-Mnk1, p-eIF4E and p-p70S6K proteins are associated with tumor recurrence and poor prognosis in astrocytomas.	J Neurooncol	8	2017 Feb	glioma	ELF4
29535786	Association of Glioblastoma Multiforme Stem Cell Characteristics, Differentiation, and Microglia Marker Genes with Patient Survival.	Stem Cells Int	6	2018	glioma	ELF4
27440383	peIF4E as an independent prognostic factor and a potential therapeutic target in diffuse infiltrating astrocytomas.	Cancer Med	6	2016 Sep	glioma	ELF4
23217424	MEF promotes stemness in the pathogenesis of gliomas.	Cell Stem Cell	13	2012 Dec 7	glioma	ELF4
29991314	Whole-Genome mRNA Gene Expression Differs Between Patients With and Without Delirium.	J Geriatr Psychiatry Neurol		2018 Jul	glioma	ELF4
24465898	The role of factor inhibiting HIF (FIH-1) in inhibiting HIF-1 transcriptional activity in glioblastoma multiforme.	PLoS One	8	2014	glioma	EP300
30054476	A novel enhancer regulates MGMT expression and promotes temozolomide resistance in glioblastoma.	Nat Commun	6	2018 Jul 27	glioma	EP300
21489305	Discovering functional modules by identifying recurrent and mutually exclusive mutational patterns in tumors.	BMC Med Genomics	50	2011 Apr 14	glioma	EP300
18779315	The ING4 tumor suppressor attenuates NF-kappaB activity at the promoters of target genes.	Mol Cell Biol	47	2008 Nov	glioma	EP300
29084603	Characterizing temporal genomic heterogeneity in pediatric high-grade gliomas.	Acta Neuropathol Commun	4	2017 Oct 30	glioma	EP300
27633132	Combination of lentivirus-mediated silencing of PPM1D and temozolomide chemotherapy eradicates malignant glioma through cell apoptosis and cell cycle arrest.	Oncol Rep	3	2016 Nov	glioma	EP300
14712485	Fine mapping of chromosome 22q tumor suppressor gene candidate regions in astrocytoma.	Int J Cancer	3	2004 Mar 1	glioma	EP300
22923450	Arylsulfonamide KCN1 inhibits in vivo glioma growth and interferes with HIF signaling by disrupting HIF-1Î± interaction with cofactors p300/CBP.	Clin Cancer Res	25	2012 Dec 15	glioma	EP300
21304179	p300- and Myc-mediated regulation of glioblastoma multiforme cell differentiation.	Oncotarget	14	2010 Aug	glioma	EP300
24607407	Osteopontin-CD44 signaling in the glioma perivascular niche enhances cancer stem cell phenotypes and promotes aggressive tumor growth.	Cell Stem Cell	126	2014 Mar 6	glioma	EP300
21807073	Candidate genes influencing sensitivity and resistance of human glioblastoma to Semustine.	Brain Res Bull	12	2011 Oct 10	glioma	EP300
26972001	Retinoblastoma Binding Protein 4 Modulates Temozolomide Sensitivity in Glioblastoma by Regulating DNA Repair Proteins.	Cell Rep	11	2016 Mar 22	glioma	EP300
25909290	Expression alterations define unique molecular characteristics of spinal ependymomas.	Oncotarget	1	2015 Aug 14	glioma	EP300
31104347	High-grade neuroepithelial tumor with BCOR exon 15 internal tandem duplication-a comprehensive clinical, radiographic, pathologic, and genomic analysis.	Brain Pathol		2019 May 18	glioma	EP300
30366000	Bradykinin B1 receptor contributes to interleukin-8 production and glioblastoma migration through interaction of STAT3 and SP-1.	Neuropharmacology		2019 Jan	glioma	EP300
25875864	Resveratrol Represses Pokemon Expression in Human Glioma Cells.	Mol Neurobiol		2016 Mar	glioma	EP300
23407894	Expression of histone acetylases p300 and PCAF in pediatric astrocytomas.	Childs Nerv Syst		2013 Jul	glioma	EP300
17982672	Oncostatin M-induced genes in human astrocytomas.	Int J Oncol	5	2007 Dec	glioma	EPAS1
28302031	HIF1A is Overexpressed in Medulloblastoma and its Inhibition Reduces Proliferation and Increases EPAS1 and ATG16L1 Methylation.	Curr Cancer Drug Targets	3	2018	glioma	EPAS1
26735018	An ID2-dependent mechanism for VHL inactivation in cancer.	Nature	26	2016 Jan 14	glioma	EPAS1
24994751	Decreased expression of cystathionine Î²-synthase promotes glioma tumorigenesis.	Mol Cancer Res	13	2014 Oct	glioma	EPAS1
26255341	INHIBITION OF ERN1 SIGNALING ENZYME AFFECTS HYPOXIC REGULATION OF THE EXPRESSION OF E2F8, EPAS1, HOXC6, ATF3, TBX3 AND FOXF1 GENES IN U87 GLIOMA CELLS.	Ukr Biochem J	1	2015 Mar-Apr	glioma	EPAS1
29537195	Expression of proliferation related transcription factor genes in U87 glioma cells with IRE1 knockdown: upon glucose and glutamine deprivation.	Fiziol Zh		2016	glioma	EPAS1
24306026	Ehd3, a regulator of vesicular trafficking, is silenced in gliomas and functions as a tumor suppressor by controlling cell cycle arrest and apoptosis.	Carcinogenesis	5	2014 Apr	glioma	EPS15
10673336	EHD2, EHD3, and EHD4 encode novel members of a highly conserved family of EH domain-containing proteins.	Genomics	30	2000 Jan 15	glioma	EPS15
16101684	ApoER2 is endocytosed by a clathrin-mediated process involving the adaptor protein Dab2 independent of its Rafts' association.	Traffic	27	2005 Sep	glioma	EPS15
17919781	Internalization and degradation of the glutamate transporter GLT-1 in response to phorbol ester.	Neurochem Int	23	2008 Mar-Apr	glioma	EPS15
25859842	An open-label, two-stage, phase II study of bevacizumab and lapatinib in children with recurrent or refractory ependymoma: a collaborative ependymoma research network study (CERN).	J Neurooncol	9	2015 May	glioma	ERBB4
20467331	Differential distribution of erbB receptors in human glioblastoma multiforme: expression of erbB3 in CD133-positive putative cancer stem cells.	J Neuropathol Exp Neurol	9	2010 Jun	glioma	ERBB4
17987795	Coexpression of c-erbB 1-4 receptor proteins in human glioblastomas. An immunohistochemical study.	J Exp Clin Cancer Res	8	2007 Sep	glioma	ERBB4
19017278	Real-time quantitative polymerase chain reaction (qPCR) analysis with fluorescence resonance energy transfer (FRET) probes reveals differential expression of the four ERBB4 juxtamembrane region variants between medulloblastoma and pilocytic astrocytoma.	Neuropathol Appl Neurobiol	6	2009 Aug	glioma	ERBB4
17308352	Suppressors of hedgehog signaling: Linking aberrant development of neural progenitors and tumorigenesis.	Mol Neurobiol	6	2006 Dec	glioma	ERBB4
16097449	Epidermal growth factor receptor (EGFR) expression in childhood brain tumors.	In Vivo	6	2005 Sep-Oct	glioma	ERBB4
30205043	Aberrant ERBB4-SRC Signaling as a Hallmark of Group 4 Medulloblastoma Revealed by Integrative Phosphoproteomic Profiling.	Cancer Cell	5	2018 Sep 10	glioma	ERBB4
15148612	Epidermal growth factor receptor family (EGFR, ErbB2-4) in gliomas and meningiomas.	Acta Neuropathol	40	2004 Aug	glioma	ERBB4
17579610	Molecular dissection of NRG1-ERBB4 signaling implicates PTPRZ1 as a potential schizophrenia susceptibility gene.	Mol Psychiatry	30	2008 Feb	glioma	ERBB4
21361082	Prognostic significance of expression patterns of EGFR family, p21 and p27 in high-grade astrocytoma.	Hiroshima J Med Sci	3	2010 Dec	glioma	ERBB4
19793689	[Expression pattern of invasion-related molecules in brain tumors of different origin].	Magy Onkol	3	2009 Sep	glioma	ERBB4
17183845	Does c-erbB-2 expression have a role in medulloblastoma prognosis?	Indian J Pathol Microbiol	3	2006 Oct	glioma	ERBB4
16842254	Expression of c-erbB-4 in medulloblastoma and its correlation with prognosis.	Histopathology	3	2006 Jul	glioma	ERBB4
15492843	Molecular analysis of the erbB gene family calmodulin-binding and calmodulin-like domains in astrocytic gliomas.	Int J Oncol	3	2004 Nov	glioma	ERBB4
16878160	Alternative splicing of the ErbB-4 cytoplasmic domain and its regulation by hedgehog signaling identify distinct medulloblastoma subsets.	Oncogene	24	2006 Nov 23	glioma	ERBB4
15812817	Neuregulin-1 enhances survival of human astrocytic glioma cells.	Glia	15	2005 Aug 15	glioma	ERBB4
20331873	Overexpression of c-erbB2 is a negative prognostic factor in anaplastic astrocytomas.	Diagn Pathol	13	2010 Mar 23	glioma	ERBB4
21691733	Expression of stem cell marker and receptor kinase genes in glioblastoma tissue quantified by real-time RT-PCR.	Brain Tumor Pathol	12	2011 Oct	glioma	ERBB4
20535528	Molecular analysis of WWOX expression correlation with proliferation and apoptosis in glioblastoma multiforme.	J Neurooncol	12	2011 Jan	glioma	ERBB4
27258564	Identification of New Biomarkers Associated With IDH Mutation and Prognosis in Astrocytic Tumors Using NanoString nCounter Analysis System.	Appl Immunohistochem Mol Morphol		2018 Feb	glioma	ERBB4
17151930	Single nucleotide polymorphisms and expression of ERCC1 and ERCC2 vis-Ã -vis chemotherapy drug cytotoxicity in human glioma.	J Neurooncol	6	2007 May	glioma	ERCC2
26336131	Inhibition of DNA-repair genes Ercc1 and Mgmt enhances temozolomide efficacy in gliomas treatment: a pre-clinical study.	Oncotarget	5	2015 Oct 6	glioma	ERCC2
10738106	Absence of evidence for allelic loss or allelic gain for ERCC1 or for XPD in human ovarian cancer cells and tissues.	Cancer Lett	2	2000 Apr 14	glioma	ERCC2
8876669	Comparative analyses of relative ERCC3 and ERCC6 mRNA levels in gliomas and adjacent non-neoplastic brain.	Mol Carcinog	2	1996 Sep	glioma	ERCC2
12359753	Regulation of cisplatin resistance and homologous recombinational repair by the TFIIH subunit XPD.	Cancer Res	17	2002 Oct 1	glioma	ERCC2
17034947	Expression analyses of 27 DNA repair genes in astrocytoma by TaqMan low-density array.	Neurosci Lett	10	2006 Dec 1	glioma	ERCC2
9588557	Excision repair cross-complementing rodent repair deficiency gene 2 expression and chloroethylnitrosourea resistance in human glioma cell lines.	Neurosurgery	1	1998 May	glioma	ERCC2
21418965	[Comparison of MGMT and ERCCâ expression in temozolomide for the treatment of malignant glioma drug resistance and their genetic relationship].	Zhonghua Yi Xue Za Zhi		2011 Jan 4	glioma	ERCC2
9025907	Quantitation of ERCC-2 gene expression in human tumor cell lines by reverse transcription-polymerase chain reaction in comparison to northern blot analysis.	Anal Biochem		1997 Jan 1	glioma	ERCC2
8876669	Comparative analyses of relative ERCC3 and ERCC6 mRNA levels in gliomas and adjacent non-neoplastic brain.	Mol Carcinog	2	1996 Sep	glioma	ERCC3
17034947	Expression analyses of 27 DNA repair genes in astrocytoma by TaqMan low-density array.	Neurosci Lett	10	2006 Dec 1	glioma	ERCC3
9923544	Multiple DNA repair mechanisms and alkylator resistance in the human medulloblastoma cell line D-283 Med (4-HCR).	Cancer Chemother Pharmacol	5	1999	glioma	ERCC4
17034947	Expression analyses of 27 DNA repair genes in astrocytoma by TaqMan low-density array.	Neurosci Lett	10	2006 Dec 1	glioma	ERCC4
23374632	Gene expression changes associated with erlotinib response in glioma cell lines.	Eur J Cancer	8	2013 May	glioma	ERCC5
26338418	A common polymorphism in the 5' UTR of ERCC5 creates an upstream ORF that confers resistance to platinum-based chemotherapy.	Genes Dev	14	2015 Sep 15	glioma	ERCC5
23368093	Discovery and analysis of consistent active sub-networks in cancers.	BMC Bioinformatics	4	2013	glioma	ESR1
19399471	An expression module of WIPF1-coexpressed genes identifies patients with favorable prognosis in three tumor types.	J Mol Med (Berl)	25	2009 Jun	glioma	ESR1
27258564	Identification of New Biomarkers Associated With IDH Mutation and Prognosis in Astrocytic Tumors Using NanoString nCounter Analysis System.	Appl Immunohistochem Mol Morphol		2018 Feb	glioma	ESR1
30171197	Molecular characterization of cancers with NTRK gene fusions.	Mod Pathol	8	2019 Jan	glioma	ETV6
11508811	Identification of uncommon chromosomal aberrations in the neuroglioma cell line H4 by spectral karyotyping.	J Neurooncol	6	2001 Apr	glioma	ETV6
17265049	Ependymoma gene expression profiles associated with histological subtype, proliferation, and patient survival.	Acta Neuropathol	35	2007 Mar	glioma	ETV6
27426982	Causal Mechanistic Regulatory Network for Glioblastoma Deciphered Using Systems Genetics Network Analysis.	Cell Syst	18	2016 Aug	glioma	ETV6
29157673	Circulating microRNAs as Biomarkers for Pediatric Astrocytomas.	Arch Med Res	3	2017 May	glioma	EXT1
29104277	Heparan Sulfate Biosynthetic System Is Inhibited in Human Glioma Due to EXT1/2 and HS6ST1/2 Down-Regulation.	Int J Mol Sci	1	2017 Nov 1	glioma	EXT1
1	Heparan Sulfate Biosynthetic System Is Inhibited in Human Glioma Due to EXT1/2 and HS6ST1/2 Down-Regulation.	Int J Mol Sci	1	2017 Nov 1	glioma	EXT2
30683859	The functional synergism of microRNA clustering provides therapeutically relevant epigenetic interference in glioblastoma.	Nat Commun	4	2019 Jan 25	glioma	EZH2
31240814	Long non-coding RNA LINC00526 represses glioma progression via forming a double negative feedback loop with AXL.	J Cell Mol Med	2	2019 Aug	glioma	EZH2
30854231	Sustained NF-ÎºB-STAT3 signaling promotes resistance to Smac mimetics in Glioma stem-like cells but creates a vulnerability to EZH2 inhibition.	Cell Death Discov	2	2019	glioma	EZH2
30105866	Long noncoding RNA HOXB13-AS1 regulates HOXB13 gene methylation by interacting with EZH2 in glioma.	Cancer Med	2	2018 Sep	glioma	EZH2
31367244	A Compound AC1Q3QWB Selectively Disrupts HOTAIR-Mediated Recruitment of PRC2 and Enhances Cancer Therapy of DZNep.	Theranostics	1	2019	glioma	EZH2
30376874	Over-expressed lncRNA HOTAIRM1 promotes tumor growth and invasion through up-regulating HOXA1 and sequestering G9a/EZH2/Dnmts away from the HOXA1 gene in glioblastoma multiforme.	J Exp Clin Cancer Res	1	2018 Oct 30	glioma	EZH2
30131250	microRNA-124a suppresses PHF19 over-expression, EZH2 hyper-activation, and aberrant cell proliferation in human glioma.	Biochem Biophys Res Commun	1	2018 Sep 10	glioma	EZH2
31468686	Redistribution of EZH2 promotes malignant phenotypes by rewiring developmental programmes.	EMBO Rep		2019 Aug 29	glioma	EZH2
31434700	MELK mediates the stability of EZH2 through site-specific phosphorylation in extranodal natural killer/T-cell lymphoma.	Blood		2019 Aug 21	glioma	EZH2
31399646	Spermidine/spermine N1-acetyltransferase 1 is a gene-specific transcriptional regulator that drives brain tumor aggressiveness.	Oncogene		2019 Aug 9	glioma	EZH2
31214915	Evaluation of EZH2 expression, BRAF V600E mutation, and CDKN2A/B deletions in epithelioid glioblastoma and anaplastic pleomorphic xanthoastrocytoma.	J Neurooncol		2019 Aug	glioma	EZH2
31171769	Silencing of microRNA-708 promotes cell growth and epithelial-to-mesenchymal transition by activating the SPHK2/AKT/Î²-catenin pathway in glioma.	Cell Death Dis		2019 Jun 6	glioma	EZH2
31138033	MiR-32 Inhibits Proliferation and Metastasis by Targeting EZH2 in Glioma.	Technol Cancer Res Treat		2019 Jan-Dec	glioma	EZH2
31096221	Immunostaining of Increased Expression of Enhancer of Zeste Homolog 2 (EZH2) in Diffuse Midline Glioma H3K27M-Mutant Patients with Poor Survival.	Pathobiology		2019	glioma	EZH2
31086175	PFA ependymoma-associated protein EZHIP inhibits PRC2 activity through a H3 K27M-like mechanism.	Nat Commun		2019 May 13	glioma	EZH2
31043779	Targeting EZH2 for glioma therapy with a novel nanoparticle-siRNA complex.	Int J Nanomedicine		2019	glioma	EZH2
31008529	Polycomb complex mediated epigenetic reprogramming alters TGF-Î² signaling via a novel EZH2/miR-490/TGIF2 axis thereby inducing migration and EMT potential in glioblastomas.	Int J Cancer		2019 Sep 1	glioma	EZH2
30632221	Inhibition of enhancer of zest homologue 2 is a potential therapeutic target for high-MYC medulloblastoma.	Neuropathology		2019 Apr	glioma	EZH2
30425057	Aberrant Activation of Î²-Catenin Signaling Drives Glioma Tumorigenesis via USP1-Mediated Stabilization of EZH2.	Cancer Res		2019 Jan 1	glioma	EZH2
30305602	Effects of Enhancer of Zeste Homolog 2 (EZH2) Expression on Brain Glioma Cell Proliferation and Tumorigenesis.	Med Sci Monit		2018 Oct 11	glioma	EZH2
1	Radiosensitization of Glioblastoma Cells by a Novel DNA Methyltransferase-inhibiting Phthalimido-Alkanamide Derivative.	Anticancer Res		2019 Feb	glioma	FANCA
25351918	Evaluation of novel imidazotetrazine analogues designed to overcome temozolomide resistance and glioblastoma regrowth.	Mol Cancer Ther	8	2015 Jan	glioma	FANCD2
25337721	Downregulation of BRCA1-BRCA2-containing complex subunit 3 sensitizes glioma cells to temozolomide.	Oncotarget	7	2014 Nov 15	glioma	FANCD2
29973652	Subependymal giant cell astrocytoma-like astrocytoma: a neoplasm with a distinct phenotype and frequent neurofibromatosis type-1-association.	Mod Pathol	5	2018 Dec	glioma	FANCD2
25071006	FANCD2 re-expression is associated with glioma grade and chemical inhibition of the Fanconi Anaemia pathway sensitises gliomas to chemotherapeutic agents.	Oncotarget	5	2014 Aug 15	glioma	FANCD2
1	Subependymal giant cell astrocytoma-like astrocytoma: a neoplasm with a distinct phenotype and frequent neurofibromatosis type-1-association.	Mod Pathol	5	2018 Dec	glioma	FANCF
19273547	Transcriptional changes in U343 MG-a glioblastoma cell line exposed to ionizing radiation.	Hum Exp Toxicol	9	2008 Dec	glioma	FANCG
15899798	High-resolution genome-wide mapping of genetic alterations in human glial brain tumors.	Cancer Res	52	2005 May 15	glioma	FANCG
29973652	Subependymal giant cell astrocytoma-like astrocytoma: a neoplasm with a distinct phenotype and frequent neurofibromatosis type-1-association.	Mod Pathol	5	2018 Dec	glioma	FANCG
28359080	Lithium enhances the antitumour effect of temozolomide against TP53 wild-type glioblastoma cells via NFAT1/FasL signalling.	Br J Cancer	8	2017 May 9	glioma	FAS
29475910	Amentoflavone Induces Apoptosis and Inhibits NF-Ä¸B-modulated Anti-apoptotic Signaling in Glioblastoma Cells.	In Vivo	3	2018 Mar-Apr	glioma	FAS
27601165	Inhibition of fatty acid synthase suppresses neovascularization via regulating the expression of VEGF-A in glioma.	J Cancer Res Clin Oncol	3	2016 Dec	glioma	FAS
27175997	Saponin 6 derived from AnemoneÂ taipaiensis induces U87 human malignant glioblastoma cell apoptosis via regulation of Fas and Bclâ2 family proteins.	Mol Med Rep	3	2016 Jul	glioma	FAS
29324390	NFAT-1 hyper-activation by methionine enkephalin (MENK) significantly induces cell apoptosis of rats C6 glioma in vivo and in vitro.	Int Immunopharmacol	2	2018 Mar	glioma	FAS
27579489	Decitabine Treatment of Glioma-Initiating Cells Enhances Immune Recognition and Killing.	PLoS One	2	2016	glioma	FAS
30796178	The SIAH1-HIPK2-p53ser46 Damage Response Pathway is Involved in Temozolomide-Induced Glioblastoma Cell Death.	Mol Cancer Res	1	2019 May	glioma	FAS
30359578	C-27-carboxylated oleanane triterpenoids up-regulate TRAIL DISC assembly via p38 MAPK and CHOP-mediated DR5 expression in human glioblastoma cells.	Biochem Pharmacol	1	2018 Dec	glioma	FAS
29187439	Expression of FAS-L Differs from Primary to Relapsed Low-grade Gliomas and Predicts Progression-free Survival.	Anticancer Res	1	2017 Dec	glioma	FAS
29164574	Mechanism of As2O3 induces apoptosis of glioma U87 cells.	Eur Rev Med Pharmacol Sci	1	2017 Nov	glioma	FAS
28623138	HP1Î± is highly expressed in glioma cells and facilitates cell proliferation and survival.	Biochem Biophys Res Commun	1	2017 Aug 19	glioma	FAS
28618251	Overexpression of FADD and Caspase-8 inhibits proliferation and promotes apoptosis of human glioblastoma cells.	Biomed Pharmacother	1	2017 Sep	glioma	FAS
30915356	C&lt;sub&gt;18&lt;/sub&gt;H&lt;sub&gt;17&lt;/sub&gt;NO&lt;sub&gt;6&lt;/sub&gt; and Its Combination with Scutellarin Suppress the Proliferation and Induce the Apoptosis of Human Glioma Cells via Upregulation of Fas-Associated Factor 1 Expression.	Biomed Res Int		2019	glioma	FAS
30227940	RBM17 controls apoptosis and proliferation to promote Glioma progression.	Biochem Biophys Res Commun		2018 Oct 20	glioma	FAS
29436625	Allicin induces apoptosis through activation of both intrinsic and extrinsic pathways in glioma cells.	Mol Med Rep		2018 Apr	glioma	FAS
29159775	Toxic effects of phytol and retinol on human glioblastoma cells are associated with modulation of cholesterol and fatty acid biosynthetic pathways.	J Neurooncol		2018 Feb	glioma	FAS
28946550	HP1Î± is highly expressed in glioma cells and facilitates cell proliferation and survival.	Cancer Biomark		2017 Dec 6	glioma	FAS
28233371	T11TS repress gliomagenic apoptosis of bone marrow hematopoietic stem cells.	J Cell Physiol		2018 Jan	glioma	FAS
27255231	T11TS Treatment Augments Apoptosis of Glioma Associated Brain Endothelial Cells, Hint Toward Anti-Angiogenic Action in Glioma.	J Cell Physiol		2017 Mar	glioma	FAS
27176716	RNaseH2A is involved in human gliomagenesis through the regulation of cell proliferation and apoptosis.	Oncol Rep		2016 Jul	glioma	FAS
19126244	Frequent loss of heterozygosity and altered expression of the candidate tumor suppressor gene 'FAT' in human astrocytic tumors.	BMC Cancer	9	2009 Jan 7	glioma	FAT1
27536856	FAT1 is a novel upstream regulator of HIF1Î± and invasion of high grade glioma.	Int J Cancer	6	2016 Dec 1	glioma	FAT1
28994107	FAT1 modulates EMT and stemness genes expression in hypoxic glioblastoma.	Int J Cancer	3	2018 Feb 15	glioma	FAT1
22986533	FAT1 acts as an upstream regulator of oncogenic and inflammatory pathways, via PDCD4, in glioma cells.	Oncogene	13	2013 Aug 15	glioma	FAT1
27834469	The expression of FAT1 is associated with overall survival in children with medulloblastoma.	Tumori		2017 Jan 21	glioma	FAT1
1	Knock-Down of Endogenous Bornavirus-Like Nucleoprotein 1 Inhibits Cell Growth and Induces Apoptosis in Human Oligodendroglia Cells.	Int J Mol Sci	8	2016 Mar 24	glioma	FAT4
25589783	The oncogenic microRNA-21 inhibits the tumor suppressive activity of FBXO11 to promote tumorigenesis.	J Biol Chem	30	2015 Mar 6	glioma	FBXO11
24928548	Gene expression analysis in MCF-7 breast cancer cells treated with recombinant bromelain.	Appl Biochem Biotechnol	3	2014 Aug	glioma	FBXO11
17274947	The FBXW7 beta-form is suppressed in human glioma cells.	Biochem Biophys Res Commun	9	2007 Mar 23	glioma	FBXW7
28903484	Novel Role of FBXW7 Circular RNA in Repressing Glioma Tumorigenesis.	J Natl Cancer Inst	81	2018 Mar 1	glioma	FBXW7
25486598	Inhibition of the NOTCH pathway using Î³-secretase inhibitor RO4929097 has limited antitumor activity in established glial tumors.	Anticancer Drugs	8	2015 Mar	glioma	FBXW7
29427543	FBW7 is associated with prognosis, inhibits malignancies and enhances temozolomide sensitivity in glioblastoma cells.	Cancer Sci	5	2018 Apr	glioma	FBXW7
17326833	FBXW7/hCDC4 controls glioma cell proliferation in vitro and is a prognostic marker for survival in glioblastoma patients.	Cell Div	29	2007 Feb 27	glioma	FBXW7
27904771	Tumor-suppressive function of long noncoding RNA MALAT1 in glioma cells by suppressing miR-155 expression and activating FBXW7 function.	Am J Cancer Res	23	2016	glioma	FBXW7
18931460	Promoter hypermethylation is not the major mechanism for inactivation of the FBXW7 beta-form in human gliomas.	Genes Genet Syst	2	2008 Aug	glioma	FBXW7
25738367	MicroRNA-10b inhibition reduces E2F1-mediated transcription and miR-15/16 activity in glioblastoma.	Oncotarget	19	2015 Feb 28	glioma	FBXW7
16204036	Functional network analysis reveals extended gliomagenesis pathway maps and three novel MYC-interacting genes in human gliomas.	Cancer Res	111	2005 Oct 1	glioma	FBXW7
22986743	Gliomagenesis arising from Pten- and Ink4a/Arf-deficient neural progenitor cells is mediated by the p53-Fbxw7/Cdc4 pathway, which controls c-Myc.	Cancer Res	10	2012 Nov 15	glioma	FBXW7
31519156	FBXW7 circular RNA regulates proliferation, migration and invasion of colorectal carcinoma through NEK2, mTOR, and PTEN signaling pathways in vitro and in vivo.	BMC Cancer		2019 Sep 13	glioma	FBXW7
31258712	miR-25-3p promotes glioma cell proliferation and migration by targeting FBXW7 and DKK3.	Exp Ther Med		2019 Jul	glioma	FBXW7
15494095	Detrended fluctuation analysis of genome-wide copy number profiles of glioblastomas using array-based comparative genomic hybridization.	Neuro Oncol	4	2004 Oct	glioma	FES
21095843	Comparing finite elements and finite differences for developing diffusive models of glioma growth.	Conf Proc IEEE Eng Med Biol Soc		2010	glioma	FES
24552272	Small molecule-initiated light-activated semiconducting polymer dots: an integrated nanoplatform for targeted photodynamic therapy and imaging of cancer cells.	Anal Chem	9	2014 Mar 18	glioma	FH
27020328	Corticosteroids compromise survival in glioblastoma.	Brain	40	2016 May	glioma	FH
23707781	SDH mutations establish a hypermethylator phenotype in paraganglioma.	Cancer Cell	164	2013 Jun 10	glioma	FH
15340263	A homozygous MSH6 mutation in a child with cafÃ©-au-lait spots, oligodendroglioma and rectal cancer.	Fam Cancer	10	2004	glioma	FH
16616114	Methylation of RASSF1A and TRAIL pathway-related genes is frequent in childhood intracranial ependymomas and benign choroid plexus papilloma.	Cancer Genet Cytogenet	14	2006 Apr 1	glioma	FHIT
21928112	The promoter hypermethylation status of GATA6, MGMT, and FHIT in glioblastoma.	Cell Mol Neurobiol	12	2012 Mar	glioma	FHIT
19760177	FHIT gene sequence variants and reduced Fhit protein expression in glioblastoma multiforme.	Cell Mol Neurobiol	1	2010 Mar	glioma	FHIT
10023002	Abnormal transcripts of FHIT gene in Chinese brain tumors.	Oncol Rep		1999 Mar-Apr	glioma	FHIT
1	The role of the Birt-Hogg-DubÃ© protein in mTOR activation and renal tumorigenesis.	Oncogene	71	2009 Apr 2	glioma	FLCN
25566967	Fenofibrate induces G0/G1 phase arrest by modulating the PPARÎ±/FoxO1/p27 kip pathway in human glioblastoma cells.	Tumour Biol	7	2015 May	glioma	FOXO1
29867200	Decreased expression of ARHGAP15 promotes the development of colorectal cancer through PTEN/AKT/FOXO1 axis.	Cell Death Dis	6	2018 Jun 4	glioma	FOXO1
26977882	HDAC and PI3K Antagonists Cooperate to Inhibit Growth of MYC-Driven Medulloblastoma.	Cancer Cell	43	2016 Mar 14	glioma	FOXO1
27653874	NS1619 regulates the expression of caveolin-1 protein in a time-dependent manner via ROS/PI3K/PKB/FoxO1 signaling pathway in brain tumor microvascular endothelial cells.	J Neurol Sci	4	2016 Oct 15	glioma	FOXO1
27835585	Transcriptional repression of FOXO1 by KLF4 contributes to glioma progression.	Oncotarget	3	2016 Dec 6	glioma	FOXO1
27448972	FoxO proteins or loss of functional p53 maintain stemness of glioblastoma stem cells and survival after ionizing radiation plus PI3K/mTOR inhibition.	Oncotarget	3	2016 Aug 23	glioma	FOXO1
26449824	Caffeine-induced nuclear translocation of FoxO1 triggers Bim-mediated apoptosis in human glioblastoma cells.	Tumour Biol	3	2016 Mar	glioma	FOXO1
25597410	Decreased miRNA-637 is an unfavorable prognosis marker and promotes glioma cell growth, migration and invasion via direct targeting Akt1.	Oncogene	21	2015 Sep 17	glioma	FOXO1
28666797	GAS5 suppresses malignancy of human glioma stem cells via a miR-196a-5p/FOXO1 feedback loop.	Biochim Biophys Acta Mol Cell Res	16	2017 Oct	glioma	FOXO1
27035875	Curcumin induces G2/M arrest and triggers apoptosis via FoxO1 signaling in U87 human glioma cells.	Mol Med Rep	12	2016 May	glioma	FOXO1
30811978	Aberrant Active cis-Regulatory Elements Associated with Downregulation of RET Finger Protein Overcome Chemoresistance in Glioblastoma.	Cell Rep	1	2019 Feb 26	glioma	FOXO1
30272254	Trifluoperazine prevents FOXO1 nuclear excretion and reverses doxorubicin-resistance in the SHG44/DOX drug-resistant glioma cell line.	Int J Mol Med	1	2018 Dec	glioma	FOXO1
29207098	FOXO1 is crucial in glioblastoma cell tumorigenesis and regulates the expression of SIRT1 to suppress senescence in the brain.	Mol Med Rep	1	2018 Feb	glioma	FOXO1
31098771	LITAF Enhances Radiosensitivity of Human Glioma Cells via the FoxO1 Pathway.	Cell Mol Neurobiol		2019 Aug	glioma	FOXO1
30841958	miR-374a Inhibitor Enhances Etoposide-Induced Cytotoxicity Against Glioma Cells Through Upregulation of FOXO1.	Oncol Res		2019 Jun 21	glioma	FOXO1
30453847	Forced FoxO1:S&lt;sup&gt;249&lt;/sup&gt;V expression suppressed glioma cell proliferation through G2/M cell cycle arrests and increased apoptosis.	Neurol Res		2019 Feb	glioma	FOXO1
30254149	Cyclin F-Dependent Degradation of RBPJ Inhibits IDH1&lt;sup&gt;R132H&lt;/sup&gt;-Mediated Tumorigenesis.	Cancer Res		2018 Nov 15	glioma	FOXO1
30172378	FoxG1 facilitates proliferation and inhibits differentiation by downregulating FoxO/Smad signaling in glioblastoma.	Biochem Biophys Res Commun		2018 Sep 26	glioma	FOXO1
30024610	miR-135a inhibits glioma cell proliferation and invasion by directly targeting FOXO1.	Eur Rev Med Pharmacol Sci		2018 Jul	glioma	FOXO1
30015885	Candidate genes and microRNAs for glioma pathogenesis and prognosis based on gene expression profiles.	Mol Med Rep		2018 Sep	glioma	FOXO1
28295288	Overexpression of FoxO3a is associated with glioblastoma progression and predicts poor patient prognosis.	Int J Cancer	8	2017 Jun 15	glioma	FOXO3
26740175	Over-expression of CHAF1A promotes cell proliferation and apoptosis resistance in glioblastoma cells via AKT/FOXO3a/Bim pathway.	Biochem Biophys Res Commun	8	2016 Jan 22	glioma	FOXO3
23390247	Dual inactivation of Akt and ERK by TIC10 signals Foxo3a nuclear translocation, TRAIL gene induction, and potent antitumor effects.	Sci Transl Med	73	2013 Feb 6	glioma	FOXO3
25078449	Systemic approaches identify a garlic-derived chemical, Z-ajoene, as a glioblastoma multiforme cancer stem cell-specific targeting agent.	Mol Cells	6	2014 Jul	glioma	FOXO3
27050366	Cdc2-like kinase 2 is a key regulator of the cell cycle via FOXO3a/p27 in glioblastoma.	Oncotarget	5	2016 May 3	glioma	FOXO3
23034333	MicroRNA-10b pleiotropically regulates invasion, angiogenicity and apoptosis of tumor cells resembling mesenchymal subtype of glioblastoma multiforme.	Cell Death Dis	43	2012 Oct 4	glioma	FOXO3
23970205	microRNA-155 regulates cell proliferation and invasion by targeting FOXO3a in glioma.	Oncol Rep	40	2013 Nov	glioma	FOXO3
25129459	MicroRNA-184 promotes proliferation ability of glioma cells by regulating FOXO3.	Asian Pac J Trop Med	4	2014 Oct	glioma	FOXO3
27225222	Bioinformatic profiling identifies an immune-related risk signature for glioblastoma.	Neurology	32	2016 Jun 14	glioma	FOXO3
27840901	FOXO3a orchestrates glioma cell responses to starvation conditions and promotes hypoxia-induced cell death.	Int J Oncol	3	2016 Dec	glioma	FOXO3
27448972	FoxO proteins or loss of functional p53 maintain stemness of glioblastoma stem cells and survival after ionizing radiation plus PI3K/mTOR inhibition.	Oncotarget	3	2016 Aug 23	glioma	FOXO3
25823655	miR-93 promotes cell proliferation in gliomas through activation of PI3K/Akt signaling pathway.	Oncotarget	29	2015 Apr 10	glioma	FOXO3
22782899	Comparison of spheroids formed by rat glioma stem cells and neural stem cells reveals differences in glucose metabolism and promising therapeutic applications.	J Biol Chem	20	2012 Sep 28	glioma	FOXO3
28465359	Elevated FOXG1 and SOX2 in glioblastoma enforces neural stem cell identity through transcriptional control of cell cycle and epigenetic regulators.	Genes Dev	14	2017 Apr 15	glioma	FOXO3
28549468	MicroRNA-608 inhibits proliferation of bladder cancer via AKT/FOXO3a signaling pathway.	Mol Cancer	11	2017 May 26	glioma	FOXO3
23621269	AntagomiR-27a targets FOXO3a in glioblastoma and suppresses U87 cell growth in vitro and in vivo.	Asian Pac J Cancer Prev	11	2013	glioma	FOXO3
28554130	Betulinic acid derivative B10 inhibits glioma cell proliferation through suppression of SIRT1, acetylation of FOXO3a and upregulation of Bim/PUMA.	Biomed Pharmacother	1	2017 Aug	glioma	FOXO3
28260024	FoxO3a induces temozolomide resistance in glioblastoma cells via the regulation of Î²-catenin nuclear accumulation.	Oncol Rep	1	2017 Apr	glioma	FOXO3
27633065	FoxO3a mediates glioma cell invasion by regulating MMP9 expression.	Oncol Rep	1	2016 Nov	glioma	FOXO3
31053733	Lnc-TALC promotes O&lt;sup&gt;6&lt;/sup&gt;-methylguanine-DNA methyltransferase expression via regulating the c-Met pathway by competitively binding with miR-20b-3p.	Nat Commun		2019 May 3	glioma	FOXO3
29409329	Downregulation of MicroRNA 29a/b exacerbated diabetic retinopathy by impairing the function of MÃ¼ller cells via Forkhead box protein O4.	Diab Vasc Dis Res	4	2018 May	glioma	FOXO4
12782577	Analysis of the phosphatidylinositol 3'-kinase signaling pathway in glioblastoma patients in vivo.	Cancer Res	120	2003 Jun 1	glioma	FOXO4
28963932	FOXO4 expression is associated with the occurrence and outcome of seizures: An RNA-sequencing analysis of low-grade gliomas.	Seizure		2017 Nov	glioma	FOXO4
15368589	Gene therapy for malignant glioma using Sindbis vectors expressing a fusogenic membrane glycoprotein.	J Gene Med	5	2004 Oct	glioma	FUS
28408200	Angiogenesis-targeting microbubbles combined with ultrasound-mediated gene therapy in brain tumors.	J Control Release	4	2017 Jun 10	glioma	FUS
25153169	Evaluation of prognostic integrin Î±2Î²1 PET tracer and concurrent targeting delivery using focused ultrasound for brain glioma detection.	Mol Pharm	4	2014 Nov 3	glioma	FUS
12926233	Image-guided control of transgene expression based on local hyperthermia.	Mol Imaging	4	2003 Jan	glioma	FUS
29956460	Mechanisms of enhanced antiglioma efficacy of polysorbate 80-modified paclitaxel-loaded PLGA nanoparticles by focused ultrasound.	J Cell Mol Med	3	2018 Sep	glioma	FUS
11339897	Use of viral fusogenic membrane glycoproteins as novel therapeutic transgenes in gliomas.	Hum Gene Ther	28	2001 May 1	glioma	FUS
21630086	Further characterisation of the cellular activity of the DNA-PK inhibitor, NU7441, reveals potential cross-talk with homologous recombination.	Cancer Chemother Pharmacol	23	2012 Jan	glioma	FUS
12788648	Expression of a fusogenic membrane glycoprotein by an oncolytic herpes simplex virus potentiates the viral antitumor effect.	Mol Ther	22	2003 Jun	glioma	FUS
26429860	Focused ultrasound enhanced molecular imaging and gene therapy for multifusion reporter gene in glioma-bearing rat model.	Oncotarget	2	2015 Nov 3	glioma	FUS
12692867	Spatial and temporal control of transgene expression in vivo using a heat-sensitive promoter and MRI-guided focused ultrasound.	J Gene Med	15	2003 Apr	glioma	FUS
30895378	DNA methylation profiling distinguishes Ewing-like sarcoma with EWSR1-NFATc2 fusion from Ewing sarcoma.	J Cancer Res Clin Oncol	1	2019 May	glioma	FUS
30736838	FUS/circ_002136/miR-138-5p/SOX13 feedback loop regulates angiogenesis in Glioma.	J Exp Clin Cancer Res	1	2019 Feb 8	glioma	FUS
30305211	Noninvasive and Local Delivery of Adenoviral-Mediated Herpes Simplex Virus Thymidine Kinase to Treat Glioma Through Focused Ultrasound-Induced Blood-Brain Barrier Opening in Rats.	J Biomed Nanotechnol		2018 Dec 1	glioma	FUS
12816724	Molecular cloning and identification of the human interleukin 13 alpha 2 receptor (IL-13Ra2) promoter.	Neuro Oncol	9	2003 Jul	glioma	GATA3
28614770	Transcription factor GATA3 expression is induced by GLS2 overexpression in a glioblastoma cell line but is GLS2-independent in patient-derived glioblastoma.	J Physiol Pharmacol	1	2017 Apr	glioma	GATA3
31075138	CD276 and the gene signature composed of GATA3 and LGALS3 enable prognosis prediction of glioblastoma multiforme.	PLoS One		2019	glioma	GATA3
30868892	MiR-374b targets GATA3 to promote progression and development of glioblastoma via regulating SEMA3B.	Neoplasma		2019 Jul 23	glioma	GATA3
26934681	LOC283731 promoter hypermethylation prognosticates survival after radiochemotherapy in IDH1 wild-type glioblastoma patients.	Int J Cancer	8	2016 Jul 15	glioma	GPC3
25361488	Myelin-forming cell-specific cadherin-19 is a marker for minimally infiltrative glioblastoma stem-like cells.	J Neurosurg	5	2015 Jan	glioma	GPC3
24034848	[Short hairpin RNA mediated glypican-3 silencing inhibits hepatoma cell invasiveness and disrupts molecular pathways of angiogenesis].	Zhonghua Gan Zang Bing Za Zhi	1	2013 Jun	glioma	GPC3
1	Case Report: Next generation sequencing identifies a NAB2-STAT6 fusion in Glioblastoma.	Diagn Pathol	3	2016 Jan 27	glioma	HNF1A
19550145	A microarray-based DNA methylation study of glioblastoma multiforme.	Epigenetics	73	2009 May 16	glioma	HOXA11
29992790	HOXA11 antisense long noncoding RNA (HOXA11-AS): A promising lncRNA in human cancers.	Cancer Med	6	2018 Aug	glioma	HOXA11
26828136	A novel cell cycle-associated lncRNA, HOXA11-AS, is transcribed from the 5-prime end of the HOXA transcript and is a biomarker of progression in glioma.	Cancer Lett	45	2016 Apr 10	glioma	HOXA11
30064227	Long non-coding RNA homeobox (HOX) A11-AS promotes malignant progression of glioma by targeting miR-124-3p.	Neoplasma	2	2018	glioma	HOXA11
28832185	Long Noncoding RNA HOXA11-AS Functions as miRNA Sponge to Promote the Glioma Tumorigenesis Through Targeting miR-140-5p.	DNA Cell Biol	15	2017 Oct	glioma	HOXA11
28946213	Regulation of HOXA11-AS/miR-214-3p/EZH2 axis on the growth, migration and invasion of glioma cells.	Biomed Pharmacother	13	2017 Nov	glioma	HOXA11
27456940	Underexpression of HOXA11 Is Associated with Treatment Resistance and Poor Prognosis in Glioblastoma.	Cancer Res Treat	11	2017 Apr	glioma	HOXA11
29616096	A comprehensive analysis of the predicted targets of miR-642b-3p associated with the long non-coding RNA HOXA11-AS in NSCLC cells.	Oncol Lett	1	2018 May	glioma	HOXA11
30657566	The lncRNA HOXA11-AS promotes glioma cell growth and metastasis by targeting miR-130a-5p/HMGB2.	Eur Rev Med Pharmacol Sci		2019 Jan	glioma	HOXA11
28653605	WITHDRAWN: Knockdown of LncRNA HOXA11 Antisense Promotes Glioma Cell Apoptosis Via Sponging MiR-140-5p.	Oncol Res		2017 Jun 12	glioma	HOXA11
23954893	Mutant IDH1 promotes leukemogenesis in vivo and can be specifically targeted in human AML.	Blood	62	2013 Oct 17	glioma	HOXA9
20935218	MGMT-independent temozolomide resistance in pediatric glioblastoma cells associated with a PI3-kinase-mediated HOX/stem cell gene signature.	Cancer Res	55	2010 Nov 15	glioma	HOXA9
20068170	Reversing HOXA9 oncogene activation by PI3K inhibition: epigenetic mechanism and prognostic significance in human glioblastoma.	Cancer Res	47	2010 Jan 15	glioma	HOXA9
21339190	DNA hypermethylation profiles associated with glioma subtypes and EZH2 and IGFBP2 mRNA expression.	Neuro Oncol	28	2011 Mar	glioma	HOXA9
25762636	A transcriptomic signature mediated by HOXA9 promotes human glioblastoma initiation, aggressiveness and resistance to temozolomide.	Oncotarget	12	2015 Apr 10	glioma	HOXA9
29644006	The long non-coding RNA &lt;i&gt;HOTAIR&lt;/i&gt; is transcriptionally activated by HOXA9 and is an independent prognostic marker in patients with malignant glioma.	Oncotarget	1	2018 Mar 20	glioma	HOXA9
30536324	MiR-638 serves as a tumor suppressor by targeting HOXA9 in glioma.	Eur Rev Med Pharmacol Sci		2018 Nov	glioma	HOXA9
30031196	Is NF2 a Key Player of the Differentially Expressed Gene Between Spinal Cord Ependymoma and Intracranial Ependymoma?	World Neurosurg		2018 Oct	glioma	HOXA9
25785959	The Molecular Feature of HOX Gene Family in the Intramedullary Spinal Tumors.	Spine (Phila Pa 1976)		2017 Mar	glioma	HOXA9
23466061	Potential roles for Gfi1 in the pathogenesis and proliferation of glioma.	Med Hypotheses		2013 May	glioma	HOXA9
1	Differential correlation analysis of glioblastoma reveals immune ceRNA interactions predictive of patient survival.	BMC Bioinformatics	4	2017 Feb 28	glioma	IRF4
24584142	Downregulation of microRNA-431 by human interferon-Î² inhibits viability of medulloblastoma and glioblastoma cells via upregulation of SOCS6.	Int J Oncol	9	2014 May	glioma	JAK1
23387973	The microarray gene profiling analysis of glioblastoma cancer cells reveals genes affected by FAK inhibitor Y15 and combination of Y15 and temozolomide.	Anticancer Agents Med Chem	8	2014 Jan	glioma	JAK1
20371721	Sorafenib induces growth arrest and apoptosis of human glioblastoma cells through the dephosphorylation of signal transducers and activators of transcription 3.	Mol Cancer Ther	52	2010 Apr	glioma	JAK1
29155422	Secretion-mediated STAT3 activation promotes self-renewal of glioma stem-like cells during hypoxia.	Oncogene	5	2018 Feb 22	glioma	JAK1
25218441	Progesterone-induced blocking factor is hormonally regulated in human astrocytoma cells, and increases their growth through the IL-4R/JAK1/STAT6 pathway.	J Steroid Biochem Mol Biol	5	2014 Oct	glioma	JAK1
22027691	Therapeutic potential of AZD1480 for the treatment of human glioblastoma.	Mol Cancer Ther	41	2011 Dec	glioma	JAK1
26853466	HDAC7 inhibition resets STAT3 tumorigenic activity in human glioblastoma independently of EGFR and PTEN: new opportunities for selected targeted therapies.	Oncogene	4	2016 Aug 25	glioma	JAK1
21138870	Dietary curcumin attenuates glioma growth in a syngeneic mouse model by inhibition of the JAK1,2/STAT3 signaling pathway.	Clin Cancer Res	37	2010 Dec 1	glioma	JAK1
8798467	Characterization of beta-R1, a gene that is selectively induced by interferon beta (IFN-beta) compared with IFN-alpha.	J Biol Chem	34	1996 Sep 13	glioma	JAK1
15937643	Interferons upregulate thymidine phosphorylase expression via JAK-STAT-dependent transcriptional activation and mRNA stabilization in human glioblastoma cells.	J Neurooncol	3	2005 May	glioma	JAK1
22394507	Quercetin abrogates IL-6/STAT3 signaling and inhibits glioblastoma cell line growth and migration.	Exp Cell Res	27	2012 May 1	glioma	JAK1
24462646	Induction of autophagy biomarker BNIP3 requires a JAK2/STAT3 and MT1-MMP signaling interplay in Concanavalin-A-activated U87 glioblastoma cells.	Cell Signal	22	2014 May	glioma	JAK1
11284716	Differential effects of oncostatin M and leukaemia inhibitory factor expression in astrocytoma cells.	Biochem J	2	2001 Apr 15	glioma	JAK1
19345330	TGF-beta increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma.	Cancer Cell	150	2009 Apr 7	glioma	JAK1
25482928	Cucurbitacin-I inhibits Aurora kinase A, Aurora kinase B and survivin, induces defects in cell cycle progression and promotes ABT-737-induced cell death in a caspase-independent manner in malignant human glioma cells.	Cancer Biol Ther	10	2015	glioma	JAK1
22555804	Novel small molecular inhibitors disrupt the JAK/STAT3 and FAK signaling pathways and exhibit a potent antitumor activity in glioma cells.	Cancer Biol Ther	10	2012 Jun	glioma	JAK1
20135364	Activation of JAK/STAT signal pathway predicts poor prognosis of patients with gliomas.	Med Oncol	10	2011 Mar	glioma	JAK1
31241046	Knockdown long non-coding RNA PEG10 inhibits proliferation, migration and invasion of glioma cell line U251 by regulating miR-506.	Gen Physiol Biophys		2019 Jul	glioma	JAK1
25959841	Acrylamide inhibits cellular differentiation of human neuroblastoma and glioblastoma cells.	Food Chem Toxicol		2015 Aug	glioma	JAK1
11038252	Activation of the Jak-Stat- and MAPK-pathways by oncostatin M is not sufficient to cause growth inhibition of human glioma cells.	Brain Res Mol Brain Res		2000 Sep 15	glioma	JAK1
28415684	The long noncoding RNA linc-NeD125 controls the expression of medulloblastoma driver genes by microRNA sponge activity.	Oncotarget	9	2017 May 9	glioma	KDM6A
27989769	Adaptive Chromatin Remodeling Drives Glioblastoma Stem Cell Plasticity and Drug Tolerance.	Cell Stem Cell	43	2017 Feb 2	glioma	KDM6A
22832583	Dissecting the genomic complexity underlying medulloblastoma.	Nature	287	2012 Aug 2	glioma	KDM6A
23179372	OTX2 sustains a bivalent-like state of OTX2-bound promoters in medulloblastoma by maintaining their H3K27me3 levels.	Acta Neuropathol	14	2013 Mar	glioma	KDM6A
24710217	The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes.	Nat Commun	111	2014 Apr 8	glioma	KDM6A
22946929	2-Deoxy-D-glucose and 6-aminonicotinamide-mediated Nrf2 down regulation leads to radiosensitization of malignant cells via abrogation of GSH-mediated defense.	Free Radic Res	5	2012 Dec	glioma	KEAP1
21173573	Regulation of KEAP1 expression by promoter methylation in malignant gliomas and association with patient's outcome.	Epigenetics	40	2011 Mar	glioma	KEAP1
22982731	Neuroprotective cyclopentenone prostaglandins up-regulate neurotrophic factors in C6 glioma cells.	Brain Res	2	2012 Oct 30	glioma	KEAP1
28805788	Nrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosis.	Oncogenesis	19	2017 Aug 14	glioma	KEAP1
21596795	Nrf2 regulates NGF mRNA induction by carnosic acid in T98G glioblastoma cells and normal human astrocytes.	J Biochem	14	2011 Aug	glioma	KEAP1
25304134	Activation of the NRF2 pathway and its impact on the prognosis of anaplastic glioma patients.	Neuro Oncol	11	2015 Apr	glioma	KEAP1
25612817	Cytoprotection against beta-amyloid (AÎ²) peptide-mediated oxidative damage and autophagy by Keap1 RNAi in human glioma U87mg cells.	Neurosci Res	1	2015 May	glioma	KEAP1
28927033	All-trans retinoic acid enhances temozolomide-induced autophagy in human glioma cells U251 via targeting Keap1/Nrf2/ARE signaling pathway.	Oncol Lett		2017 Sep	glioma	KEAP1
26356851	Overexpression of miR-18a negatively regulates myocyte enhancer factor 2D to increase the permeability of the blood-tumor barrier via KrÃ¼ppel-like factor 4-mediated downregulation of zonula occluden-1, claudin-5, and occludin.	J Neurosci Res	6	2015 Dec	glioma	KLF4
27600094	Stem cell markers in glioma progression and recurrence.	Int J Oncol	5	2016 Nov	glioma	KLF4
30962630	Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39.	Nat Neurosci	3	2019 May	glioma	KLF4
29479058	Targeting UDP-Î±-D-glucose 6-dehydrogenase inhibits glioblastoma growth and migration.	Oncogene	3	2018 May	glioma	KLF4
27835585	Transcriptional repression of FOXO1 by KLF4 contributes to glioma progression.	Oncotarget	3	2016 Dec 6	glioma	KLF4
25605243	Targeting miR-381-NEFL axis sensitizes glioblastoma cells to temozolomide by regulating stemness factors and multidrug resistance factors.	Oncotarget	24	2015 Feb 20	glioma	KLF4
25651893	Expression and Functional Role of Reprogramming-Related Long Noncoding RNA (lincRNA-ROR) in Glioma.	J Mol Neurosci	23	2015 Jul	glioma	KLF4
29507094	KrÃ¼ppel-like factor 4 (KLF4) induces mitochondrial fusion and increases spare respiratory capacity of human glioblastoma cells.	J Biol Chem	2	2018 Apr 27	glioma	KLF4
28656310	KLF4 inhibits colorectal cancer cell proliferation dependent on NDRG2 signaling.	Oncol Rep	2	2017 Aug	glioma	KLF4
28256619	A Core Regulatory Circuit in Glioblastoma Stem Cells Links MAPK Activation to a Transcriptional Program of Neural Stem Cell Identity.	Sci Rep	2	2017 Mar 3	glioma	KLF4
25991553	Expression of the miR-302/367 cluster in glioblastoma cells suppresses tumorigenic gene expression patterns and abolishes transformation related phenotypes.	Int J Cancer	11	2015 Nov 15	glioma	KLF4
30563094	The Disruption of the Î²-Catenin/TCF-1/STAT3 Signaling Axis by 4-Acetylantroquinonol B Inhibits the Tumorigenesis and Cancer Stem-Cell-Like Properties of Glioblastoma Cells, In Vitro and In Vivo.	Cancers (Basel)	1	2018 Dec 5	glioma	KLF4
30058478	Analysis of KLF4 regulated genes in cancer cells reveals a role of DNA methylation in promoter- enhancer interactions.	Epigenetics	1	2018	glioma	KLF4
27585657	OCT4 spliced variants are highly expressed in brain cancer tissues and inhibition of OCT4B1 causes G2/M arrest in brain cancer cells.	J Neurooncol	1	2016 Dec	glioma	KLF4
31414341	Transcriptome analysis reveals the molecular mechanisms of combined gamma-tocotrienol and hydroxychavicol in preventing the proliferation of 1321N1, SW1783, and LN18 glioma cancer cells.	J Physiol Biochem		2019 Aug 14	glioma	KLF4
31378903	MiRNA-92a promotes cell proliferation and invasion through binding to KLF4 in glioma.	Eur Rev Med Pharmacol Sci		2019 Aug	glioma	KLF4
31078262	Gli signaling pathway modulates fibroblast activation and facilitates scar formation in pulmonary fibrosis.	Biochem Biophys Res Commun		2019 Jun 30	glioma	KLF4
30926789	Interleukin-8/CXCR2 signaling regulates therapy-induced plasticity and enhances tumorigenicity in glioblastoma.	Cell Death Dis		2019 Mar 29	glioma	KLF4
30837601	Molecular imaging HDACs class IIa expression-activity and pharmacologic inhibition in intracerebral glioma models in rats using PET/CT/(MRI) with [&lt;sup&gt;18&lt;/sup&gt;F]TFAHA.	Sci Rep		2019 Mar 5	glioma	KLF4
30658712	Reciprocal regulation of integrin Î²4 and KLF4 promotes gliomagenesis through maintaining cancer stem cell traits.	J Exp Clin Cancer Res		2019 Jan 18	glioma	KLF4
28166199	KLF6 depletion promotes NF-ÎºB signaling in glioblastoma.	Oncogene	8	2017 Jun 22	glioma	KLF6
21555372	Correlation of somatic mutation and expression identifies genes important in human glioblastoma progression and survival.	Cancer Res	68	2011 Jul 1	glioma	KLF6
21987444	LOH on 10p14-p15 targets the PFKFB3 gene locus in human glioblastomas.	Genes Chromosomes Cancer	6	2011 Dec	glioma	KLF6
20545576	Increased expression of the oncogenic KLF6-SV1 transcript in human glioblastoma.	Clin Chem Lab Med	6	2010 Aug	glioma	KLF6
15172991	KrÃ¼ppel-like factor 6 is frequently down-regulated and induces apoptosis in non-small cell lung cancer cells.	Cancer Res	48	2004 Jun 1	glioma	KLF6
17143513	KLF6: mutational analysis and effect on cancer cell proliferation.	Int J Oncol	4	2007 Jan	glioma	KLF6
17514651	Functional inactivation of the KLF6 tumor suppressor gene by loss of heterozygosity and increased alternative splicing in glioblastoma.	Int J Cancer	33	2007 Sep 15	glioma	KLF6
12740910	KLF6, a putative tumor suppressor gene, is mutated in astrocytic gliomas.	Int J Cancer	27	2003 Jul 10	glioma	KLF6
15064720	Suppression of glioblastoma tumorigenicity by the Kruppel-like transcription factor KLF6.	Oncogene	18	2004 Jun 24	glioma	KLF6
25230316	miR-101 acts as a tumor suppressor by targeting Kruppel-like factor 6 in glioblastoma stem cells.	CNS Neurosci Ther	16	2015 Jan	glioma	KLF6
25182666	MiR-181a regulates blood-tumor barrier permeability by targeting KrÃ¼ppel-like factor 6.	J Cereb Blood Flow Metab	12	2014 Nov	glioma	KLF6
31210314	Long noncoding RNA LINC00052 suppressed the proliferation, migration and invasion of glioma cells by upregulating KLF6.	Eur Rev Med Pharmacol Sci		2019 Jun	glioma	KLF6
29861161	MLL4 Is Required to Maintain Broad H3K4me3 Peaks and Super-Enhancers at Tumor Suppressor Genes.	Mol Cell	9	2018 Jun 7	glioma	KMT2D
26902498	Pygo2 functions as a prognostic factor for glioma due to its up-regulation of H3K4me3 and promotion of MLL1/MLL2 complex recruitment.	Sci Rep	6	2016 Feb 23	glioma	KMT2D
22832583	Dissecting the genomic complexity underlying medulloblastoma.	Nature	287	2012 Aug 2	glioma	KMT2D
10637508	MLL2, the second human homolog of the Drosophila trithorax gene, maps to 19q13.1 and is amplified in solid tumor cell lines.	Oncogene	27	1999 Dec 23	glioma	KMT2D
23685277	What causes relapses of autoimmune diseases? The etiological role of autoreactive T cells.	Autoimmun Rev	9	2013 Sep	glioma	LEF1
9570512	Human immunodeficiency virus type 1 long terminal repeat quasispecies differ in basal transcription and nuclear factor recruitment in human glial cells and lymphocytes.	J Biomed Sci	9	1998	glioma	LEF1
23707066	An aberrant transcription factor network essential for Wnt signaling and stem cell maintenance in glioblastoma.	Cell Rep	75	2013 May 30	glioma	LEF1
24876153	Protein tyrosine phosphatase receptor U (PTPRU) is required for glioma growth and motility.	Carcinogenesis	6	2014 Aug	glioma	LEF1
23429286	Wnt activation promotes neuronal differentiation of glioblastoma.	Cell Death Dis	40	2013 Feb 21	glioma	LEF1
29903919	Zeb1 potentiates genome-wide gene transcription with Lef1 to promote glioblastoma cell invasion.	EMBO J	4	2018 Aug 1	glioma	LEF1
19576519	Activation of Wnt/beta-catenin/Tcf signaling pathway in human astrocytomas.	Neurochem Int	38	2009 Sep	glioma	LEF1
22766851	MiR-218 reverses high invasiveness of glioblastoma cells by targeting             the oncogenic transcription factor LEF1.	Oncol Rep	35	2012 Sep	glioma	LEF1
27903708	Astrocyte Elevated Gene-1 Regulates Î²-Catenin Signaling to Maintain Glioma Stem-like Stemness and Self-Renewal.	Mol Cancer Res	2	2017 Feb	glioma	LEF1
19148749	Wnt/beta-catenin/Tcf signaling pathway activation in malignant progression of rat gliomas induced by transplacental N-ethyl-N-nitrosourea exposure.	Neurochem Res	17	2009 Jul	glioma	LEF1
11521197	Involvement of Wnt signaling pathway in murine medulloblastoma induced by human neurotropic JC virus.	Oncogene	16	2001 Aug 9	glioma	LEF1
25128061	LEF1 regulates glioblastoma cell proliferation, migration, invasion, and cancer stem-like cell self-renewal.	Tumour Biol	14	2014 Nov	glioma	LEF1
23695168	Downregulation of miR-452 promotes stem-like traits and tumorigenicity of gliomas.	Clin Cancer Res	14	2013 Jul 1	glioma	LEF1
24858819	Wnt signaling transcription factors TCF-1 and LEF-1 are upregulated in malignant astrocytic brain tumors.	Histol Histopathol	13	2014 Dec	glioma	LEF1
30563094	The Disruption of the Î²-Catenin/TCF-1/STAT3 Signaling Axis by 4-Acetylantroquinonol B Inhibits the Tumorigenesis and Cancer Stem-Cell-Like Properties of Glioblastoma Cells, In Vitro and In Vivo.	Cancers (Basel)	1	2018 Dec 5	glioma	LEF1
21922255	Increased Î²-catenin/Tcf signaling in pilocytic astrocytomas: a comparative study to distinguish pilocytic astrocytomas from low-grade diffuse astrocytomas.	Neurochem Res	1	2012 Jan	glioma	LEF1
31410149	MicroRNA-6852 suppresses glioma A172 cell proliferation and invasion by targeting LEF1.	Exp Ther Med		2019 Sep	glioma	LEF1
30530053	Attenuation of Tumor Suppressive Function of FBXO16 Ubiquitin Ligase Activates Wnt Signaling In Glioblastoma.	Neoplasia		2019 Jan	glioma	LEF1
30394013	Hypermethylation of Secreted Frizzled Related Protein 1 gene promoter in different astrocytoma grades.	Croat Med J		2018 Oct 31	glioma	LEF1
27834469	The expression of FAT1 is associated with overall survival in children with medulloblastoma.	Tumori		2017 Jan 21	glioma	LEF1
19216216	Expression of leucine-rich repeats and immunoglobulin-like domains (LRIG) proteins in human ependymoma relates to tumor location, WHO grade, and patient age.	Clin Neuropathol	5	2009 Jan-Feb	glioma	LRIG3
16532360	Perinuclear leucine-rich repeats and immunoglobulin-like domain proteins (LRIG1-3) as prognostic indicators in astrocytic tumors.	Acta Neuropathol	22	2006 Mar	glioma	LRIG3
22038358	Effect of over-expressed LRIG3 on cell cycle and survival of glioma cells.	J Huazhong Univ Sci Technolog Med Sci	2	2011 Oct	glioma	LRIG3
19448407	Effect of RNAi-mediated LRIG3 gene silencing on proliferation of glioma GL15 cells and expression of PCNA and Ki-67.	Ai Zheng	2	2009 Jan	glioma	LRIG3
24023893	Lrig2-deficient mice are protected against PDGFB-induced glioma.	PLoS One	18	2013	glioma	LRIG3
18992012	Cytoplasmic LRIG2 expression is associated with poor oligodendroglioma patient survival.	Neuropathology	17	2009 Jun	glioma	LRIG3
25180912	LRIG and cancer prognosis.	Acta Oncol	15	2014 Sep	glioma	LRIG3
19200647	Inhibition of LRIG3 gene expression via RNA interference modulates the proliferation, cell cycle, cell apoptosis, adhesion and invasion of glioblastoma cell (GL15).	Cancer Lett	10	2009 Jun 8	glioma	LRIG3
19224171	Effects of RNAi-mediated gene silencing of LRIG3 expression on cell cycle and survival of glioma cells.	J Huazhong Univ Sci Technolog Med Sci	1	2009 Feb	glioma	LRIG3
31245283	The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma.	Front Oncol		2019	glioma	LRIG3
18925709	[LRIG3 gene regulates biological activity of GL15 cell line].	Zhejiang Da Xue Xue Bao Yi Xue Ban		2008 Sep	glioma	LRIG3
19435819	High-resolution genomic copy number profiling of glioblastoma multiforme by single nucleotide polymorphism DNA microarray.	Mol Cancer Res	49	2009 May	glioma	LRP1B
16247447	Identification of novel genomic markers related to progression to glioblastoma through genomic profiling of 25 primary glioma cell lines.	Oncogene	40	2006 Mar 9	glioma	LRP1B
30414097	A cancer tissue-specific FAM72 expression profile defines a novel glioblastoma multiform (GBM) gene-mutation signature.	J Neurooncol	2	2019 Jan	glioma	LRP1B
26428308	LRP1B deletion is associated with poor outcome for glioblastoma patients.	J Neurol Sci	11	2015 Nov 15	glioma	LRP1B
1	The integrated landscape of driver genomic alterations in glioblastoma.	Nat Genet	139	2013 Oct	glioma	LZTR1
1	Intronic miR-744 Inhibits Glioblastoma Migration by Functionally Antagonizing Its Host Gene MAP2K4.	Cancers (Basel)	1	2018 Oct 25	glioma	MAP2K4
12692905	Involvement of calcium/calmodulin-dependent protein kinase II in the induction of mPer1.	J Neurosci Res	7	2003 May 1	glioma	MAP3K1
12421350	Activation of the rat dopamine D2 receptor promoter by mitogen-activated protein kinase and Ca2+/calmodulin-dependent protein kinase II pathways.	J Neurochem	7	2002 Nov	glioma	MAP3K1
30483764	Mitogen-activated kinase kinase kinase 1 inhibits hedgehog signaling and medulloblastoma growth through GLI1 phosphorylation.	Int J Oncol	4	2019 Feb	glioma	MAP3K1
31318172	Combined elevation of TRIB2 and MAP3K1 indicates poor prognosis and chemoresistance to temozolomide in glioblastoma.	CNS Neurosci Ther		2019 Jul 18	glioma	MAP3K1
30764877	Comprehensive gene expression meta-analysis identifies signature genes that distinguish microglia from peripheral monocytes/macrophages in health and glioma.	Acta Neuropathol Commun	3	2019 Feb 14	glioma	MAX
30718358	Targeting APLN/APLNR Improves Antiangiogenic Efficiency and Blunts Proinvasive Side Effects of VEGFA/VEGFR2 Blockade in Glioblastoma.	Cancer Res	3	2019 May 1	glioma	MAX
29276753	Indian Hedgehog Suppresses a Stromal Cell-Driven Intestinal Immune Response.	Cell Mol Gastroenterol Hepatol	3	2018	glioma	MAX
29161257	Regulation of cAMP and GSK3 signaling pathways contributes to the neuronal conversion of glioma.	PLoS One	3	2017	glioma	MAX
29016864	Loss of host-derived osteopontin creates a glioblastoma-promoting microenvironment.	Neuro Oncol	3	2018 Feb 19	glioma	MAX
29258295	Therapeutic targeting of ependymoma as informed by oncogenic enhancer profiling.	Nature	22	2018 Jan 4	glioma	MAX
29967069	A carcinogenic trigger to study the function of tumor suppressor genes in &lt;i&gt;Schmidtea mediterranea&lt;/i&gt;.	Dis Model Mech	2	2018 Aug 16	glioma	MAX
29632086	Athymic mice reveal a requirement for T-cell-microglia interactions in establishing a microenvironment supportive of &lt;i&gt;Nf1&lt;/i&gt; low-grade glioma growth.	Genes Dev	2	2018 Apr 1	glioma	MAX
28945795	Cellular heterogeneity contributes to subtype-specific expression of ZEB1 in human glioblastoma.	PLoS One	2	2017	glioma	MAX
28671669	Human SLFN5 is a transcriptional co-repressor of STAT1-mediated interferon responses and promotes the malignant phenotype in glioblastoma.	Oncogene	2	2017 Oct 26	glioma	MAX
30895378	DNA methylation profiling distinguishes Ewing-like sarcoma with EWSR1-NFATc2 fusion from Ewing sarcoma.	J Cancer Res Clin Oncol	1	2019 May	glioma	MAX
30584325	Expression of activating transcription factor 5 (ATF5) is increased in astrocytomas of different WHO grades and correlates with survival of glioblastoma patients.	Onco Targets Ther	1	2018	glioma	MAX
30366472	Intronic miR-744 Inhibits Glioblastoma Migration by Functionally Antagonizing Its Host Gene MAP2K4.	Cancers (Basel)	1	2018 Oct 25	glioma	MAX
30315471	Imaging Glioma Progression by Intravital Microscopy.	Methods Mol Biol	1	2019	glioma	MAX
30092720	Cancer Subtype Discovery Using Prognosis-Enhanced Neural Network Classifier in Multigenomic Data.	Technol Cancer Res Treat	1	2018 Jan 1	glioma	MAX
29427211	Treatment with 5-azacitidine delay growth of glioblastoma xenografts: a potential new treatment approach for glioblastomas.	J Cancer Res Clin Oncol	1	2018 May	glioma	MAX
31169500	GPIHBP1 expression in gliomas promotes utilization of lipoprotein-derived nutrients.	Elife		2019 Jun 6	glioma	MAX
31145643	Controlling distinct signaling states in cultured cancer cells provides a new platform for drug discovery.	FASEB J		2019 Aug	glioma	MAX
31125770	Expression of CD40 Correlates Negatively with Overall and Progression-Free Survival of Low- and High-Grade Gliomas.	World Neurosurg		2019 May 21	glioma	MAX
29633022	Association between mutant IDHs and tumorigenesis in gliomas.	Med Mol Morphol		2018 Dec	glioma	MAX
1	Cancer association study of aminoacyl-tRNA synthetase signaling network in glioblastoma.	PLoS One	7	2012	glioma	MED12
25525250	Use of human embryonic stem cells to model pediatric gliomas with H3.3K27M histone mutation.	Science	97	2014 Dec 19	glioma	MEN1
26902498	Pygo2 functions as a prognostic factor for glioma due to its up-regulation of H3K4me3 and promotion of MLL1/MLL2 complex recruitment.	Sci Rep	6	2016 Feb 23	glioma	MEN1
22970022	Expression and subcellular localization of menin in human cancer cells.	Exp Ther Med	2	2012 Jun	glioma	MEN1
24563334	LRRC4 haplotypes are associated with pituitary adenoma in a Chinese population.	Med Oncol	1	2014 Apr	glioma	MEN1
31383953	Abnormal expression of menin predicts the pathogenesis and poor prognosis of adult gliomas.	Cancer Gene Ther		2019 Aug 6	glioma	MEN1
11172596	Gene expression of angiogenesis related factors in glioma.	Int J Oncol		2001 Feb	glioma	MEN1
14712485	Fine mapping of chromosome 22q tumor suppressor gene candidate regions in astrocytoma.	Int J Cancer	3	2004 Mar 1	glioma	MKL1
29400712	Noncanonical hedgehog pathway activation through SRF-MKL1 promotes drug resistance in basal cell carcinomas.	Nat Med	14	2018 Mar	glioma	MKL1
25909290	Expression alterations define unique molecular characteristics of spinal ependymomas.	Oncotarget	1	2015 Aug 14	glioma	MKL1
1	Regulation of myeloid leukemia factor-1 interacting protein (MLF1IP) expression in glioblastoma.	Brain Res	12	2005 Jun 14	glioma	MLF1
25155585	Effects of temozolomide (TMZ) on the expression and interaction of heat shock proteins (HSPs) and DNA repair proteins in human malignant glioma cells.	Cell Stress Chaperones	8	2015 Mar	glioma	MLH1
26778701	Nimotuzumab enhances temozolomide-induced growth suppression of glioma cells expressing mutant EGFR in vivo.	Cancer Med	7	2016 Mar	glioma	MLH1
21425258	Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and recurrent glioblastomas.	Int J Cancer	65	2011 Aug 1	glioma	MLH1
24995467	Expression of DNA mismatch repair proteins MLH1, MSH2, and MSH6 in recurrent glioblastoma.	Neurol Res	6	2015 Feb	glioma	MLH1
24073290	Integrated analysis of mismatch repair system in malignant astrocytomas.	PLoS One	6	2013	glioma	MLH1
17498554	Cytogenetic and molecular genetic analyses of giant cell glioblastoma multiforme reveal distinct profiles in giant cell and non-giant cell subpopulations.	Cancer Genet Cytogenet	5	2007 May	glioma	MLH1
28371827	Mutational burden, immune checkpoint expression, and mismatch repair in glioma: implications for immune checkpoint immunotherapy.	Neuro Oncol	40	2017 Aug 1	glioma	MLH1
26967246	The clinical value of aberrant epigenetic changes of DNA damage repair genes in human cancer.	Oncotarget	24	2016 Jun 14	glioma	MLH1
23553268	Phase 2 study of dose-intense temozolomide in recurrent glioblastoma.	Neuro Oncol	24	2013 Jul	glioma	MLH1
17440981	Biallelic germline mutations of mismatch-repair genes: a possible cause for multiple pediatric malignancies.	Cancer	23	2007 Jun 1	glioma	MLH1
23255519	Anaplastic oligodendroglioma in an adolescent with Lynch syndrome.	Pediatr Blood Cancer	2	2013 Jun	glioma	MLH1
19101824	Homozygosity of MSH2 c.1906G--&amp;gt;C germline mutation is associated with childhood colon cancer, astrocytoma and signs of Neurofibromatosis type I.	Fam Cancer	2	2009	glioma	MLH1
24259277	Reduction of MLH1 and PMS2 confers temozolomide resistance and is associated with recurrence of glioblastoma.	Oncotarget	17	2013 Dec	glioma	MLH1
21637783	Microsatellite instability in pediatric high grade glioma is associated with genomic profile and differential target gene inactivation.	PLoS One	13	2011	glioma	MLH1
24105770	Multiplex mapping of chromatin accessibility and DNA methylation within targeted single molecules identifies epigenetic heterogeneity in neural stem cells and glioblastoma.	Genome Res	11	2014 Feb	glioma	MLH1
20223108	The expression of mismatch repair proteins MLH1, MSH2 and MSH6 correlates with the Ki67 proliferation index and survival in patients with recurrent glioblastoma.	Neurol Res	11	2010 Oct	glioma	MLH1
22976800	Mismatch repair deficiency: a temozolomide resistance factor in medulloblastoma cell lines that is uncommon in primary medulloblastoma tumours.	Br J Cancer	10	2012 Oct 9	glioma	MLH1
30230914	TGF-Î²/Smads Signaling Affects Radiation Response and Prolongs Survival by Regulating DNA Repair Genes in Malignant Glioma.	DNA Cell Biol	1	2018 Nov	glioma	MLH1
29509313	Creutzfeldt astrocytes may be seen in IDH-wildtype glioblastoma and retain expression of DNA repair and chromatin binding proteins.	Brain Pathol		2018 Nov	glioma	MLH1
20195615	An unusual loss of EGFR gene copy in glioblastoma multiforme in a child: a case report and analysis of a successfully derived HGG-02 cell line.	Childs Nerv Syst		2010 Jun	glioma	MLH1
25991676	Modulation of miR-21 signaling by MPS1 in human glioblastoma.	Oncotarget	8	2016 Aug 16	glioma	MSH2
25155585	Effects of temozolomide (TMZ) on the expression and interaction of heat shock proteins (HSPs) and DNA repair proteins in human malignant glioma cells.	Cell Stress Chaperones	8	2015 Mar	glioma	MSH2
18095118	Detection of genetic and chromosomal aberrations in medulloblastomas and primitive neuroectodermal tumors with DNA microarrays.	Brain Tumor Pathol	8	2006 Apr	glioma	MSH2
21425258	Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and recurrent glioblastomas.	Int J Cancer	65	2011 Aug 1	glioma	MSH2
24995467	Expression of DNA mismatch repair proteins MLH1, MSH2, and MSH6 in recurrent glioblastoma.	Neurol Res	6	2015 Feb	glioma	MSH2
24073290	Integrated analysis of mismatch repair system in malignant astrocytomas.	PLoS One	6	2013	glioma	MSH2
17498554	Cytogenetic and molecular genetic analyses of giant cell glioblastoma multiforme reveal distinct profiles in giant cell and non-giant cell subpopulations.	Cancer Genet Cytogenet	5	2007 May	glioma	MSH2
28371827	Mutational burden, immune checkpoint expression, and mismatch repair in glioma: implications for immune checkpoint immunotherapy.	Neuro Oncol	40	2017 Aug 1	glioma	MSH2
19127257	Temozolomide- and fotemustine-induced apoptosis in human malignant melanoma cells: response related to MGMT, MMR, DSBs, and p53.	Br J Cancer	31	2009 Jan 27	glioma	MSH2
23553268	Phase 2 study of dose-intense temozolomide in recurrent glioblastoma.	Neuro Oncol	24	2013 Jul	glioma	MSH2
23255519	Anaplastic oligodendroglioma in an adolescent with Lynch syndrome.	Pediatr Blood Cancer	2	2013 Jun	glioma	MSH2
19101824	Homozygosity of MSH2 c.1906G--&amp;gt;C germline mutation is associated with childhood colon cancer, astrocytoma and signs of Neurofibromatosis type I.	Fam Cancer	2	2009	glioma	MSH2
26025730	Minor Changes in Expression of the Mismatch Repair Protein MSH2 Exert a Major Impact on Glioblastoma Response to Temozolomide.	Cancer Res	19	2015 Aug 1	glioma	MSH2
21637783	Microsatellite instability in pediatric high grade glioma is associated with genomic profile and differential target gene inactivation.	PLoS One	13	2011	glioma	MSH2
20223108	The expression of mismatch repair proteins MLH1, MSH2 and MSH6 correlates with the Ki67 proliferation index and survival in patients with recurrent glioblastoma.	Neurol Res	11	2010 Oct	glioma	MSH2
23904372	MiR-21 mediates the radiation resistance of glioblastoma cells by regulating PDCD4 and hMSH2.	J Huazhong Univ Sci Technolog Med Sci	10	2013 Aug	glioma	MSH2
30230914	TGF-Î²/Smads Signaling Affects Radiation Response and Prolongs Survival by Regulating DNA Repair Genes in Malignant Glioma.	DNA Cell Biol	1	2018 Nov	glioma	MSH2
29302048	Diagnostic challenges in a child with early onset desmoplastic medulloblastoma and homozygous variants in MSH2 and MSH6.	Eur J Hum Genet	1	2018 Mar	glioma	MSH2
29845423	G6PD as a predictive marker for glioma risk, prognosis and chemosensitivity.	J Neurooncol		2018 Sep	glioma	MSH2
29509313	Creutzfeldt astrocytes may be seen in IDH-wildtype glioblastoma and retain expression of DNA repair and chromatin binding proteins.	Brain Pathol		2018 Nov	glioma	MSH2
26778701	Nimotuzumab enhances temozolomide-induced growth suppression of glioma cells expressing mutant EGFR in vivo.	Cancer Med	7	2016 Mar	glioma	MSH6
24995467	Expression of DNA mismatch repair proteins MLH1, MSH2, and MSH6 in recurrent glioblastoma.	Neurol Res	6	2015 Feb	glioma	MSH6
24073290	Integrated analysis of mismatch repair system in malignant astrocytomas.	PLoS One	6	2013	glioma	MSH6
22173583	Oncolytic virus-mediated manipulation of DNA damage responses: synergy with chemotherapy in killing glioblastoma stem cells.	J Natl Cancer Inst	41	2012 Jan 4	glioma	MSH6
28371827	Mutational burden, immune checkpoint expression, and mismatch repair in glioma: implications for immune checkpoint immunotherapy.	Neuro Oncol	40	2017 Aug 1	glioma	MSH6
30217967	PLK1 Inhibition Targets Myc-Activated Malignant Glioma Cells Irrespective of Mismatch Repair Deficiency-Mediated Acquired Resistance to Temozolomide.	Mol Cancer Ther	3	2018 Dec	glioma	MSH6
25078279	Novel MSH6 mutations in treatment-naÃ¯ve glioblastoma and anaplastic oligodendroglioma contribute to temozolomide resistance independently of MGMT promoter methylation.	Clin Cancer Res	21	2014 Sep 15	glioma	MSH6
29366782	Up-regulation of MSH6 is associated with temozolomide resistance in human glioblastoma.	Biochem Biophys Res Commun	2	2018 Feb 19	glioma	MSH6
29046615	Integrated genomic characterization of cancer genes in glioma.	Cancer Cell Int	2	2017	glioma	MSH6
23255519	Anaplastic oligodendroglioma in an adolescent with Lynch syndrome.	Pediatr Blood Cancer	2	2013 Jun	glioma	MSH6
26025730	Minor Changes in Expression of the Mismatch Repair Protein MSH2 Exert a Major Impact on Glioblastoma Response to Temozolomide.	Cancer Res	19	2015 Aug 1	glioma	MSH6
28831025	LncRNA-XIST interacts with &lt;i&gt;miR-29c&lt;/i&gt; to modulate the chemoresistance of glioma cell to TMZ through DNA mismatch repair pathway.	Biosci Rep	18	2017 Oct 31	glioma	MSH6
21637783	Microsatellite instability in pediatric high grade glioma is associated with genomic profile and differential target gene inactivation.	PLoS One	13	2011	glioma	MSH6
26466313	Recurrent Glioblastomas Reveal Molecular Subtypes Associated with Mechanistic Implications of Drug-Resistance.	PLoS One	11	2015	glioma	MSH6
29302048	Diagnostic challenges in a child with early onset desmoplastic medulloblastoma and homozygous variants in MSH2 and MSH6.	Eur J Hum Genet	1	2018 Mar	glioma	MSH6
21874248	Molecular characteristics of pediatric non-ependymal, nonâpilocytic gliomas associated with resistance to temozolomide.	Mol Med Rep	1	2011 Nov-Dec	glioma	MSH6
30867843	Oncogenic MSH6-CXCR4-TGFB1 Feedback Loop: A Novel Therapeutic Target of Photothermal Therapy in Glioblastoma Multiforme.	Theranostics		2019	glioma	MSH6
30077762	A four-protein expression prognostic signature predicts clinical outcome of lower-grade glioma.	Gene		2018 Dec 30	glioma	MSH6
29845423	G6PD as a predictive marker for glioma risk, prognosis and chemosensitivity.	J Neurooncol		2018 Sep	glioma	MSH6
29509313	Creutzfeldt astrocytes may be seen in IDH-wildtype glioblastoma and retain expression of DNA repair and chromatin binding proteins.	Brain Pathol		2018 Nov	glioma	MSH6
26336131	Inhibition of DNA-repair genes Ercc1 and Mgmt enhances temozolomide efficacy in gliomas treatment: a pre-clinical study.	Oncotarget	5	2015 Oct 6	glioma	MUTYH
29923053	Reduced expression of DNA repair genes and chemosensitivity in 1p19q codeleted lower-grade gliomas.	J Neurooncol	1	2018 Sep	glioma	MUTYH
1	Case Report: Next generation sequencing identifies a NAB2-STAT6 fusion in Glioblastoma.	Diagn Pathol	3	2016 Jan 27	glioma	NAB2
21297581	L1CAM regulates DNA damage checkpoint response of glioblastoma stem cells through NBS1.	EMBO J	50	2011 Mar 2	glioma	NBN
25026297	Dissecting DNA repair in adult high grade gliomas for patient stratification in the post-genomic era.	Oncotarget	5	2014 Jul 30	glioma	NBN
19151620	Mutational inactivation of the nijmegen breakage syndrome gene (NBS1) in glioblastomas is associated with multiple TP53 mutations.	J Neuropathol Exp Neurol	2	2009 Feb	glioma	NBN
30943920	Decrease of Nibrin expression in chronic hypoxia is associated with hypoxia-induced chemoresistance in some brain tumour cells.	BMC Cancer		2019 Apr 3	glioma	NBN
30535026	SMAD3 silencing enhances DNA damage in radiation therapy by interacting with MRE11-RAD50-NBS1 complex in glioma.	J Biochem		2019 Apr 1	glioma	NBN
27447975	Molecular mechanisms of OLIG2 transcription factor in brain cancer.	Oncotarget	4	2016 Aug 16	glioma	NCOR1
24335696	NCoR controls glioblastoma tumor cell characteristics.	Neuro Oncol	4	2014 Jan	glioma	NCOR1
17312396	N-CoR pathway targeting induces glioblastoma derived cancer stem cell differentiation.	Cell Cycle	25	2007 Feb 15	glioma	NCOR1
20001590	The effect of a PP2A inhibitor on the nuclear receptor corepressor pathway in glioma.	J Neurosurg	21	2010 Aug	glioma	NCOR1
28855213	Exosomes from Glioma-Associated Mesenchymal Stem Cells Increase the Tumorigenicity of Glioma Stem-like Cells via Transfer of miR-1587.	Cancer Res	18	2017 Nov 1	glioma	NCOR1
23312906	HDAC1-mSin3a-NCOR1, Dnmt3b-HDAC1-Egr1 and Dnmt1-PCNA-UHRF1-G9a regulate the NY-ESO1 gene expression.	Mol Oncol	12	2013 Jun	glioma	NCOR1
21143702	Expression of nuclear receptor corepressors and class I histone deacetylases in astrocytic gliomas.	Cancer Sci	10	2011 Feb	glioma	NCOR1
20957337	Inhibition of Sonic hedgehog and Notch pathways enhances sensitivity of CD133(+) glioma stem cells to temozolomide therapy.	Mol Med	54	2011 Jan-Feb	glioma	NCOR2
24244722	microRNA-100 targets SMRT/NCOR2, reduces proliferation, and improves survival in glioblastoma animal models.	PLoS One	17	2013	glioma	NCOR2
16818736	Mechanism of IFN-beta-mediated inhibition of IL-8 gene expression in astroglioma cells.	J Immunol	16	2006 Jul 15	glioma	NCOR2
21143702	Expression of nuclear receptor corepressors and class I histone deacetylases in astrocytic gliomas.	Cancer Sci	10	2011 Feb	glioma	NCOR2
28453552	Specific blockade of Rictor-mTOR association inhibits mTORC2 activity and is cytotoxic in glioblastoma.	PLoS One	8	2017	glioma	NDRG1
25777142	Overexpression of N-myc downstream-regulated gene 1 inhibits human glioma proliferation and invasion via phosphoinositide 3-kinase/AKT pathways.	Mol Med Rep	8	2015 Jul	glioma	NDRG1
19082468	Oxygen-dependent regulation of NDRG1 in human glioblastoma cells in vitro and in vivo.	Oncol Rep	8	2009 Jan	glioma	NDRG1
18636206	Rapid detection of the hypoxia-regulated CA-IX and NDRG1 gene expression in different glioblastoma cells in vitro.	Oncol Rep	7	2008 Aug	glioma	NDRG1
24367102	mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapy.	Proc Natl Acad Sci U S A	51	2014 Jan 7	glioma	NDRG1
26297987	NDRG1 overexpressing gliomas are characterized by reduced tumor vascularization and resistance to antiangiogenic treatment.	Cancer Lett	5	2016 Oct 1	glioma	NDRG1
24395351	NDRG1 prognosticates the natural course of disease in WHO grade II glioma.	J Neurooncol	5	2014 Mar	glioma	NDRG1
27698340	Golgi Phosphoprotein 3 Inhibits the Apoptosis of Human Glioma Cells in Part by Downregulating N-myc Downstream Regulated Gene 1.	Med Sci Monit	2	2016 Oct 4	glioma	NDRG1
22906261	Transcriptome and coexpression network analysis of the human glioma cell line Hs683 exposed to candoxin.	J Int Med Res	2	2012	glioma	NDRG1
19592488	NDRG4 is required for cell cycle progression and survival in glioblastoma cells.	J Biol Chem	19	2009 Sep 11	glioma	NDRG1
19337694	Decreased expression of NDRG1 in glioma is related to tumor progression and survival of patients.	J Neurooncol	12	2009 Sep	glioma	NDRG1
31485792	Nervous NDRGs: the N-myc downstream-regulated gene family in the central and peripheral nervous system.	Neurogenetics		2019 Sep 4	glioma	NDRG1
31414267	Discovery of a novel rhein-SAHA hybrid as a multi-targeted anti-glioblastoma drug.	Invest New Drugs		2019 Aug 14	glioma	NDRG1
28498432	Time-Â and oxygen-dependent expression and regulation of NDRG1 in human brain cancer cells.	Oncol Rep		2017 Jun	glioma	NDRG1
28984190	Unsupervised deep learning reveals prognostically relevant subtypes of glioblastoma.	BMC Bioinformatics	6	2017 Oct 3	glioma	NF1
30192422	Alternative lengthening of telomeres, ATRX loss and H3-K27M mutations in histologically defined pilocytic astrocytoma with anaplasia.	Brain Pathol	5	2019 Jan	glioma	NF1
29973652	Subependymal giant cell astrocytoma-like astrocytoma: a neoplasm with a distinct phenotype and frequent neurofibromatosis type-1-association.	Mod Pathol	5	2018 Dec	glioma	NF1
29084603	Characterizing temporal genomic heterogeneity in pediatric high-grade gliomas.	Acta Neuropathol Commun	4	2017 Oct 30	glioma	NF1
30531922	The molecular landscape of glioma in patients with Neurofibromatosis 1.	Nat Med	3	2019 Jan	glioma	NF1
29575648	Spontaneous development of intratumoral heterogeneity in a transposon-induced mouse model of glioma.	Cancer Sci	3	2018 May	glioma	NF1
30946477	The landscape of the mesenchymal signature in brain tumours.	Brain	2	2019 Apr 1	glioma	NF1
29787563	Graph complexity analysis identifies an ETV5 tumor-specific network in human and murine low-grade glioma.	PLoS One	2	2018	glioma	NF1
29632086	Athymic mice reveal a requirement for T-cell-microglia interactions in establishing a microenvironment supportive of &lt;i&gt;Nf1&lt;/i&gt; low-grade glioma growth.	Genes Dev	2	2018 Apr 1	glioma	NF1
28950062	Integrating Transcriptomic Data with Mechanistic Systems Pharmacology Models for Virtual Drug Combination Trials.	ACS Chem Neurosci	2	2018 Jan 17	glioma	NF1
29564591	Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations.	Acta Neuropathol	17	2018 Aug	glioma	NF1
30504225	Effects of nuclear factor I phosphorylation on calpastatin (&lt;i&gt;CAST&lt;/i&gt;) gene variant expression and subcellular distribution in malignant glioma cells.	J Biol Chem	1	2019 Jan 25	glioma	NF1
29643433	Neurofibromin knockdown in glioma cell lines is associated with changes in cytokine and chemokine secretion in vitro.	Sci Rep	1	2018 Apr 11	glioma	NF1
29599344	Racial Disparities in the Molecular Landscape of Cancer.	Anticancer Res	1	2018 Apr	glioma	NF1
31346129	Molecular Profiling Reclassifies Adult Astroblastoma into Known and Clinically Distinct Tumor Entities with Frequent Mitogen-Activated Protein Kinase Pathway Alterations.	Oncologist		2019 Jul 25	glioma	NF1
31290679	Comparative proteogenomic characterization of glioblastoma.	CNS Oncol		2019 Jun	glioma	NF1
31111915	Genetic and genomic alterations differentially dictate low-grade glioma growth through cancer stem cell-specific chemokine recruitment of T cells and microglia.	Neuro Oncol		2019 May 3	glioma	NF1
30967630	Pathogenic mutations in neurofibromin identifies a leucine-rich domain regulating glioma cell invasiveness.	Oncogene		2019 Jul	glioma	NF1
30570705	MicroRNA profile of pediatric pilocytic astrocytomas identifies two tumor-specific signatures when compared to non-neoplastic white matter.	J Neurooncol		2019 Jan	glioma	NF1
30222900	Granular cell astrocytoma: an aggressive IDH-wildtype diffuse glioma with molecular genetic features of primary glioblastoma.	Brain Pathol		2019 Mar	glioma	NF1
25043298	Oncogenic role of Merlin/NF2 in glioblastoma.	Oncogene	7	2015 May 14	glioma	NF2
17210637	Identification and characterization of putative tumor suppressor NGB, a GTP-binding protein that interacts with the neurofibromatosis 2 protein.	Mol Cell Biol	7	2007 Mar	glioma	NF2
25832504	Sox2 antagonizes the Hippo pathway to maintain stemness in cancer cells.	Nat Commun	66	2015 Apr 2	glioma	NF2
28764788	Regulation of human glioma cell apoptosis and invasion by miR-152-3p through targeting DNMT1 and regulating NF2 : MiR-152-3p regulate glioma cell apoptosis and invasion.	J Exp Clin Cancer Res	6	2017 Aug 1	glioma	NF2
23308224	Neurofibromatosis type 2 tumor suppressor protein, NF2, induces proteasome-mediated degradation of JC virus T-antigen in human glioblastoma.	PLoS One	6	2013	glioma	NF2
27927008	MicroRNA-296-5p Promotes Invasiveness through Downregulation of Nerve Growth Factor Receptor and Caspase-8.	Mol Cells	5	2017 Apr	glioma	NF2
18632626	Merlin is a potent inhibitor of glioma growth.	Cancer Res	46	2008 Jul 15	glioma	NF2
25750037	Role of Yes-associated protein 1 in gliomas: pathologic and therapeutic aspects.	Tumour Biol	4	2015 Apr	glioma	NF2
27229317	NHERF1/EBP50 and NF2 as diagnostic markers for choroid plexus tumors.	Acta Neuropathol Commun	3	2016 May 27	glioma	NF2
24817309	Nf2/Merlin controls spinal cord neural progenitor function in a Rac1/ErbB2-dependent manner.	PLoS One	3	2014	glioma	NF2
19333554	'Putting our heads together': insights into genomic conservation between human and canine intracranial tumors.	J Neurooncol	27	2009 Sep	glioma	NF2
23221384	Moesin is a glioma progression marker that induces proliferation and Wnt/Î²-catenin pathway activation via interaction with CD44.	Cancer Res	22	2013 Feb 1	glioma	NF2
20156804	Overexpression of ezrin inactivates NF2 tumor suppressor in glioblastoma.	Neuro Oncol	16	2010 Jun	glioma	NF2
26923924	Neurofibromatosis 2 (NF2) controls the invasiveness of glioblastoma through YAP-dependent expression of CYR61/CCN1 and miR-296-3p.	Biochim Biophys Acta	13	2016 Apr	glioma	NF2
26369495	Bevacizumab treatment for symptomatic spinal ependymomas in neurofibromatosis type 2.	Acta Neurol Scand	1	2016 Jun	glioma	NF2
25909290	Expression alterations define unique molecular characteristics of spinal ependymomas.	Oncotarget	1	2015 Aug 14	glioma	NF2
22900848	Assessment of antiangiogenic effect of imatinib mesylate on vestibular schwannoma tumors using in vivo corneal angiogenesis assay.	J Neurosurg	1	2012 Oct	glioma	NF2
20594149	Merlin expression in pediatric anaplastic ependymomas real time PCR study.	Fetal Pediatr Pathol	1	2010	glioma	NF2
30031196	Is NF2 a Key Player of the Differentially Expressed Gene Between Spinal Cord Ependymoma and Intracranial Ependymoma?	World Neurosurg		2018 Oct	glioma	NF2
29637450	The association of NF2 (neurofibromin 2) gene polymorphism and the risk of medulloblastomas.	Neurol Sci		2018 Jul	glioma	NF2
26046590	Parkinsonian toxin-induced oxidative stress inhibits basal autophagy in astrocytes via NQO2/quinone oxidoreductase 2: Implications for neuroprotection.	Autophagy	9	2015	glioma	NFE2L2
26011642	ATF4-dependent induction of heme oxygenase 1 prevents anoikis and promotes metastasis.	J Clin Invest	60	2015 Jul 1	glioma	NFE2L2
28782555	Nrf2 suppresses the function of dendritic cells to facilitate the immune escape of glioma cells.	Exp Cell Res	6	2017 Nov 15	glioma	NFE2L2
27187376	Nrf2 Expressions Correlate with WHO Grades in Gliomas and Meningiomas.	Int J Mol Sci	5	2016 May 13	glioma	NFE2L2
28685346	Hinokitiol suppresses cancer stemness and oncogenicity in glioma stem cells by Nrf2 regulation.	Cancer Chemother Pharmacol	4	2017 Aug	glioma	NFE2L2
28427200	IDH1 R132H mutation regulates glioma chemosensitivity through Nrf2 pathway.	Oncotarget	4	2017 Apr 25	glioma	NFE2L2
27000259	Overexpression of ubiquitin-specific protease 2a (USP2a) and nuclear factor erythroid 2-related factor 2 (Nrf2) in human gliomas.	J Neurol Sci	4	2016 Apr 15	glioma	NFE2L2
25590811	Reactive oxygen species-mediated therapeutic response and resistance in glioblastoma.	Cell Death Dis	34	2015 Jan 15	glioma	NFE2L2
25998888	Melatonin Protects Methamphetamine-Induced Neuroinflammation Through NF-ÎºB and Nrf2 Pathways in Glioma Cell Line.	Neurochem Res	3	2015 Jul	glioma	NFE2L2
25585997	Erastin sensitizes glioblastoma cells to temozolomide by restraining xCT and cystathionine-Î³-lyase function.	Oncol Rep	22	2015 Mar	glioma	NFE2L2
26687633	Insulin-like growth factor 1 specifically up-regulates expression of modifier subunit of glutamate-cysteine ligase and enhances glutathione synthesis in SH-SY5Y cells.	Eur J Pharmacol	2	2016 Jan 15	glioma	NFE2L2
26124081	MicroRNA-153/Nrf-2/GPx1 pathway regulates radiosensitivity and stemness of glioma stem cells via reactive oxygen species.	Oncotarget	19	2015 Sep 8	glioma	NFE2L2
27148686	Nrf2-driven TERT regulates pentose phosphate pathway in glioblastoma.	Cell Death Dis	13	2016 May 5	glioma	NFE2L2
25841304	Impact of nuclear factor erythroid-derived 2-like 2 and p62/sequestosome expression on prognosis of patients with gliomas.	Hum Pathol	13	2015 Jun	glioma	NFE2L2
25304134	Activation of the NRF2 pathway and its impact on the prognosis of anaplastic glioma patients.	Neuro Oncol	11	2015 Apr	glioma	NFE2L2
25612817	Cytoprotection against beta-amyloid (AÎ²) peptide-mediated oxidative damage and autophagy by Keap1 RNAi in human glioma U87mg cells.	Neurosci Res	1	2015 May	glioma	NFE2L2
30942197	Low expression of pentraxin 3 and nuclear factor-like 2 implying a relatively longer overall survival time in gliomas.	Chin J Physiol		2019 Jan-Feb	glioma	NFE2L2
29441509	NRF2, DJ1 and SNRX1 and their prognostic impact in astrocytic gliomas.	Histol Histopathol		2018 Aug	glioma	NFE2L2
29414774	Hexokinase 2 and nuclear factor erythroid 2-related factor 2 transcriptionally coactivate xanthine oxidoreductase expression in stressed glioma cells.	J Biol Chem		2018 Mar 30	glioma	NFE2L2
28260004	GSH depletion and consequent AKT inhibition contribute to the Nrf2 knockdown-induced decrease in proliferation in glioblastoma U251 cells.	Oncol Rep		2017 Apr	glioma	NFE2L2
26389665	Non-canonical NF-ÎºB signalling and ETS1/2 cooperatively drive C250T mutant TERT promoter activation.	Nat Cell Biol	50	2015 Oct	glioma	NFKB2
31240814	Long non-coding RNA LINC00526 represses glioma progression via forming a double negative feedback loop with AXL.	J Cell Mol Med	2	2019 Aug	glioma	NFKB2
1	Retinol dehydrogenase-10 promotes development and progression of human glioma via the TWEAK-NF-ÎºB axis.	Oncotarget	1	2017 Dec 1	glioma	NFKBIE
19525896	Thyroid transcription factor 1 expression in sellar tumors: a histogenetic marker?	J Neuropathol Exp Neurol	8	2009 May	glioma	NKX2-1
12122016	Regulation of pituitary adenylate cyclase-activating polypeptide gene transcription by TTF-1, a homeodomain-containing transcription factor.	J Biol Chem	7	2002 Sep 27	glioma	NKX2-1
25786084	Chordoid gliomas of the third ventricle share TTF-1 expression with organum vasculosum of the lamina terminalis.	Am J Surg Pathol	4	2015 Jul	glioma	NKX2-1
15452173	Expression of thyroid transcription factor 1 in primary brain tumours.	J Clin Pathol	4	2004 Oct	glioma	NKX2-1
25934249	Suprasellar chordoid neoplasm with expression of thyroid transcription factor 1: evidence that chordoid glioma of the third ventricle and pituicytoma may form part of a spectrum of lineage-related tumors of the basal forebrain.	Hum Pathol	2	2015 Jul	glioma	NKX2-1
25669749	Consistent nuclear expression of thyroid transcription factor 1 in subependymal giant cell astrocytomas suggests lineage-restricted histogenesis.	Clin Neuropathol	2	2015 May-Jun	glioma	NKX2-1
12730191	TTF-1, a homeodomain-containing transcription factor, participates in the control of body fluid homeostasis by regulating angiotensinogen gene transcription in the rat subfornical organ.	J Biol Chem	11	2003 Jul 18	glioma	NKX2-1
26779746	Increased Thyroid Hormone Activation Accompanies the Formation of Thyroid Hormone-Dependent Negative Feedback in Developing Chicken Hypothalamus.	Endocrinology	1	2016 Mar	glioma	NKX2-1
25248954	Expression of thyroid transcription factor 1 in a chordoid glioma.	J Neurol Sci	1	2014 Nov 15	glioma	NKX2-1
30072869	NFIX Circular RNA Promotes Glioma Progression by Regulating miR-34a-5p via Notch Signaling Pathway.	Front Mol Neurosci	7	2018	glioma	NOTCH1
29410396	Notch1 is a prognostic factor that is distinctly activated in the classical and proneural subtype of glioblastoma and that promotes glioma cell survival via the NF-ÎºB(p65) pathway.	Cell Death Dis	7	2018 Feb 6	glioma	NOTCH1
30559479	Invasion of white matter tracts by glioma stem cells is regulated by a NOTCH1-SOX2 positive-feedback loop.	Nat Neurosci	5	2019 Jan	glioma	NOTCH1
29427543	FBW7 is associated with prognosis, inhibits malignancies and enhances temozolomide sensitivity in glioblastoma cells.	Cancer Sci	5	2018 Apr	glioma	NOTCH1
29908894	MicroRNA-499a decelerates glioma cell proliferation while accelerating apoptosis through the suppression of Notch1 and the MAPK signaling pathway.	Brain Res Bull	4	2018 Sep	glioma	NOTCH1
29575026	AG-1031 induced autophagic cell death and apoptosis in C6 glioma cells associated with Notch-1 signaling pathway.	J Cell Biochem	4	2018 Jul	glioma	NOTCH1
29857516	Mir-34a-5p Mediates Cross-Talk between M2 Muscarinic Receptors and Notch-1/EGFR Pathways in U87MG Glioblastoma Cells: Implication in Cell Proliferation.	Int J Mol Sci	3	2018 May 31	glioma	NOTCH1
30297829	Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastoma.	Nat Commun	1	2018 Oct 8	glioma	NOTCH1
30170559	Targeting the Notch1 oncogene by miR-139-5p inhibits glioma metastasis and epithelial-mesenchymal transition (EMT).	BMC Neurol	1	2018 Aug 31	glioma	NOTCH1
31497354	Wild-type &lt;i&gt;TP53&lt;/i&gt; defined gamma-secretase inhibitor sensitivity and synergistic activity with doxorubicin in GSCs.	Am J Cancer Res		2019	glioma	NOTCH1
31382985	Notch1 signaling pathway promotes invasion, self-renewal and growth of glioma initiating cells via modulating chemokine system CXCL12/CXCR4.	J Exp Clin Cancer Res		2019 Aug 5	glioma	NOTCH1
31277684	NKAP alters tumor immune microenvironment and promotes glioma growth via Notch1 signaling.	J Exp Clin Cancer Res		2019 Jul 6	glioma	NOTCH1
31008529	Polycomb complex mediated epigenetic reprogramming alters TGF-Î² signaling via a novel EZH2/miR-490/TGIF2 axis thereby inducing migration and EMT potential in glioblastomas.	Int J Cancer		2019 Sep 1	glioma	NOTCH1
30443974	Knockdown of TMPRSS3 inhibits cell proliferation, migration/invasion and induces apoptosis of glioma cells.	J Cell Biochem		2018 Nov 15	glioma	NOTCH1
30405767	Regulating glioma stem cells by hypoxia through the Notch1 and Oct3/4 signaling pathway.	Oncol Lett		2018 Nov	glioma	NOTCH1
30396954	&lt;i&gt;GLI1&lt;/i&gt; and &lt;i&gt;CTNNB1&lt;/i&gt; Knockdown Activates NOTCH and mTOR Signalling in NB4 Myeloid Leukaemia Cells.	Anticancer Res		2018 Nov	glioma	NOTCH1
30226603	Overexpression of EpsinÂ 3 enhances migration and invasion of glioma cells by inducing epithelialâmesenchymal transition.	Oncol Rep		2018 Nov	glioma	NOTCH1
30112068	Yes-associated protein 1 promotes the metastasis of U251 glioma cells by upregulating Jagged-1 expression and activating the Notch signal pathway.	Exp Ther Med		2018 Aug	glioma	NOTCH1
30066161	High-Dose Tanshinone IIA Suppresses Migration and Proliferation While Promoting Apoptosis of Astrocytoma Cells Via Notch-1 Pathway.	Neurochem Res		2018 Sep	glioma	NOTCH1
29269413	Î²1,4-Galactosyltransferase V activates Notch1 signaling in glioma stem-like cells and promotes their transdifferentiation into endothelial cells.	J Biol Chem		2018 Feb 9	glioma	NOTCH1
24305720	Differential patterns of NOTCH1-4 receptor expression are markers of glioma cell differentiation.	Neuro Oncol	9	2014 Jan	glioma	NOTCH2
23852537	Notch1-induced brain tumor models the sonic hedgehog subgroup of human medulloblastoma.	Cancer Res	7	2013 Sep 1	glioma	NOTCH2
29258209	Loss of miR-107, miR-181c and miR-29a-3p Promote Activation of Notch2 Signaling in Pediatric High-Grade Gliomas (pHGGs).	Int J Mol Sci	6	2017 Dec 17	glioma	NOTCH2
25338527	Interference of Notch 2 inhibits the progression of gliomas and induces cell apoptosis by induction of the cell cycle at the G0/G1 phase.	Mol Med Rep	6	2015 Jan	glioma	NOTCH2
25323114	Short hairpin RNA targeting Notch2 inhibits U87 human glioma cell proliferation by inducing cell cycle arrest and apoptosis in vitro and in vivo.	Mol Med Rep	6	2014 Dec	glioma	NOTCH2
28389242	Upregulation of miR-181a suppresses the formation of glioblastoma stem cells by targeting the Notch2 oncogene and correlates with good prognosis in patients with glioblastoma multiforme.	Biochem Biophys Res Commun	3	2017 May 13	glioma	NOTCH2
26472724	The vascular delta-like ligand-4 (DLL4)-Notch4 signaling correlates with angiogenesis in primary glioblastoma: an immunohistochemical study.	Tumour Biol	3	2016 Mar	glioma	NOTCH2
24179539	Differential effects of miR-34c-3p and miR-34c-5p on the proliferation, apoptosis and invasion of glioma cells.	Oncol Lett	26	2013 Nov	glioma	NOTCH2
26669487	A Tumor Suppressor Function for Notch Signaling in Forebrain Tumor Subtypes.	Cancer Cell	25	2015 Dec 14	glioma	NOTCH2
26662803	Aberrant expression of Notch1, HES1, and DTX1 genes in glioblastoma formalin-fixed paraffin-embedded tissues.	Tumour Biol	2	2016 May	glioma	NOTCH2
26165719	A functional polymorphism in the preâmiRâ146a gene influences the prognosis of glioblastoma multiforme by interfering with the balance between Notch1 and Notch2.	Mol Med Rep	2	2015 Oct	glioma	NOTCH2
25575134	Notch signaling activation in pediatric low-grade astrocytoma.	J Neuropathol Exp Neurol	2	2015 Feb	glioma	NOTCH2
25494473	Tumor suppressor miR-181c attenuates proliferation, invasion, and self-renewal abilities in glioblastoma.	Neuroreport	18	2015 Jan 21	glioma	NOTCH2
23572380	MicroRNA-107 inhibits U87 glioma stem cells growth and invasion.	Cell Mol Neurobiol	17	2013 Jul	glioma	NOTCH2
24708907	NOTCH ligands JAG1 and JAG2 as critical pro-survival factors in childhood medulloblastoma.	Acta Neuropathol Commun	14	2014 Apr 7	glioma	NOTCH2
26983574	Epigenetic silencing of miR-181c by DNA methylation in glioblastoma cell lines.	BMC Cancer	12	2016 Mar 16	glioma	NOTCH2
24695855	SHH, WNT, and NOTCH pathways in medulloblastoma: when cancer stem cells maintain self-renewal and differentiation properties.	Childs Nerv Syst	12	2014 Jul	glioma	NOTCH2
23349727	The different role of Notch1 and Notch2 in astrocytic gliomas.	PLoS One	11	2013	glioma	NOTCH2
30763736	Constitutive activation of Notch2 signalling confers chemoresistance to neural stem cells via transactivation of fibroblast growth factor receptor-1.	Stem Cell Res		2019 Mar	glioma	NOTCH2
28856557	Endothelial Cells Promote Formation of Medulloblastoma Stem-Like Cells via Notch Pathway Activation.	J Mol Neurosci		2017 Oct	glioma	NOTCH2
20515335	Upregulation of SOX2, NOTCH1, and ID1 in supratentorial primitive neuroectodermal tumors: a distinct differentiation pattern from that of medulloblastomas.	J Neurosurg Pediatr	5	2010 Jun	glioma	NRG1
15015657	Constitutive activation of the neuregulin-1/erbB signaling pathway promotes the proliferation of a human peripheral neuroepithelioma cell line.	J Neurooncol	5	2004 Feb	glioma	NRG1
17579610	Molecular dissection of NRG1-ERBB4 signaling implicates PTPRZ1 as a potential schizophrenia susceptibility gene.	Mol Psychiatry	30	2008 Feb	glioma	NRG1
9731505	Expression of the ErbB-neuregulin signaling network during human cerebellar development: implications for the biology of medulloblastoma.	Cancer Res	18	1998 Sep 1	glioma	NRG1
25560389	MiR-125a-3p regulates glioma apoptosis and invasion by regulating Nrg1.	PLoS One	13	2015	glioma	NRG1
23399902	Neuregulin 1 enhances cell adhesion molecule l1 expression in human glioma cells and promotes their migration as a function of malignancy.	J Neuropathol Exp Neurol	10	2013 Mar	glioma	NRG1
22753229	RNAi-mediated inhibition of presenilin 2 inhibits glioma cell growth and invasion and is involved in the regulation of Nrg1/ErbB signaling.	Neuro Oncol	10	2012 Aug	glioma	NRG1
30171197	Molecular characterization of cancers with NTRK gene fusions.	Mod Pathol	8	2019 Jan	glioma	NTRK1
24840578	Methylation and expression patterns of tropomyosin-related kinase genes in different grades of glioma.	Neuromolecular Med	4	2014 Sep	glioma	NTRK1
23371454	Supra- and infratentorial pediatric ependymomas differ significantly in NeuN, p75 and GFAP expression.	J Neurooncol	4	2013 Apr	glioma	NTRK1
24647444	NTRK1 fusion in glioblastoma multiforme.	PLoS One	27	2014	glioma	NTRK1
24705251	The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma.	Nat Genet	222	2014 May	glioma	NTRK1
19301967	Candidate genes for sensitivity and resistance of human glioblastoma multiforme cell lines to erlotinib. Laboratory investigation.	J Neurosurg	12	2009 Aug	glioma	NTRK1
30303712	A conditionally immortalized Gli1-positive kidney mesenchymal cell line models myofibroblast transition.	Am J Physiol Renal Physiol	1	2019 Jan 1	glioma	NTRK1
30637364	Analysis of &lt;i&gt;NTRK&lt;/i&gt; Alterations in Pan-Cancer Adult and Pediatric Malignancies: Implications for NTRK-Targeted Therapeutics.	JCO Precis Oncol		2018	glioma	NTRK1
29753700	Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort.	Lancet Oncol	10	2018 Jun	glioma	PALB2
21873780	[Transcriptomic regulation and molecular mechanism of polygenic tumor at different stages].	Zhong Nan Da Xue Xue Bao Yi Xue Ban	1	2011 Jul	glioma	PALB2
30222900	Granular cell astrocytoma: an aggressive IDH-wildtype diffuse glioma with molecular genetic features of primary glioblastoma.	Brain Pathol		2019 Mar	glioma	PALB2
16086408	p53 Pathway dysfunction in primary childhood ependymomas.	Pediatr Blood Cancer	9	2006 May 1	glioma	PAX5
8521821	Loss of p53 function through PAX-mediated transcriptional repression.	EMBO J	37	1995 Nov 15	glioma	PAX5
27572852	Identification of hub genes and regulatory factors of glioblastoma multiforme subgroups by RNA-seq data analysis.	Int J Mol Med	3	2016 Oct	glioma	PAX5
26145723	Characterization of Inflammatory Changes Associated with Canine Oligodendroglioma.	J Comp Pathol	3	2015 Aug-Oct	glioma	PAX5
24602166	Increased paired box transcription factor 8 has a survival function in glioma.	BMC Cancer	3	2014 Mar 6	glioma	PAX5
7777574	Deregulated expression of PAX5 in medulloblastoma.	Proc Natl Acad Sci U S A	21	1995 Jun 6	glioma	PAX5
27623204	Expression of SOX11, PAX5, TTF-1 and ISL-1 in medulloblastoma.	Pathol Res Pract	2	2016 Nov	glioma	PAX5
22552444	PAX2 is an antiapoptotic molecule with deregulated expression in medulloblastoma.	Int J Oncol	2	2012 Jul	glioma	PAX5
9815975	PAX5 expression correlates with increasing malignancy in human astrocytomas.	Clin Cancer Res	10	1995 Feb	glioma	PAX5
1	[Chromatin remodeling defects and cancer: the SWI/SNF example].	Bull Cancer	2	2012 Dec	glioma	PBRM1
25760074	Circadian genes Per1 and Per2 increase radiosensitivity of glioma in vivo.	Oncotarget	8	2015 Apr 30	glioma	PER1
12692905	Involvement of calcium/calmodulin-dependent protein kinase II in the induction of mPer1.	J Neurosci Res	7	2003 May 1	glioma	PER1
20595783	Noradrenaline induces clock gene Per1 mRNA expression in C6 glioma cells through beta(2)-adrenergic receptor coupled with protein kinase A - cAMP response element binding protein (PKA-CREB) and Src-tyrosine kinase - glycogen synthase kinase-3beta (Src-GSK-3beta).	J Pharmacol Sci	6	2010	glioma	PER1
20481271	Deregulated expression of the Per1 and Per2 in human gliomas.	Can J Neurol Sci	25	2010 May	glioma	PER1
23752693	Posttranscriptional regulation of PER1 underlies the oncogenic function of IREÎ±.	Cancer Res	22	2013 Aug 1	glioma	PER1
24135790	Circadian pathway genes in relation to glioma risk and outcome.	Cancer Causes Control	12	2014 Jan	glioma	PER1
29881948	Proliferative Glioblastoma Cancer Cells Exhibit Persisting Temporal Control of Metabolism and Display Differential Temporal Drug Susceptibility in Chemotherapy.	Mol Neurobiol	1	2019 Feb	glioma	PER1
31350984	The Circadian Gene Per1 Plays an Important Role in Radiation-Induced Apoptosis and DNA Damage in Glioma.	Asian Pac J Cancer Prev		2019 Jul 1	glioma	PER1
24710217	The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes.	Nat Commun	111	2014 Apr 8	glioma	PHF6
24919120	Identification of temozolomide resistance factors in glioblastoma via integrative miRNA/mRNA regulatory network analysis.	Sci Rep	11	2014 Jun 11	glioma	PHF6
1	MiR-185 targets the DNA methyltransferases 1 and regulates global DNA methylation in human glioma.	Mol Cancer	32	2011 Sep 30	glioma	PHOX2B
27893811	The Inhibition of microRNA-128 on IGF-1-Activating mTOR Signaling Involves in Temozolomide-Induced Glioma Cell Apoptotic Death.	PLoS One	8	2016	glioma	PIK3R1
19305146	Inhibitory effects of adenovirus mediated Akt1 and PIK3R1 shRNA on the growth of malignant tumor cells in vitro and in vivo.	Cancer Biol Ther	7	2009 Jun	glioma	PIK3R1
22064833	Abrogation of PIK3CA or PIK3R1 reduces proliferation, migration, and invasion in glioblastoma multiforme cells.	Oncotarget	53	2011 Nov	glioma	PIK3R1
27852048	IGFBP2 expression predicts IDH-mutant glioma patient survival.	Oncotarget	5	2017 Jan 3	glioma	PIK3R1
21663587	Docosahexaenoic acid (DHA) sensitizes brain tumor cells to etoposide-induced apoptosis.	Curr Mol Med	5	2011 Aug	glioma	PIK3R1
27048880	Spatial and temporal homogeneity of driver mutations in diffuse intrinsic pontine glioma.	Nat Commun	42	2016 Apr 6	glioma	PIK3R1
24728992	Similarity in targets with REST points to neural and glioblastoma related miRNAs.	Nucleic Acids Res	4	2014 May	glioma	PIK3R1
21649900	Cell cycle and aging, morphogenesis, and response to stimuli genes are individualized biomarkers of glioblastoma progression and survival.	BMC Med Genomics	31	2011 Jun 7	glioma	PIK3R1
27633132	Combination of lentivirus-mediated silencing of PPM1D and temozolomide chemotherapy eradicates malignant glioma through cell apoptosis and cell cycle arrest.	Oncol Rep	3	2016 Nov	glioma	PIK3R1
30333046	TERT promoter wild-type glioblastomas show distinct clinical features and frequent PI3K pathway mutations.	Acta Neuropathol Commun	2	2018 Oct 17	glioma	PIK3R1
29677490	EGFR-Phosphorylated Platelet Isoform of Phosphofructokinase 1 Promotes PI3K Activation.	Mol Cell	2	2018 Apr 19	glioma	PIK3R1
29046615	Integrated genomic characterization of cancer genes in glioma.	Cancer Cell Int	2	2017	glioma	PIK3R1
19639178	Inhibitory effects of adenovirus mediated COX-2, Akt1 and PIK3R1 shRNA on the growth of malignant tumor cells in vitro and in vivo.	Int J Oncol	2	2009 Sep	glioma	PIK3R1
25031725	LncRNA TSLC1-AS1 is a novel tumor suppressor in glioma.	Int J Clin Exp Pathol	18	2014	glioma	PIK3R1
26286747	MicroRNA-542-3p Suppresses Tumor Cell Invasion via Targeting AKT Pathway in Human Astrocytoma.	J Biol Chem	14	2015 Oct 9	glioma	PIK3R1
23441165	High-resolution mutational profiling suggests the genetic validity of glioblastoma patient-derived pre-clinical models.	PLoS One	12	2013	glioma	PIK3R1
30053126	Subtype-specific signaling pathways and genomic aberrations associated with prognosis of glioblastoma.	Neuro Oncol	1	2019 Jan 1	glioma	PIK3R1
28785028	PIK3R1Met326Ile germline mutation correlates with cysteine-rich protein 61 expression and poor prognosis in glioblastoma.	Sci Rep	1	2017 Aug 7	glioma	PIK3R1
31290679	Comparative proteogenomic characterization of glioblastoma.	CNS Oncol		2019 Jun	glioma	PIK3R1
31008529	Polycomb complex mediated epigenetic reprogramming alters TGF-Î² signaling via a novel EZH2/miR-490/TGIF2 axis thereby inducing migration and EMT potential in glioblastomas.	Int J Cancer		2019 Sep 1	glioma	PIK3R1
9010300	Activity of JC virus archetype and PML-type regulatory regions in glial cells.	J Gen Virol	9	1997 Jan	glioma	PML
15671549	A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas.	Clin Cancer Res	74	2005 Jan 1	glioma	PML
10998333	Human cytomegalovirus immediate-early gene 2 expression leads to JCV replication in nonpermissive cells via transcriptional activation of JCV T antigen.	Virology	6	2000 Sep 30	glioma	PML
10623737	Glial cell-specific regulation of the JC virus early promoter by large T antigen.	J Virol	6	2000 Jan	glioma	PML
11432836	PML mediates the interferon-induced antiviral state against a complex retrovirus via its association with the viral transactivator.	EMBO J	54	2001 Jul 2	glioma	PML
2159152	Trans-activation of the JC virus late promoter by the tat protein of type 1 human immunodeficiency virus in glial cells.	Proc Natl Acad Sci U S A	44	1990 May	glioma	PML
28526854	Induction of senescence in primary glioblastoma cells by serum and TGFÎ².	Sci Rep	4	2017 May 19	glioma	PML
18812519	Promyelocytic leukemia protein induces apoptosis due to caspase-8 activation via the repression of NFkappaB activation in glioblastoma.	Neuro Oncol	4	2009 Apr	glioma	PML
9926918	Human ubiquitous JCV(CY) T-antigen gene induces brain tumors in experimental animals.	Oncogene	33	1999 Jan 7	glioma	PML
8818966	Evidence for a mechanism of demyelination by human JC virus: negative transcriptional regulation of RNA and protein levels from myelin basic protein gene by large tumor antigen in human glioblastoma cells.	J Med Virol	3	1996 Jul	glioma	PML
23440206	PML mediates glioblastoma resistance to mammalian target of rapamycin (mTOR)-targeted therapies.	Proc Natl Acad Sci U S A	21	2013 Mar 12	glioma	PML
16297951	JC virus induces altered patterns of cellular gene expression: interferon-inducible genes as major transcriptional targets.	Virology	21	2006 Feb 20	glioma	PML
24487962	USP11 regulates PML stability to control Notch-induced malignancy in brain tumours.	Nat Commun	20	2014	glioma	PML
10576656	Altered expression of the suppressors PML and p53 in glioblastoma cells with the antisense-EGF-receptor.	Br J Cancer	2	1999 Nov	glioma	PML
22641694	Formation of telomeric repeat-containing RNA (TERRA) foci in highly proliferating mouse cerebellar neuronal progenitors and medulloblastoma.	J Cell Sci	17	2012 Sep 15	glioma	PML
17201119	Analysis of a mutant p53 protein arising in a medulloblastoma from a mouse transgenic for the JC virus early region.	Anticancer Res	14	2006 Nov-Dec	glioma	PML
22834637	Potential of anti-cancer therapy based on anti-miR-155 oligonucleotides in glioma and brain tumours.	Chem Biol Drug Des	11	2013 Jan	glioma	PML
22362285	Molecular targeting therapy against promyelocytic leukemia protein using arsenic acids in experimental intracranial medulloblastoma.	Neurol Med Chir (Tokyo)		2012	glioma	PML
15331927	Molecular mechanisms associated with chromosomal and microsatellite instability in sporadic glioblastoma multiforme.	Oncology	9	2004	glioma	PMS2
21425258	Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and recurrent glioblastomas.	Int J Cancer	65	2011 Aug 1	glioma	PMS2
25026297	Dissecting DNA repair in adult high grade gliomas for patient stratification in the post-genomic era.	Oncotarget	5	2014 Jul 30	glioma	PMS2
28371827	Mutational burden, immune checkpoint expression, and mismatch repair in glioma: implications for immune checkpoint immunotherapy.	Neuro Oncol	40	2017 Aug 1	glioma	PMS2
17993636	Multifocal anaplastic astrocytoma in a patient with hereditary colorectal cancer, transcobalamin II deficiency, agenesis of the corpus callosum, mental retardation, and inherited PMS2 mutation.	Neuro Oncol	3	2008 Feb	glioma	PMS2
17440981	Biallelic germline mutations of mismatch-repair genes: a possible cause for multiple pediatric malignancies.	Cancer	23	2007 Jun 1	glioma	PMS2
23255519	Anaplastic oligodendroglioma in an adolescent with Lynch syndrome.	Pediatr Blood Cancer	2	2013 Jun	glioma	PMS2
24259277	Reduction of MLH1 and PMS2 confers temozolomide resistance and is associated with recurrence of glioblastoma.	Oncotarget	17	2013 Dec	glioma	PMS2
11960598	Biochemical changes associated with a multidrug-resistant phenotype of a human glioma cell line with temozolomide-acquired resistance.	Biochem Pharmacol	14	2002 Apr 1	glioma	PMS2
21637783	Microsatellite instability in pediatric high grade glioma is associated with genomic profile and differential target gene inactivation.	PLoS One	13	2011	glioma	PMS2
9135006	Reduced expression of mismatch repair genes measured by multiplex reverse transcription-polymerase chain reaction in human gliomas.	Cancer Res	12	1997 May 1	glioma	PMS2
15340263	A homozygous MSH6 mutation in a child with cafÃ©-au-lait spots, oligodendroglioma and rectal cancer.	Fam Cancer	10	2004	glioma	PMS2
29509313	Creutzfeldt astrocytes may be seen in IDH-wildtype glioblastoma and retain expression of DNA repair and chromatin binding proteins.	Brain Pathol		2018 Nov	glioma	PMS2
1	Reduced expression of DNA repair genes and chemosensitivity in 1p19q codeleted lower-grade gliomas.	J Neurooncol	1	2018 Sep	glioma	POLD1
22537279	Molecular characterization of circumventricular organs and third ventricle ependyma in the rat: potential markers for periventricular tumors.	Neuropathology	6	2013 Feb	glioma	POLE
25313693	The future of antiangiogenic treatment in glioblastoma.	Curr Opin Neurol	5	2014 Dec	glioma	POLE
28371827	Mutational burden, immune checkpoint expression, and mismatch repair in glioma: implications for immune checkpoint immunotherapy.	Neuro Oncol	40	2017 Aug 1	glioma	POLE
27367907	Fenretinide (4-HPR) Targets Caspase-9, ERK 1/2 and the Wnt3a/Î²-Catenin Pathway in Medulloblastoma Cells and Medulloblastoma Cell Spheroids.	PLoS One	4	2016	glioma	POLE
25407774	Prognostic Relevance of Histomolecular Classification of Diffuse Adult High-Grade Gliomas with Necrosis.	Brain Pathol	4	2015 Jul	glioma	POLE
22619067	GAS41 amplification results in overexpression of a new spindle pole protein.	Genes Chromosomes Cancer	4	2012 Sep	glioma	POLE
24030701	The mTOR kinase inhibitors, CC214-1 and CC214-2, preferentially block the growth of EGFRvIII-activated glioblastomas.	Clin Cancer Res	15	2013 Oct 15	glioma	POLE
24723566	Mitotic index, microvascular proliferation, and necrosis define 3 groups of 1p/19q codeleted anaplastic oligodendrogliomas associated with different genomic alterations.	Neuro Oncol	14	2014 Sep	glioma	POLE
26826650	Calcium signaling orchestrates glioblastoma development: Facts and conjunctures.	Biochim Biophys Acta	13	2016 Jun	glioma	POLE
29936294	Serotonin and human cancer: A critical view.	Biochimie	1	2019 Jun	glioma	POLE
27807100	Successful Treatment of a Patient with Glioblastoma and a Germline POLE Mutation: Where Next?	Cancer Discov	1	2016 Nov	glioma	POLE
28467792	Assessment of citalopram and escitalopram on neuroblastoma cell lines. Cell toxicity and gene modulation.	Oncotarget		2017 Jun 27	glioma	POLE
23065374	Telomere profiling: toward glioblastoma personalized medicine.	Mol Neurobiol	9	2013 Feb	glioma	POT1
26143636	TERT promoter mutations and polymorphisms as prognostic factors in primary glioblastoma.	Oncotarget	24	2015 Jun 30	glioma	POT1
30279734	Mesenchymal glioblastoma constitutes a major ceRNA signature in the TGF-Î² pathway.	Theranostics	2	2018	glioma	PPARG
22109108	Supratentorial and spinal pediatric ependymomas display a hypermethylated phenotype which includes the loss of tumor suppressor genes involved in the control of cell growth and death.	Acta Neuropathol	10	2012 May	glioma	PPARG
25332711	AEG-1 expression correlates with CD133 and PPP6c levels in human glioma tissues.	J Biomed Res	2	2014 Sep	glioma	PPP6C
22395973	Integration of global spectral karyotyping, CGH arrays, and expression arrays reveals important genes in the pathogenesis of glioblastoma multiforme.	Ann Surg Oncol		2012 Jul	glioma	PPP6C
23348703	PRDM1 is directly targeted by miR-30a-5p and modulates the Wnt/Î²-catenin pathway in a Dkk1-dependent manner during glioma growth.	Cancer Lett	25	2013 May 1	glioma	PRDM1
19860666	Hedgehog target genes: mechanisms of carcinogenesis induced by aberrant hedgehog signaling activation.	Curr Mol Med	188	2009 Sep	glioma	PRDM1
28378641	Downregulation of PRDM1 promotes cellular invasion and lung cancer metastasis.	Tumour Biol		2017 Apr	glioma	PRDM1
29515971	The Expression and Prognostic Impact of Immune Cytolytic Activity-Related Markers in Human Malignancies: A Comprehensive Meta-analysis.	Front Oncol	4	2018	glioma	PRF1
31202362	Can CpG methylation serve as surrogate markers for immune infiltration in cancer?	Adv Cancer Res		2019	glioma	PRF1
30353265	RNA-seq for identification of therapeutically targetable determinants of immune activation in human glioblastoma.	J Neurooncol		2019 Jan	glioma	PRF1
1	Glioma exosomes mediate the expansion and function of myeloid-derived suppressor cells through microRNA-29a/Hbp1 and microRNA-92a/Prkar1a pathways.	Int J Cancer	3	2019 Jun 15	glioma	PRKAR1A
29531057	Lateral cerebellum is preferentially sensitive to high sonic hedgehog signaling and medulloblastoma formation.	Proc Natl Acad Sci U S A	6	2018 Mar 27	glioma	PTCH1
28703798	mTORC2 regulates hedgehog pathway activity by promoting stability to Gli2 protein and its nuclear translocation.	Cell Death Dis	6	2017 Jul 13	glioma	PTCH1
29222038	HDAC6 inhibition induces glioma stem cells differentiation and enhances cellular radiation sensitivity through the SHH/Gli1 signaling pathway.	Cancer Lett	4	2018 Feb 28	glioma	PTCH1
29276753	Indian Hedgehog Suppresses a Stromal Cell-Driven Intestinal Immune Response.	Cell Mol Gastroenterol Hepatol	3	2018	glioma	PTCH1
29274272	The role of the Hedgehog signaling pathway in cancer: A comprehensive review.	Bosn J Basic Med Sci	20	2018 Feb 20	glioma	PTCH1
29244790	Lentivirus-mediated silencing of the PTC1 and PTC2 genes promotes recovery from spinal cord injury by activating the Hedgehog signaling pathway in a rat model.	Exp Mol Med	2	2017 Dec 15	glioma	PTCH1
28986380	Astrocytes Promote Medulloblastoma Progression through Hedgehog Secretion.	Cancer Res	2	2017 Dec 1	glioma	PTCH1
29753700	Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort.	Lancet Oncol	10	2018 Jun	glioma	PTCH1
30096798	Sonic Hedgehog Medulloblastoma Cancer Stem Cells Mirnome and Transcriptome Highlight Novel Functional Networks.	Int J Mol Sci	1	2018 Aug 8	glioma	PTCH1
29550418	SOX9 Transcriptionally Regulates mTOR-Induced Proliferation of Basal CellÂ Carcinomas.	J Invest Dermatol	1	2018 Aug	glioma	PTCH1
29187450	Oral Squamous Cell Carcinoma-derived Sonic Hedgehog Promotes Angiogenesis.	Anticancer Res	1	2017 Dec	glioma	PTCH1
29079783	Nanog-driven cell-reprogramming and self-renewal maintenance in Ptch1 &lt;sup&gt;+/-&lt;/sup&gt; granule cell precursors after radiation injury.	Sci Rep	1	2017 Oct 27	glioma	PTCH1
31120491	Placental sonic hedgehog pathway regulates foetal growth via insulin-like growth factor axis in preeclampsia.	J Clin Endocrinol Metab		2019 May 23	glioma	PTCH1
30795814	MiR-9 promotes tumorigenesis and angiogenesis and is activated by MYC and OCT4 in human glioma.	J Exp Clin Cancer Res		2019 Feb 22	glioma	PTCH1
30766964	Hedgehog Signaling Modulates Interleukin-33-Dependent Extrahepatic Bile Duct Cell Proliferation in Mice.	Hepatol Commun		2019 Feb	glioma	PTCH1
30452905	Genetic ablation of Gpr37l1 delays tumor occurrence in Ptch1&lt;sup&gt;+/-&lt;/sup&gt; mouse models of medulloblastoma.	Exp Neurol		2019 Feb	glioma	PTCH1
30127121	&lt;i&gt;Baihui&lt;/i&gt; (DU20)-penetrating-&lt;i&gt;Qubin&lt;/i&gt; (GB7) acupuncture inhibits apoptosis in the perihemorrhagic penumbra.	Neural Regen Res		2018 Sep	glioma	PTCH1
29691553	[Klf10 silencing inhibited mechanical force induced osteogenic differentiation of human periodontal ligament cells].	Shanghai Kou Qiang Yi Xue		2017 Dec	glioma	PTCH1
29582169	Medulloblastoma, WNT-activated/SHH-activated: clinical impact of molecular analysis and histogenetic evaluation.	Childs Nerv Syst		2018 May	glioma	PTCH1
29423837	Analysis of hedgehog signaling in periocular sebaceous carcinoma.	Graefes Arch Clin Exp Ophthalmol		2018 Apr	glioma	PTCH1
31066040	Long noncoding RNA MT1JP inhibits proliferation, invasion, and migration while promoting apoptosis of glioma cells through the activation of PTEN/Akt signaling pathway.	J Cell Physiol	1	2019 Nov	glioma	PTEN
31025173	FGFR2-mediated phosphorylation of PTEN at tyrosine 240 contributes to the radioresistance of glioma.	J Cell Commun Signal	1	2019 Sep	glioma	PTEN
30943918	Differential effects of the Akt inhibitor MK-2206 on migration and radiation sensitivity of glioblastoma cells.	BMC Cancer	1	2019 Apr 3	glioma	PTEN
31519156	FBXW7 circular RNA regulates proliferation, migration and invasion of colorectal carcinoma through NEK2, mTOR, and PTEN signaling pathways in vitro and in vivo.	BMC Cancer		2019 Sep 13	glioma	PTEN
31469661	LINC01198 promotes proliferation and temozolomide resistance in a NEDD4-1-dependent manner, repressing PTEN expression in glioma.	Aging (Albany NY)		2019 Aug 30	glioma	PTEN
31423236	ILF2 promotes anchorage independence through direct regulation of PTEN.	Oncol Lett		2019 Aug	glioma	PTEN
31391185	Mutant IDH sensitizes gliomas to endoplasmic reticulum stress and triggers apoptosis by MicroRNA183-mediated inhibition of Semaphorin 3E.	Cancer Res		2019 Aug 7	glioma	PTEN
31378455	Participation of tumor suppressors long non-coding RNA MEG3, microRNA-377 and PTEN in glioma cell invasion and migration.	Pathol Res Pract		2019 Jul 23	glioma	PTEN
31328874	Signal Transduction in Diffuse Intrinsic Pontine Glioma.	Proteomics		2019 Jul 22	glioma	PTEN
31290679	Comparative proteogenomic characterization of glioblastoma.	CNS Oncol		2019 Jun	glioma	PTEN
31289362	Stepwise detection and evaluation reveal miR-10b and miR-222 as a remarkable prognostic pair for glioblastoma.	Oncogene		2019 Aug	glioma	PTEN
31241130	CELF2 suppresses non-small cell lung carcinoma growth by inhibiting the PREX2-PTEN interaction.	Carcinogenesis		2019 Jun 25	glioma	PTEN
31218569	MicroRNA-32 targeting PTEN enhances M2 macrophage polarization in the glioma microenvironment and further promotes the progression of glioma.	Mol Cell Biochem		2019 Oct	glioma	PTEN
31185211	Symbiotic Macrophage-Glioma Cell Interactions Reveal Synthetic Lethality in PTEN-Null Glioma.	Cancer Cell		2019 Jun 10	glioma	PTEN
31101062	Glioma stem cells-derived exosomal miR-26a promotes angiogenesis of microvessel endothelial cells in glioma.	J Exp Clin Cancer Res		2019 May 17	glioma	PTEN
31081101	Research on miR-126 in glioma targeted regulation of PTEN/PI3K/Akt and MDM2-p53 pathways.	Eur Rev Med Pharmacol Sci		2019 Apr	glioma	PTEN
31010146	Diamond Nanoparticles Downregulate Expression of &lt;i&gt;CycD&lt;/i&gt; and &lt;i&gt;CycE&lt;/i&gt; in Glioma Cells.	Molecules		2019 Apr 19	glioma	PTEN
30987862	Immune checkpoint molecule herpes virus entry mediator is overexpressed and associated with poor prognosis in human glioblastoma.	EBioMedicine		2019 May	glioma	PTEN
30948364	Intratumoral platelet aggregate formation in a murine preclinical glioma model depends on podoplanin expression on tumor cells.	Blood Adv		2019 Apr 9	glioma	PTEN
30837348	Long intergenic non-coding LINC00657 regulates tumorigenesis of glioblastoma by acting as a molecular sponge of miR-190a-3p.	Aging (Albany NY)		2019 Mar 5	glioma	PTEN
16187021	FAS associated phosphatase (FAP-1) blocks apoptosis of astrocytomas through dephosphorylation of FAS.	J Neurooncol	14	2005 Sep	glioma	PTPN13
27339696	Divergent viral presentation among human tumors and adjacent normal tissues.	Sci Rep	12	2016 Jun 24	glioma	PTPN13
26047211	Glioblastoma cells induce differential glutamatergic gene expressions in human tumor-associated microglia/macrophages and monocyte-derived macrophages.	Cancer Biol Ther	7	2015	glioma	PTPRC
28982901	Association Between Interleukin-10 Receptors and the CD45-Immunophenotype of Central Nervous System Tumors: A Preliminary Study.	Anticancer Res		2017 Oct	glioma	PTPRC
25169130	Copy number alterations of chromosomal regions enclosing protein tyrosine phosphatase receptor-like genes in colorectal cancer.	Pathol Res Pract	4	2014 Dec	glioma	PTPRT
27586084	Comprehensive protein tyrosine phosphatase mRNA profiling identifies new regulators in the progression of glioma.	Acta Neuropathol Commun	3	2016 Sep 1	glioma	PTPRT
28212562	Overexpression of miR-29a reduces the oncogenic properties of glioblastoma stem cells by downregulating Quaking gene isoform 6.	Oncotarget	9	2017 Apr 11	glioma	QKI
27402815	Tyrosine receptor kinase B is a drug target in astrocytomas.	Neuro Oncol	6	2017 Jan	glioma	QKI
22355603	Loss of p53 in quaking viable mice leads to Purkinje cell defects and reduced survival.	Sci Rep	5	2011	glioma	QKI
19435819	High-resolution genomic copy number profiling of glioblastoma multiforme by single nucleotide polymorphism DNA microarray.	Mol Cancer Res	49	2009 May	glioma	QKI
22751500	STAR RNA-binding protein Quaking suppresses cancer via stabilization of specific miRNA.	Genes Dev	46	2012 Jul 1	glioma	QKI
26829751	MYB-QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanism.	Nat Genet	45	2016 Mar	glioma	QKI
19335891	Haloperidol changes mRNA expression of a QKI splice variant in human astrocytoma cells.	BMC Pharmacol	3	2009 Mar 31	glioma	QKI
16582634	Genomic profiling identifies discrete deletions associated with translocations in glioblastoma multiforme.	Cell Cycle	26	2006 Apr	glioma	QKI
11856480	Expression of Hqk encoding a KH RNA binding protein is altered in human glioma.	Jpn J Cancer Res	17	2002 Feb	glioma	QKI
25971746	NF-ÎºB induces miR-148a to sustain TGF-Î²/Smad signaling activation in glioblastoma.	Mol Cancer	12	2015 Feb 11	glioma	QKI
20927331	QKI-7 regulates expression of interferon-related genes in human astrocyte glioma cells.	PLoS One	1	2010 Sep 29	glioma	QKI
31292920	QKI deficiency maintains glioma stem cell stemness by activating the SHH/GLI1 signaling pathway.	Cell Oncol (Dordr)		2019 Jul 10	glioma	QKI
1	Knocking down SMC1A inhibits growth and leads to G2/M arrest in human glioma cells.	Int J Clin Exp Pathol	10	2013	glioma	RAD21
1	Expression analysis of genes involved in brain tumor progression driven by retroviral insertional mutagenesis in mice.	Oncogene	35	2005 Jun 2	glioma	RAD51B
11857388	Analysis of the antibody repertoire of astrocytoma patients against antigens expressed by gliomas.	Int J Cancer	14	2002 Mar 1	glioma	RANBP2
29616096	A comprehensive analysis of the predicted targets of miR-642b-3p associated with the long non-coding RNA HOXA11-AS in NSCLC cells.	Oncol Lett	1	2018 May	glioma	RANBP2
28002790	Establishment and application of a novel patient-derived KIAA1549:BRAF-driven pediatric pilocytic astrocytoma model for preclinical drug testing.	Oncotarget	8	2017 Feb 14	glioma	RB1
25135958	RNA-seq of 272 gliomas revealed a novel, recurrent PTPRZ1-MET fusion transcript in secondary glioblastomas.	Genome Res	74	2014 Nov	glioma	RB1
24548782	The prognostic role of intragenic copy number breakpoints and identification of novel fusion genes in paediatric high grade glioma.	Acta Neuropathol Commun	7	2014 Feb 18	glioma	RB1
27344175	PDGFRÎ± depletion attenuates glioblastoma stem cells features by modulation of STAT3, RB1 and multiple oncogenic signals.	Oncotarget	6	2016 Aug 16	glioma	RB1
25808605	Molecular signalling pathways in canine gliomas.	Vet Comp Oncol	6	2017 Mar	glioma	RB1
28135248	Systematic analysis of telomere length and somatic alterations in 31 cancer types.	Nat Genet	52	2017 Mar	glioma	RB1
23377830	Down-regulation of miR-106b suppresses the growth of human glioma cells.	J Neurooncol	5	2013 Apr	glioma	RB1
23864165	Tumor-infiltrating lymphocytes in glioblastoma are associated with specific genomic alterations and related to transcriptional class.	Clin Cancer Res	46	2013 Sep 15	glioma	RB1
28970140	MicroRNA-675 promotes glioma cell proliferation and motility by negatively regulating retinoblastoma 1.	Hum Pathol	3	2017 Nov	glioma	RB1
27837373	MicroRNA-215 enhances invasion and migration by targeting retinoblastoma tumor suppressor gene 1 in high-grade glioma.	Biotechnol Lett	3	2017 Feb	glioma	RB1
27633132	Combination of lentivirus-mediated silencing of PPM1D and temozolomide chemotherapy eradicates malignant glioma through cell apoptosis and cell cycle arrest.	Oncol Rep	3	2016 Nov	glioma	RB1
28805815	AAV-mediated direct in vivo CRISPR screen identifies functional suppressors in glioblastoma.	Nat Neurosci	23	2017 Oct	glioma	RB1
29250158	Function of miR-25 in the invasion and metastasis of esophageal squamous carcinoma cells and bioinformatical analysis of the miR-106b-25 cluster.	Exp Ther Med	2	2018 Jan	glioma	RB1
28573541	miR-215 functions as an oncogene in high-grade glioma by regulating retinoblastoma 1.	Biotechnol Lett	2	2017 Sep	glioma	RB1
27733172	CRM1/XPO1 is associated with clinical outcome in glioma and represents a therapeutic target by perturbing multiple core pathways.	J Hematol Oncol	13	2016 Oct 12	glioma	RB1
28716024	MiR-661 promotes tumor invasion and metastasis by directly inhibiting RB1 in non small cell lung cancer.	Mol Cancer	12	2017 Jul 17	glioma	RB1
30816530	InÂ silico analysis identified miRNAâbased therapeutic agents against glioblastoma multiforme.	Oncol Rep	1	2019 Apr	glioma	RB1
30151703	Phase-2 trial of palbociclib in adult patients with recurrent RB1-positive glioblastoma.	J Neurooncol	1	2018 Nov	glioma	RB1
29443735	Identification of gene expression models for laryngeal squamous cell carcinoma using co-expression network analysis.	Medicine (Baltimore)	1	2018 Feb	glioma	RB1
26317630	Expression Analysis of Genes Involved in the RB/E2F Pathway in Astrocytic Tumors.	PLoS One	1	2015	glioma	RB1
1	Differential expression of the RNA-binding motif protein 3 in human astrocytoma.	Chin Med J (Engl)	5	2013	glioma	RBM10
1	Subependymal giant cell astrocytoma-like astrocytoma: a neoplasm with a distinct phenotype and frequent neurofibromatosis type-1-association.	Mod Pathol	5	2018 Dec	glioma	RECQL4
29887596	YAP and MRTF-A, transcriptional co-activators of RhoA-mediated gene expression, are critical for glioblastoma tumorigenicity.	Oncogene	5	2018 Oct	glioma	RHOA
29035824	Knockdown of Diaph1 expression inhibits migration and decreases the expression of MMP2 and MMP9 in human glioma cells.	Biomed Pharmacother	5	2017 Dec	glioma	RHOA
27726098	Downregulation of ARHGDIA contributes to human glioma progression through activation of Rho GTPase signaling pathway.	Tumour Biol	5	2016 Oct 10	glioma	RHOA
27989700	Cathepsin L is involved in X-ray-induced invasion and migration of human glioma U251 cells.	Cell Signal	4	2017 Jan	glioma	RHOA
27852062	Disrupted in schizophrenia 1 (DISC1) inhibits glioblastoma development by regulating mitochondria dynamics.	Oncotarget	4	2016 Dec 27	glioma	RHOA
27667169	AEG-1 promotes mesenchymal transition through the activation of Rho GTPases in human glioblastoma cells.	Oncol Rep	4	2016 Nov	glioma	RHOA
29207169	Daam1 activates RhoA to regulate Wnt5aâinduced glioblastoma cell invasion.	Oncol Rep	3	2018 Feb	glioma	RHOA
30753603	The novel chromatin architectural regulator SND1 promotes glioma proliferation and invasion and predicts the prognosis of patients.	Neuro Oncol	2	2019 Jun 10	glioma	RHOA
30159893	NKCC1 promotes EMT-like process in GBM via RhoA and Rac1 signaling pathways.	J Cell Physiol	2	2019 Feb	glioma	RHOA
28770500	Loss of Pericytes in Radiation Necrosis after Glioblastoma Treatments.	Mol Neurobiol	2	2018 Jun	glioma	RHOA
28679472	NKCC1 Regulates Migration Ability of Glioblastoma Cells by Modulation of Actin Dynamics and Interacting with Cofilin.	EBioMedicine	10	2017 Jul	glioma	RHOA
30848088	Pard3 suppresses glioma invasion by regulating RhoA through atypical protein kinase C/NF-ÎºB signaling.	Cancer Med	1	2019 May	glioma	RHOA
30400005	Otubain 1: a non-canonical deubiquitinase with an emerging role in cancer.	Endocr Relat Cancer	1	2019 Jan 1	glioma	RHOA
29115617	Three-dimensional hydrogel is suitable for targeted investigation of amoeboid migration of glioma cells.	Mol Med Rep	1	2018 Jan	glioma	RHOA
28821879	Musashi-1 Enhances Glioblastoma Cell Migration and Cytoskeletal Dynamics through Translational Inhibition of Tensin3.	Sci Rep	1	2017 Aug 18	glioma	RHOA
31419797	Inhibition of motility by NEO100 through the calpain-1/RhoA pathway.	J Neurosurg		2019 Aug 16	glioma	RHOA
31412547	Coordinated Expression of Ras Suppressor 1 (RSU-1) and Growth Differentiation Factor 15 (GDF15) Affects Glioma Cell Invasion.	Cancers (Basel)		2019 Aug 13	glioma	RHOA
31098343	Molecular Characterization of Primary Human Astrocytes Using Digital Gene Expression Analysis.	Korean J Neurotrauma		2019 Apr	glioma	RHOA
30886866	Paeoniflorin Inhibits Hepatocyte Growth Factor- (HGF-) Induced Migration and Invasion and Actin Rearrangement via Suppression of c-Met-Mediated RhoA/ROCK Signaling in Glioblastoma.	Biomed Res Int		2019	glioma	RHOA
30219706	PDZ-RhoGEF Is a Signaling Effector for TROY-Induced Glioblastoma Cell Invasion and Survival.	Neoplasia		2018 Oct	glioma	RHOA
1	Downregulation of ring-finger protein 43 in glioma associates with poor prognosis.	Int J Clin Exp Pathol	1	2015	glioma	RNF43
1	Role of ribosomal protein mutations in tumor development (Review).	Int J Oncol	32	2016 Apr	glioma	RPL10
1	Role of ribosomal protein mutations in tumor development (Review).	Int J Oncol	32	2016 Apr	glioma	RPL22
20221446	Silencing of ribosomal protein S9 elicits a multitude of cellular responses inhibiting the growth of cancer cells subsequent to p53 activation.	PLoS One	33	2010 Mar 8	glioma	RPL5
26892688	Role of ribosomal protein mutations in tumor development (Review).	Int J Oncol	32	2016 Apr	glioma	RPL5
28147343	The ribosomal protein gene RPL5 is a haploinsufficient tumor suppressor in multiple cancer types.	Oncotarget	19	2017 Feb 28	glioma	RPL5
27469411	Caspase-related apoptosis genes in gliomas by RNA-seq and bioinformatics analysis.	J Clin Neurosci		2016 Nov	glioma	RPL5
22440258	The tumor microenvironment strongly impacts master transcriptional regulators and gene expression class of glioblastoma.	Am J Pathol	60	2012 May	glioma	RUNX1
11508811	Identification of uncommon chromosomal aberrations in the neuroglioma cell line H4 by spectral karyotyping.	J Neurooncol	6	2001 Apr	glioma	RUNX1
28012022	RUNX1 Regulates Migration, Invasion, and Angiogenesis via p38 MAPK Pathway in Human Glioblastoma.	Cell Mol Neurobiol	5	2017 Oct	glioma	RUNX1
22000015	An extensive microRNA-mediated network of RNA-RNA interactions regulates established oncogenic pathways in glioblastoma.	Cell	264	2011 Oct 14	glioma	RUNX1
27434586	Role of HCP5-miR-139-RUNX1 Feedback Loop in Regulating Malignant Behavior of Glioma Cells.	Mol Ther	26	2016 Oct	glioma	RUNX1
30279734	Mesenchymal glioblastoma constitutes a major ceRNA signature in the TGF-Î² pathway.	Theranostics	2	2018	glioma	RUNX1
25903924	Cannabidiol stimulates Aml-1a-dependent glial differentiation and inhibits glioma stem-like cells proliferation by inducing autophagy in a TRPV2-dependent manner.	Int J Cancer	18	2015 Oct 15	glioma	RUNX1
18438928	Runx2 is expressed in human glioma cells and mediates the expression of galectin-3.	J Neurosci Res	18	2008 Aug 15	glioma	RUNX1
12466963	Complex regulation of acetylcholinesterase gene expression in human brain tumors.	Oncogene	16	2002 Dec 5	glioma	RUNX1
25452107	MiR-18a increased the permeability of BTB via RUNX1 mediated down-regulation of ZO-1, occludin and claudin-5.	Cell Signal	10	2015 Jan	glioma	RUNX1
28443460	Augmented expression of RUNX1 deregulates the global gene expression of U87 glioblastoma multiforme cells and inhibits tumor growth in mice.	Tumour Biol		2017 Apr	glioma	RUNX1
1	Integrated genomic characterization of cancer genes in glioma.	Cancer Cell Int	2	2017	glioma	RUNX1T1
17562167	Metabolic and antioxidant system alterations in an astrocytoma cell line challenged with mitochondrial DNA deletion.	Neurochem Res	4	2007 Nov	glioma	SDHA
20511187	Identification of valid endogenous control genes for determining gene expression in human glioma.	Neuro Oncol	16	2010 Jun	glioma	SDHA
8643086	Comparison of Na+-dependent glutamate transport activity in synaptosomes, C6 glioma, and Xenopus oocytes expressing excitatory amino acid carrier 1 (EAAC1).	Mol Pharmacol	16	1996 Mar	glioma	SDHA
29187439	Expression of FAS-L Differs from Primary to Relapsed Low-grade Gliomas and Predicts Progression-free Survival.	Anticancer Res	1	2017 Dec	glioma	SDHA
30894197	Identification of potential biomarkers related to glioma survival by gene expression profile analysis.	BMC Med Genomics		2019 Mar 20	glioma	SDHA
30259794	ACTB and SDHA Are Suitable Endogenous Reference Genes for Gene Expression Studies in Human Astrocytomas Using Quantitative RT-PCR.	Technol Cancer Res Treat		2018 Jan 1	glioma	SDHA
23842546	Landscape of the mitochondrial Hsp90 metabolome in tumours.	Nat Commun	49	2013	glioma	SDHB
29890994	Network-based analysis of oligodendrogliomas predicts novel cancer gene candidates within the region of the 1p/19q co-deletion.	Acta Neuropathol Commun	2	2018 Jun 11	glioma	SDHB
23707781	SDH mutations establish a hypermethylator phenotype in paraganglioma.	Cancer Cell	164	2013 Jun 10	glioma	SDHB
29235326	Effect of hypoxia on the expression of nuclear genes encoding mitochondrial proteins in U87 glioma cells.	Ukr Biochem J	1	2016 May-Jun	glioma	SDHB
1	Effect of hypoxia on the expression of nuclear genes encoding mitochondrial proteins in U87 glioma cells.	Ukr Biochem J	1	2016 May-Jun	glioma	SDHD
28852847	Distinct molecular profile of diffuse cerebellar gliomas.	Acta Neuropathol	6	2017 Dec	glioma	SETD2
26496030	Elucidating the cancer-specific genetic alteration spectrum of glioblastoma derived cell lines from whole exome and RNA sequencing.	Oncotarget	13	2015 Dec 22	glioma	SETD2
24710217	The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes.	Nat Commun	111	2014 Apr 8	glioma	SETD2
1	BNIP3 (Bcl-2 19 kDa interacting protein) acts as transcriptional repressor of apoptosis-inducing factor expression preventing cell death in human malignant gliomas.	J Neurosci	16	2009 Apr 1	glioma	SFPQ
15221014	Expression of the secreted frizzled-related protein gene family is downregulated in human mesothelioma.	Oncogene	45	2004 Aug 26	glioma	SFRP4
19847810	Frequent promoter hypermethylation of Wnt pathway inhibitor genes in malignant astrocytic gliomas.	Int J Cancer	44	2010 Jun 1	glioma	SFRP4
26030909	Secreted frizzled-related protein 4 inhibits glioma stem-like cells by reversing epithelial to mesenchymal transition, inducing apoptosis and decreasing cancer stem cell properties.	PLoS One	22	2015	glioma	SFRP4
20133820	Novel proteins regulated by mTOR in subependymal giant cell astrocytomas of patients with tuberous sclerosis complex and new therapeutic implications.	Am J Pathol	17	2010 Apr	glioma	SFRP4
26712519	Wnt inhibition is dysregulated in gliomas and its re-establishment inhibits proliferation and tumor sphere formation.	Exp Cell Res	15	2016 Jan 1	glioma	SFRP4
1	Knockdown of SLC34A2 inhibits cell proliferation, metastasis, and elevates chemosensitivity in glioma.	J Cell Biochem		2019 Jun	glioma	SLC34A2
29145888	TGF-Î²2 initiates autophagy via Smad and non-Smad pathway to promote glioma cells' invasion.	J Exp Clin Cancer Res	8	2017 Nov 16	glioma	SMAD2
28778566	EGFR/c-myc axis regulates TGFÎ²/Hippo/Notch pathway via epigenetic silencing miR-524 in gliomas.	Cancer Lett	6	2017 Oct 10	glioma	SMAD2
28381482	USP26 regulates TGF-Î² signaling by deubiquitinating and stabilizing SMAD7.	EMBO Rep	6	2017 May	glioma	SMAD2
28377490	Biological Role and Therapeutic Targeting of TGF-Î²&lt;sub&gt;3&lt;/sub&gt; in Glioblastoma.	Mol Cancer Ther	5	2017 Jun	glioma	SMAD2
29316328	Anti-fibrotic effects of pirfenidone by interference with the hedgehog signalling pathway in patients with systemic sclerosis-associated interstitial lung disease.	Int J Rheum Dis	4	2018 Feb	glioma	SMAD2
28735518	The possible prognostic role of histone deacetylase and transforming growth factor Î²/Smad signaling in high grade gliomas treated by radio-chemotherapy: a preliminary immunohistochemical study.	Eur J Histochem	4	2017 May 16	glioma	SMAD2
28160566	miR-320a functions as a suppressor for gliomas by targeting SND1 and Î²-catenin, and predicts the prognosis of patients.	Oncotarget	4	2017 Mar 21	glioma	SMAD2
28481241	Biomarker and Histopathology Evaluation of Patients with Recurrent Glioblastoma Treated with Galunisertib, Lomustine, or the Combination of Galunisertib and Lomustine.	Int J Mol Sci	3	2017 May 6	glioma	SMAD2
30320350	TGF-Î²1 secreted by M2 phenotype macrophages enhances the stemness and migration of gliomaÂ cells via the SMAD2/3 signalling pathway.	Int J Mol Med	2	2018 Dec	glioma	SMAD2
28903341	APOBEC3G acts as a therapeutic target in mesenchymal gliomas by sensitizing cells to radiation-induced cell death.	Oncotarget	2	2017 Aug 15	glioma	SMAD2
30366472	Intronic miR-744 Inhibits Glioblastoma Migration by Functionally Antagonizing Its Host Gene MAP2K4.	Cancers (Basel)	1	2018 Oct 25	glioma	SMAD2
29861845	Microglial SMAD4 regulated by microRNA-146a promotes migration of microglia which support tumor progression in a glioma environment.	Oncotarget	1	2018 May 18	glioma	SMAD2
29443735	Identification of gene expression models for laryngeal squamous cell carcinoma using co-expression network analysis.	Medicine (Baltimore)	1	2018 Feb	glioma	SMAD2
28912531	TGF-Ã¢1-induced miR-503 controls cell growth and apoptosis by targeting PDCD4 in glioblastoma cells.	Sci Rep	1	2017 Sep 14	glioma	SMAD2
31114328	Growth and differentiation factor 15 regulates PD-L1 expression in glioblastoma.	Cancer Manag Res		2019	glioma	SMAD2
30867843	Oncogenic MSH6-CXCR4-TGFB1 Feedback Loop: A Novel Therapeutic Target of Photothermal Therapy in Glioblastoma Multiforme.	Theranostics		2019	glioma	SMAD2
30862693	HERC3-Mediated SMAD7 Ubiquitination Degradation Promotes Autophagy-Induced EMT and Chemoresistance in Glioblastoma.	Clin Cancer Res		2019 Jun 15	glioma	SMAD2
30744607	Ligustrazin increases lung cell autophagy and ameliorates paraquat-induced pulmonary fibrosis by inhibiting PI3K/Akt/mTOR and hedgehog signalling via increasing miR-193a expression.	BMC Pulm Med		2019 Feb 11	glioma	SMAD2
29955125	FHL3 links cell growth and self-renewal by modulating SOX4 in glioma.	Cell Death Differ		2019 May	glioma	SMAD2
28694302	Up-regulation of ANKDR49, a poor prognostic factor, regulates cell proliferation of gliomas.	Biosci Rep		2017 Aug 31	glioma	SMAD2
25991676	Modulation of miR-21 signaling by MPS1 in human glioblastoma.	Oncotarget	8	2016 Aug 16	glioma	SMAD3
25315188	Androgen receptor signaling regulates growth of glioblastoma multiforme in men.	Tumour Biol	8	2015 Feb	glioma	SMAD3
25701598	TGF-Î²/Smad2/3 signal pathway involves in U251 cell proliferation and apoptosis.	Gene	7	2015 May 10	glioma	SMAD3
28834297	TGF-Î²1 targets Smad, p38 MAPK, and PI3K/Akt signaling pathways to induce PFKFB3 gene expression and glycolysis in glioblastoma cells.	FEBS J	6	2017 Oct	glioma	SMAD3
26715270	Let-7a suppresses glioma cell proliferation and invasion through TGF-Î²/Smad3 signaling pathway by targeting HMGA2.	Tumour Biol	6	2016 Jun	glioma	SMAD3
26770324	Analysis of differentially expressed genes based on microarray data of glioma.	Int J Clin Exp Med	5	2015	glioma	SMAD3
30320350	TGF-Î²1 secreted by M2 phenotype macrophages enhances the stemness and migration of gliomaÂ cells via the SMAD2/3 signalling pathway.	Int J Mol Med	2	2018 Dec	glioma	SMAD3
25304053	Lefty inhibits glioma growth by suppressing Nodal-activated Smad and ERK1/2 pathways.	J Neurol Sci	2	2014 Dec 15	glioma	SMAD3
26356815	HOXA13 is a potential GBM diagnostic marker and promotes glioma invasion by activating the Wnt and TGF-Î² pathways.	Oncotarget	19	2015 Sep 29	glioma	SMAD3
25084773	Active CREB1 promotes a malignant TGFÎ²2 autocrine loop in glioblastoma.	Cancer Discov	17	2014 Oct	glioma	SMAD3
25165192	Differential regulation of TGF-Î²-induced, ALK-5-mediated VEGF release by SMAD2/3 versus SMAD1/5/8 signaling in glioblastoma.	Neuro Oncol	13	2015 Feb	glioma	SMAD3
26755653	Ablation of Neuropilin 1 from glioma-associated microglia and macrophages slows tumor progression.	Oncotarget	12	2016 Mar 1	glioma	SMAD3
30129155	Hsa-miR-5582-3P regulatory effect on TGFÎ² signaling through targeting of TGFÎ²-R1, TGFÎ²-R2, SMAD3, and SMAD4 transcripts.	J Cell Biochem	1	2018 Dec	glioma	SMAD3
29861845	Microglial SMAD4 regulated by microRNA-146a promotes migration of microglia which support tumor progression in a glioma environment.	Oncotarget	1	2018 May 18	glioma	SMAD3
28586047	Identification and functional analysis of the risk microRNAs associated with cerebral low-grade glioma prognosis.	Mol Med Rep	1	2017 Aug	glioma	SMAD3
25832460	Nuclear SMAD2 restrains proliferation of glioblastoma.	Cell Physiol Biochem	1	2015	glioma	SMAD3
31250154	MSI2-TGF-Î²/TGF-Î² R1/SMAD3 positive feedback regulation in glioblastoma.	Cancer Chemother Pharmacol		2019 Aug	glioma	SMAD3
30850588	Deciphering the complex role of thrombospondin-1 in glioblastoma development.	Nat Commun		2019 Mar 8	glioma	SMAD3
30535026	SMAD3 silencing enhances DNA damage in radiation therapy by interacting with MRE11-RAD50-NBS1 complex in glioma.	J Biochem		2019 Apr 1	glioma	SMAD3
25891822	Identification of the proliferative effect of Smad2 and 3 in the TGF Î²2/Smad signaling pathway using RNA interference in a glioma cell line.	Mol Med Rep		2015 Aug	glioma	SMAD3
27574009	TGF-Î²1 regulating miR-205/miR-195 expression affects the TGF-Î² signal pathway by respectively targeting SMAD2/SMAD7.	Oncol Rep	8	2016 Oct	glioma	SMAD4
27621042	MicroRNA-564 is downregulated in glioblastoma and inhibited proliferation and invasion of glioblastoma cells by targeting TGF-Î²1.	Oncotarget	6	2016 Aug 30	glioma	SMAD4
25078449	Systemic approaches identify a garlic-derived chemical, Z-ajoene, as a glioblastoma multiforme cancer stem cell-specific targeting agent.	Mol Cells	6	2014 Jul	glioma	SMAD4
21791112	Reduced expression of SMAD4 in gliomas correlates with progression and survival of patients.	J Exp Clin Cancer Res	5	2011 Jul 27	glioma	SMAD4
22750848	microRNA regulatory network inference identifies miR-34a as a novel regulator of TGF-Î² signaling in glioblastoma.	Cancer Discov	49	2012 Aug	glioma	SMAD4
28160566	miR-320a functions as a suppressor for gliomas by targeting SND1 and Î²-catenin, and predicts the prognosis of patients.	Oncotarget	4	2017 Mar 21	glioma	SMAD4
22484521	Dynamics of signaling, cytoskeleton and cell cycle regulation proteins in glioblastoma cells after sub-lethal photodynamic treatment: antibody microarray study.	Biochim Biophys Acta	4	2012 Jul	glioma	SMAD4
20730570	Effect of bone morphogenetic protein 4 in the human brain glioma cell line U251.	Cell Biochem Biophys	4	2010 Nov	glioma	SMAD4
22879069	TGF beta signaling and its role in glioma pathogenesis.	Adv Exp Med Biol	31	2013	glioma	SMAD4
29256899	SUMOylation regulates TGF-Î²1/Smad4 signalling in-resistant glioma cells.	Anticancer Drugs	3	2017 Dec 18	glioma	SMAD4
28791348	MicroRNA-124 inhibits the proliferation of C6 glioma cells by targeting Smad4.	Int J Mol Med	3	2017 Oct	glioma	SMAD4
25326894	The Downregulation of MicroRNA-146a Modulates TGF-Î² Signaling Pathways Activity in Glioblastoma.	Mol Neurobiol	3	2015 Dec	glioma	SMAD4
22707243	Rosiglitazone suppresses glioma cell growth and cell cycle by blocking the transforming growth factor-beta mediated pathway.	Neurochem Res	2	2012 Oct	glioma	SMAD4
23524585	Snail depletes the tumorigenic potential of glioblastoma.	Oncogene	17	2013 Nov 21	glioma	SMAD4
30914782	B7H3 regulates differentiation and serves as a potential biomarker and theranostic target for human glioblastoma.	Lab Invest	1	2019 Jul	glioma	SMAD4
30129155	Hsa-miR-5582-3P regulatory effect on TGFÎ² signaling through targeting of TGFÎ²-R1, TGFÎ²-R2, SMAD3, and SMAD4 transcripts.	J Cell Biochem	1	2018 Dec	glioma	SMAD4
29861845	Microglial SMAD4 regulated by microRNA-146a promotes migration of microglia which support tumor progression in a glioma environment.	Oncotarget	1	2018 May 18	glioma	SMAD4
25919028	A BMP7 Variant Inhibits Tumor Angiogenesis In Vitro and In Vivo through Direct Modulation of Endothelial Cell Biology.	PLoS One	1	2015	glioma	SMAD4
25639227	Adenovirus encoding Smad4 suppresses glioma cell proliferation and increases apoptosis through cell cycle arrest at G1 phase.	Int Immunopharmacol	1	2015 Mar	glioma	SMAD4
31417657	The Loss of &lt;i&gt;SMAD4/DPC4&lt;/i&gt; Expression Associated with a Strongly Activated Hedgehog Signaling Pathway Predicts Poor Prognosis in Resected Pancreatic Cancer.	J Cancer		2019	glioma	SMAD4
23671189	Tumor necrosis factor Î±-induced hypoxia-inducible factor 1Î±-Î²-catenin axis regulates major histocompatibility complex class I gene activation through chromatin remodeling.	Mol Cell Biol	8	2013 Jul	glioma	SMARCA4
23698369	BAF complexes facilitate decatenation of DNA by topoisomerase IIÎ±.	Nature	77	2013 May 30	glioma	SMARCA4
27065321	SMARCA4/Brg1 coordinates genetic and epigenetic networks underlying Shh-type medulloblastoma development.	Oncogene	7	2016 Nov 3	glioma	SMARCA4
22832583	Dissecting the genomic complexity underlying medulloblastoma.	Nature	287	2012 Aug 2	glioma	SMARCA4
22362300	BRG1 expression is increased in human glioma and controls glioma cell proliferation, migration and invasion in vitro.	J Cancer Res Clin Oncol	23	2012 Jun	glioma	SMARCA4
30333046	TERT promoter wild-type glioblastomas show distinct clinical features and frequent PI3K pathway mutations.	Acta Neuropathol Commun	2	2018 Oct 17	glioma	SMARCA4
28792659	Molecular alterations in pediatric brainstem gliomas.	Pediatr Blood Cancer	2	2018 Jan	glioma	SMARCA4
23222069	[Chromatin remodeling defects and cancer: the SWI/SNF example].	Bull Cancer	2	2012 Dec	glioma	SMARCA4
24710217	The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes.	Nat Commun	111	2014 Apr 8	glioma	SMARCA4
29463646	Mutant Isocitrate Dehydrogenase 1 Disrupts PKM2-Î²-Catenin-BRG1 Transcriptional Network-Driven CD47 Expression.	Mol Cell Biol	1	2018 May 1	glioma	SMARCA4
27579614	GBM-associated mutations and altered protein expression are more common in young patients.	Oncotarget		2016 Oct 25	glioma	SMARCA4
25085602	Expression of the HOX genes and HOTAIR in atypical teratoid rhabdoid tumors and other pediatric brain tumors.	Cancer Genet	8	2014 Sep	glioma	SMARCB1
21076395	Loss of the tumor suppressor Snf5 leads to aberrant activation of the Hedgehog-Gli pathway.	Nat Med	78	2010 Dec	glioma	SMARCB1
22082607	Atypical teratoid/rhabdoid tumor arising in a ganglioglioma:  genetic characterization.	Am J Surg Pathol	6	2011 Dec	glioma	SMARCB1
21795858	Insulin-like growth factor binding protein 7 exhibits tumor suppressive and vessel stabilization properties in U87MG and T98G glioblastoma cell lines.	Cancer Biol Ther	6	2011 Oct 1	glioma	SMARCB1
28181325	Recurrent copy number alterations in low-grade and anaplastic pleomorphic xanthoastrocytoma with and without BRAF V600E mutation.	Brain Pathol	4	2018 Mar	glioma	SMARCB1
26109171	Integrated genomics has identified a new AT/RT-like yet INI1-positive brain tumor subtype among primary pediatric embryonal tumors.	BMC Med Genomics	4	2015 Jun 25	glioma	SMARCB1
24457079	Rhabdoid glioblastoma is distinguishable from classical glioblastoma by cytogenetics and molecular genetics.	Hum Pathol	3	2014 Mar	glioma	SMARCB1
23435428	Activation of Î²-catenin/TCF targets following loss of the tumor suppressor SNF5.	Oncogene	20	2014 Feb 13	glioma	SMARCB1
30333046	TERT promoter wild-type glioblastomas show distinct clinical features and frequent PI3K pathway mutations.	Acta Neuropathol Commun	2	2018 Oct 17	glioma	SMARCB1
26769252	Atypical Teratoid/Rhabdoid Tumor (AT/RT) Arising From    Ependymoma: A Type of AT/RT Secondarily Developing   From Other Primary Central Nervous System Tumors.	J Neuropathol Exp Neurol	2	2016 Feb	glioma	SMARCB1
25018128	Malignant rhabdoid tumor of the bladder and ganglioglioma in a 14 year-old male with a germline 22q11.2 deletion.	Cancer Genet	2	2014 Sep	glioma	SMARCB1
23222069	[Chromatin remodeling defects and cancer: the SWI/SNF example].	Bull Cancer	2	2012 Dec	glioma	SMARCB1
20118769	Epithelioid versus rhabdoid glioblastomas are distinguished by monosomy 22 and immunohistochemical expression of INI-1 but not claudin 6.	Am J Surg Pathol	16	2010 Mar	glioma	SMARCB1
16616114	Methylation of RASSF1A and TRAIL pathway-related genes is frequent in childhood intracranial ependymomas and benign choroid plexus papilloma.	Cancer Genet Cytogenet	14	2006 Apr 1	glioma	SMARCB1
25268025	Atypical teratoid/rhabdoid tumor arising in pleomorphic xanthoastrocytoma: a case report.	Neuropathology	1	2014 Aug	glioma	SMARCB1
21240060	INI1 immunohistochemical expression in glioblastoma: correlation with MGMT gene promoter methylation status and patient survival.	Pathology	1	2011 Jan	glioma	SMARCB1
18422908	Melanocytic medulloblastoma with ganglioneurocytomatous differentiation: a case report.	Neuropathology	1	2009 Feb	glioma	SMARCB1
15993274	No evidence of INI1hSNF5 (SMARCB1) and PARVG point mutations in oligodendroglial neoplasms.	Cancer Genet Cytogenet	1	2005 Jul 15	glioma	SMARCB1
15759130	Differentiation of classic medulloblastoma into metastatic large cell medulloblastoma with focal rhabdoid differentiation in the absence of posterior fossa recurrence.	Acta Neuropathol	1	2005 May	glioma	SMARCB1
29774876	[Clinicopathological features for epithelioid glioblastoma: A newly defined tumor by the 2016 World Health Organization Classification of Tumors of the Central Nervous System].	Zhong Nan Da Xue Xue Bao Yi Xue Ban		2018 Apr 28	glioma	SMARCB1
17438093	Reciprocal regulation of SOCS 1 and SOCS3 enhances resistance to ionizing radiation in glioblastoma multiforme.	Clin Cancer Res	32	2007 Apr 15	glioma	SOCS1
21339190	DNA hypermethylation profiles associated with glioma subtypes and EZH2 and IGFBP2 mRNA expression.	Neuro Oncol	28	2011 Mar	glioma	SOCS1
18770864	Prognostic relevance of SOCS3 hypermethylation in patients with glioblastoma multiforme.	Int J Cancer	24	2008 Dec 15	glioma	SOCS1
28035384	Correlative analyses of the expression levels of PIAS3, p-SHP2, SOCS1 and SOCS3 with STAT3 activation in human astrocytomas.	Mol Med Rep	1	2017 Feb	glioma	SOCS1
1	SPOCD1 promotes the proliferation and metastasis of glioma cells by up-regulating PTX3.	Am J Cancer Res		2018	glioma	SPEN
27930311	Spop promotes skeletal development and homeostasis by positively regulating Ihh signaling.	Proc Natl Acad Sci U S A	9	2016 Dec 20	glioma	SPOP
25351530	Decreased expression of the SPOP gene is associated with poor prognosis in glioma.	Int J Oncol	5	2015 Jan	glioma	SPOP
24318971	STAG2 expression in oral cancer and potentially malignant lesions.	Tumour Biol	2	2014 Apr	glioma	STAG2
21852505	Mutational inactivation of STAG2 causes aneuploidy in human cancer.	Science	154	2011 Aug 19	glioma	STAG2
24080485	MRNA and miRNA expression patterns associated to pathways linked to metal mixture health effects.	Gene	12	2014 Jan 10	glioma	STAG2
31290679	Comparative proteogenomic characterization of glioblastoma.	CNS Oncol		2019 Jun	glioma	STAG2
31104347	High-grade neuroepithelial tumor with BCOR exon 15 internal tandem duplication-a comprehensive clinical, radiographic, pathologic, and genomic analysis.	Brain Pathol		2019 May 18	glioma	STAG2
30222900	Granular cell astrocytoma: an aggressive IDH-wildtype diffuse glioma with molecular genetic features of primary glioblastoma.	Brain Pathol		2019 Mar	glioma	STAG2
26770324	Analysis of differentially expressed genes based on microarray data of glioma.	Int J Clin Exp Med	5	2015	glioma	STAT5B
25907517	Nucleophosmin overexpression is associated with poor survival in astrocytoma.	APMIS	4	2015 Jun	glioma	STAT5B
25302990	Signal transducer and activator of transcription 5b drives malignant progression in a PDGFB-dependent proneural glioma model by suppressing apoptosis.	Int J Cancer	4	2015 May 1	glioma	STAT5B
21896743	Crosstalk between the urokinase-type plasminogen activator receptor and EGF receptor variant III supports survival and growth of glioblastoma cells.	Proc Natl Acad Sci U S A	28	2011 Sep 20	glioma	STAT5B
24440911	Multiple receptor tyrosine kinases converge on microRNA-134 to control KRAS, STAT5B, and glioblastoma.	Cell Death Differ	26	2014 May	glioma	STAT5B
18793823	Inhibition of transcription factor STAT5b suppresses proliferation, induces G1 cell cycle arrest and reduces tumor cell invasion in human glioblastoma multiforme cells.	Cancer Lett	25	2009 Jan 8	glioma	STAT5B
22729867	Nuclear EGFRvIII-STAT5b complex contributes to glioblastoma cell survival by direct activation of the Bcl-XL promoter.	Int J Cancer	20	2013 Feb 1	glioma	STAT5B
29193056	Identification of a novel fusion gene HMGA2-EGFR in glioblastoma.	Int J Cancer	2	2018 Apr 15	glioma	STAT5B
23250732	DARPP32, STAT5 and STAT3 mRNA expression ratios in glioblastomas are associated with patient outcome.	Pathol Oncol Res	2	2013 Apr	glioma	STAT5B
11038252	Activation of the Jak-Stat- and MAPK-pathways by oncostatin M is not sufficient to cause growth inhibition of human glioma cells.	Brain Res Mol Brain Res		2000 Sep 15	glioma	STAT5B
26001218	Fyn-phosphorylated PIKE-A binds and inhibits AMPK signaling, blocking its tumor suppressive activity.	Cell Death Differ	8	2016 Jan	glioma	STK11
20647762	microRNA-451: A conditional switch controlling glioma cell proliferation and migration.	Cell Cycle	69	2010 Jul 15	glioma	STK11
25399650	Probucol suppresses human glioma cell proliferation in vitro via ROS production and LKB1-AMPK activation.	Acta Pharmacol Sin	6	2014 Dec	glioma	STK11
26968235	The role of octamer binding transcription factors in glioblastoma multiforme.	Biochim Biophys Acta	3	2016 Jun	glioma	STK11
16733653	Ganglioglioma arising in a Peutz-Jeghers patient: a case report with molecular implications.	Acta Neuropathol	2	2006 Jul	glioma	STK11
20227367	MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells.	Mol Cell	155	2010 Mar 12	glioma	STK11
23861764	LKB1 inhibits breast cancer partially through repressing the Hedgehog signaling pathway.	PLoS One	11	2013	glioma	STK11
24854174	Overlapping binding sites for importin Î²1 and suppressor of fused (SuFu) on glioma-associated oncogene homologue 1 (Gli1) regulate its nuclear localization.	Biochem J	7	2014 Aug 1	glioma	SUFU
29662197	MEKK2 and MEKK3 suppress Hedgehog pathway-dependent medulloblastoma by inhibiting GLI1 function.	Oncogene	5	2018 Jul	glioma	SUFU
27785591	The DNA methyltransferase inhibitor zebularine exerts antitumor effects and reveals BATF2 as a poor prognostic marker for childhood medulloblastoma.	Invest New Drugs	5	2017 Feb	glioma	SUFU
22027544	Medulloblastomas in adults:  prognostic factors and lessons from paediatrics.	Curr Opin Neurol	5	2011 Dec	glioma	SUFU
28545823	Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study.	Lancet Oncol	45	2017 Jul	glioma	SUFU
29316328	Anti-fibrotic effects of pirfenidone by interference with the hedgehog signalling pathway in patients with systemic sclerosis-associated interstitial lung disease.	Int J Rheum Dis	4	2018 Feb	glioma	SUFU
25355313	The BET bromodomain inhibitor I-BET151 acts downstream of smoothened protein to abrogate the growth of hedgehog protein-driven cancers.	J Biol Chem	37	2014 Dec 19	glioma	SUFU
28463091	Curcumin increases efficiency of Î³-irradiation in gliomas by inhibiting Hedgehog signaling pathway.	Cell Cycle	3	2017 Jun 18	glioma	SUFU
26573582	Arsenic Attenuates GLI Signaling, Increasing or Decreasing its Transcriptional Program in a Context-Dependent Manner.	Mol Pharmacol	3	2016 Feb	glioma	SUFU
26130651	RAS/MAPK Activation Drives Resistance to Smo Inhibition, Metastasis, and Tumor Evolution in Shh Pathway-Dependent Tumors.	Cancer Res	27	2015 Sep 1	glioma	SUFU
25373737	Suppressor of fused (Sufu) represses Gli1 transcription and nuclear accumulation, inhibits glioma cell proliferation, invasion and vasculogenic mimicry, improving glioma chemo-sensitivity and prognosis.	Oncotarget	26	2014 Nov 30	glioma	SUFU
29274272	The role of the Hedgehog signaling pathway in cancer: A comprehensive review.	Bosn J Basic Med Sci	20	2018 Feb 20	glioma	SUFU
30251117	Inhibition of sonic hedgehog and PI3K/Akt/mTOR pathways cooperate in suppressing survival, self-renewal and tumorigenic potential of glioblastoma-initiating cells.	Mol Cell Biochem	2	2019 Apr	glioma	SUFU
24651015	Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition.	Cancer Cell	171	2014 Mar 17	glioma	SUFU
24252690	Identification of a neuronal transcription factor network involved in medulloblastoma development.	Acta Neuropathol Commun	17	2013 Jul 11	glioma	SUFU
21893610	Hedgehog signalling promotes germ cell survival in the rat testis.	Reproduction	13	2011 Nov	glioma	SUFU
23861764	LKB1 inhibits breast cancer partially through repressing the Hedgehog signaling pathway.	PLoS One	11	2013	glioma	SUFU
29753700	Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort.	Lancet Oncol	10	2018 Jun	glioma	SUFU
26176320	Suppressor of Fused Plays an Important Role in Regulating Mesodermal Differentiation of Murine Embryonic Stem Cells In Vivo.	Stem Cells Dev	1	2015 Nov 1	glioma	SUFU
30790292	Oroxylin A increases the sensitivity of temozolomide on glioma cells by hypoxia-inducible factor 1Î±/hedgehog pathway under hypoxia.	J Cell Physiol		2019 Aug	glioma	SUFU
27135271	No Significant Cytotoxic Effect of the EZH2 Inhibitor Tazemetostat (EPZ-6438) on Pediatric Glioma Cells with Wildtype Histone 3 or Mutated Histone 3.3.	Klin Padiatr	7	2016 Apr	glioma	SUZ12
23733246	MicroRNA-128 coordinately targets Polycomb Repressor Complexes in glioma stem cells.	Neuro Oncol	51	2013 Sep	glioma	SUZ12
28618952	MicroRNA-105 inhibits human glioma cell malignancy by directly targeting SUZ12.	Tumour Biol	5	2017 Jun	glioma	SUZ12
20920292	Clinical significance of Polycomb gene expression in brain tumors.	Mol Cancer	28	2010 Sep 30	glioma	SUZ12
23660940	Differential expression and methylation of brain developmental genes define location-specific subsets of pilocytic astrocytoma.	Acta Neuropathol	25	2013 Aug	glioma	SUZ12
24183680	Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomas.	Cancer Cell	179	2013 Nov 11	glioma	SUZ12
28329683	Inactivation of Ezh2 Upregulates Gfi1 and Drives Aggressive Myc-Driven Group 3 Medulloblastoma.	Cell Rep	15	2017 Mar 21	glioma	SUZ12
23179372	OTX2 sustains a bivalent-like state of OTX2-bound promoters in medulloblastoma by maintaining their H3K27me3 levels.	Acta Neuropathol	14	2013 Mar	glioma	SUZ12
25119042	PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapies.	Nature	105	2014 Oct 9	glioma	SUZ12
30131250	microRNA-124a suppresses PHF19 over-expression, EZH2 hyper-activation, and aberrant cell proliferation in human glioma.	Biochem Biophys Res Commun	1	2018 Sep 10	glioma	SUZ12
31115583	miRâ767â5p inhibits glioma proliferation and metastasis by targeting SUZ12.	Oncol Rep		2019 Jul	glioma	SUZ12
21156036	DNA methylation in glioblastoma: impact on gene expression and clinical outcome.	BMC Genomics	67	2010 Dec 14	glioma	TBX3
26255341	INHIBITION OF ERN1 SIGNALING ENZYME AFFECTS HYPOXIC REGULATION OF THE EXPRESSION OF E2F8, EPAS1, HOXC6, ATF3, TBX3 AND FOXF1 GENES IN U87 GLIOMA CELLS.	Ukr Biochem J	1	2015 Mar-Apr	glioma	TBX3
29537195	Expression of proliferation related transcription factor genes in U87 glioma cells with IRE1 knockdown: upon glucose and glutamine deprivation.	Fiziol Zh		2016	glioma	TBX3
28767654	Cancer stem cell-related gene expression as a potential biomarker of response for first-in-class imipridone ONC201 in solid tumors.	PLoS One	5	2017	glioma	TCF3
27105323	Transcription factor 3 controls cell proliferation and migration in glioblastoma multiforme cell lines.	Biochem Cell Biol	4	2016 Jun	glioma	TCF3
14730454	Expression of oligodendrocyte lineage genes in oligodendroglial and astrocytic gliomas.	Acta Neuropathol	12	2004 Mar	glioma	TCF3
29235836	Hypoxic regulation of MYBL1, MEST, TCF3, TCF8, GTF2B, GTF2F2 and SNAI2 genes expression in U87 glioma cells upon IRE1 inhibition.	Ukr Biochem J	1	2016 Nov-Dec	glioma	TCF3
29537195	Expression of proliferation related transcription factor genes in U87 glioma cells with IRE1 knockdown: upon glucose and glutamine deprivation.	Fiziol Zh		2016	glioma	TCF3
30205050	Disruption of the Î²1L Isoform of GABP Reverses Glioblastoma Replicative Immortality in a TERT Promoter Mutation-Dependent Manner.	Cancer Cell	8	2018 Sep 10	glioma	TERT
30333046	TERT promoter wild-type glioblastomas show distinct clinical features and frequent PI3K pathway mutations.	Acta Neuropathol Commun	2	2018 Oct 17	glioma	TERT
30887243	A novel antisense oligonucleotide anchored on the intronic splicing enhancer of hTERT pre-mRNA inhibits telomerase activity and induces apoptosis in glioma cells.	J Neurooncol	1	2019 May	glioma	TERT
30877769	Molecular classification of IDH-mutant glioblastomas based on gene expression profiles.	Carcinogenesis	1	2019 Jul 20	glioma	TERT
30611004	Allergy may confer better survival on patients with gliomas.	Clin Neurol Neurosurg	1	2019 Feb	glioma	TERT
30159779	Molecular subgroups and B7-H4 expression levels predict responses to dendritic cell vaccines in glioblastoma: an exploratory randomized phase II clinical trial.	Cancer Immunol Immunother	1	2018 Nov	glioma	TERT
31508376	Recurrent Glioma With Lineage Conversion From Oligodendroglioma to Astrocytoma in Two Cases.	Front Oncol		2019	glioma	TERT
31391125	TERT expression is susceptible to BRAF and ETS-factor inhibition in BRAF&lt;sup&gt;V600E&lt;/sup&gt;/TERT promoter double-mutated glioma.	Acta Neuropathol Commun		2019 Aug 7	glioma	TERT
31157866	Systematically characterize the clinical and biological significances of 1p19q genes in 1p/19q non-codeletion glioma.	Carcinogenesis		2019 Jun 3	glioma	TERT
31111685	SEL1L Plays a Major Role in Human Malignant Gliomas.	J Pathol Clin Res		2019 May 20	glioma	TERT
31104347	High-grade neuroepithelial tumor with BCOR exon 15 internal tandem duplication-a comprehensive clinical, radiographic, pathologic, and genomic analysis.	Brain Pathol		2019 May 18	glioma	TERT
30937985	High frequency of H3K27M immunopositivity in adult thalamic glioblastoma.	Neuropathology		2019 Apr	glioma	TERT
30936423	Increased expression of NAF1 contributes to malignant phenotypes of glioma cells through promoting protein synthesis and associates with poor patient survival.	Oncogenesis		2019 Apr 1	glioma	TERT
30842153	Clinicopathological Significance of Autophagy-related Proteins and its Association With Genetic Alterations in Gliomas.	Anticancer Res		2019 Mar	glioma	TERT
30830680	Telomere elongation via alternative lengthening of telomeres (ALT) and telomerase activation in primary metastatic medulloblastoma of childhood.	J Neurooncol		2019 May	glioma	TERT
30705664	ZEB1 Is a Transcription Factor That Is Prognostic and Predictive in Diffuse Gliomas.	Front Neurol		2018	glioma	TERT
30655743	Significance of TERT and ATRX mutations in glioma.	Oncol Lett		2019 Jan	glioma	TERT
30599247	Role of a Promoter Mutation in TERT in Malignant Transformation of Pleomorphic Xanthoastrocytoma.	World Neurosurg		2018 Dec 30	glioma	TERT
30535594	Comprehensive genetic alteration profiling in primary and recurrent glioblastoma.	J Neurooncol		2019 Mar	glioma	TERT
30222900	Granular cell astrocytoma: an aggressive IDH-wildtype diffuse glioma with molecular genetic features of primary glioblastoma.	Brain Pathol		2019 Mar	glioma	TERT
21251613	Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of Î±-ketoglutarate-dependent dioxygenases.	Cancer Cell	730	2011 Jan 18	glioma	TET1
24395347	TET family proteins: new players in gliomas.	J Neurooncol	5	2014 Feb	glioma	TET1
22688054	Nuclear exclusion of TET1 is associated with loss of 5-hydroxymethylcytosine in IDH1 wild-type gliomas.	Am J Pathol	38	2012 Aug	glioma	TET1
25284789	5-Hydroxymethylcytosine plays a critical role in glioblastomagenesis by recruiting the CHTOP-methylosome complex.	Cell Rep	32	2014 Oct 9	glioma	TET1
28376560	Hypoxia-Mediated Epigenetic Regulation of Stemness in Brain Tumor Cells.	Stem Cells	3	2017 Jun	glioma	TET1
24894482	Increased 5-hydroxymethylcytosine and decreased 5-methylcytosine are indicators of global epigenetic dysregulation in diffuse intrinsic pontine glioma.	Acta Neuropathol Commun	13	2014 Jun 3	glioma	TET1
27346347	Oncogenic EGFR Represses the TET1 DNA Demethylase to Induce Silencing of Tumor Suppressors in Cancer Cells.	Cell Rep	10	2016 Jul 12	glioma	TET1
28228863	Medulloblastoma and ependymoma cells display increased levels of 5-carboxylcytosine and elevated &lt;i&gt;TET1&lt;/i&gt; expression.	Clin Epigenetics	1	2017	glioma	TET1
30730955	Abnormal activity of transcription factors gli in high-grade gliomas.	PLoS One		2019	glioma	TET1
29582271	Reduced hydroxymethylation characterizes medulloblastoma while TET and IDH genes are differentially expressed within molecular subgroups.	J Neurooncol		2018 Aug	glioma	TET1
28341638	TET1 exerts its tumour suppressor function by regulating autophagy in glioma cells.	Biosci Rep		2017 Dec 22	glioma	TET1
21251613	Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of Î±-ketoglutarate-dependent dioxygenases.	Cancer Cell	730	2011 Jan 18	glioma	TET2
23863747	Meta-analysis of IDH-mutant cancers identifies EBF1 as an interaction partner for TET2.	Nat Commun	54	2013	glioma	TET2
28564603	2-HG Inhibits Necroptosis by Stimulating DNMT1-Dependent Hypermethylation of the RIP3 Promoter.	Cell Rep	5	2017 May 30	glioma	TET2
24395347	TET family proteins: new players in gliomas.	J Neurooncol	5	2014 Feb	glioma	TET2
28260066	Repression of the expression of TET2 by ZEB1 contributes to invasion and growth in glioma cells.	Mol Med Rep	4	2017 May	glioma	TET2
22688054	Nuclear exclusion of TET1 is associated with loss of 5-hydroxymethylcytosine in IDH1 wild-type gliomas.	Am J Pathol	38	2012 Aug	glioma	TET2
28376560	Hypoxia-Mediated Epigenetic Regulation of Stemness in Brain Tumor Cells.	Stem Cells	3	2017 Jun	glioma	TET2
30388142	Methylation dependent down-regulation of G0S2 leads to suppression of invasion and improved prognosis of IDH1-mutant glioma.	PLoS One	2	2018	glioma	TET2
30888082	AC016405.3, a novel long noncoding RNA, acts as a tumor suppressor through modulation of TET2 by microRNA-19a-5p sponging in glioblastoma.	Cancer Sci	1	2019 May	glioma	TET2
27527869	Epithelial membrane protein 3 regulates TGF-Î² signaling activation in CD44-high glioblastoma.	Oncotarget	9	2017 Feb 28	glioma	TGFBR2
19179424	Analysis of microsatellite instability in medulloblastoma.	Neuro Oncol	8	2009 Oct	glioma	TGFBR2
17684491	Microglia-derived TGF-beta as an important regulator of glioblastoma invasion--an inhibition of TGF-beta-dependent effects by shRNA against human TGF-beta type II receptor.	Oncogene	73	2008 Feb 7	glioma	TGFBR2
28938007	Neuropilin-1 modulates TGFÎ² signaling to drive glioblastoma growth and recurrence after anti-angiogenic therapy.	PLoS One	7	2017	glioma	TGFBR2
28109751	Cord blood natural killer cells expressing a dominant negative TGF-Î² receptor: Implications for adoptive immunotherapy for glioblastoma.	Cytotherapy	7	2017 Mar	glioma	TGFBR2
26858153	miR-373 Inhibits Glioma Cell U251 Migration and Invasion by Down-Regulating CD44 and TGFBR2.	Cell Mol Neurobiol	6	2016 Nov	glioma	TGFBR2
30196284	Enhanced Expression of TGFBI Promotes the Proliferation and Migration of Glioma Cells.	Cell Physiol Biochem	5	2018	glioma	TGFBR2
22402626	Induced transgene expression for the treatment of solid tumors by hematopoietic stem cell-based gene therapy.	Cancer Gene Ther	5	2012 May	glioma	TGFBR2
28184932	MicroRNA-520c inhibits glioma cell migration and invasion by the suppression of transforming growth factor-Î² receptor typeÂ 2.	Oncol Rep	4	2017 Mar	glioma	TGFBR2
26670566	Integrative Network Analysis Combined with Quantitative Phosphoproteomics Reveals Transforming Growth Factor-beta Receptor type-2 (TGFBR2) as a Novel Regulator of Glioblastoma Stem Cell Properties.	Mol Cell Proteomics	4	2016 Mar	glioma	TGFBR2
24090655	Immature mesenchymal stem cell-like pericytes as mediators of immunosuppression in human malignant glioma.	J Neuroimmunol	23	2013 Dec 15	glioma	TGFBR2
30279734	Mesenchymal glioblastoma constitutes a major ceRNA signature in the TGF-Î² pathway.	Theranostics	2	2018	glioma	TGFBR2
29888103	ERBB3, IGF1R, and TGFBR2 expression correlate with PDGFR expression in glioblastoma and participate in PDGFR inhibitor resistance of glioblastoma cells.	Am J Cancer Res	2	2018	glioma	TGFBR2
28101577	Viscumins functionally modulate cell motility-associated gene expression.	Int J Oncol	2	2017 Feb	glioma	TGFBR2
27716259	Microarray data analysis to identify crucial genes regulated by CEBPB in human SNB19 glioma cells.	World J Surg Oncol	2	2016 Oct 6	glioma	TGFBR2
27456940	Underexpression of HOXA11 Is Associated with Treatment Resistance and Poor Prognosis in Glioblastoma.	Cancer Res Treat	11	2017 Apr	glioma	TGFBR2
26682928	MicroRNA-181c inhibits glioblastoma cell invasion, migration and mesenchymal transition by targeting TGF-Î² pathway.	Biochem Biophys Res Commun	11	2016 Jan 22	glioma	TGFBR2
22664874	Tumor-associated microglia/macrophages enhance the invasion of glioma stem-like cells via TGF-Î²1 signaling pathway.	J Immunol	101	2012 Jul 1	glioma	TGFBR2
27048878	Nuclear receptor TLX inhibits TGF-Î² signaling in glioblastoma.	Exp Cell Res	1	2016 May 1	glioma	TGFBR2
30256570	Gene Silencing of TGFÎ²RII Can Inhibit Glioblastoma Cell Growth	Asian Pac J Cancer Prev		2018 Sep 26	glioma	TGFBR2
11322796	A MEK inhibitor, PD98059 enhances IL-1-induced NF-kappaB activation by the enhanced and sustained degradation of IkappaBalpha.	Biochem Biophys Res Commun	5	2001 Apr 27	glioma	TNFAIP3
16365179	Tumor necrosis factor-alpha-induced protein 3 as a putative regulator of nuclear factor-kappaB-mediated resistance to O6-alkylating agents in human glioblastomas.	J Clin Oncol	45	2006 Jan 10	glioma	TNFAIP3
20186265	Targeting A20 decreases glioma stem cell survival and tumor growth.	PLoS Biol	41	2010 Feb 23	glioma	TNFAIP3
19536297	Modulation of angiogenic and inflammatory response in glioblastoma by hypoxia.	PLoS One	39	2009 Jun 17	glioma	TNFAIP3
30899304	MiR-21, miR-34a, miR-125b, miR-181d and miR-648 levels inversely correlate with MGMT and TP53 expression in primary glioblastoma patients.	Arch Med Sci	3	2019 Mar	glioma	TNFAIP3
24901050	miR-125b controls apoptosis and temozolomide resistance by targeting TNFAIP3 and NKIRAS2 in glioblastomas.	Cell Death Dis	19	2014 Jun 5	glioma	TNFAIP3
19492975	A20 is overexpressed in glioma cells and may serve as a potential therapeutic target.	Expert Opin Ther Targets	11	2009 Jul	glioma	TNFAIP3
24479486	Î²â-adrenergic agonists modulate TNF-Î± induced astrocytic inflammatory gene expression and brain inflammatory cell populations.	J Neuroinflammation	10	2014 Jan 30	glioma	TNFAIP3
29285249	Retinol dehydrogenase-10 promotes development and progression of human glioma via the TWEAK-NF-ÎºB axis.	Oncotarget	1	2017 Dec 1	glioma	TNFAIP3
27025058	INHIBITION OF IRE1 MODIFIES EFFECT OF GLUCOSE DEPRIVATION ON THE EXPRESSION OF TNFÎ±-RELATED GENES IN U87 GLIOMA CELLS.	Ukr Biochem J	1	2015 Nov-Dec	glioma	TNFAIP3
24962072	Differential effects of antofine N-oxide on solid tumor and leukemia cells.	Anticancer Agents Med Chem		2014	glioma	TNFAIP3
15827141	Characterization of a recombinant herpes simplex virus 1 designed to enter cells via the IL13Ralpha2 receptor of malignant glioma cells.	J Virol	20	2005 May	glioma	TNFRSF14
28512247	Targetable T-type Calcium Channels Drive Glioblastoma.	Cancer Res	11	2017 Jul 1	glioma	TNFRSF14
30899304	MiR-21, miR-34a, miR-125b, miR-181d and miR-648 levels inversely correlate with MGMT and TP53 expression in primary glioblastoma patients.	Arch Med Sci	3	2019 Mar	glioma	TP53
30531922	The molecular landscape of glioma in patients with Neurofibromatosis 1.	Nat Med	3	2019 Jan	glioma	TP53
30595505	Histone H3.3 K27M Accelerates Spontaneous Brainstem Glioma and Drives Restricted Changes in Bivalent Gene Expression.	Cancer Cell	10	2019 Jan 14	glioma	TP53
30760578	IDH1-R132H acts as a tumor suppressor in glioma via epigenetic up-regulation of the DNA damage response.	Sci Transl Med	1	2019 Feb 13	glioma	TP53
30611004	Allergy may confer better survival on patients with gliomas.	Clin Neurol Neurosurg	1	2019 Feb	glioma	TP53
31508376	Recurrent Glioma With Lineage Conversion From Oligodendroglioma to Astrocytoma in Two Cases.	Front Oncol		2019	glioma	TP53
31497354	Wild-type &lt;i&gt;TP53&lt;/i&gt; defined gamma-secretase inhibitor sensitivity and synergistic activity with doxorubicin in GSCs.	Am J Cancer Res		2019	glioma	TP53
31417657	The Loss of &lt;i&gt;SMAD4/DPC4&lt;/i&gt; Expression Associated with a Strongly Activated Hedgehog Signaling Pathway Predicts Poor Prognosis in Resected Pancreatic Cancer.	J Cancer		2019	glioma	TP53
31402948	TIGAR promotes growth, survival and metastasis through oxidation resistance and AKT activation in glioblastoma.	Oncol Lett		2019 Sep	glioma	TP53
31350684	Anaplastic pleomorphic xanthoastrocytoma associated with an H3G34 mutation: a case report with review of literature.	Brain Tumor Pathol		2019 Jul 26	glioma	TP53
31329636	Detection of the KIAA1549-BRAF fusion gene in cells forming microvascular proliferations in pilocytic astrocytoma.	PLoS One		2019	glioma	TP53
31328874	Signal Transduction in Diffuse Intrinsic Pontine Glioma.	Proteomics		2019 Jul 22	glioma	TP53
31290679	Comparative proteogenomic characterization of glioblastoma.	CNS Oncol		2019 Jun	glioma	TP53
31233763	LncRNA PLAC2 upregulates p53 to induce hepatocellular carcinoma cell apoptosis.	Gene		2019 Sep 5	glioma	TP53
31104347	High-grade neuroepithelial tumor with BCOR exon 15 internal tandem duplication-a comprehensive clinical, radiographic, pathologic, and genomic analysis.	Brain Pathol		2019 May 18	glioma	TP53
31081046	Targeted therapy based on p53 reactivation reduces both glioblastoma cell growth and resistance to temozolomide.	Int J Oncol		2019 Jun	glioma	TP53
31062529	von Willebrand Factor Gene Expression in Primary Lower Grade Glioma: Mutually Co-Occurring Mutations in von Willebrand Factor, ATRX, and TP53.	Brain Tumor Res Treat		2019 Apr	glioma	TP53
30945456	Developmental origins and oncogenic pathways in malignant brain tumors.	Wiley Interdiscip Rev Dev Biol		2019 Jul	glioma	TP53
30725256	Modulating native GABA&lt;sub&gt;A&lt;/sub&gt; receptors in medulloblastoma with positive allosteric benzodiazepine-derivatives induces cell death.	J Neurooncol		2019 May	glioma	TP53
30610508	Induction of apoptosis by in vitro and in vivo plant extracts derived from Menyanthes trifoliata L. in human cancer cells.	Cytotechnology		2019 Feb	glioma	TP53
21623385	Cytoplasmic p63 immunohistochemistry is a useful marker for muscle differentiation: an immunohistochemical and immunoelectron microscopic study.	Mod Pathol	6	2011 Oct	glioma	TP63
27810075	Co-localized genomic regulation of miRNA and mRNA via DNA methylation affects survival in multiple tumor types.	Cancer Genet	5	2016 Oct	glioma	TP63
22964638	Effect of miR-21 and miR-30b/c on TRAIL-induced apoptosis in glioma cells.	Oncogene	44	2013 Aug 22	glioma	TP63
23362460	Temozolomide suppresses MYC via activation of TAp63 to inhibit progression of human glioblastoma.	Sci Rep	3	2013	glioma	TP63
28166194	Mutant p53 oncogenic functions in cancer stem cells are regulated by WIP through YAP/TAZ.	Oncogene	14	2017 Jun 22	glioma	TP63
19176381	Transcriptional switch of dormant tumors to fast-growing angiogenic phenotype.	Cancer Res	80	2009 Feb 1	glioma	TPM3
30171197	Molecular characterization of cancers with NTRK gene fusions.	Mod Pathol	8	2019 Jan	glioma	TPM3
25873252	Silencing of the TPM1 gene induces radioresistance of glioma U251 cells.	Oncol Rep	7	2015 Jun	glioma	TPM3
27402815	Tyrosine receptor kinase B is a drug target in astrocytomas.	Neuro Oncol	6	2017 Jan	glioma	TPM3
18719857	Zhangfei induces the expression of the nerve growth factor receptor, trkA, in medulloblastoma cells and causes their differentiation or apoptosis.	J Neurooncol	6	2009 Jan	glioma	TPM3
24913705	TPM3, a strong prognosis predictor, is involved in malignant progression through MMP family members and EMT-like activators in gliomas.	Tumour Biol	5	2014 Sep	glioma	TPM3
20971066	4'-Acetoamido-4-hydroxychalcone, a chalcone derivative, inhibits glioma growth and invasion through regulation of the tropomyosin 1 gene.	Biochem Biophys Res Commun	5	2010 Nov 19	glioma	TPM3
24076132	Diagnostic and prognostic value of circulating miR-21 for cancer: a systematic review and meta-analysis.	Gene	44	2014 Jan 1	glioma	TPM3
24840578	Methylation and expression patterns of tropomyosin-related kinase genes in different grades of glioma.	Neuromolecular Med	4	2014 Sep	glioma	TPM3
22766763	Co-inhibition of microRNA-10b and microRNA-21 exerts synergistic inhibition             on the proliferation and invasion of human glioma cells.	Int J Oncol	29	2012 Sep	glioma	TPM3
18086126	Novel Brn3a cis-acting sequences mediate transcription of human trkA in neurons.	J Neurochem	2	2008 Apr	glioma	TPM3
17635673	Autophagic cell death induced by TrkA receptor activation in human glioblastoma cells.	J Neurochem	19	2007 Oct	glioma	TPM3
17616673	Endothelin receptor type B counteracts tenascin-C-induced endothelin receptor type A-dependent focal adhesion and actin stress fiber disorganization.	Cancer Res	19	2007 Jul 1	glioma	TPM3
18757408	Combined lysophosphatidic acid/platelet-derived growth factor signaling triggers glioma cell migration in a tenascin-C microenvironment.	Cancer Res	15	2008 Sep 1	glioma	TPM3
27385098	TrkB-containing exosomes promote the transfer of glioblastoma aggressiveness to YKL-40-inactivated glioblastoma cells.	Oncotarget	11	2016 Aug 2	glioma	TPM3
28695340	Tropomyosin receptor kinase C (TrkC) expression in medulloblastoma: relation to the molecular subgroups and impact on treatment response.	Childs Nerv Syst	1	2017 Sep	glioma	TPM3
28011163	Lactucopicrin potentiates neuritogenesis and neurotrophic effects by regulating Ca&lt;sup&gt;2+&lt;/sup&gt;/CaMKII/ATF1 signaling pathway.	J Ethnopharmacol	1	2017 Feb 23	glioma	TPM3
30637364	Analysis of &lt;i&gt;NTRK&lt;/i&gt; Alterations in Pan-Cancer Adult and Pediatric Malignancies: Implications for NTRK-Targeted Therapeutics.	JCO Precis Oncol		2018	glioma	TPM3
30535593	Tropomyosin Tpm 2.1 loss induces glioblastoma spreading in soft brain-like environments.	J Neurooncol		2019 Jan	glioma	TPM3
30417351	Ectopic nerve growth factor prevents proliferation in glioma cells by senescence induction.	J Cell Physiol		2019 May	glioma	TPM3
29021135	Histone Acetyltransferase KAT6A Upregulates PI3K/AKT Signaling through TRIM24 Binding.	Cancer Res	6	2017 Nov 15	glioma	TRIM24
24469053	TRIM24 promotes glioma progression and enhances chemoresistance through activation of the PI3K/Akt signaling pathway.	Oncogene	25	2015 Jan 29	glioma	TRIM24
29129908	TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma.	Nat Commun	12	2017 Nov 13	glioma	TRIM24
19234517	The role of the Birt-Hogg-DubÃ© protein in mTOR activation and renal tumorigenesis.	Oncogene	71	2009 Apr 2	glioma	TSC1
27519418	Therapeutic Strategy for Targeting Aggressive Malignant Gliomas by Disrupting Their Energy Balance.	J Biol Chem	7	2016 Oct 7	glioma	TSC1
18759130	Signal transduction molecules in gliomas of all grades.	J Neurooncol	7	2009 Jan	glioma	TSC1
17071037	Upregulation of the WNT pathway in tuberous sclerosis-associated subependymal giant cell astrocytomas.	Brain Dev	6	2007 Jun	glioma	TSC1
22431589	MicroRNAs/TP53 feedback circuitry in glioblastoma multiforme.	Proc Natl Acad Sci U S A	44	2012 Apr 3	glioma	TSC1
29143563	Mammalian target of rapamycin complex 2 (mTORC2) controls glycolytic gene expression by regulating Histone H3 Lysine 56 acetylation.	Cell Cycle	3	2018	glioma	TSC1
17359356	Mutational and expression analysis of CDK1, cyclinA2 and cyclinB1 in epilepsy-associated glioneuronal lesions.	Neuropathol Appl Neurobiol	3	2007 Apr	glioma	TSC1
19435890	RIP1 activates PI3K-Akt via a dual mechanism involving NF-kappaB-mediated inhibition of the mTOR-S6K-IRS1 negative feedback loop and down-regulation of PTEN.	Cancer Res	25	2009 May 15	glioma	TSC1
19738049	Tuberous sclerosis complex suppression in cerebellar development and medulloblastoma: separate regulation of mammalian target of rapamycin activity and p27 Kip1 localization.	Cancer Res	20	2009 Sep 15	glioma	TSC1
22627626	Evidence of ambiguous differentiation and mTOR pathway dysregulation in subependymal giant cell astrocytoma.	Turk Patoloji Derg	2	2012	glioma	TSC1
16909113	Frequent loss of chromosome 9, homozygous CDKN2A/p14(ARF)/CDKN2B deletion and low TSC1 mRNA expression in pleomorphic xanthoastrocytomas.	Oncogene	18	2007 Feb 15	glioma	TSC1
20133820	Novel proteins regulated by mTOR in subependymal giant cell astrocytomas of patients with tuberous sclerosis complex and new therapeutic implications.	Am J Pathol	17	2010 Apr	glioma	TSC1
15851742	Developmental origin of subependymal giant cell astrocytoma in tuberous sclerosis complex.	Neurology	16	2005 Apr 26	glioma	TSC1
17910583	Alterations of phosphatidylinositol 3-kinase pathway components in epilepsy-associated glioneuronal lesions.	Epilepsia	12	2007	glioma	TSC1
30467464	Multiple Critical Periods for Rapamycin Treatment to Correct Structural Defects in &lt;i&gt;Tsc-1&lt;/i&gt;-Suppressed Brain.	Front Mol Neurosci	1	2018	glioma	TSC1
29687738	Ganglioglioma, Epilepsy, and Intellectual Impairment due to Familial TSC1 Deletion.	J Child Neurol	1	2018 Jun	glioma	TSC1
30509037	The level of microRNA 21 is upregulated by rapamycin in serum of tuberous sclerosis complex patients and subependymal giant cell astrocytoma (SEGA)-derived cell cultures.	Folia Neuropathol		2018	glioma	TSC1
30034322	Leucine-Rich Glioma Inactivated 1 Promotes Oligodendrocyte Differentiation and Myelination via TSC-mTOR Signaling.	Front Mol Neurosci		2018	glioma	TSC1
27625244	Role of mTOR signaling pathway in the pathogenesis of subependymal giant cell astrocytoma - A study of 28 cases.	Neurol India		2016 Sep-Oct	glioma	TSC1
22932407	[Expression of PI3K pathway proteins in refractory epilepsy associated with cortical malformation development].	Zhonghua Bing Li Xue Za Zhi		2012 Jun	glioma	TSC1
19234517	The role of the Birt-Hogg-DubÃ© protein in mTOR activation and renal tumorigenesis.	Oncogene	71	2009 Apr 2	glioma	TSC2
18759130	Signal transduction molecules in gliomas of all grades.	J Neurooncol	7	2009 Jan	glioma	TSC2
17071037	Upregulation of the WNT pathway in tuberous sclerosis-associated subependymal giant cell astrocytomas.	Brain Dev	6	2007 Jun	glioma	TSC2
29973652	Subependymal giant cell astrocytoma-like astrocytoma: a neoplasm with a distinct phenotype and frequent neurofibromatosis type-1-association.	Mod Pathol	5	2018 Dec	glioma	TSC2
16740698	AKT activation in human glioblastomas enhances proliferation via TSC2 and S6 kinase signaling.	Cancer Res	46	2006 Jun 1	glioma	TSC2
23152448	Pediatric glioma-associated KIAA1549:BRAF expression regulates neuroglial cell growth in a cell type-specific and mTOR-dependent manner.	Genes Dev	39	2012 Dec 1	glioma	TSC2
17359356	Mutational and expression analysis of CDK1, cyclinA2 and cyclinB1 in epilepsy-associated glioneuronal lesions.	Neuropathol Appl Neurobiol	3	2007 Apr	glioma	TSC2
19047102	Akt-dependent proapoptotic effects of dietary restriction on late-stage management of a phosphatase and tensin homologue/tuberous sclerosis complex 2-deficient mouse astrocytoma.	Clin Cancer Res	27	2008 Dec 1	glioma	TSC2
23129310	Cytotoxicity of withaferin A in glioblastomas involves induction of an oxidative stress-mediated heat shock response while altering Akt/mTOR and MAPK signaling pathways.	Invest New Drugs	21	2013 Jun	glioma	TSC2
19738049	Tuberous sclerosis complex suppression in cerebellar development and medulloblastoma: separate regulation of mammalian target of rapamycin activity and p27 Kip1 localization.	Cancer Res	20	2009 Sep 15	glioma	TSC2
25946256	Glioblastoma multiforme in a child with tuberous sclerosis complex.	Am J Med Genet A	2	2015 Oct	glioma	TSC2
22627626	Evidence of ambiguous differentiation and mTOR pathway dysregulation in subependymal giant cell astrocytoma.	Turk Patoloji Derg	2	2012	glioma	TSC2
20133820	Novel proteins regulated by mTOR in subependymal giant cell astrocytomas of patients with tuberous sclerosis complex and new therapeutic implications.	Am J Pathol	17	2010 Apr	glioma	TSC2
17910583	Alterations of phosphatidylinositol 3-kinase pathway components in epilepsy-associated glioneuronal lesions.	Epilepsia	12	2007	glioma	TSC2
30467464	Multiple Critical Periods for Rapamycin Treatment to Correct Structural Defects in &lt;i&gt;Tsc-1&lt;/i&gt;-Suppressed Brain.	Front Mol Neurosci	1	2018	glioma	TSC2
31195027	Phospho-mTOR expression in human glioblastoma microglia-macrophage cells.	Neurochem Int		2019 Oct	glioma	TSC2
30917457	[The effect of downregulation of MCT1 on the proliferation of glioma cells].	Zhonghua Zhong Liu Za Zhi		2019 Mar 23	glioma	TSC2
30509037	The level of microRNA 21 is upregulated by rapamycin in serum of tuberous sclerosis complex patients and subependymal giant cell astrocytoma (SEGA)-derived cell cultures.	Folia Neuropathol		2018	glioma	TSC2
27625244	Role of mTOR signaling pathway in the pathogenesis of subependymal giant cell astrocytoma - A study of 28 cases.	Neurol India		2016 Sep-Oct	glioma	TSC2
22932407	[Expression of PI3K pathway proteins in refractory epilepsy associated with cortical malformation development].	Zhonghua Bing Li Xue Za Zhi		2012 Jun	glioma	TSC2
23338840	The VHL tumor suppressor protein regulates tumorigenicity of U87-derived             glioma stem-like cells by inhibiting the JAK/STAT signaling pathway.	Int J Oncol	7	2013 Mar	glioma	VHL
27536856	FAT1 is a novel upstream regulator of HIF1Î± and invasion of high grade glioma.	Int J Cancer	6	2016 Dec 1	glioma	VHL
22649212	VHL regulates the effects of miR-23b on glioma survival and invasion via suppression of HIF-1Î±/VEGF and Î²-catenin/Tcf-4 signaling.	Neuro Oncol	41	2012 Aug	glioma	VHL
26572705	MicroRNAâ566 modulates vascular endothelial growth factor by targeting Von HippelâLandau in human glioblastoma in vitro and in vivo.	Mol Med Rep	3	2016 Jan	glioma	VHL
24810017	BASI, a potent small molecular inhibitor, inhibits glioblastoma progression by targeting microRNA-mediated Î²-catenin signaling.	CNS Neurosci Ther	3	2014 Sep	glioma	VHL
26735018	An ID2-dependent mechanism for VHL inactivation in cancer.	Nature	26	2016 Jan 14	glioma	VHL
24747440	Profilin-1 phosphorylation directs angiocrine expression and glioblastoma progression throughÂ HIF-1Î± accumulation.	Nat Cell Biol	25	2014 May	glioma	VHL
24012640	Blockage of a miR-21/EGFR regulatory feedback loop augments anti-EGFR therapy in glioblastomas.	Cancer Lett	24	2014 Jan 1	glioma	VHL
29053101	Daam2 driven degradation of VHL promotes gliomagenesis.	Elife	2	2017 Oct 20	glioma	VHL
25805832	A novel role of sphingosine kinase-1 in the invasion and angiogenesis of VHL mutant clear cell renal cell carcinoma.	FASEB J	19	2015 Jul	glioma	VHL
24503899	A lentivirus-mediated miR-23b sponge diminishes the malignant phenotype of glioma cells in vitro and in vivo.	Oncol Rep	19	2014 Apr	glioma	VHL
25031725	LncRNA TSLC1-AS1 is a novel tumor suppressor in glioma.	Int J Clin Exp Pathol	18	2014	glioma	VHL
23707781	SDH mutations establish a hypermethylator phenotype in paraganglioma.	Cancer Cell	164	2013 Jun 10	glioma	VHL
26861754	Induction of WNT11 by hypoxia and hypoxia-inducible factor-1Î± regulates cell proliferation, migration and invasion.	Sci Rep	16	2016 Feb 10	glioma	VHL
27279905	MiR675-5p Acts on HIF-1Î± to Sustain Hypoxic Responses: A New Therapeutic Strategy for Glioma.	Theranostics	10	2016	glioma	VHL
24650032	MicroRNA-566 activates EGFR signaling and its inhibition sensitizes glioblastoma cells to nimotuzumab.	Mol Cancer	10	2014 Mar 20	glioma	VHL
30082910	Hypermethylated gene ANKDD1A is a candidate tumor suppressor that interacts with FIH1 and decreases HIF1Î± stability to inhibit cell autophagy in the glioblastoma multiforme hypoxia microenvironment.	Oncogene	1	2019 Jan	glioma	VHL
30790292	Oroxylin A increases the sensitivity of temozolomide on glioma cells by hypoxia-inducible factor 1Î±/hedgehog pathway under hypoxia.	J Cell Physiol		2019 Aug	glioma	VHL
30658712	Reciprocal regulation of integrin Î²4 and KLF4 promotes gliomagenesis through maintaining cancer stem cell traits.	J Exp Clin Cancer Res		2019 Jan 18	glioma	VHL
30089425	Hypoxia-inducible factor 2Î±: a novel target in gliomas.	Future Med Chem		2018 Sep 1	glioma	VHL
20539942	Downregulation of WIF-1 by hypermethylation in astrocytomas.	Acta Biochim Biophys Sin (Shanghai)	9	2010 Jun 15	glioma	WIF1
20334650	Expression and aberrant promoter methylation of Wnt inhibitory factor-1 in human astrocytomas.	J Exp Clin Cancer Res	8	2010 Mar 24	glioma	WIF1
29164578	miR-590-3p promotes colon cancer cell proliferation via Wnt/Î²-catenin signaling pathway by inhibiting WIF1 and DKK1.	Eur Rev Med Pharmacol Sci	7	2017 Nov	glioma	WIF1
23328978	Promoter methylation of WNT inhibitory factor-1 and expression pattern of WNT/Î²-catenin pathway in human astrocytoma: pathologic and prognostic correlations.	Mod Pathol	5	2013 May	glioma	WIF1
22901505	Wnt inhibitory factor-1 regulates glioblastoma cell cycle and proliferation.	J Clin Neurosci	5	2012 Oct	glioma	WIF1
25772239	WIF1 re-expression in glioblastoma inhibits migration through attenuation of non-canonical WNT signaling by downregulating the lncRNA MALAT1.	Oncogene	35	2016 Jan 7	glioma	WIF1
21642372	The Wnt inhibitory factor 1 (WIF1) is targeted in glioblastoma and has a tumor suppressing function potentially by induction of senescence.	Neuro Oncol	29	2011 Jul	glioma	WIF1
25681036	miR-603 promotes glioma cell growth via Wnt/Î²-catenin pathway by inhibiting WIF1 and CTNNBIP1.	Cancer Lett	16	2015 Apr 28	glioma	WIF1
24695855	SHH, WNT, and NOTCH pathways in medulloblastoma: when cancer stem cells maintain self-renewal and differentiation properties.	Childs Nerv Syst	12	2014 Jul	glioma	WIF1
28040794	Native Oligodendrocytes in Astrocytomas Might Inhibit Tumor Proliferation by WIF1 Expression.	J Neuropathol Exp Neurol	1	2017 Jan 1	glioma	WIF1
30228024	Knockdown of HOXC6 inhibits glioma cell proliferation and induces cell cycle arrest by targeting WIF-1 in vitro and vivo.	Pathol Res Pract		2018 Nov	glioma	WIF1
29417580	In vivo characterization of brain metabolism by &lt;sup&gt;1&lt;/sup&gt; H MRS, &lt;sup&gt;13&lt;/sup&gt; C MRS and &lt;sup&gt;18&lt;/sup&gt; FDG PET reveals significant glucose oxidation of invasively growing glioma cells.	Int J Cancer		2018 Jul 1	glioma	WIF1
26781164	Norcantharidin blocks Wnt/Î²-catenin signaling via promoter demethylation of WIF-1 in glioma.	Oncol Rep		2016 Apr	glioma	WIF1
1	Regulators of G-protein signaling 3 and 4 (RGS3, RGS4) are associated with glioma cell motility.	J Neuropathol Exp Neurol	23	2004 Mar	glioma	WRN
28370670	Origin and characterization of alpha smooth muscle actin-positive cells during murine lung development.	Stem Cells	9	2017 Jun	glioma	WT1
22313360	Novel report of expression and function of CD97 in malignant gliomas: correlation with Wilms tumor 1 expression and glioma cell invasiveness.	J Neurosurg	8	2012 Apr	glioma	WT1
21622185	WT1/EGR1-mediated control of STIM1 expression and function in cancer cells.	Front Biosci (Landmark Ed)	8	2011 Jun 1	glioma	WT1
20820871	Wilms' tumor 1 silencing decreases the viability and chemoresistance of glioblastoma cells in vitro: a potential role for IGF-1R de-repression.	J Neurooncol	8	2011 May	glioma	WT1
20425045	Prognostic value of WT1 protein expression level and MIB-1 staining index as predictor of response to WT1 immunotherapy in glioblastoma patients.	Brain Tumor Pathol	6	2010 Apr	glioma	WT1
19578047	High-grade astrocytomas show increased Nestin and Wilms's tumor gene (WT1) protein expression.	Int J Surg Pathol	6	2010 Aug	glioma	WT1
29932419	H3.3K27M mutant proteins reprogram epigenome by sequestering the PRC2 complex to poised enhancers.	Elife	5	2018 Jun 22	glioma	WT1
24607494	WT1 expression increases with malignancy and indicates unfavourable outcome in astrocytoma.	J Clin Pathol	5	2014 Jul	glioma	WT1
20576027	WT1 is not a reliable marker to distinguish reactive from neoplastic astrocyte populations in the central nervous system.	Brain Pathol	5	2010 Nov	glioma	WT1
18371184	WT1 expression distinguishes astrocytic tumor cells from normal and reactive astrocytes.	Brain Pathol	5	2008 Jul	glioma	WT1
24403445	Wilms' tumor 1 is involved in tumorigenicity of glioblastoma by regulating cell proliferation and apoptosis.	Anticancer Res	4	2014 Jan	glioma	WT1
19392599	Effect of WT1 gene silencing on the tumorigenicity of human glioblastoma multiforme cells.	J Neurosurg	4	2010 Jan	glioma	WT1
27889611	Anti-apoptotic quinolinate phosphoribosyltransferase (QPRT) is a target gene of Wilms' tumor gene 1 (WT1) protein in leukemic cells.	Biochem Biophys Res Commun	3	2017 Jan 22	glioma	WT1
20661018	Application of mutant IDH1 antibody to differentiate diffuse glioma from nonneoplastic central nervous system lesions and therapy-induced changes.	Am J Surg Pathol	26	2010 Aug	glioma	WT1
29967069	A carcinogenic trigger to study the function of tumor suppressor genes in &lt;i&gt;Schmidtea mediterranea&lt;/i&gt;.	Dis Model Mech	2	2018 Aug 16	glioma	WT1
28116121	Syndecan-4 as a biomarker to predict clinical outcome for glioblastoma multiforme treated with WT1 peptide vaccine.	Future Sci OA	2	2016 Dec	glioma	WT1
23179498	Increased expression of tumor-associated antigens in pediatric and adult ependymomas: implication for vaccine therapy.	J Neurooncol	11	2013 Jan	glioma	WT1
24286141	CD97 and glioma invasion.	J Neurosurg	1	2014 Feb	glioma	WT1
30990879	Differential Expression of Wilms' Tumor Protein in Diffuse Intrinsic Pontine Glioma.	J Neuropathol Exp Neurol		2019 May 1	glioma	WT1
29218546	Establishing cut-off points with clinical relevance for bcl-2, cyclin D1, p16, p21, p27, p53, Sox11 and WT1 expression in glioblastoma - a short report.	Cell Oncol (Dordr)		2018 Apr	glioma	WT1
10738106	Absence of evidence for allelic loss or allelic gain for ERCC1 or for XPD in human ovarian cancer cells and tissues.	Cancer Lett	2	2000 Apr 14	glioma	XPA
12359753	Regulation of cisplatin resistance and homologous recombinational repair by the TFIIH subunit XPD.	Cancer Res	17	2002 Oct 1	glioma	XPA
18089819	Differential sensitivity of malignant glioma cells to methylating and chloroethylating anticancer drugs: p53 determines the switch by regulating xpc, ddb2, and DNA double-strand breaks.	Cancer Res	28	2007 Dec 15	glioma	XPC
20403967	XPC silencing sensitizes glioma cells to arsenic trioxide via increased oxidative damage.	Toxicol Sci	11	2010 Jul	glioma	XPC
31347685	Acquired temozolomide resistance in MGMT-deficient glioblastoma cells is associated with regulation of DNA repair by DHC2.	Brain		2019 Aug 1	glioma	XPC
15519529	Analysis of transcripts from 17p13.3 in medulloblastoma suggests ROX/MNT as a potential tumour suppressor gene.	Eur J Cancer	8	2004 Nov	glioma	YWHAE
17265049	Ependymoma gene expression profiles associated with histological subtype, proliferation, and patient survival.	Acta Neuropathol	35	2007 Mar	glioma	YWHAE
1	Bioinformatic profiling identifies an immune-related risk signature for glioblastoma.	Neurology	32	2016 Jun 14	glioma	ZBTB16
18095118	Detection of genetic and chromosomal aberrations in medulloblastomas and primitive neuroectodermal tumors with DNA microarrays.	Brain Tumor Pathol	8	2006 Apr	NA	APC
23525311	CTNNB1, AXIN1 and APC expression analysis of different medulloblastoma variants.	Clinics (Sao Paulo)	6	2013	NA	APC
15446583	Genetic and expression profiles of cerebellar liponeurocytomas.	Brain Pathol	6	2004 Jul	NA	APC
12082624	Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines.	Oncogene	41	2002 Jun 20	NA	APC
10580987	beta-catenin signaling and cancer.	Bioessays	210	1999 Dec	NA	APC
17455096	Intracellular distribution of beta-catenin in human medulloblastoma cell lines with different degree of neuronal differentiation.	Ultrastruct Pathol	2	2007 Jan-Feb	NA	APC
10551328	Analysis of APCL, a brain-specific adenomatous polyposis coli homologue, for mutations and expression in brain tumors.	Jpn J Cancer Res	2	1999 Sep	NA	APC
17373666	Mutations of the Wnt antagonist AXIN2 (Conductin) result in TCF-dependent transcription in medulloblastomas.	Int J Cancer	17	2007 Jul 15	NA	APC
19293793	An investigation of WNT pathway activation and association with survival in central nervous system primitive neuroectodermal tumours (CNS PNET).	Br J Cancer	15	2009 Apr 21	NA	APC
24695855	SHH, WNT, and NOTCH pathways in medulloblastoma: when cancer stem cells maintain self-renewal and differentiation properties.	Childs Nerv Syst	12	2014 Jul	NA	APC
25843713	Casein kinase 1Î´ is an APC/C(Cdh1) substrate that regulates cerebellar granule cell neurogenesis.	Cell Rep	11	2015 Apr 14	NA	APC
23826121	CARP-1 functional mimetics: a novel class of small molecule inhibitors of medulloblastoma cell growth.	PLoS One	11	2013	NA	APC
15077159	Failure of a medulloblastoma-derived mutant of SUFU to suppress WNT signaling.	Oncogene	11	2004 Jun 3	NA	APC
11212243	Loss of p53 but not ARF accelerates medulloblastoma in mice heterozygous for patched.	Cancer Res	102	2001 Jan 15	NA	APC
29753700	Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort.	Lancet Oncol	10	2018 Jun	NA	APC
30523493	Immunohistochemical detection of ALK protein identifies APC mutated medulloblastoma and differentiates the WNT-activated medulloblastoma from other types of posterior fossa childhood tumors.	Brain Tumor Pathol		2019 Jan	NA	APC
27592301	The ubiquitin-proteasome system and chromosome 17 in cerebellar granule cells and medulloblastoma subgroups.	Cell Mol Life Sci		2017 Feb	NA	APC
11370631	A distinct splice form of APC is highly expressed      in neurones but not commonly mutated in      neuroepithelial tumours.	J Med Genet		2001 Apr	NA	APC
23698369	BAF complexes facilitate decatenation of DNA by topoisomerase IIÎ±.	Nature	77	2013 May 30	NA	ARID1A
23222069	[Chromatin remodeling defects and cancer: the SWI/SNF example].	Bull Cancer	2	2012 Dec	NA	ARID1A
1	[Chromatin remodeling defects and cancer: the SWI/SNF example].	Bull Cancer	2	2012 Dec	NA	ARID1B
1	[Chromatin remodeling defects and cancer: the SWI/SNF example].	Bull Cancer	2	2012 Dec	NA	ARID2
25059231	Genetic drivers of metastatic dissemination in sonic hedgehog medulloblastoma.	Acta Neuropathol Commun	8	2014 Jul 25	NA	ARNT
15184363	Identification of a novel family of ankyrin repeats containing cofactors for p160 nuclear receptor coactivators.	J Biol Chem	27	2004 Aug 6	NA	ARNT
1	The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes.	Nat Commun	111	2014 Apr 8	NA	ASXL1
29654065	Induced Telomere Damage to Treat Telomerase Expressing Therapy-Resistant Pediatric Brain Tumors.	Mol Cancer Ther	6	2018 Jul	NA	ATM
21874045	Oncogenic YAP promotes radioresistance and genomic instability in medulloblastoma through IGF2-mediated Akt activation.	Oncogene	48	2012 Apr 12	NA	ATM
28383788	Replication stress, DNA damage signalling, and cytomegalovirus infection in human medulloblastomas.	Mol Oncol	4	2017 Aug	NA	ATM
25879388	Knockdown of EphB1 receptor decreases medulloblastoma cell growth and migration and increases cellular radiosensitization.	Oncotarget	11	2015 Apr 20	NA	ATM
19805107	Inhibition of Hsp90 via 17-DMAG induces apoptosis in a p53-dependent manner to prevent medulloblastoma.	Proc Natl Acad Sci U S A	11	2009 Oct 6	NA	ATM
30943920	Decrease of Nibrin expression in chronic hypoxia is associated with hypoxia-induced chemoresistance in some brain tumour cells.	BMC Cancer		2019 Apr 3	NA	ATM
1	Immunohistochemical analyses of alpha1 and alpha3 Na+/K+-ATPase subunit expression in medulloblastomas.	Anticancer Res	7	2011 Mar	NA	ATP1A1
19179424	Analysis of microsatellite instability in medulloblastoma.	Neuro Oncol	8	2009 Oct	NA	ATR
29654065	Induced Telomere Damage to Treat Telomerase Expressing Therapy-Resistant Pediatric Brain Tumors.	Mol Cancer Ther	6	2018 Jul	NA	ATR
28383788	Replication stress, DNA damage signalling, and cytomegalovirus infection in human medulloblastomas.	Mol Oncol	4	2017 Aug	NA	ATR
18955550	Sonic Hedgehog signaling impairs ionizing radiation-induced checkpoint activation and induces genomic instability.	J Cell Biol	26	2008 Nov 3	NA	ATR
21652733	A sensitized RNA interference screen identifies a novel role for the PI3K p110Î³ isoform in medulloblastoma cell proliferation and chemoresistance.	Mol Cancer Res	19	2011 Jul	NA	ATR
29753759	Multiple DNA damage-dependent and DNA damage-independent stress responses define the outcome of ATR/Chk1 targeting in medulloblastoma cells.	Cancer Lett	1	2018 Aug 28	NA	ATR
27803059	ATR maintains chromosomal integrity during postnatal cerebellar neurogenesis and is required for medulloblastoma formation.	Development	1	2016 Nov 1	NA	ATR
24710217	The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes.	Nat Commun	111	2014 Apr 8	NA	ATRX
30830680	Telomere elongation via alternative lengthening of telomeres (ALT) and telomerase activation in primary metastatic medulloblastoma of childhood.	J Neurooncol		2019 May	NA	ATRX
19633924	Changes of AXIN-1 and beta-catenin in neuroepithelial brain tumors.	Pathol Oncol Res	7	2010 Mar	NA	AXIN1
23525311	CTNNB1, AXIN1 and APC expression analysis of different medulloblastoma variants.	Clinics (Sao Paulo)	6	2013	NA	AXIN1
12209999	Role of Wnt pathway in medulloblastoma oncogenesis.	Int J Cancer	23	2002 Sep 10	NA	AXIN1
17373666	Mutations of the Wnt antagonist AXIN2 (Conductin) result in TCF-dependent transcription in medulloblastomas.	Int J Cancer	17	2007 Jul 15	NA	AXIN1
25821199	Biflavone Ginkgetin, a Novel Wnt Inhibitor, Suppresses the Growth of Medulloblastoma.	Nat Prod Bioprospect	4	2015 Mar 29	NA	AXIN2
17373666	Mutations of the Wnt antagonist AXIN2 (Conductin) result in TCF-dependent transcription in medulloblastomas.	Int J Cancer	17	2007 Jul 15	NA	AXIN2
30292066	Targeting DDX3 in Medulloblastoma Using the Small Molecule Inhibitor RK-33.	Transl Oncol	1	2019 Jan	NA	AXIN2
1	Novel tumor antigens identified by autologous antibody screening of childhood medulloblastoma cDNA libraries.	Int J Cancer	16	2003 Aug 20	NA	BAP1
19179424	Analysis of microsatellite instability in medulloblastoma.	Neuro Oncol	8	2009 Oct	NA	BAX
17669439	Inhibition of telomerase activity and human telomerase reverse transcriptase gene expression by histone deacetylase inhibitor in human brain cancer cells.	Mutat Res	7	2007 Dec 1	NA	BAX
21880625	RASSF1A and the BH3-only mimetic ABT-737 promote apoptosis in pediatric medulloblastoma cell lines.	Neuro Oncol	6	2011 Dec	NA	BAX
27601167	Suppression of GLI sensitizes medulloblastoma cells to mitochondria-mediated apoptosis.	J Cancer Res Clin Oncol	5	2016 Dec	NA	BAX
27785591	The DNA methyltransferase inhibitor zebularine exerts antitumor effects and reveals BATF2 as a poor prognostic marker for childhood medulloblastoma.	Invest New Drugs	5	2017 Feb	NA	BAX
24037645	Apoptosis-related gene expression in glioblastoma (LN-18) and medulloblastoma (Daoy) cell lines.	Hum Cell	5	2013 Dec	NA	BAX
27197166	Radiation Sensitivity in a Preclinical Mouse Model of Medulloblastoma Relies on the Function of the Intrinsic Apoptotic Pathway.	Cancer Res	4	2016 Jun 1	NA	BAX
17372745	Human parathyroid hormone-related protein and human parathyroid hormone receptor type 1 are expressed in human medulloblastomas and regulate cell proliferation and apoptosis in medulloblastoma-derived cell lines.	Acta Neuropathol	4	2007 Aug	NA	BAX
12455884	Molecular studies in pediatric medulloblastomas.	Brain Tumor Pathol	4	2002	NA	BAX
24955161	Effects of matrine on the proliferation and apoptosis of human medulloblastoma cell line D341.	Int J Clin Exp Med	3	2014	NA	BAX
14672267	Cell-cycle gene expression in lovastatin-induced medulloblastoma apoptosis.	Can J Neurol Sci	3	2003 Nov	NA	BAX
16964520	Betulinic acid decreases expression of bcl-2 and cyclin D1, inhibits proliferation, migration and induces apoptosis in cancer cells.	Naunyn Schmiedebergs Arch Pharmacol	22	2006 Oct	NA	BAX
23192708	Curcumin inhibits telomerase and induces telomere shortening and apoptosis in brain tumour cells.	J Cell Biochem	21	2013 Jun	NA	BAX
21181094	Downregulation of uPA/uPAR inhibits intermittent hypoxia-induced epithelial-mesenchymal transition (EMT) in DAOY and D283 medulloblastoma cells.	Int J Oncol	21	2011 Mar	NA	BAX
12584169	2-Methoxyestradiol interferes with NF kappa B transcriptional activity in primitive neuroectodermal brain tumors: implications for management.	Carcinogenesis	16	2003 Feb	NA	BAX
29141249	Î²-Catenin Cooperates with CREB Binding Protein to Promote the Growth of Tumor Cells.	Cell Physiol Biochem	1	2017	NA	BAX
27803059	ATR maintains chromosomal integrity during postnatal cerebellar neurogenesis and is required for medulloblastoma formation.	Development	1	2016 Nov 1	NA	BAX
31319483	Simvastatin Induces Apoptosis in Medulloblastoma Brain Tumor Cells via Mevalonate Cascade Prenylation Substrates.	Cancers (Basel)		2019 Jul 17	NA	BAX
30304554	Effects of microRNA-494 on proliferation, migration, invasion, and apoptosis of medulloblastoma cells by mediating c-myc through the p38 MAPK signaling pathway.	J Cell Biochem		2018 Oct 10	NA	BAX
30244244	Ligustrazine Inhibits Growth, Migration and Invasion of Medulloblastoma Daoy Cells by Up-Regulation of miR-211.	Cell Physiol Biochem		2018	NA	BAX
1	Controlling COR competence: BCL-6 regulates neurogenesis and tumor suppression.	Cancer Cell		2014 Dec 8	NA	BCOR
1	Expression of different extracellular matrix components in human brain tumor and melanoma cells in respect to variant culture conditions.	J Neurooncol	12	1999 Aug	NA	BLM
1	Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues.	Genomics	115	2005 Aug	NA	BRCA1
24145349	BCCIP suppresses tumor initiation but is required for tumor progression.	Cancer Res	14	2013 Dec 1	NA	BRCA2
29753700	Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort.	Lancet Oncol	10	2018 Jun	NA	BRCA2
1	Control of the Normal and Pathological Development of Neural Stem and Progenitor Cells by the PC3/Tis21/Btg2 and Btg1 Genes.	J Cell Physiol	5	2015 Dec	NA	BTG1
15289853	Deletion and aberrant CpG island methylation of Caspase 8 gene in medulloblastoma.	Oncol Rep	7	2004 Sep	NA	CASP8
11948413	IFNgamma sensitizes for apoptosis by upregulating caspase-8 expression through the Stat1 pathway.	Oncogene	51	2002 Apr 4	NA	CASP8
16186793	Epigenetic repression of RASSF1A but not CASP8 in supratentorial PNET (sPNET) and atypical teratoid/rhabdoid tumors (AT/RT) of childhood.	Oncogene	4	2006 Feb 16	NA	CASP8
16607283	5-Aza-2'-deoxycytidine and IFN-gamma cooperate to sensitize for TRAIL-induced apoptosis by upregulating caspase-8.	Oncogene	29	2006 Aug 24	NA	CASP8
14695141	Loss of caspase-8 protein expression correlates with unfavorable survival outcome in childhood medulloblastoma.	Clin Cancer Res	28	2003 Dec 15	NA	CASP8
14688019	Identification of tumour-specific epigenetic events in medulloblastoma development by hypermethylation profiling.	Carcinogenesis	27	2004 May	NA	CASP8
11750844	Loss of caspase-8 mRNA expression is common in childhood primitive neuroectodermal brain tumour/medulloblastoma.	Eur J Cancer	21	2002 Jan	NA	CASP8
16398460	Epigenetic events in medulloblastoma development.	Neurosurg Focus	13	2005 Nov 15	NA	CASP8
15029256	Promoter methylation pattern of caspase-8, P16INK4A, MGMT, TIMP-3, and E-cadherin in medulloblastoma.	Pathol Oncol Res	12	2004	NA	CASP8
16688669	[Risk stratification in medulloblastoma: screening for molecular markers].	Klin Padiatr		2006 May-Jun	NA	CASP8
1	Integrins mediate adhesion of medulloblastoma cells to tenascin and activate pathways associated with survival and proliferation.	Lab Invest	20	2008 Nov	NA	CCDC6
27463676	Cdk5 disruption attenuates tumor PD-L1 expression and promotes antitumor immunity.	Science	56	2016 Jul 22	NA	CD274
27135656	Low Frequency of Programmed Death Ligand 1 Expression in Pediatric Cancers.	Pediatr Blood Cancer	10	2016 Aug	NA	CD274
29730815	PD-1/PD-L1 and immune-related gene expression pattern in pediatric malignant brain tumors: clinical correlation with survival data in Korean population.	J Neurooncol		2018 Sep	NA	CD274
12082624	Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines.	Oncogene	41	2002 Jun 20	NA	CDH1
18664619	Global analysis of the medulloblastoma epigenome identifies disease-subgroup-specific inactivation of COL1A2.	Neuro Oncol	18	2008 Dec	NA	CDH1
15029256	Promoter methylation pattern of caspase-8, P16INK4A, MGMT, TIMP-3, and E-cadherin in medulloblastoma.	Pathol Oncol Res	12	2004	NA	CDH1
25843713	Casein kinase 1Î´ is an APC/C(Cdh1) substrate that regulates cerebellar granule cell neurogenesis.	Cell Rep	11	2015 Apr 14	NA	CDH1
31346954	Biological characterization of the UW402, UW473, ONS-76 and DAOY pediatric medulloblastoma cell lines.	Cytotechnology		2019 Jul 26	NA	CDH1
29039452	Molecular analysis of keratocystic odontogenic tumor cell lines derived from sporadic and basal cell nevus syndrome patients.	Int J Oncol		2017 Dec	NA	CDH1
16688669	[Risk stratification in medulloblastoma: screening for molecular markers].	Klin Padiatr		2006 May-Jun	NA	CDH1
28483947	Regulation of &lt;i&gt;USP37&lt;/i&gt; Expression by REST-Associated G9a-Dependent Histone Methylation.	Mol Cancer Res	7	2017 Aug	NA	CDKN1B
16230398	The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.	Cancer Res	33	2005 Oct 15	NA	CDKN1B
19147535	Two tumor suppressors, p27Kip1 and patched-1, collaborate to prevent medulloblastoma.	Mol Cancer Res	29	2009 Jan	NA	CDKN1B
16148242	Hedgehog antagonist REN(KCTD11) regulates proliferation and apoptosis of developing granule cell progenitors.	J Neurosci	24	2005 Sep 7	NA	CDKN1B
21051932	p27(Kip1), a double-edged sword in Shh-mediated medulloblastoma: Tumor accelerator and suppressor.	Cell Cycle	16	2010 Nov 1	NA	CDKN1B
22313636	Bortezomib induces apoptosis and growth suppression in human medulloblastoma cells, associated with inhibition of AKT and NF-Ä¸B signaling, and synergizes with an ERK inhibitor.	Cancer Biol Ther	15	2012 Apr	NA	CDKN1B
20103640	ZNF238 is expressed in postmitotic brain cells and inhibits brain tumor growth.	Cancer Res	14	2010 Feb 1	NA	CDKN1B
16623784	High promoter hypermethylation frequency of p14/ARF in supratentorial PNET but not in medulloblastoma.	Histopathology	9	2006 Apr	NA	CDKN2A
19147556	p18Ink4c and p53 Act as tumor suppressors in cyclin D1-driven primitive neuroectodermal tumor.	Cancer Res	7	2009 Jan 15	NA	CDKN2A
15537876	Interferon-gamma induced medulloblastoma in the developing cerebellum.	J Neurosci	46	2004 Nov 10	NA	CDKN2A
12082624	Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines.	Oncogene	41	2002 Jun 20	NA	CDKN2A
19806481	A novel role of cyclinD1 and p16 in clinical pathology and prognosis of childhood medulloblastoma.	Med Oncol	4	2010 Sep	NA	CDKN2A
12839926	Ewing tumor fusion proteins block the differentiation of pluripotent marrow stromal cells.	Cancer Res	36	2003 Jul 1	NA	CDKN2A
14672267	Cell-cycle gene expression in lovastatin-induced medulloblastoma apoptosis.	Can J Neurol Sci	3	2003 Nov	NA	CDKN2A
19048113	Bmi1 is required for Hedgehog pathway-driven medulloblastoma expansion.	Neoplasia	29	2008 Dec	NA	CDKN2A
14688019	Identification of tumour-specific epigenetic events in medulloblastoma development by hypermethylation profiling.	Carcinogenesis	27	2004 May	NA	CDKN2A
16783165	High-resolution array-based comparative genomic hybridization of medulloblastomas and supratentorial primitive neuroectodermal tumors.	J Neuropathol Exp Neurol	26	2006 Jun	NA	CDKN2A
21798848	Genome-wide molecular characterization of central nervous system primitive neuroectodermal tumor and pineoblastoma.	Neuro Oncol	20	2011 Aug	NA	CDKN2A
15029199	Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas.	Nature	170	2004 Mar 18	NA	CDKN2A
20600931	Bmi1 directly represses p21Waf1/Cip1 in Shh-induced proliferation of cerebellar granule cell progenitors.	Mol Cell Neurosci	17	2010 Oct	NA	CDKN2A
17592618	Supratentorial primitive neuroectodermal tumors of the central nervous system frequently harbor deletions of the CDKN2A locus and other genomic aberrations distinct from medulloblastomas.	Genes Chromosomes Cancer	16	2007 Sep	NA	CDKN2A
15029256	Promoter methylation pattern of caspase-8, P16INK4A, MGMT, TIMP-3, and E-cadherin in medulloblastoma.	Pathol Oncol Res	12	2004	NA	CDKN2A
21617231	Response of medulloblastoma cells to vincristine and lomustine: role of TRKC, CTNNB1 and STK15.	Anticancer Res		2011 May	NA	CDKN2A
16688669	[Risk stratification in medulloblastoma: screening for molecular markers].	Klin Padiatr		2006 May-Jun	NA	CDKN2A
19147556	p18Ink4c and p53 Act as tumor suppressors in cyclin D1-driven primitive neuroectodermal tumor.	Cancer Res	7	2009 Jan 15	NA	CDKN2C
16260494	The tumor suppressors Ink4c and p53 collaborate independently with Patched to suppress medulloblastoma formation.	Genes Dev	69	2005 Nov 15	NA	CDKN2C
17363588	Genetic alterations in mouse medulloblastomas and generation of tumors de novo from primary cerebellar granule neuron precursors.	Cancer Res	38	2007 Mar 15	NA	CDKN2C
20516124	Atoh1 inhibits neuronal differentiation and collaborates with Gli1 to generate medulloblastoma-initiating cells.	Cancer Res	31	2010 Jul 1	NA	CDKN2C
19147535	Two tumor suppressors, p27Kip1 and patched-1, collaborate to prevent medulloblastoma.	Mol Cancer Res	29	2009 Jan	NA	CDKN2C
19805107	Inhibition of Hsp90 via 17-DMAG induces apoptosis in a p53-dependent manner to prevent medulloblastoma.	Proc Natl Acad Sci U S A	11	2009 Oct 6	NA	CDKN2C
16479172	The CDK inhibitor p18Ink4c is a tumor suppressor in medulloblastoma.	Cell Cycle	10	2006 Feb	NA	CDKN2C
1	Sonic Hedgehog signaling impairs ionizing radiation-induced checkpoint activation and induces genomic instability.	J Cell Biol	26	2008 Nov 3	NA	CHEK2
1	CIC, a gene involved in cerebellar development and ErbB signaling, is significantly expressed in medulloblastomas.	J Neurooncol	12	2005 Jun	NA	CIC
24252690	Identification of a neuronal transcription factor network involved in medulloblastoma development.	Acta Neuropathol Commun	17	2013 Jul 11	NA	CREBBP
24710217	The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes.	Nat Commun	111	2014 Apr 8	NA	CREBBP
18599546	Temporal recruitment of transcription factors at the 3',5'-cyclic adenosine 5'-monophosphate-response element of the human GnRH-II promoter.	Endocrinology	1	2008 Oct	NA	CREBBP
1	Integrating role of T antigen, Rb2/p130, CTCF and BORIS in mediating non-canonical endoplasmic reticulum-dependent death pathways triggered by chronic ER stress in mouse medulloblastoma.	Cell Cycle	3	2012 May 1	NA	CTCF
1	The transcription factor Cux1 in cerebellar granule cell development and medulloblastoma pathogenesis.	Cerebellum	1	2014 Dec	NA	CUX1
1	Microarray-based screening for molecular markers in medulloblastoma revealed STK15 as independent predictor for survival.	Cancer Res	33	2004 May 1	NA	DAXX
24608801	RNA binding protein-mediated post-transcriptional gene regulation in medulloblastoma.	Mol Cells	8	2014 May	NA	DDX3X
25043297	DDX3 modulates cell adhesion and motility and cancer cell metastasis via Rac1-mediated signaling pathway.	Oncogene	33	2015 May 21	NA	DDX3X
22832583	Dissecting the genomic complexity underlying medulloblastoma.	Nature	287	2012 Aug 2	NA	DDX3X
24651015	Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition.	Cancer Cell	171	2014 Mar 17	NA	DDX3X
25724843	Cancer-associated mutants of RNA helicase DDX3X are defective in RNA-stimulated ATP hydrolysis.	J Mol Biol	15	2015 May 8	NA	DDX3X
27058758	Medulloblastoma-associated DDX3 variant selectively alters the translational response to stress.	Oncotarget	13	2016 May 10	NA	DDX3X
27180681	Cancer-associated DDX3X mutations drive stress granule assembly and impair global translation.	Sci Rep	12	2016 May 16	NA	DDX3X
26598523	Autoinhibitory Interdomain Interactions and Subfamily-specific Extensions Redefine the Catalytic Core of the Human DEAD-box Protein DDX3.	J Biol Chem	10	2016 Jan 29	NA	DDX3X
29582169	Medulloblastoma, WNT-activated/SHH-activated: clinical impact of molecular analysis and histogenetic evaluation.	Childs Nerv Syst		2018 May	NA	DDX3X
25978641	Fibroblast Growth Factor 9 Regulation by MicroRNAs Controls Lung Development and Links DICER1 Loss to the Pathogenesis of Pleuropulmonary Blastoma.	PLoS Genet	5	2015 May	NA	DICER1
25910616	MicroRNAs Promote Granule Cell Expansion in the Cerebellum Through Gli2.	Cerebellum	4	2015 Dec	NA	DICER1
26773048	MicroRNA Biogenesis and Hedgehog-Patched Signaling Cooperate to Regulate an Important Developmental Transition in Granule Cell Development.	Genetics	3	2016 Mar	NA	DICER1
27600805	Dicer1 Ablation Impairs Responsiveness of Cerebellar Granule Neuron Precursors to Sonic Hedgehog and Disrupts Expression of Distinct Cell Cycle Regulator Genes.	Cerebellum		2017 Apr	NA	DICER1
29861161	MLL4 Is Required to Maintain Broad H3K4me3 Peaks and Super-Enhancers at Tumor Suppressor Genes.	Mol Cell	9	2018 Jun 7	NA	DNMT3A
27543768	High expression of DNA methyltransferases in primary human medulloblastoma.	Folia Neuropathol	1	2016	NA	DNMT3A
25978641	Fibroblast Growth Factor 9 Regulation by MicroRNAs Controls Lung Development and Links DICER1 Loss to the Pathogenesis of Pleuropulmonary Blastoma.	PLoS Genet	5	2015 May	NA	DROSHA
25910616	MicroRNAs Promote Granule Cell Expansion in the Cerebellum Through Gli2.	Cerebellum	4	2015 Dec	NA	DROSHA
26773048	MicroRNA Biogenesis and Hedgehog-Patched Signaling Cooperate to Regulate an Important Developmental Transition in Granule Cell Development.	Genetics	3	2016 Mar	NA	DROSHA
27600805	Dicer1 Ablation Impairs Responsiveness of Cerebellar Granule Neuron Precursors to Sonic Hedgehog and Disrupts Expression of Distinct Cell Cycle Regulator Genes.	Cerebellum		2017 Apr	NA	DROSHA
1	HIF1A is Overexpressed in Medulloblastoma and its Inhibition Reduces Proliferation and Increases EPAS1 and ATG16L1 Methylation.	Curr Cancer Drug Targets	3	2018	NA	EPAS1
19017278	Real-time quantitative polymerase chain reaction (qPCR) analysis with fluorescence resonance energy transfer (FRET) probes reveals differential expression of the four ERBB4 juxtamembrane region variants between medulloblastoma and pilocytic astrocytoma.	Neuropathol Appl Neurobiol	6	2009 Aug	NA	ERBB4
17308352	Suppressors of hedgehog signaling: Linking aberrant development of neural progenitors and tumorigenesis.	Mol Neurobiol	6	2006 Dec	NA	ERBB4
16097449	Epidermal growth factor receptor (EGFR) expression in childhood brain tumors.	In Vivo	6	2005 Sep-Oct	NA	ERBB4
30205043	Aberrant ERBB4-SRC Signaling as a Hallmark of Group 4 Medulloblastoma Revealed by Integrative Phosphoproteomic Profiling.	Cancer Cell	5	2018 Sep 10	NA	ERBB4
9242460	Prognostic significance of HER2 and HER4 coexpression in childhood medulloblastoma.	Cancer Res	44	1997 Aug 1	NA	ERBB4
17183845	Does c-erbB-2 expression have a role in medulloblastoma prognosis?	Indian J Pathol Microbiol	3	2006 Oct	NA	ERBB4
16842254	Expression of c-erbB-4 in medulloblastoma and its correlation with prognosis.	Histopathology	3	2006 Jul	NA	ERBB4
16878160	Alternative splicing of the ErbB-4 cytoplasmic domain and its regulation by hedgehog signaling identify distinct medulloblastoma subsets.	Oncogene	24	2006 Nov 23	NA	ERBB4
9731505	Expression of the ErbB-neuregulin signaling network during human cerebellar development: implications for the biology of medulloblastoma.	Cancer Res	18	1998 Sep 1	NA	ERBB4
11391800	Novel ERBB4 juxtamembrane splice variants are frequently expressed in childhood medulloblastoma.	Genes Chromosomes Cancer	16	2001 Jul	NA	ERBB4
1	Multiple DNA repair mechanisms and alkylator resistance in the human medulloblastoma cell line D-283 Med (4-HCR).	Cancer Chemother Pharmacol	5	1999	NA	ERCC4
28536141	MELK and EZH2 Cooperate to Regulate Medulloblastoma Cancer Stem-like Cell Proliferation and Differentiation.	Mol Cancer Res	7	2017 Sep	NA	EZH2
24264533	Epigenetic repression of the dopamine receptor D4 in pediatric tumors of the central nervous system.	J Neurooncol	7	2014 Jan	NA	EZH2
29644394	Genomic analysis reveals secondary glioblastoma after radiotherapy in a subset of recurrent medulloblastomas.	Acta Neuropathol	4	2018 Jun	NA	EZH2
23190500	Inhibition of EZH2 suppresses self-renewal and induces radiation sensitivity in atypical rhabdoid teratoid tumor cells.	Neuro Oncol	34	2013 Feb	NA	EZH2
22287205	Targeting the enhancer of zeste homologue 2 in medulloblastoma.	Int J Cancer	25	2012 Oct 15	NA	EZH2
22696229	EZH2-regulated DAB2IP is a medulloblastoma tumor suppressor and a positive marker for survival.	Clin Cancer Res	22	2012 Aug 1	NA	EZH2
28329683	Inactivation of Ezh2 Upregulates Gfi1 and Drives Aggressive Myc-Driven Group 3 Medulloblastoma.	Cell Rep	15	2017 Mar 21	NA	EZH2
23179372	OTX2 sustains a bivalent-like state of OTX2-bound promoters in medulloblastoma by maintaining their H3K27me3 levels.	Acta Neuropathol	14	2013 Mar	NA	EZH2
24710217	The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes.	Nat Commun	111	2014 Apr 8	NA	EZH2
29108280	Trimethylation of H3K27 during human cerebellar development in relation to medulloblastoma.	Oncotarget	1	2017 Oct 3	NA	EZH2
30632221	Inhibition of enhancer of zest homologue 2 is a potential therapeutic target for high-MYC medulloblastoma.	Neuropathology		2019 Apr	NA	EZH2
22406992	Sorafenib and HDAC inhibitors synergize to kill CNS tumor cells.	Cancer Biol Ther	9	2012 May	NA	FAS
21824652	The intracellular uptake of CD95 modified paclitaxel-loaded poly(lactic-co-glycolic acid) microparticles.	Biomaterials	8	2011 Nov	NA	FAS
15586236	Ectopic expression of Par-4 leads to induction of apoptosis in CNS tumor cell lines.	Int J Oncol	8	2005 Jan	NA	FAS
9458162	A rapid and sensitive protocol for competitive reverse transcriptase (cRT) PCR analysis of cellular genes.	Brain Pathol	8	1998 Jan	NA	FAS
15182955	Differential regulation of CYP1A1 and CYP1B1 expression in resveratrol-treated human medulloblastoma cells.	Neurosci Lett	7	2004 Jun 17	NA	FAS
11584892	Ex vivo pediatric brain tumors express Fas (CD95) and FasL (CD95L) and are resistant to apoptosis induction.	Neuro Oncol	7	2001 Oct	NA	FAS
19633536	Camptothecin and Fas receptor agonists synergistically induce medulloblastoma cell death: ROS-dependent mechanisms.	Anticancer Drugs	6	2009 Oct	NA	FAS
24037645	Apoptosis-related gene expression in glioblastoma (LN-18) and medulloblastoma (Daoy) cell lines.	Hum Cell	5	2013 Dec	NA	FAS
17372745	Human parathyroid hormone-related protein and human parathyroid hormone receptor type 1 are expressed in human medulloblastomas and regulate cell proliferation and apoptosis in medulloblastoma-derived cell lines.	Acta Neuropathol	4	2007 Aug	NA	FAS
11750844	Loss of caspase-8 mRNA expression is common in childhood primitive neuroectodermal brain tumour/medulloblastoma.	Eur J Cancer	21	2002 Jan	NA	FAS
11204498	The role of apoptosis in normal ontogenesis and solid human neoplasms.	In Vivo	2	2000 Nov-Dec	NA	FAS
10639592	All-trans retinoic acid modulates fas expression and enhances chemosensitivity of human medulloblastoma cells.	Int J Mol Med	2	2000 Feb	NA	FAS
19148581	Reactivation of death receptor 4 (DR4) expression sensitizes medulloblastoma cell lines to TRAIL.	J Neurooncol	15	2009 Jul	NA	FAS
14583387	Resveratrol promotes differentiation and induces Fas-independent apoptosis of human medulloblastoma cells.	Neurosci Lett	15	2003 Nov 13	NA	FAS
14968374	Lymphokine activated killer cells from umbilical cord blood show higher antitumor effect against anaplastic astrocytoma cell line (U87) and medulloblastoma cell line (TE671) than lymphokine activated killer cells from peripheral blood.	Childs Nerv Syst	1	2004 Mar	NA	FAS
10652626	Fas (APO-1, CD95) receptor expression and new options for immunotherapy in childhood medulloblastomas.	Anticancer Res	1	1999 Jul-Aug	NA	FAS
11776585	[Retinoic acid enhances chemosensitivity of medulloblastoma cells in vitro and its potential mechanism].	Zhonghua Zhong Liu Za Zhi		2000 Jan	NA	FAS
9683272	CD95 ligand-induced apoptosis of human medulloblastoma cells.	Cancer Lett		1998 Jun 19	NA	FAS
1	The expression of FAT1 is associated with overall survival in children with medulloblastoma.	Tumori		2017 Jan 21	NA	FAT1
26977882	HDAC and PI3K Antagonists Cooperate to Inhibit Growth of MYC-Driven Medulloblastoma.	Cancer Cell	43	2016 Mar 14	NA	FOXO1
19787258	Impaired medulloblastoma cell survival following activation of the FOXO1 transcription factor.	Int J Oncol	2	2009 Nov	NA	FOXO1
1	Impact of miRNA-mRNA Profiling and Their Correlation on Medulloblastoma Tumorigenesis.	Mol Ther Nucleic Acids	1	2018 Sep 7	NA	FOXO3
1	Expression of glypican 3 (GPC3) in embryonal tumors.	Int J Cancer	24	2000 Sep 20	NA	GPC3
1	Differentially expressed genes are marked by histone 3 lysine 9 trimethylation in human cancer cells.	Oncogene	46	2008 Apr 10	NA	HOXA9
1	Downregulation of microRNA-431 by human interferon-Î² inhibits viability of medulloblastoma and glioblastoma cells via upregulation of SOCS6.	Int J Oncol	9	2014 May	NA	JAK1
28415684	The long noncoding RNA linc-NeD125 controls the expression of medulloblastoma driver genes by microRNA sponge activity.	Oncotarget	9	2017 May 9	NA	KDM6A
22832583	Dissecting the genomic complexity underlying medulloblastoma.	Nature	287	2012 Aug 2	NA	KDM6A
23179372	OTX2 sustains a bivalent-like state of OTX2-bound promoters in medulloblastoma by maintaining their H3K27me3 levels.	Acta Neuropathol	14	2013 Mar	NA	KDM6A
24710217	The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes.	Nat Commun	111	2014 Apr 8	NA	KDM6A
29108280	Trimethylation of H3K27 during human cerebellar development in relation to medulloblastoma.	Oncotarget	1	2017 Oct 3	NA	KDM6A
29785653	Valproic acid treatment response in vitro is determined by TP53 status in medulloblastoma.	Childs Nerv Syst		2018 Aug	NA	KDM6A
1	Genetic and epigenetic inactivation of Kruppel-like factor 4 in medulloblastoma.	Neoplasia	24	2010 Jan	NA	KLF4
29861161	MLL4 Is Required to Maintain Broad H3K4me3 Peaks and Super-Enhancers at Tumor Suppressor Genes.	Mol Cell	9	2018 Jun 7	NA	KMT2D
22832583	Dissecting the genomic complexity underlying medulloblastoma.	Nature	287	2012 Aug 2	NA	KMT2D
11521197	Involvement of Wnt signaling pathway in murine medulloblastoma induced by human neurotropic JC virus.	Oncogene	16	2001 Aug 9	NA	LEF1
27834469	The expression of FAT1 is associated with overall survival in children with medulloblastoma.	Tumori		2017 Jan 21	NA	LEF1
1	Mitogen-activated kinase kinase kinase 1 inhibits hedgehog signaling and medulloblastoma growth through GLI1 phosphorylation.	Int J Oncol	4	2019 Feb	NA	MAP3K1
26814967	Active medulloblastoma enhancers reveal subgroup-specific cellular origins.	Nature	83	2016 Feb 4	NA	MAX
15519529	Analysis of transcripts from 17p13.3 in medulloblastoma suggests ROX/MNT as a potential tumour suppressor gene.	Eur J Cancer	8	2004 Nov	NA	MAX
17102621	Identification and analysis of tumor suppressor loci at chromosome 10q23.3-10q25.3 in medulloblastoma.	Cell Cycle	7	2006 Oct	NA	MAX
25930724	Phase I trial of weekly MK-0752 in children with refractory central nervous system malignancies: a pediatric brain tumor consortium study.	Childs Nerv Syst	6	2015 Aug	NA	MAX
10778725	Pediatric medulloblastoma: prognostic value of p53, bcl-2, Mib-1, and microvessel density.	J Neurooncol	5	1999	NA	MAX
10446446	Analysis of the Max-binding protein MNT in human medulloblastomas.	Int J Cancer	5	1999 Sep 9	NA	MAX
20876797	Silencing of thrombospondin-1 is critical for myc-induced metastatic phenotypes in medulloblastoma.	Cancer Res	21	2010 Oct 15	NA	MAX
18235219	From cerebellar proliferation to tumorigenesis: new insights into the role of Mad3.	Cell Cycle	18	2008 Feb 15	NA	MAX
27058758	Medulloblastoma-associated DDX3 variant selectively alters the translational response to stress.	Oncotarget	13	2016 May 10	NA	MAX
17893326	A novel role of the Mad family member Mad3 in cerebellar granule neuron precursor proliferation.	Mol Cell Biol	12	2007 Dec	NA	MAX
24847876	Decoding the regulatory landscape of medulloblastoma using DNA methylation sequencing.	Nature	117	2014 Jun 26	NA	MAX
22898254	Discovery of the investigational drug TAK-441, a pyrrolo[3,2-c]pyridine derivative, as a highly potent and orally active hedgehog signaling inhibitor: modification of the core skeleton for improved solubility.	Bioorg Med Chem	11	2012 Sep 15	NA	MAX
30611741	Synergistic activity of BET inhibitor MK-8628 and PLK inhibitor Volasertib in preclinical models of medulloblastoma.	Cancer Lett	1	2019 Mar 31	NA	MAX
28833911	Discovery of a Novel Inhibitor of the Hedgehog Signaling Pathway through Cell-based Compound Discovery and Target Prediction.	Angew Chem Int Ed Engl	1	2017 Oct 9	NA	MAX
31454140	Discovery of the Hedgehog Pathway Inhibitor Pipinib that Targets PI4KIIIÃ.	Angew Chem Int Ed Engl		2019 Aug 27	NA	MAX
31319483	Simvastatin Induces Apoptosis in Medulloblastoma Brain Tumor Cells via Mevalonate Cascade Prenylation Substrates.	Cancers (Basel)		2019 Jul 17	NA	MAX
30838212	Alternative Splicing of MXD3 and Its Regulation of MXD3 Levels in Glioblastoma.	Front Mol Biosci		2019	NA	MAX
30810905	Differential Expression of Genes for Ubiquitin Ligases in Medulloblastoma Subtypes.	Cerebellum		2019 Jun	NA	MAX
28427187	RITA displays anti-tumor activity in medulloblastomas independent of TP53 status.	Oncotarget		2017 Apr 25	NA	MAX
27592301	The ubiquitin-proteasome system and chromosome 17 in cerebellar granule cells and medulloblastoma subgroups.	Cell Mol Life Sci		2017 Feb	NA	MAX
17440981	Biallelic germline mutations of mismatch-repair genes: a possible cause for multiple pediatric malignancies.	Cancer	23	2007 Jun 1	NA	MLH1
22976800	Mismatch repair deficiency: a temozolomide resistance factor in medulloblastoma cell lines that is uncommon in primary medulloblastoma tumours.	Br J Cancer	10	2012 Oct 9	NA	MLH1
18095118	Detection of genetic and chromosomal aberrations in medulloblastomas and primitive neuroectodermal tumors with DNA microarrays.	Brain Tumor Pathol	8	2006 Apr	NA	MSH2
29302048	Diagnostic challenges in a child with early onset desmoplastic medulloblastoma and homozygous variants in MSH2 and MSH6.	Eur J Hum Genet	1	2018 Mar	NA	MSH2
19179424	Analysis of microsatellite instability in medulloblastoma.	Neuro Oncol	8	2009 Oct	NA	MSH6
17440981	Biallelic germline mutations of mismatch-repair genes: a possible cause for multiple pediatric malignancies.	Cancer	23	2007 Jun 1	NA	MSH6
29302048	Diagnostic challenges in a child with early onset desmoplastic medulloblastoma and homozygous variants in MSH2 and MSH6.	Eur J Hum Genet	1	2018 Mar	NA	MSH6
1	Decrease of Nibrin expression in chronic hypoxia is associated with hypoxia-induced chemoresistance in some brain tumour cells.	BMC Cancer		2019 Apr 3	NA	NBN
26067104	Somatic CRISPR/Cas9-mediated tumour suppressor disruption enables versatile brain tumour modelling.	Nat Commun	66	2015 Jun 11	NA	NF1
17440981	Biallelic germline mutations of mismatch-repair genes: a possible cause for multiple pediatric malignancies.	Cancer	23	2007 Jun 1	NA	NF1
27314542	Using urinary bFGF and TIMP3 levels to predict the presence of juvenile pilocytic astrocytoma and establish a distinct biomarker signature.	J Neurosurg Pediatr	1	2016 Oct	NA	NF1
7657385	Analysis of the GAP-related domain of the neurofibromatosis type 1 (NF1) gene in childhood brain tumors.	Int J Cancer	1	1995 Aug 22	NA	NF1
1	The association of NF2 (neurofibromin 2) gene polymorphism and the risk of medulloblastomas.	Neurol Sci		2018 Jul	NA	NF2
1	Expression of thyroid transcription factor 1 in primary brain tumours.	J Clin Pathol	4	2004 Oct	NA	NKX2-1
23852537	Notch1-induced brain tumor models the sonic hedgehog subgroup of human medulloblastoma.	Cancer Res	7	2013 Sep 1	NA	NOTCH1
25930724	Phase I trial of weekly MK-0752 in children with refractory central nervous system malignancies: a pediatric brain tumor consortium study.	Childs Nerv Syst	6	2015 Aug	NA	NOTCH1
21825264	Phase I trial of MK-0752 in children with refractory CNS malignancies: a pediatric brain tumor consortium study.	J Clin Oncol	50	2011 Sep 10	NA	NOTCH1
20515335	Upregulation of SOX2, NOTCH1, and ID1 in supratentorial primitive neuroectodermal tumors: a distinct differentiation pattern from that of medulloblastomas.	J Neurosurg Pediatr	5	2010 Jun	NA	NOTCH1
25966102	Isolation and characterization of cancer stem cells from medulloblastoma.	Genet Mol Res	3	2015 Apr 13	NA	NOTCH1
19773441	MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes.	Cancer Res	212	2009 Oct 1	NA	NOTCH1
18928660	Notch signaling in pediatric malignancies.	Curr Oncol Rep	20	2008 Nov	NA	NOTCH1
19424825	Differential expression of Notch family members in astrocytomas and medulloblastomas.	Pathol Oncol Res	19	2009 Dec	NA	NOTCH1
21613407	SPARC stimulates neuronal differentiation of medulloblastoma cells via the Notch1/STAT3 pathway.	Cancer Res	15	2011 Jul 15	NA	NOTCH1
15520184	Notch1 and notch2 have opposite effects on embryonal brain tumor growth.	Cancer Res	142	2004 Nov 1	NA	NOTCH1
30297829	Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastoma.	Nat Commun	1	2018 Oct 8	NA	NOTCH1
19035115	[Differential expression of Notch1 and Notch2 in astrocytoma and medulloblastoma].	Zhonghua Bing Li Xue Za Zhi	1	2008 Jul	NA	NOTCH1
31063715	TSP2 acts as a suppresser of cell invasion, migration and angiogenesis in medulloblastoma by inhibiting the Notch signaling pathway.	Brain Res		2019 Sep 1	NA	NOTCH1
19020777	Characteristic overexpression of the forkhead box transcription factor Foxf1 in Patched-associated tumors.	Int J Mol Med	8	2008 Dec	NA	NOTCH2
23852537	Notch1-induced brain tumor models the sonic hedgehog subgroup of human medulloblastoma.	Cancer Res	7	2013 Sep 1	NA	NOTCH2
22753727	Effects of Zeng Sheng Ping/ACAPHA on malignant brain tumor growth and Notch signaling.	Anticancer Res	3	2012 Jul	NA	NOTCH2
21614651	Upregulation of E2F1 in cerebellar neuroprogenitor cells and cell cycle arrest during postnatal brain development.	In Vitro Cell Dev Biol Anim	3	2011 Aug	NA	NOTCH2
18826648	Musashi1 modulates cell proliferation genes in the medulloblastoma cell line Daoy.	BMC Cancer	28	2008 Sep 30	NA	NOTCH2
19773441	MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes.	Cancer Res	212	2009 Oct 1	NA	NOTCH2
16598417	Expression of Notch and Wnt pathway components and activation of Notch signaling in medulloblastomas from heterozygous patched mice.	J Neurooncol	21	2006 Sep	NA	NOTCH2
19424825	Differential expression of Notch family members in astrocytomas and medulloblastomas.	Pathol Oncol Res	19	2009 Dec	NA	NOTCH2
15520185	The SmoA1 mouse model reveals that notch signaling is critical for the growth and survival of sonic hedgehog-induced medulloblastomas.	Cancer Res	165	2004 Nov 1	NA	NOTCH2
15520184	Notch1 and notch2 have opposite effects on embryonal brain tumor growth.	Cancer Res	142	2004 Nov 1	NA	NOTCH2
24708907	NOTCH ligands JAG1 and JAG2 as critical pro-survival factors in childhood medulloblastoma.	Acta Neuropathol Commun	14	2014 Apr 7	NA	NOTCH2
24695855	SHH, WNT, and NOTCH pathways in medulloblastoma: when cancer stem cells maintain self-renewal and differentiation properties.	Childs Nerv Syst	12	2014 Jul	NA	NOTCH2
19035115	[Differential expression of Notch1 and Notch2 in astrocytoma and medulloblastoma].	Zhonghua Bing Li Xue Za Zhi	1	2008 Jul	NA	NOTCH2
29785653	Valproic acid treatment response in vitro is determined by TP53 status in medulloblastoma.	Childs Nerv Syst		2018 Aug	NA	NOTCH2
28856557	Endothelial Cells Promote Formation of Medulloblastoma Stem-Like Cells via Notch Pathway Activation.	J Mol Neurosci		2017 Oct	NA	NOTCH2
20515335	Upregulation of SOX2, NOTCH1, and ID1 in supratentorial primitive neuroectodermal tumors: a distinct differentiation pattern from that of medulloblastomas.	J Neurosurg Pediatr	5	2010 Jun	NA	NRG1
9731505	Expression of the ErbB-neuregulin signaling network during human cerebellar development: implications for the biology of medulloblastoma.	Cancer Res	18	1998 Sep 1	NA	NRG1
1	Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort.	Lancet Oncol	10	2018 Jun	NA	PALB2
17016584	Overexpression of PAX5 in oral carcinogenesis.	Oncol Rep	4	2006 Nov	NA	PAX5
7777574	Deregulated expression of PAX5 in medulloblastoma.	Proc Natl Acad Sci U S A	21	1995 Jun 6	NA	PAX5
27623204	Expression of SOX11, PAX5, TTF-1 and ISL-1 in medulloblastoma.	Pathol Res Pract	2	2016 Nov	NA	PAX5
22552444	PAX2 is an antiapoptotic molecule with deregulated expression in medulloblastoma.	Int J Oncol	2	2012 Jul	NA	PAX5
1	[Chromatin remodeling defects and cancer: the SWI/SNF example].	Bull Cancer	2	2012 Dec	NA	PBRM1
1	The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes.	Nat Commun	111	2014 Apr 8	NA	PHF6
1	PHOX2B is a reliable immunomarker in distinguishing peripheral neuroblastic tumours from CNS embryonal tumours.	Histopathology	1	2018 Sep	NA	PHOX2B
1	Docosahexaenoic acid (DHA) sensitizes brain tumor cells to etoposide-induced apoptosis.	Curr Mol Med	5	2011 Aug	NA	PIK3R1
15573377	The agnoprotein of polyomaviruses: a multifunctional auxiliary protein.	J Cell Physiol	37	2005 Jul	NA	PML
9926918	Human ubiquitous JCV(CY) T-antigen gene induces brain tumors in experimental animals.	Oncogene	33	1999 Jan 7	NA	PML
22641694	Formation of telomeric repeat-containing RNA (TERRA) foci in highly proliferating mouse cerebellar neuronal progenitors and medulloblastoma.	J Cell Sci	17	2012 Sep 15	NA	PML
17201119	Analysis of a mutant p53 protein arising in a medulloblastoma from a mouse transgenic for the JC virus early region.	Anticancer Res	14	2006 Nov-Dec	NA	PML
22984599	Bag3-induced autophagy is associated with degradation of JCV oncoprotein, T-Ag.	PLoS One	12	2012	NA	PML
30108683	Viral tumor antigen expression is no longer required in radiation-resistant subpopulation of JCV induced mouse medulloblastoma cells.	Genes Cancer		2018 Mar	NA	PML
22362285	Molecular targeting therapy against promyelocytic leukemia protein using arsenic acids in experimental intracranial medulloblastoma.	Neurol Med Chir (Tokyo)		2012	NA	PML
1	Biallelic germline mutations of mismatch-repair genes: a possible cause for multiple pediatric malignancies.	Cancer	23	2007 Jun 1	NA	PMS2
1	Fenretinide (4-HPR) Targets Caspase-9, ERK 1/2 and the Wnt3a/Î²-Catenin Pathway in Medulloblastoma Cells and Medulloblastoma Cell Spheroids.	PLoS One	4	2016	NA	POLE
1	Hedgehog target genes: mechanisms of carcinogenesis induced by aberrant hedgehog signaling activation.	Curr Mol Med	188	2009 Sep	NA	PRDM1
29531057	Lateral cerebellum is preferentially sensitive to high sonic hedgehog signaling and medulloblastoma formation.	Proc Natl Acad Sci U S A	6	2018 Mar 27	NA	PTCH1
28726779	Maml1 acts cooperatively with Gli proteins to regulate sonic hedgehog signaling pathway.	Cell Death Dis	5	2017 Jul 20	NA	PTCH1
28548041	FOXR2 Promotes the Proliferation, Invasion, and Epithelial-Mesenchymal Transition in Human Colorectal Cancer Cells.	Oncol Res	4	2017 May 24	NA	PTCH1
28490517	ATOH1 Promotes Leptomeningeal Dissemination and Metastasis of Sonic Hedgehog Subgroup Medulloblastomas.	Cancer Res	4	2017 Jul 15	NA	PTCH1
29274272	The role of the Hedgehog signaling pathway in cancer: A comprehensive review.	Bosn J Basic Med Sci	20	2018 Feb 20	NA	PTCH1
28986380	Astrocytes Promote Medulloblastoma Progression through Hedgehog Secretion.	Cancer Res	2	2017 Dec 1	NA	PTCH1
27965576	Functional Genomics Identifies Tis21-Dependent Mechanisms and Putative Cancer Drug Targets Underlying Medulloblastoma Shh-Type Development.	Front Pharmacol	2	2016	NA	PTCH1
27802424	Dual role of the integrated stress response in medulloblastoma tumorigenesis.	Oncotarget	2	2016 Sep 27	NA	PTCH1
29753700	Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort.	Lancet Oncol	10	2018 Jun	NA	PTCH1
30096798	Sonic Hedgehog Medulloblastoma Cancer Stem Cells Mirnome and Transcriptome Highlight Novel Functional Networks.	Int J Mol Sci	1	2018 Aug 8	NA	PTCH1
29079783	Nanog-driven cell-reprogramming and self-renewal maintenance in Ptch1 &lt;sup&gt;+/-&lt;/sup&gt; granule cell precursors after radiation injury.	Sci Rep	1	2017 Oct 27	NA	PTCH1
28328116	Brain morphology in children with nevoid basal cell carcinoma syndrome.	Am J Med Genet A	1	2017 Apr	NA	PTCH1
30670636	Transcriptional repressor REST drives lineage stage-specific chromatin compaction at &lt;i&gt;Ptch1&lt;/i&gt; and increases AKT activation in a mouse model of medulloblastoma.	Sci Signal		2019 Jan 22	NA	PTCH1
30657775	Identification of CD24 as a marker of Patched1 deleted medulloblastoma-initiating neural progenitor cells.	PLoS One		2019	NA	PTCH1
30483126	Low Expression of miR-466f-3p Sustains Epithelial to Mesenchymal Transition in Sonic Hedgehog Medulloblastoma Stem Cells Through Vegfa-Nrp2 Signaling Pathway.	Front Pharmacol		2018	NA	PTCH1
30452905	Genetic ablation of Gpr37l1 delays tumor occurrence in Ptch1&lt;sup&gt;+/-&lt;/sup&gt; mouse models of medulloblastoma.	Exp Neurol		2019 Feb	NA	PTCH1
30374857	Molecular characterization of Wnt pathway and function of Î²-catenin overexpression in medulloblastoma cell lines.	Cytotechnology		2018 Dec	NA	PTCH1
29785653	Valproic acid treatment response in vitro is determined by TP53 status in medulloblastoma.	Childs Nerv Syst		2018 Aug	NA	PTCH1
29582169	Medulloblastoma, WNT-activated/SHH-activated: clinical impact of molecular analysis and histogenetic evaluation.	Childs Nerv Syst		2018 May	NA	PTCH1
29039452	Molecular analysis of keratocystic odontogenic tumor cell lines derived from sporadic and basal cell nevus syndrome patients.	Int J Oncol		2017 Dec	NA	PTCH1
24862126	Oncogenes and the coagulation system--forces that modulate dormant and aggressive states in cancer.	Thromb Res	9	2014 May	NA	PTEN
26938241	PI-3K Inhibitors Preferentially Target CD15+ Cancer Stem Cell Population in SHH Driven Medulloblastoma.	PLoS One	8	2016	NA	PTEN
26067104	Somatic CRISPR/Cas9-mediated tumour suppressor disruption enables versatile brain tumour modelling.	Nat Commun	66	2015 Jun 11	NA	PTEN
28431179	miRNA Regulation in Gliomas: Usual Suspects in Glial Tumorigenesis and Evolving Clinical Applications.	J Neuropathol Exp Neurol	6	2017 Apr 1	NA	PTEN
25475127	DJ-1 is activated in medulloblastoma and is associated with cell proliferation and differentiation.	World J Surg Oncol	6	2014 Dec 5	NA	PTEN
25386346	Brain neoplasms and coagulation-lessons from heterogeneity.	Rambam Maimonides Med J	5	2014 Oct	NA	PTEN
24108471	Brain neoplasms and coagulation.	Semin Thromb Hemost	5	2013 Nov	NA	PTEN
29490009	Metastatic group 3 medulloblastoma is driven by PRUNE1 targeting NME1-TGF-Î²-OTX2-SNAIL via PTEN inhibition.	Brain	4	2018 May 1	NA	PTEN
28137592	Usp7 promotes medulloblastoma cell survival and metastasis by activating Shh pathway.	Biochem Biophys Res Commun	4	2017 Mar 4	NA	PTEN
27067976	Biological basis of personalized anticoagulation in cancer: oncogene and oncomir networks as putative regulators of coagulopathy.	Thromb Res	4	2016 Apr	NA	PTEN
24599437	Genetic basis of thrombosis in cancer.	Semin Thromb Hemost	4	2014 Apr	NA	PTEN
29869738	Rethinking medulloblastoma from a targeted therapeutics perspective.	J Neurooncol	2	2018 Sep	NA	PTEN
25940061	Gorlin syndrome and desmoplastic medulloblastoma: Report of 3 cases with unfavorable clinical course and novel mutations.	Pediatr Blood Cancer	2	2015 Oct	NA	PTEN
24252690	Identification of a neuronal transcription factor network involved in medulloblastoma development.	Acta Neuropathol Commun	17	2013 Jul 11	NA	PTEN
25041637	miR-106b is overexpressed in medulloblastomas and interacts directly with PTEN.	Neuropathol Appl Neurobiol	13	2015 Feb	NA	PTEN
24285947	The miR-183â¼96â¼182 cluster promotes tumorigenesis in a mouse model of medulloblastoma.	J Biomed Res	11	2013 Nov	NA	PTEN
30670636	Transcriptional repressor REST drives lineage stage-specific chromatin compaction at &lt;i&gt;Ptch1&lt;/i&gt; and increases AKT activation in a mouse model of medulloblastoma.	Sci Signal		2019 Jan 22	NA	PTEN
30304554	Effects of microRNA-494 on proliferation, migration, invasion, and apoptosis of medulloblastoma cells by mediating c-myc through the p38 MAPK signaling pathway.	J Cell Biochem		2018 Oct 10	NA	PTEN
30049282	Medulloblastoma therapy generates risk of a poorly-prognostic H3 wild-type subgroup of diffuse intrinsic pontine glioma: a report from the International DIPG Registry.	Acta Neuropathol Commun		2018 Jul 26	NA	PTEN
25140280	Case comparison and literature review of glioblastoma: A tale of two tumors.	Surg Neurol Int		2014	NA	PTEN
16314645	Genomic and protein expression profiling identifies CDK6 as novel independent prognostic marker in medulloblastoma.	J Clin Oncol	59	2005 Dec 1	NA	RB1
12684707	Epigenetic changes in pilocytic astrocytomas and medulloblastomas.	Int J Mol Med	5	2003 May	NA	RB1
27503856	Unravelling the Mechanism of TrkA-Induced Cell Death by Macropinocytosis in Medulloblastoma Daoy Cells.	Mol Cell Biol	4	2016 Oct 15	NA	RHOA
22528793	Rho GTPases in primary brain tumor malignancy and invasion.	J Neurooncol	11	2012 Jul	NA	RHOA
21798346	SPARC mediates Src-induced disruption of actin cytoskeleton via inactivation of small GTPases Rho-Rac-Cdc42.	Cell Signal	10	2011 Dec	NA	RHOA
21442027	Heparanase Modulates Shh and Wnt3a Signaling in Human Medulloblastoma Cells.	Exp Ther Med	10	2011 Mar 1	NA	RHOA
31185958	Subgroup-specific prognostic signaling and metabolic pathways in pediatric medulloblastoma.	BMC Cancer		2019 Jun 11	NA	RHOA
1	Identification of RPL5 and RPL10 as novel diagnostic biomarkers of Atypical teratoid/rhabdoid tumors.	Cancer Cell Int		2018	NA	RPL10
1	Identification of RPL5 and RPL10 as novel diagnostic biomarkers of Atypical teratoid/rhabdoid tumors.	Cancer Cell Int		2018	NA	RPL5
1	The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes.	Nat Commun	111	2014 Apr 8	NA	SETD2
1	Modulation of gene expression in human central nervous system tumors under methionine deprivation-induced stress.	Cancer Res	14	2004 Oct 15	NA	SMAD2
22966790	Canonical TGF-Î² pathway activity is a predictor of SHH-driven medulloblastoma survival and delineates putative precursors in cerebellar development.	Brain Pathol	6	2013 Mar	NA	SMAD3
24469054	ASC deficiency suppresses proliferation and prevents medulloblastoma incidence.	Oncogene	2	2015 Jan 15	NA	SMAD3
23698369	BAF complexes facilitate decatenation of DNA by topoisomerase IIÎ±.	Nature	77	2013 May 30	NA	SMARCA4
27065321	SMARCA4/Brg1 coordinates genetic and epigenetic networks underlying Shh-type medulloblastoma development.	Oncogene	7	2016 Nov 3	NA	SMARCA4
27695363	Atypical teratoid/rhabdoid tumors: challenges and search for solutions.	Cancer Manag Res	4	2016	NA	SMARCA4
22832583	Dissecting the genomic complexity underlying medulloblastoma.	Nature	287	2012 Aug 2	NA	SMARCA4
23222069	[Chromatin remodeling defects and cancer: the SWI/SNF example].	Bull Cancer	2	2012 Dec	NA	SMARCA4
25274825	Loss of Smarc proteins impairs cerebellar development.	J Neurosci	12	2014 Oct 1	NA	SMARCA4
24710217	The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes.	Nat Commun	111	2014 Apr 8	NA	SMARCA4
25085602	Expression of the HOX genes and HOTAIR in atypical teratoid rhabdoid tumors and other pediatric brain tumors.	Cancer Genet	8	2014 Sep	NA	SMARCB1
15105654	Immunohistochemical analysis of hSNF5/INI1 in pediatric CNS neoplasms.	Am J Surg Pathol	48	2004 May	NA	SMARCB1
27695363	Atypical teratoid/rhabdoid tumors: challenges and search for solutions.	Cancer Manag Res	4	2016	NA	SMARCB1
26109171	Integrated genomics has identified a new AT/RT-like yet INI1-positive brain tumor subtype among primary pediatric embryonal tumors.	BMC Med Genomics	4	2015 Jun 25	NA	SMARCB1
23190500	Inhibition of EZH2 suppresses self-renewal and induces radiation sensitivity in atypical rhabdoid teratoid tumor cells.	Neuro Oncol	34	2013 Feb	NA	SMARCB1
27095948	LIN28B is highly expressed in atypical teratoid/rhabdoid tumor (AT/RT) and suppressed through the restoration of SMARCB1.	Cancer Cell Int	3	2016	NA	SMARCB1
22020042	Intact INI1 gene region with paradoxical loss of protein expression in AT/RT: implications for a possible novel mechanism associated with absence of INI1 protein immunoreactivity.	Am J Surg Pathol	3	2012 Jan	NA	SMARCB1
20882288	Molecular diagnostics of CNS embryonal tumors.	Acta Neuropathol	21	2010 Nov	NA	SMARCB1
23435428	Activation of Î²-catenin/TCF targets following loss of the tumor suppressor SNF5.	Oncogene	20	2014 Feb 13	NA	SMARCB1
27966820	Overexpression of TEAD4 in atypical teratoid/rhabdoid tumor: New insight to the pathophysiology of an aggressive brain tumor.	Pediatr Blood Cancer	2	2017 Jul	NA	SMARCB1
23222069	[Chromatin remodeling defects and cancer: the SWI/SNF example].	Bull Cancer	2	2012 Dec	NA	SMARCB1
25274825	Loss of Smarc proteins impairs cerebellar development.	J Neurosci	12	2014 Oct 1	NA	SMARCB1
18422908	Melanocytic medulloblastoma with ganglioneurocytomatous differentiation: a case report.	Neuropathology	1	2009 Feb	NA	SMARCB1
15759130	Differentiation of classic medulloblastoma into metastatic large cell medulloblastoma with focal rhabdoid differentiation in the absence of posterior fossa recurrence.	Acta Neuropathol	1	2005 May	NA	SMARCB1
30479569	Identification of RPL5 and RPL10 as novel diagnostic biomarkers of Atypical teratoid/rhabdoid tumors.	Cancer Cell Int		2018	NA	SMARCB1
28777153	A Diagnostic Pitfall: Atypical Teratoid Rhabdoid Tumor Versus Dedifferentiated/Poorly Differentiated Chordoma: Analysis of a Mono-institutional Series.	Appl Immunohistochem Mol Morphol		2019 Feb	NA	SMARCB1
1	Cytokine-mediated inflammation, tumorigenesis, and disease-associated JAK/STAT/SOCS signaling circuits in the CNS.	Brain Res Brain Res Rev	28	2005 Apr	NA	SOCS1
1	Expression and clinical relevance of SPOPL in medulloblastoma.	Oncol Lett	1	2017 Sep	NA	SPOP
24973920	Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition.	Nat Med	90	2014 Jul	NA	SUFU
17452975	Loss of suppressor-of-fused function promotes tumorigenesis.	Oncogene	83	2007 Sep 27	NA	SUFU
16316410	Negative regulation of Gli1 and Gli2 activator function by Suppressor of fused through multiple mechanisms.	Differentiation	70	2005 Oct	NA	SUFU
17102621	Identification and analysis of tumor suppressor loci at chromosome 10q23.3-10q25.3 in medulloblastoma.	Cell Cycle	7	2006 Oct	NA	SUFU
29662197	MEKK2 and MEKK3 suppress Hedgehog pathway-dependent medulloblastoma by inhibiting GLI1 function.	Oncogene	5	2018 Jul	NA	SUFU
27785591	The DNA methyltransferase inhibitor zebularine exerts antitumor effects and reveals BATF2 as a poor prognostic marker for childhood medulloblastoma.	Invest New Drugs	5	2017 Feb	NA	SUFU
22027544	Medulloblastomas in adults:  prognostic factors and lessons from paediatrics.	Curr Opin Neurol	5	2011 Dec	NA	SUFU
21572341	GLI2 is a potential therapeutic target in pediatric medulloblastoma.	J Neuropathol Exp Neurol	5	2011 Jun	NA	SUFU
28545823	Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study.	Lancet Oncol	45	2017 Jul	NA	SUFU
25355313	The BET bromodomain inhibitor I-BET151 acts downstream of smoothened protein to abrogate the growth of hedgehog protein-driven cancers.	J Biol Chem	37	2014 Dec 19	NA	SUFU
21325292	Rapid diagnosis of medulloblastoma molecular subgroups.	Clin Cancer Res	29	2011 Apr 1	NA	SUFU
26130651	RAS/MAPK Activation Drives Resistance to Smo Inhibition, Metastasis, and Tumor Evolution in Shh Pathway-Dependent Tumors.	Cancer Res	27	2015 Sep 1	NA	SUFU
29274272	The role of the Hedgehog signaling pathway in cancer: A comprehensive review.	Bosn J Basic Med Sci	20	2018 Feb 20	NA	SUFU
26619401	A positive feedback loop between Gli1 and tyrosine kinase Hck amplifies shh signaling activities in medulloblastoma.	Oncogenesis	2	2015 Nov 30	NA	SUFU
19860666	Hedgehog target genes: mechanisms of carcinogenesis induced by aberrant hedgehog signaling activation.	Curr Mol Med	188	2009 Sep	NA	SUFU
24651015	Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition.	Cancer Cell	171	2014 Mar 17	NA	SUFU
24252690	Identification of a neuronal transcription factor network involved in medulloblastoma development.	Acta Neuropathol Commun	17	2013 Jul 11	NA	SUFU
18781608	Tumor suppressor gene co-operativity in compound Patched1 and suppressor of fused heterozygous mutant mice.	Mol Carcinog	14	2009 May	NA	SUFU
17413002	Medulloblastomas derived from Cxcr6 mutant mice respond to treatment with a smoothened inhibitor.	Cancer Res	11	2007 Apr 15	NA	SUFU
29753700	Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort.	Lancet Oncol	10	2018 Jun	NA	SUFU
28329683	Inactivation of Ezh2 Upregulates Gfi1 and Drives Aggressive Myc-Driven Group 3 Medulloblastoma.	Cell Rep	15	2017 Mar 21	NA	SUZ12
23179372	OTX2 sustains a bivalent-like state of OTX2-bound promoters in medulloblastoma by maintaining their H3K27me3 levels.	Acta Neuropathol	14	2013 Mar	NA	SUZ12
28545823	Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study.	Lancet Oncol	45	2017 Jul	NA	TERT
24174164	TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma.	Acta Neuropathol	42	2013 Dec	NA	TERT
25843513	Recurrent TERT promoter mutations identified in a large-scale study of multiple tumour types are associated with increased TERT expression and telomerase activation.	Eur J Cancer	38	2015 May	NA	TERT
23192708	Curcumin inhibits telomerase and induces telomere shortening and apoptosis in brain tumour cells.	J Cell Biochem	21	2013 Jun	NA	TERT
18167600	Photodynamic effect in medulloblastoma: downregulation of matrix metalloproteinases and human telomerase reverse transcriptase expressions.	Photochem Photobiol Sci	2	2008 Jan	NA	TERT
24651015	Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition.	Cancer Cell	171	2014 Mar 17	NA	TERT
22736505	Genistein induces growth arrest and suppresses telomerase activity in brain tumor cells.	Genes Chromosomes Cancer	16	2012 Oct	NA	TERT
26856307	Telomere dysfunction and chromothripsis.	Int J Cancer	14	2016 Jun 15	NA	TERT
24695855	SHH, WNT, and NOTCH pathways in medulloblastoma: when cancer stem cells maintain self-renewal and differentiation properties.	Childs Nerv Syst	12	2014 Jul	NA	TERT
24337442	TERT promoter mutation and aberrant hypermethylation are associated with elevated expression in medulloblastoma and characterise the majority of non-infant SHH subgroup tumours.	Acta Neuropathol	12	2014 Feb	NA	TERT
19358275	The antiretroviral nucleoside analogue Abacavir reduces cell growth and promotes differentiation of human medulloblastoma cells.	Int J Cancer	12	2009 Jul 1	NA	TERT
27694758	Study of hTERT and Histone 3 Mutations in Medulloblastoma.	Pathobiology	1	2017	NA	TERT
30830680	Telomere elongation via alternative lengthening of telomeres (ALT) and telomerase activation in primary metastatic medulloblastoma of childhood.	J Neurooncol		2019 May	NA	TERT
29785653	Valproic acid treatment response in vitro is determined by TP53 status in medulloblastoma.	Childs Nerv Syst		2018 Aug	NA	TERT
28228863	Medulloblastoma and ependymoma cells display increased levels of 5-carboxylcytosine and elevated &lt;i&gt;TET1&lt;/i&gt; expression.	Clin Epigenetics	1	2017	NA	TET1
29582271	Reduced hydroxymethylation characterizes medulloblastoma while TET and IDH genes are differentially expressed within molecular subgroups.	J Neurooncol		2018 Aug	NA	TET1
1	Analysis of microsatellite instability in medulloblastoma.	Neuro Oncol	8	2009 Oct	NA	TGFBR2
27556362	Low-dose Actinomycin-D treatment re-establishes the tumoursuppressive function of P53 in RELA-positive ependymoma.	Oncotarget	7	2016 Sep 20	NA	TP53
27040285	Risk stratification of childhood medulloblastoma in the molecular era: the current consensus.	Acta Neuropathol	53	2016 Jun	NA	TP53
28545823	Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study.	Lancet Oncol	45	2017 Jul	NA	TP53
29644394	Genomic analysis reveals secondary glioblastoma after radiotherapy in a subset of recurrent medulloblastomas.	Acta Neuropathol	4	2018 Jun	NA	TP53
27067976	Biological basis of personalized anticoagulation in cancer: oncogene and oncomir networks as putative regulators of coagulopathy.	Thromb Res	4	2016 Apr	NA	TP53
27775567	A Proteogenomic Approach to Understanding MYC Function in Metastatic Medulloblastoma Tumors.	Int J Mol Sci	3	2016 Oct 19	NA	TP53
27682250	Complete and sustained response of adult medulloblastoma to first-line sonic hedgehog inhibition with vismodegib.	Cancer Biol Ther	2	2016 Oct 2	NA	TP53
26518543	Somatic cell transfer of c-Myc and Bcl-2 induces large-cell anaplastic medulloblastomas in mice.	J Neurooncol	2	2016 Feb	NA	TP53
26000978	Antitumour activity of AMG 900 alone or in combination with histone deacetylase inhibitor SaHa on medulloblastoma cell lines.	Neurol Res	2	2015 Aug	NA	TP53
29753700	Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort.	Lancet Oncol	10	2018 Jun	NA	TP53
31081944	The long noncoding RNA TP73-AS1 promotes tumorigenicity of medulloblastoma cells.	Int J Cancer	1	2019 May 13	NA	TP53
31423907	Differential response of SHH-expressing adult medulloblastomas to the sonic hedgehog inhibitor vismodegib: whole-genome analysis.	Cancer Biol Ther		2019 Aug 18	NA	TP53
30945456	Developmental origins and oncogenic pathways in malignant brain tumors.	Wiley Interdiscip Rev Dev Biol		2019 Jul	NA	TP53
30725256	Modulating native GABA&lt;sub&gt;A&lt;/sub&gt; receptors in medulloblastoma with positive allosteric benzodiazepine-derivatives induces cell death.	J Neurooncol		2019 May	NA	TP53
29785653	Valproic acid treatment response in vitro is determined by TP53 status in medulloblastoma.	Childs Nerv Syst		2018 Aug	NA	TP53
29702195	Hedgehog signaling negatively co-regulates BH3-only protein Noxa and TAp73 in TP53-mutated cells.	Cancer Lett		2018 Aug 10	NA	TP53
29582169	Medulloblastoma, WNT-activated/SHH-activated: clinical impact of molecular analysis and histogenetic evaluation.	Childs Nerv Syst		2018 May	NA	TP53
29377550	The FDA approved PI3K inhibitor GDC-0941 enhances inÂ vitro the anti-neoplastic efficacy of Axitinib against c-myc-amplified high-risk medulloblastoma.	J Cell Mol Med		2018 Apr	NA	TP53
29280516	Suppression of STAT3 NH&lt;sub&gt;2&lt;/sub&gt; -terminal domain chemosensitizes medulloblastoma cells by activation of protein inhibitor of activated STAT3 via de-repression by microRNA-21.	Mol Carcinog		2018 Apr	NA	TP53
28427187	RITA displays anti-tumor activity in medulloblastomas independent of TP53 status.	Oncotarget		2017 Apr 25	NA	TP53
1	Cytoplasmic p63 immunohistochemistry is a useful marker for muscle differentiation: an immunohistochemical and immunoelectron microscopic study.	Mod Pathol	6	2011 Oct	NA	TP63
18719857	Zhangfei induces the expression of the nerve growth factor receptor, trkA, in medulloblastoma cells and causes their differentiation or apoptosis.	J Neurooncol	6	2009 Jan	NA	TPM3
18086126	Novel Brn3a cis-acting sequences mediate transcription of human trkA in neurons.	J Neurochem	2	2008 Apr	NA	TPM3
28695340	Tropomyosin receptor kinase C (TrkC) expression in medulloblastoma: relation to the molecular subgroups and impact on treatment response.	Childs Nerv Syst	1	2017 Sep	NA	TPM3
31297057	Antitumor Activities and Cellular Changes Induced by TrkB Inhibition in Medulloblastoma.	Front Pharmacol		2019	NA	TPM3
1	Tuberous sclerosis complex suppression in cerebellar development and medulloblastoma: separate regulation of mammalian target of rapamycin activity and p27 Kip1 localization.	Cancer Res	20	2009 Sep 15	NA	TSC1
19738049	Tuberous sclerosis complex suppression in cerebellar development and medulloblastoma: separate regulation of mammalian target of rapamycin activity and p27 Kip1 localization.	Cancer Res	20	2009 Sep 15	NA	TSC2
11603814	Analysis of the TSC2 gene in human medulloblastoma.	Acta Neuropathol	2	2001 Oct	NA	TSC2
1	[Hypermethylation as a potential prognostic factor and a clue to a better understanding of the molecular pathogenesis of medulloblastoma--results of a genomewide methylation scan].	Klin Padiatr		2001 Jul-Aug	NA	VHL
1	SHH, WNT, and NOTCH pathways in medulloblastoma: when cancer stem cells maintain self-renewal and differentiation properties.	Childs Nerv Syst	12	2014 Jul	NA	WIF1
15696971	Expression of the Wilms' tumor gene product WT1 in glioblastomas and medulloblastomas.	Brain Tumor Pathol	7	2004	NA	WT1
11807803	Expression and mutation analysis of the Wilms' tumor 1 gene in human neural tumors.	Int J Cancer	1	2002 Feb 10	NA	WT1
1	Analysis of transcripts from 17p13.3 in medulloblastoma suggests ROX/MNT as a potential tumour suppressor gene.	Eur J Cancer	8	2004 Nov	NA	YWHAE
